Articles100
Some 50 Business Matching Sessions Support Chinese Mainland Enterprises to Expand Into International Markets HONG KONG - June 28, 2026 (NEWMEDIAWIRE) - The IP Go-Global Business Matching Session, jointly organised by the Intellectual Property Department of the Hong Kong Special Administrative Region (HKSAR) and the Guangdong Administration for Market Regulation (Guangdong Intellectual Property Administration), co-organised by the Hong Kong Trade Development Council (HKTDC) and the Intellectual Property Office of Guangzhou Development District, and supported by the Hong Kong Economic and Trade Office in Guangdong, was held today at Science City in Guangzhou. The event arranged some 50 one-to-one business matching meetings between Guangdong enterprises and Hong Kong IP service providers. It also featured a networking luncheon and a thematic seminar which attracted more than 150 industry participants. The event is aimed at helping Chinese Mainland enterprises expand into international markets by leveraging Hong Kong as their primary launchpad and enhancing Guangdong-Hong Kong collaboration in the intellectual property field and strengthening global competitiveness. In December 2025, the HKTDC and the HKSAR Government jointly organised the 15th Business of IP Asia Forum. A dedicated “IP Go-Global Business Matching Session” was hosted during that forum. Building on the success of last year’s forum, this event serves as one of the key initiatives under the Guangdong-Hong Kong cooperation framework, further reinforcing Hong Kong’s unique role as a “super connector” and “super value-adder” in overall national development. Peter Wong, HKTDC’s Regional Director of Southern China said: “Against the backdrop of the country’s proactive promotion of expansion and its emphasis on high-quality development under the 15th Five-Year Plan, enterprises in Guangdong are actively expanding into overseas markets, driving sustained demand for internationally oriented IP services - particularly in overseas IP protection and dispute resolution. Hong Kong’s legal and intellectual property system aligns with international standards, and with its well-established professional services sector, Hong Kong is positioned to provide value-added, comprehensive support to Mainland enterprises. This enables them to effectively protect their innovations, mitigate operational risks, enhance overall competitiveness, and achieve global expansion.” David Wong, Director of Intellectual Property of the HKSAR Government said: “In the latest World Competitiveness Yearbook 2026, Hong Kong's global competitiveness has risen to second globally. Hong Kong is equipped with the unique advantages of the ‘one country, two systems’ principle, a sound common law system, an international business environment and world-class professional services, and is an ideal platform for Mainland enterprises to expand into overseas markets." The event brought together government representatives, enterprises, and IP professionals from both Guangdong and Hong Kong. Among them was a delegation of around 20 representatives nominated by associations of IP practitioners, including the Asian Patent Attorneys Association Hong Kong Group (APAA), the Hong Kong Chinese Patent Attorneys Association (HKCPAA), the Hong Kong Institute of Patent Practitioners Ltd (HIPP), the Hong Kong Institute of Trade Mark Practitioners (HKITMP), and The Law Society of Hong Kong (Intellectual Property Committee). Their participation in the event highlights Hong Kong’s strengths in international legal and professional services, and consolidates its role as a strategic platform for Mainland enterprises seeking to expand globally. Facilitating some 50 one-to-one business matching sessions between Guangdong enterprises and Hong Kong IP professionals, the event focused on aligning with practical needs, promoting direct exchanges between Guangdong’s innovation & technology, cultural and creative enterprises, and Hong Kong’s IP service providers. The initiative serves a dual purpose: to better understand the key needs of Guangdong enterprises in their global expansion efforts, and to showcase Hong Kong’s diverse IP professional services. The business matching arrangements are designed to enhance collaboration outcomes by establishing a regular exchange and matching platform, strengthening cooperation between the two places in IP protection, utilisation and services, promoting regional innovation and industrial upgrading, and fostering long-term partnerships. In addition to the business matching sessions, the thematic seminar covered key issues related to global expansion, including IP risk management, cross-border dispute resolution, global patent portfolio strategies, and international development approaches. It also introduced Hong Kong’s favourable business environment and relevant support policies, providing forward-looking and practical insights to help enterprises achieve steady growth amid a complex and evolving global landscape. The HKTDC will continue to work closely with stakeholders to promote more cross-border exchange and cooperation platforms, facilitate complementary advantages between Hong Kong and the Mainland in professional services, further strengthen Hong Kong’s position as a regional IP trading centre, and support enterprises in seizing opportunities and expanding internationally. Photo download: https://bit.ly/3R3WisL Media enquiries HKTDC’s Communications & Public Affairs Department Katy Wong Tel: (852) 2584 4524 Email: katy.ky.wong@hktdc.org About HKTDC The Hong Kong Trade Development Council (HKTDC) celebrates its 60th anniversary this year. The HKTDC is a statutory body established in 1966 to promote, assist and develop Hong Kong's trade. With over 50 offices globally, including 13 in the Chinese Mainland, the HKTDC promotes Hong Kong as a two-way global investment and business hub. The HKTDC organises international exhibitions, conferences and business missions to create business opportunities for companies, particularly small and medium-sized enterprises (SMEs), in the mainland and international markets. The HKTDC also provides up-to-date market insights and product information via research reports and digital news channels. For more information, please visit: www.hktdc.com/aboutus. Follow us on @hktdc and LinkedIn
GLENDALE, CA - June 28, 2026 (NEWMEDIAWIRE) - How do you build a museum? One step, one story, and one sacrifice at a time. The Martial Arts History Museum is proud to announce a special book signing event featuring the museum’s esteemed author, founder, and president, Michael Matsuda. The event will take place on July 11, 2026 at 4 pm at the museum. For the very first time, Michael Matsuda shares the deeply personal roadmap of his life within the pages of this highly anticipated 315-page autobiography. This work stands as far more than just a historical record of martial arts; it offers a compelling, first-hand account of the childhood dreams, pivotal life events, and relentless drive that ultimately transformed a visionary concept into a tangible reality. "Warm, insightful, and fiercely dedicated, Michael invites visitors and readers alike to discover the true heart and soul behind the glass cases and cultural displays." As a seasoned martial arts practitioner, teacher, former magazine publisher, and one of the world's leading authorities on martial arts history, Matsuda chronicles his early journey and illustrates how his entire world tied beautifully together to create the Martial Arts History Museum. By the final page, readers will not only understand the man behind the institution but will find themselves inspired to stand alongside him in preserving this vital history for generations to come. In celebration of this landmark release, the event will feature a lineup of special guest speakers who will share their unique relations to the museum and to Michael. Attendees will have the opportunity to purchase signed copies of the autobiography, explore the cultural exhibits, and engage directly with the author. The event will take place at 4 pm at the museum at 201 N. Brand Blvd. B100, Glendale, CA 91203. About the Martial Arts History Museum The Martial Arts History Museum, located in Glendale, CA, is dedicated to preserving the rich history, art, culture, and tradition of martial arts. Through educational displays, cultural artifacts, and community programming, the museum highlights the positive impact of Asian culture and tradition across the globe and its deep connection to cultural heritage. The book is now available on Amazon.
GLENDALE, CA - June 26, 2026 (NEWMEDIAWIRE) - The Martial Arts History Museum is proud to announce the grand opening and ribbon-cutting ceremony for its new permanent Armenian Exhibit. The highly anticipated event will take place this Saturday, June 27, at 4:00 PM at the museum’s Glendale location. Sponsored in part by US Armenia, the celebration highlights the museum’s expanding commitment to cultural diversity and community outreach. The grand opening celebration will feature an exciting live Armenian martial arts demonstration alongside speeches from special dignitaries representing the City of Glendale. Attendees will also enjoy light food and refreshments throughout the afternoon. Founded in 1999, the Martial Arts History Museum relocated to Glendale two years ago. Since the move, the institution has successfully broadened its scope beyond Asian martial arts traditions to encompass a more global perspective. Rather than focusing solely on the physical aspects of combat, the museum centers its mission on exploring the rich art, history, culture, and traditions behind these disciplines. The permanent Armenian Exhibit marks an exciting new chapter for the museum, further enriching its diverse celebration of global cultures. Members of the community, martial arts enthusiasts, and the media are warmly invited to attend and celebrate this cultural milestone. About the Martial Arts History Museum Established in 1999, the Martial Arts History Museum is an educational cultural institution dedicated to preserving and sharing the history, art, and traditions of martial arts from around the world. Through immersive exhibits, community outreach, and special events, the museum highlights the profound cultural impact of martial arts beyond physical combat. The museum is located at 201 N. Brand Blvd., B100, Glendale, CA 91203. This event is free to the public. Contact info: Michael Matsuda Martial Arts History Museum MAmuseum.com 818 355-1109
LOS ANGELES, CA - June 26, 2026 (NEWMEDIAWIRE) - Versus Systems (NASDAQ: VS), a leading provider of gamification and audience engagement technology, has received new attention from the investment community following the initiation of research coverage by Zacks Investment Research, which highlighted the company’s recent operational progress and future growth opportunities (https://nnw.fm/VDBzc). Zacks Investment Research noted progress in the company’s gamification business and potential growth catalysts despite broader industry challenges. A key factor was the company’s unique technology, plus improved first-quarter 2026 financial results, including significantly reduced operating losses and positive operating cash flow. Versus Systems offers a unique technology platform combining interactive gaming, real-world rewards, and advertising experiences designed to increase customer engagement and loyalty. Versus’ Winfinite and Filter Fan Cam products provide opportunities across digital marketing, sports, entertainment, and live-event environments. The company’s relationship with ASPIS and the potential extension of its technology licensing agreement may provide future recurring revenue opportunities. The research assessment comes as Versus continues to refine its business model and expand its audience engagement technology during a period when companies across marketing, sports, and media… Read More Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://IBN.fm/Disclaimer Forward Looking Statements Certain statements in this article are forward-looking, as defined in the Private Securities Litigation Reform Act of 1995. These statements involve risks, uncertainties, and other factors that may cause actual results to differ materially from the information expressed or implied by these forward-looking statements and may not be indicative of future results. These forward-looking statements are subject to a number of risks and uncertainties, including, among others, various factors beyond management's control, including the risks set forth under the heading "Risk Factors" discussed under the caption "Item 1A. Risk Factors" in Part I of the Company's most recent Annual Report on Form 10-K or any updates discussed under the caption "Item 1A. Risk Factors" in Part II of the Company's Quarterly Reports on Form 10-Q and in the Company's other filings with the SEC. Undue reliance should not be placed on the forward-looking statements in this article in making an investment decision, which are based on information available to us on the date hereof. All parties undertake no duty to update this information unless required by law
LOS ANGELES, CA - June 26, 2026 (NEWMEDIAWIRE) - Datavault AI (NASDAQ: DVLT) announced a partnership with 21 In Right Inc., the Clemente family entity that manages the name, image and likeness of Baseball Hall of Famer Roberto Clemente, to apply its data valuation, monetization and digital Twin technologies to preserve and expand Clemente’s legacy. Under the agreement, 21 In Right will use Datavault AI’s platforms to manage and protect Clemente’s NIL rights, create digital Twins and archives, and develop new fan engagement initiatives in collaboration with the Roberto Clemente Foundation and other aligned organizations. The companies also plan to launch a fan activation in Philadelphia beginning in July featuring demonstrations of Datavault AI’s artificial intelligence tools, Clemente-themed digital collectibles and tributes celebrating the baseball legend’s legacy of excellence and community service. To view the full press release, visit https://ibn.fm/Crn7j About Datavault AI Inc. Datavault AI(TM) is leading the way in AI-driven data experiences, valuation and monetization of assets in the Web 3.0 environment. The Company’s cloud-based platform provides comprehensive solutions with a collaborative focus in its Acoustic Sciences and Data Sciences divisions. Datavault AI’s Acoustic Sciences division features WiSA(R), ADIO(R) and Sumerian(R) patented technologies and industry-first foundational spatial and multichannel wireless, high-definition sound transmission technologies with intellectual property covering audio timing, synchronization and multi-channel interference cancellation. The Data Science division leverages the power of Web 3.0 and high-performance computing to provide solutions for experiential data perception, valuation and secure monetization. Datavault AI’s platform serves multiple industries, including high-performance computing software licensing for sports & entertainment, events & venues, biotech, education, fintech, real estate, healthcare, energy and more. The Information Data Exchange(R) enables Digital Twins and the licensing of name, image and likeness by securely attaching physical real-world objects to immutable metadata, fostering responsible AI with integrity. The Company’s technology suite is fully customizable and offers AI- and machine-learning-based automation, third-party integration, detailed analytics and data, marketing automation and advertising monitoring. The Company is headquartered in Philadelphia, PA. Learn more about Datavault AI at https://dvlt.ai. Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://IBN.fm/Disclaimer Forward Looking Statements Certain statements in this article are forward-looking, as defined in the Private Securities Litigation Reform Act of 1995. These statements involve risks, uncertainties, and other factors that may cause actual results to differ materially from the information expressed or implied by these forward-looking statements and may not be indicative of future results. These forward-looking statements are subject to a number of risks and uncertainties, including, among others, various factors beyond management's control, including the risks set forth under the heading "Risk Factors" discussed under the caption "Item 1A. Risk Factors" in Part I of the Company's most recent Annual Report on Form 10-K or any updates discussed under the caption "Item 1A. Risk Factors" in Part II of the Company's Quarterly Reports on Form 10-Q and in the Company's other filings with the SEC. Undue reliance should not be placed on the forward-looking statements in this article in making an investment decision, which are based on information available to us on the date hereof. All parties undertake no duty to update this information unless required by law
Funding Will Accelerate Deployment of a Decentralized Network of Robotic Micro-Depots Designed to Reduce Fleet Downtime and Improve Autonomous Vehicle Economics at Scale SAN FRANCISCO - June 26, 2026 (NEWMEDIAWIRE) - Aseon Labs, the company building a distributed network of robotic pit stops for autonomous vehicle fleets, today announced it has raised $10 million in seed funding led by Crane Venture Partners, with participation from Y Combinator, Expa, the venture firm founded by Uber co-founder Garrett Camp, Robin Hood Ventures, and Founders Capital (Jeremy Hindle). The round also included investments from Adrian Aoun, serial entrepreneur, former Google executive, and technology advisor to The White House; Immad Akhund, founder and CEO of Mercury; Rajat Suri, co-founder of Lyft; and operators and founding team members from Anthropic, Nuro, Turo, Revolut, and other leading companies across mobility, artificial intelligence, and infrastructure. The news was covered exclusively in TechCrunch. Aseon is developing robotic micro-depots that allow autonomous vehicles to charge, clean, inspect, and reset directly within their operating zones. By bringing fleet servicing closer to where vehicles operate, Aseon reduces costly downtime, improves fleet utilization, and gets vehicles back into revenue-generating service faster. Operators have consistently told the company that one of the biggest bottlenecks to scaling autonomous vehicle networks is physical infrastructure. Traditional centralized depots can take one to two years to secure, permit, and build, often requiring high-voltage electrical infrastructure and significant site development, while Aseon's robotic micro-depots can be deployed in as little as one to two days. Acting as distributed edge infrastructure, the network helps fleets launch new markets faster, expand existing operating zones, and serve areas where large centralized depots are impractical or unavailable. The company was founded by the team behind Pushme, a battery-swapping infrastructure network that expanded to more than 5,000 locations across 40 markets and was acquired by Tier Mobility, which later raised more than $600 million in funding. Aseon is applying that experience in infrastructure deployment, site acquisition, and large-scale network operations to what it believes is the next major challenge facing autonomous transportation. While billions of dollars have been invested in making vehicles autonomous, keeping fleets operating efficiently remains a largely unsolved problem. Public California operating data cited by the San Francisco Chronicle shows that approximately 45% of Waymo's miles are driven without a passenger onboard. Those trips can consume up to seven hours per vehicle per day traveling for charging, cleaning, inspections, resets, and maintenance, reducing utilization and increasing operating costs. As fleets expand globally, the cost of charging, servicing, repositioning, and maintaining vehicle availability could become one of the largest operating expenses in the industry. These challenges come as operators continue investing heavily to scale autonomous transportation networks. Alphabet recently reported a $3.6 billion quarterly operating loss in its Other Bets segment, where Waymo represents the company's largest and most heavily funded autonomous vehicle initiative "Autonomous driving is working. The operational model around it is not," said George Kalligeros, Co-Founder and CEO of Aseon Labs. "Today's fleets still spend significant time traveling to and from centralized facilities for servicing. We believe autonomous vehicles need autonomous operations. Instead of vehicles leaving demand centers, the infrastructure comes to them. This funding allows us to accelerate deployment and build the operational foundation required for autonomous transportation to scale." The opportunity extends far beyond today's robotaxi deployments. Goldman Sachs estimates that the global commercial robotaxi fleet will expand from roughly 7,000 vehicles in 2024 to approximately 6 million vehicles by 2035, representing more than 850x growth. When autonomous transportation expands from dozens of markets to thousands of cities worldwide, the infrastructure required to keep those vehicles operating efficiently will become one of the largest value creation opportunities in the sector. Every transformative transportation and technology network required supporting infrastructure. Airlines needed airports. Mobile networks needed cell towers. Cloud computing and AI required data centers. Aseon believes autonomous transportation will require its own servicing infrastructure layer capable of keeping fleets operating continuously at scale. Proceeds from the funding round will be used to accelerate deployment of Aseon's robotic micro-depot network, expand its engineering and robotics teams, and onboard a growing pipeline of real estate partners. Since emerging from stealth, the company has engaged with owners and operators of commercial, mixed-use, and industrial properties interested in hosting Aseon infrastructure. The company is also working directly with several of the autonomous vehicle industry's leading companies and automotive OEMs to address fleet operations at scale. "The autonomous driving problem is increasingly being solved. The autonomous operations problem is not," said Dan Jaeck, Principal at Crane Venture Partners. "As fleets scale, keeping vehicles charged, cleaned, inspected, and in service will become one of the industry's defining challenges. George and Dan have already proven they can build and operate large-scale physical infrastructure networks, and we believe that experience gives Aseon a meaningful advantage. We're excited to support the team as they build the infrastructure layer powering the future of autonomous transportation." About Aseon Labs Aseon Labs is building the robotic pit stop network powering autonomous transportation. Through a decentralized network of robotic micro-depots, the company enables autonomous vehicles to charge, clean, inspect, and reset without leaving their operating zones, reducing downtime, eliminating unnecessary empty miles, and improving fleet economics. Founded by the team that previously built Pushme into a 5,000+ location mobility infrastructure network, Aseon is developing the operational infrastructure required to support the next generation of autonomous vehicle fleets. Contact: Jonathan Phillips Aseon@PhillComm.Global View the original release on www.newmediawire.com
Surging Interest From Indonesian Students Positions XJTLU as a Strategic Choice for International Education JAKARTA - June 26, 2026 (NEWMEDIAWIRE) - Xi’an Jiaotong-Liverpool University (XJTLU), an international joint venture university established through a collaboration between Xi’an Jiaotong University (China) and the University of Liverpool (UK), continues to strengthen its position as a leading global higher education institution, particularly in the Indonesian market. Indonesia has emerged as XJTLU’s largest international market, with approximately 700 Indonesian students currently enrolled. For the upcoming September intake, undergraduate applications from Indonesia have reached over 1,500, accounting for around 38% of total international applications. “Currently, XJTLU has faculty members from more than 60 different countries and regions around the world. Our students also come from nearly 100 different countries and regions, creating a campus environment where they are well accustomed to a diverse, multicultural atmosphere,” said Professor Youmin Xi, Executive President of XJTLU, at a Media Discussion held at DoubleTree Hotel Kemayoran, Jakarta, on Wednesday, 24 June 2026. Professor Xi added, “Our educational model focuses on how we can help students grow with agile thinking and a strong sense of wisdom. They are encouraged to develop a wide range of skills and to collaborate in advancing knowledge. We also support them in cultivating wisdom - the ability to think deeply and act wisely - by integrating knowledge from both Western and Eastern perspectives.” Currently, XJTLU offers more than 100 degree programmes across disciplines, including science, engineering, business, finance, architecture, urban planning, languages, and culture. All programmes are delivered in English, except for general and foundational courses. Undergraduate students graduate with two degrees: an XJTLU degree recognised by China’s Ministry of Education and a globally recognised degree from the University of Liverpool. Postgraduate students are awarded degrees from the University of Liverpool, which is also recognised by the Ministry of Education. All academic departments at XJTLU also offer PhD programmes, supporting the University’s vision to become a research-led international university in China with a distinctive global reputation. Meanwhile, an alumni representative, Tuty Julfa shared her experience studying at XJTLU, saying, “I feel very fortunate to have studied at XJTLU, primarily because it not only strengthened my hard skills but also developed the soft skills essential for my career growth. It’s not just about academics, but also about interpersonal skills and how we cultivate perseverance and resilience. These may seem like simple things, but they play a crucial role in shaping who I am today,” explained Tuty, who is now running a business in the fashion retail sector. As part of its international expansion strategy, XJTLU established its official representative office in Indonesia in 2024. This presence has played a key role in strengthening relationships with prospective students, academic partners, and other stakeholders. In June this year, XJTLU further expanded its recruitment team in Indonesia to enhance services and outreach. XJTLU has also built partnerships with leading educational institutions in Indonesia, including Binus University, Universitas Indonesia, Institut Teknologi Bandung, and Petra Christian University Surabaya. In addition, collaborations extend to education agencies as well as local and international schools. With strong growth momentum in Indonesia, XJTLU continues to reinforce its role as a global gateway for young talents seeking world-class education and international career opportunities. “This year marks the 20th anniversary of our university. The future world requires new pillars - individuals who are able to work alongside AI. From the first year, our students are introduced to what AI is, how to use it, and the ethics surrounding it. In the second year, they begin learning how to apply AI appropriately in subjects such as Mathematics, Engineering, and the Social Sciences. By the third year, they are supported by AI in conducting research to deepen their understanding. We use AI to support education - upgrading, restructuring, and reshaping it. However, we do not aim to use AI to replace education. As long as humanity exists, education will endure. Our philosophy is ‘X plus AI,’ not ‘AI plus X.’ AI is not only about learning, but also about building resilience for the future,” Professor Xi concluded. About Xi’an Jiaotong-Liverpool University (XJTLU) Xi’an Jiaotong-Liverpool University (XJTLU) is an international joint venture university founded by Xi’an Jiaotong University in China and the University of Liverpool in the United Kingdom. It combines the strengths of both prestigious parent institutions and is the largest of its kind approved by China’s Ministry of Education. Located in Suzhou, China, XJTLU offers a beautiful campus environment that blends rich cultural heritage with rapid economic development. Suzhou is one of China’s most advanced cities. XJTLU’s strategic location in the Suzhou Dushu Lake Science and Education Innovation District, within the Suzhou Industrial Park (SIP), provides exceptional access to business networks and industry collaboration opportunities. For more information about XJTLU, please visit: https://www.xjtlu.edu.cn/en For media inquiries, please contact Vionna Fiducia Theja International Media and Communication Team Xi'an Jiaotong-Liverpool University Email: vionna.theja@xjtlu.edu.cn Rahma Anandita PR & Media Consultant The Union Communications Tel: 0815 8593 5835 Email: dita@theunion.co.id
TOKYO, JAPAN and MANILA, PHILIPPINES - June 26, 2026 (NEWMEDIAWIRE) - JCB International Co., Ltd (JCBI), the international operations subsidiary of JCB, Japan’s only international payment brand, has strengthened its presence in the Philippines through a strategic partnership with Philippine National Bank (PNB) with the launch of the new PNB JCB Platinum Credit Card. Developed to address the evolving spending habits of Filipino consumers, the card is designed for individuals who increasingly manage a mix of digital, in-person, and international spending. It supports everyday transactions while offering added convenience for travel and larger purchases, combining rewarding earn rates, flexible payment features, and access to JCB’s extensive network, particularly in Japan and other key destinations. Among the card’s key features is an auto-convert installment option that allows eligible online purchases of at least PHP30,000 to be automatically converted into a three-month installment plan without monthly add-on interest, offering greater flexibility in managing expenses. Designed to make every purchase more rewarding, the PNB JCB Platinum Credit Card enables cardholders to earn rewards points on their everyday transactions. Cardholders receive one point for every PHP70 spent, with an enhanced earn rate of one point for every PHP40 spent in Japan or on transactions billed in Japanese Yen. These rewards can be redeemed as cash credits toward outstanding balances, allowing cardholders to enjoy greater value while benefiting from JCB’s strong connection to Japan and its unique lifestyle experiences. A key differentiator of the card is access to JCB-exclusive privileges and experiences. Cardholders can enjoy entry to select overseas airport lounges, access to JCB’s multilingual concierge service while traveling, and exclusive benefits in Japan. “We developed this card with our customers’ day-to-day needs in mind - from managing purchases more easily to making the most of travel opportunities,” said Edwin R. Bautista, President and CEO of PNB. “Our continued partnership with JCB allows us to offer features that are practical, accessible, and relevant to how people spend today.” “Through this partnership, PNB JCB Cardholders can look forward to a more rewarding journey,” said Masaki Yokawa, President and CEO of JCB International Co., Ltd. “Beyond earning rewards points faster, cardholders will gain access to exclusive JCB privileges - from airport lounge access and curated dining offers to merchant promotions across the country. These benefits reflect our commitment to delivering elevated experiences that combine convenience, prestige, and Japanese hospitality.” The card is designed for today’s consumers whose spending spans digital payments, dining, and travel, reflecting broader shifts in consumer behavior. Its features are intended to complement these patterns by combining flexibility with rewards and access. JCB has established a strong global footprint, working closely with financial institution partners to provide secure, innovative payment solutions and distinctive cardholder benefits, with a particular focus on enhancing the travel experience. The launch was commemorated through a ceremonial signing held on May 19, 2026, attended by executives from JCBI and PNB, reaffirming the organizations’ shared commitment to delivering innovative payment solutions and enhanced value to Filipino consumers. The event marked a significant milestone in the partnership between the two institutions as they continue to respond to the evolving financial and lifestyle needs of Filipino consumers. About JCB JCB is a major global payment brand and a leading credit card issuer and acquirer in Japan. JCB launched its card business in Japan in 1961 and began expanding worldwide in 1981. Its acceptance network includes about 72 million merchants around the world. JCB Cards are now issued mainly in Asian countries and territories, with more than 181 million cardmembers. As part of its international growth strategy, JCB has formed alliances with hundreds of leading banks and financial institutions globally to increase its merchant coverage and cardmember base. As a comprehensive payment solution provider, JCB commits to providing responsive and high-quality service and products to all customers worldwide. For more information, please visit: http://www.global.jcb/en/ About Philippine National Bank Philippine National Bank is one of the country’s largest private universal banks in terms of assets and deposits. It provides a full range of banking and other financial services to its highly diverse clientele comprised of individual depositors, small and medium enterprises, domestic and international corporations, government institutions, and overseas Filipinos. Backed by over a century of stability and excellence, PNB looks forward to more years of serving its customers. To know more about PNB, visit its official website: www.pnb.com.ph Contact Anna Takeda Corporate Communications Tel: +81-3-5778-8353 Email: jcb-pr@info.jcb.co.jp
Collaboration Inspired by Families' Lived Experiences Aims to Reduce Barriers to Advanced Cardiac Imaging and Ensure No Parent Faces Impossible Decisions When Seeking Answers About Their Child's Heart TORONTO, ONTARIO - June 26, 2026 (NEWMEDIAWIRE) - Ventripoint Diagnostics Ltd. ("Ventripoint" or the "Company"), (TSXV:VPT; OTC:VPTDF), a pioneer in advanced cardiac imaging, today announced a strategic collaboration with Ollie Hinkle Heart Foundation (OHHF) to expand access to AI-powered cardiac imaging and clinical decision-support technology for children and adults living with congenital and childhood-onset heart disease. The collaboration combines Ventripoint's AI-powered VMS+™ cardiac imaging platform with OHHF's Take Heart Collective Impact Model, which brings together healthcare providers, innovators, researchers, patients, families, and social partners - including Jovie's Joy and Ella's Umbrella - to accelerate innovation and improve outcomes for children and families impacted by heart disease. As part of the collaboration, OHHF will initially provide financial support enabling the placement of two VMS+™ systems within its healthcare partner network and further opportunities for education, advocacy, research, technology adoption, and community engagement initiatives. Ventripoint's VMS+™ platform uses artificial intelligence and advanced cardiac modeling to provide clinicians with highly accurate measurements of heart structure and function from a standard echocardiogram. By delivering sophisticated cardiac insights in a more accessible and efficient way, VMS+™ enhances clinical decision-making, supports ongoing patient monitoring, and expands access to advanced cardiac assessment across a wide range of heart conditions. "Improving outcomes for people living with heart disease begins with access to accurate, timely, and affordable cardiac imaging," said Joe Hostetter, Director of the Congenital Heart Disease Program at Ventripoint Diagnostics. "Ollie Hinkle Heart Foundation has become a respected leader in bringing together families, clinicians, healthcare systems, and innovators to solve complex challenges facing children and families impacted by heart disease. Together, we have an opportunity to expand access to advanced imaging solutions that help clinicians make more informed decisions and improve care throughout a patient's journey." The partnership is rooted not only in technology but in the lived experiences of families who understand firsthand the importance of better information, safer testing options, and more informed treatment decisions. "As a mother of a child living with dilated cardiomyopathy, I know firsthand the impossible decisions families can face when trying to get answers about their child's heart," said Katie Nesselbush, Founder of Jovie's Joy and Social Partner of Ollie Hinkle Heart Foundation. "Technologies like Ventripoint give physicians more information to guide care while reducing barriers and risk for families. Every parent wants confidence that they're making the best possible decisions for their child, and every child deserves access to the most advanced tools available." "When our son Ollie passed away at just 13 months old, we learned firsthand how quickly a child's condition can change," said Mark Hinkle, Co-Founder of Ollie Hinkle Heart Foundation. "We can't change Ollie's story, and we can't bring Ella back. But we can honor them by ensuring more children have access to the technology, information, and treatment options they never had. That's the future we're building through the Take Heart Collective Impact Model." Together, Ventripoint, Ollie Hinkle Heart Foundation, Jovie's Joy, and Ella's Umbrella are demonstrating how lived experience and innovation can work hand in hand to expand access to advanced cardiac imaging and innovative technologies for children living with heart disease. About Ventripoint Diagnostics Ltd. Ventripoint Diagnostics Ltd. (TSXV: VPT, OTCQB: VPTDF) has become an industry leader in the application of AI (Artificial Intelligence) to echocardiography. Ventripoint's VMS products are powered by its proprietary Knowledge Based Reconstruction technology, which is the result of a decade of development and provides accurate volumetric cardiac measurements equivalent to MRI. This affordable, gold-standard alternative allows cardiologists greater confidence in the management of their patients. Providing better care to patients serves as a springboard and basic standard for all of Ventripoint's products that guide our future developments. In addition, VMS+ is versatile and can be used with all ultrasound systems from any vendor supported by regulatory market approvals in the U.S., Europe and Canada. For more information, visit www.ventripoint.com. About the Ollie Hinkle Heart Foundation Ollie Hinkle Heart Foundation (OHHF) is transforming pediatric heart care through its Take Heart Collective Impact Model, aligning healthcare systems, innovators, researchers, nonprofits, patients, families, and community partners to accelerate innovation, address unmet needs, and improve outcomes for children and families impacted by heart disease. For more information, visit www.ohhf.org Media Contact Ventripoint Diagnostics Ltd. Hugh MacNaught hmacnaught@ventripoint.com (604) 671-4201 Media Contact Ollie Hinkle Heart Foundation Jennifer Hinkle President & Co-Founder jennifer@ohhf.org www.ohhf.org Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this news release. Forward Looking Statements This news release contains forward-looking statements and forward-looking information within the meaning of applicable securities laws. The use of any of the words "expect", "anticipate", "continue", "estimate", "objective", "ongoing", "may", "will", "project", "should", "believe", "plans", "intends'' and similar expressions are intended to identify forward-looking information or statements. The forward-looking statements and information are based on certain key expectations and assumptions made by the Company. Although the Company believes that the expectations and assumptions on which such forward-looking statements and information are based are reasonable, undue reliance should not be placed on the forward-looking statements and information because the Company can give no assurance that they will prove to be correct. Since forward-looking statements and information address future events and conditions, by their very nature they involve inherent risks and uncertainties. Actual results could differ materially from those currently anticipated due to several factors and risks. Factors which could materially affect such forward-looking information are described in the risk factors in the Company's most recent annual management's discussion and analysis that is available on the Company's profile on SEDAR at www.sedar.com. Readers are cautioned that the foregoing list of factors is not exhaustive. The forward-looking statements included in this news release are expressly qualified by this cautionary statement. The forward-looking statements and information contained in this news release are made as of the date hereof and the Company undertakes no obligation to update publicly or revise any forward-looking statements or information, whether because of new information, future events or otherwise, unless so required by applicable securities laws. View the original release on www.newmediawire.com
VANCOUVER, BRITISH COLUMBIA - June 26, 2026 (NEWMEDIAWIRE) - Western Star Resources Inc. (CSE: WSR) (OTC: WSRIF) (FRA: 4K2) (the "Company" or "Western Star") announces that the Canadian Securities Exchange ("CSE") has accepted the Company's notice of intention to commence a normal course issuer bid ("NCIB"). Under the NCIB, the Company may purchase for cancellation up to 3,842,295 common shares of the Company, being 10% of the Company’s public float, during the twelve-month period commencing July 2, 2026 and ending July 2, 2027, or such earlier date as the Company completes its purchases pursuant to the NCIB. Purchases under the NCIB may be made through the facilities of the CSE and/or alternative Canadian trading systems at prevailing market prices, in accordance with applicable securities laws and CSE policies. All common shares purchased under the NCIB will be cancelled. As set out in the NCIB, the Company has appointed Haywood Securities Inc. as its purchasing dealer and trader for the purposes of carrying out the NCIB. The Board of Directors and management of the Company believe that, from time to time, the market price of the Company's common shares may not adequately reflect their underlying value. Accordingly, the Company believes that the repurchase of common shares under the NCIB represents an appropriate use of available financial resources and is in the best interests of the Company and its shareholders. The timing and amount of any purchases under the NCIB will be determined by management, subject to applicable laws, market conditions, and CSE requirements. The Company is not obligated to acquire any specific number of common shares under the NCIB, and purchases may be suspended or discontinued at any time. About Western Star Resources Western Star Resources is an emerging junior mineral exploration company focused on revitalizing North America's tungsten supply. The company is advancing its entry into the U.S. market through the acquisition of a past-producing tungsten mine in Nevada -- one of America's most important historic tungsten districts. With this strategic move, Western Star is positioning itself to play a leading role in re-establishing a secure, domestic source of this critical mineral. The company also owns nine non-surveyed contiguous mineral claims totalling 4,740 hectares, which are located within the Revelstoke mining division of British Columbia. The Western Star property group is located approximately 50 kilometres southeast of Revelstoke, B.C., and roughly 10 kilometres north of the abandoned community of Camborne. Contact Information: Blake Morgan CEO and Director blake@acvc.vc Neither the Canadian Securities Exchange nor its Regulation Services Provider (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this press release. View the original release on www.newmediawire.com
MONTEREY PARK, CA - June 26, 2026 (NEWMEDIAWIRE) - Focus Universal Inc. (Nasdaq: FCUV) today formally continued to introduce further facets of proprietary Deterministic AI platform: a new class of artificial intelligence as a distinct category of enterprise artificial intelligence systems designed for execution of complex, compliance-driven business workflows with consistent, verifiable, and repeatable outcomes. Artificial Intelligence can be broadly divided into two categories: non-deterministic AI, which includes generative AI based on large language models, and deterministic AI, which is designed to execute known workflows with precision, consistency, and predictability. Businesses frequently encounter problems where the optimal solution is not immediately known. Generative AI excels in these situations by helping users explore alternatives, generate ideas, and identify potential solutions. Once the optimal solution or workflow has been determined, the challenge shifts from discovery to execution: how to automate the process, minimize human involvement, eliminate repetitive work, and maximize productivity. This is where Deterministic AI creates value. Organizations do not need to discover the best solution every day, but they do need to execute their workflows every day. As a result, Deterministic AI has the potential to become a daily operational tool that continuously improves efficiency, consistency, and productivity across an organization. Unlike generative AI, which relies on massive training datasets, substantial computational resources, and significant infrastructure investments, Deterministic AI is fundamentally rule-driven. It learns and applies a defined set of business rules, procedures, and relationships that only need to be established once. Because it does not depend on training enormous models, Deterministic AI generally requires significantly less computing power and infrastructure. In a Deterministic AI system, human actions are replaced by continuous electronic actions. Tasks that previously required manual effort can be performed automatically, repeatedly, and consistently. Depending on the application, efficiency gains may be measured in multiples of hundreds or even thousands of times compared to traditional manual processes. The capital required to deploy such systems can be relatively modest, while the potential return on investment may be substantial. This represents one of the fundamental distinctions between deterministic AI and generative AI. Today, generative AI is primarily applied to individual tasks or limited portions of a business process. Deterministic AI is designed to automate complete end-to-end workflows. Consider SEC financial reporting as an example: producing an SEC filing requires the integration of professional accounting expertise, public-company CFO knowledge, Edgarization procedures, XBRL tagging requirements, securities law considerations, and auditing standards. The overall workflow consists of hundreds of thousands of heterogeneous sub-tasks, decisions, validations, and cross-references. Such complexity makes traditional coding-based automation extremely difficult and often impractical. An important distinction is that SEC financial reporting is not a completely standardized process. Reporting requirements, disclosures, accounting treatments, business structures, and transaction types vary significantly from company to company. Despite this variability, our deterministic AI platform is designed to adapt to these differences and automatically apply the appropriate rules, workflows, and regulatory requirements for each reporting entity. At the same time, it is equally challenging to provide a generative AI model with sufficiently complete and accurate inputs to consistently produce correct outputs for every sub-task. Even if a generative AI model is capable of performing individual tasks within the process, its inherently non-deterministic nature makes it difficult to guarantee the consistency, repeatability, and auditability required for regulatory reporting. Generative AI often requires substantial user interaction, prompt engineering, corrections, and refinements before reaching an acceptable result. Deterministic AI approaches the problem differently. The domain knowledge, business logic, workflows, validation rules, and decision-making processes are embedded directly into the system. As a result, user input requirements are significantly reduced, and outputs become predictable, repeatable, and auditable. Deterministic AI does not compete directly with generative AI. Rather, it complements generative AI by focusing on the automation of professional workflows traditionally performed by skilled human workers. Focus Universal did not invest billions of dollars to build its deterministic AI platform, as many organizations have done with large language models. Developing deterministic AI requires a different type of investment: deep domain expertise, extensive workflow analysis, and years of engineering effort to model and automate complex business processes. The Company are grateful for the patience of our shareholders and the dedication of our engineering team throughout this development journey. While building a Deterministic AI engine is challenging and time-consuming, the Company believes that once the foundational architecture and methodology have been established, expansion into additional applications can occur much more rapidly. The Company believes the Company now possesses a comprehensive understanding of deterministic AI architecture and implementation. As a result, the Company are confident that this technology can be extended into additional workflow-intensive industries, including accounting, tax return preparation, insurance, medical billing, logistics, medical billing, insurance processing, and data-entry automation. The Company also expects to commercialize our SEC financial reporting automation platform for both public companies and filing agents during the third quarter of 2026. The efficiency gains delivered by Deterministic AI may initially sound too good to be true. For example, a complex SEC financial report that historically required years of accumulated professional experience and months of manual preparation may potentially be completed in minutes. Such claims can appear extraordinary at first glance. However, when the nature of SEC financial reporting is examined closely, the process consists largely of validating, organizing, cross-referencing, calculating, and presenting thousands of financial facts and disclosures according to established rules and regulatory requirements. These are precisely the types of repetitive, rule-based operations that computers perform exceptionally well. Most modern AI agents are built on top of large language models and are therefore generally non-deterministic. Deterministic AI serves a different purpose. When a workflow is fully understood, clearly defined, and governed by established rules, deterministic AI can automate the process with a level of speed, consistency, scalability, and reliability that is difficult to achieve through human effort alone. Although the Company has not yet generated meaningful revenue from our Deterministic AI platform, management believes the underlying technology represents a highly valuable intellectual asset. Our SEC financial reporting automation software is currently in the final stages of refinement and optimization based on feedback from accounting, legal, auditing, and filing professionals. The Company believes Deterministic AI represents a new class of artificial intelligence that has not yet been widely recognized or understood by the marketplace. As awareness grows regarding the distinction between solution discovery and workflow execution, the Company believes deterministic AI has the potential to become a transformative technology for automating professional business processes across multiple industries. “Much of the current discussion around artificial intelligence is focused on systems that help users generate content or explore possible solutions,” said Desheng Wang, Chief Executive Officer of Focus Universal. “The Company believes there is a separate and important enterprise need for systems designed to execute known workflows with consistency, traceability, and repeatable results. Our Deterministic AI platform is intended to address that need by automating complex, rule-based processes that have traditionally required significant professional time and manual effort, beginning with SEC financial reporting and potentially extending into other compliance-oriented workflows.” About Focus Universal: Focus Universal Inc. is a provider of patented hardware and software design technologies for Internet of Things (IoT) and 5G. The company has developed five disruptive patented technology platforms with 26 patents and patents pending in various phases and 8 trademarks pending in various phases to solve the major problems facing hardware and software design and production within the industry today. These technologies combined to have the potential to reduce costs, product development timelines and energy usage while increasing range, speed, efficiency, and security. Focus currently trades on the Nasdaq Capital Markets. Forward-Looking Statements: Statements in this press release about future expectations, plans and prospects, as well as any other statements regarding matters that are not historical facts, may constitute "forward-looking statements" within the meaning of The Private Securities Litigation Reform Act of 1995. The words "anticipate," "believe," "continue," "could," "estimate," "expect," "intend," "may," "plan," "potential," "predict," "project," "should," "target," "will," "would" and similar expressions are intended to identify forward-looking statements, although not all forward-looking statements contain these identifying words. Actual results may differ materially from those indicated by such forward-looking statements as a result of various important factors, including: the uncertainties related to market conditions and the completion of the public offering on the anticipated terms or at all, and other factors discussed in the "Risk Factors" section of the preliminary prospectus filed with the SEC. Any forward-looking statements contained in this press release speak only as of the date hereof and Focus Universal specifically disclaims any obligation to update any forward-looking statement, whether because of new information, future events or otherwise. For investor and media inquiries, please contact: Investor Relations 626-272-3883 ir@focusuniversal.com View the original release on www.newmediawire.com
Key Highlights: Smart City Solutions and Green Tech Boost Innovation Within Hong Kong's Start-up Ecosystem HONG KONG - June 25, 2026 (NEWMEDIAWIRE) - The ninth edition of Start-up Express, organised by the Hong Kong Trade Development Council (HKTDC), successfully concluded its Final Pitching Day today, with 10 winning start-ups emerging from the competition. The winning start-ups span sectors including smart city solutions, green tech and health tech, reflecting growing momentum among Hong Kong start-ups in translating innovative technologies into practical applications. The ESG Award was presented to BioZein Technology Corporation Limited in recognition of its outstanding commitment to sustainability and social impact, while Homing Therapeutics Limited received the My Favourite Start-up Award. The 10 winning start-ups will next participate in a series of local and overseas business events organised by the HKTDC which provides opportunities to build capability and connections, explore markets, seek business and funding partners, and enhance brand awareness. The HKTDC has long been committed to fostering the growth of start-ups by actively providing platforms that help them raise market visibility and expand into Chinese Mainland and international markets, to further promote Hong Kong’s strengths as an international innovation and technology hub. HKTDC Assistant Executive Director Anna Cheung said: “When we launched Start-up Express in 2018, we had one simple goal: to help Hong Kong start-ups grow and flourish. Since then, we have supported 80 start-ups in building capacity, enhancing their visibility, making connections, finding new partners and investors and seizing opportunities and markets previously out of their reach. We champion Hong Kong’s brightest startups by connecting them to the world to scale and succeed. Proudly, we stand with our winners every step of the way, unlocking partnerships, investment, and the power to build a global brand.” Ten winning start-ups were selected, with the majority operating in the fields of smart city solutions, alongside a number of ventures specialising in green tech, health tech and med tech, highlighting the increasing diversity of innovation and technology solutions and their growing adoption across a wide range of industries and everyday applications. This year’s Start-up Express Final Pitching Day attracted more than 200 industry participants, including investors and business leaders. Booths were also set up during the event to enable the Start-up Express finalists to showcase their businesses to all attendees and participants, fostering networking and collaboration opportunities. The 20 Start-up Express finalists took to the stage today to present their innovative business ideas and answer questions raised by the judging panel. Following the selection process, the 10 start-ups were announced as winners: Alpha AI Technology Limited, BioZein Technology Corporation Limited, GABES Limited, Hay-koze Limited, Homing Therapeutics Limited, Muuse Limited, O-Spheres Limited, PetWell HK Limited, PregnaSense Co. Limited and Pyramid AI Limited. The HKTDC will arrange a series of exposure opportunities for the winning teams to interact with potential investors, buyers and partners, helping them expand their business networks and capture opportunities in both local and global markets. Judges commend start-ups for embracing emerging technology trends One of the judges, Jimmy Tao, Chairman of the Hong Kong Startup Council, said: “The quality of participating start-ups continues to improve year after year. Many of this year’s finalists have successfully integrated artificial intelligence and other innovative technologies into practical applications, demonstrating strong commercial potential. Hong Kong’s start-up ecosystem has continued to flourish in recent years, with the number of start-ups reaching a record high. Last year, the total increased 11% year-on-year to 5,221, reflecting the city’s growing appeal to global entrepreneurs and reinforcing its position as an ideal destination for business and investment. Through the Start-up Express platform, this year’s winners will be well placed to expand into new markets while gaining valuable opportunities to build networks and accelerate growth.” Start-up Express helps start-ups expand markets and commercialise innovation Taranjit Singh, Chief Technology Officer of Entoptica, one of the 10 winning start-ups of Start-up Express 2025 and the world’s first start-up to apply quantum technology to vision science, said: “Start-up Express provided valuable opportunities to connect with investors and industry mentors, helping us secure funding to advance clinical trials and expand production capacity. Participation in HKTDC events has also enabled us to broaden our network within the ophthalmic healthcare sector.” He added that participation in CES 2026 in the United States in January this year, a participation led by the HKTDC, enabled the company to establish connections with potential partners, manufacturers and investors from Shanghai, Japan and the United States. The company also successfully sold two prototype products at US$100,000 each, achieving pricing and overall results that exceeded its expectations. Start-up Express International supports overseas start-ups to establish a presence in Hong Kong In addition to promoting local innovation and technology ventures, the HKTDC is committed to strengthening exchanges between Hong Kong and overseas start-up ecosystems, further reinforcing Hong Kong’s competitive edge as a leading innovation and technology hub in Asia. Since the launch of Start-up Express International in 2022, the competition has attracted start-ups from around the world over four editions, including participants from Chinese Mainland, Australia, France, Germany, the United Kingdom, Italy, Singapore, Thailand, Vietnam, the United Arab Emirates and the United States. The fifth edition of Start-up Express International will be held during Entrepreneur Day in December this year, providing winning overseas start-ups with support to establish a presence in Hong Kong and leverage the city as a gateway to explore opportunities in the Guangdong-Hong Kong-Macao Greater Bay Area and international markets. Start-up Express: https://portal.hktdc.com/startupexpress/en/ The 20 finalists: https://portal.hktdc.com/startupexpress/en/s/Top-20 Photo download: https://bit.ly/4wu3EFd HKTDC Media Room: https://mediaroom.hktdc.com/en Media enquiries HKTDC’s Communications & Public Affairs Department Noah Qiu Tel: (852) 2584 4575 Email: noah.yl.qiu@hktdc.org Johnny Tsui Tel: (852) 2584 4395 Email: johnny.cy.tsui@hktdc.org Clayton Lauw Tel: (852) 2584 4472 Email: clayton.y.lauw@hktdc.org About HKTDC The Hong Kong Trade Development Council (HKTDC) celebrates its 60th anniversary this year. The HKTDC is a statutory body established in 1966 to promote, assist and develop Hong Kong's trade. With over 50 offices globally, including 13 in the Chinese Mainland, the HKTDC promotes Hong Kong as a two-way global investment and business hub. The HKTDC organises international exhibitions, conferences and business missions to create business opportunities for companies, particularly small and medium-sized enterprises (SMEs), in the mainland and international markets. The HKTDC also provides up-to-date market insights and product information via research reports and digital news channels. For more information, please visit: www.hktdc.com/aboutus.
HKTDC's Response to Hong Kong's May Export Figures HONG KONG - June 25, 2026 (NEWMEDIAWIRE) - Hong Kong’s merchandise exports rose by 40.8% year-on-year to HK$611.2 billion in May, according to data released today by the Census and Statistics Department. For the first five months of 2026, total exports of goods reached HK$2,776.6 billion, representing robust growth of 36.2% compared with the same period last year. “Hong Kong’s export performance continues to be underpinned by robust electronics demand, fueled by the ongoing surge in artificial intelligence (AI) adoption worldwide,” said Bruce Pang, Director of Research at the Hong Kong Trade Development Council. Market sentiment improved somewhat following the Xi-Trump meeting in Beijing in mid-May, though concerns over the Middle East conflict lingered. Looking ahead, the tentative easing of tensions after the US–Iran MoU signed in mid-June - despite potential volatility - together with softer oil prices, is expected to positively impact business prospects. “Overall, Hong Kong’s trade outlook will continue to hinge on several factors, including the technology upcycle, geopolitical developments, energy prices and global end-market demand,” Mr Pang added. HKTDC Research will unveil its latest export forecast at a press conference on Monday, 29 June. HKTDC Media Room: https://mediaroom.hktdc.com/en Media enquiries Please contact the HKTDC’s Communications & Public Affairs Department: Jane Cheung Tel: (852) 2584 4137 Email: jane.mh.cheung@hktdc.org About HKTDC The Hong Kong Trade Development Council (HKTDC) celebrates its 60th anniversary this year. The HKTDC is a statutory body established in 1966 to promote, assist and develop Hong Kong's trade. With over 50 offices globally, including 13 in the Chinese Mainland, the HKTDC promotes Hong Kong as a two-way global investment and business hub. The HKTDC organises international exhibitions, conferences and business missions to create business opportunities for companies, particularly small and medium-sized enterprises (SMEs), in the mainland and international markets. The HKTDC also provides up-to-date market insights and product information via research reports and digital news channels. For more information, please visit: www.hktdc.com/aboutus. View the original release on www.newmediawire.com
Exhibiting Start-ups Attract Recognition, Demonstrating Hong Kong's Innovation and Technology Strength HONG KONG - June 25, 2026 (NEWMEDIAWIRE) - Viva Technology (VivaTech) 2026, the annual technology and start-up extravaganza, successfully concluded in Paris, France last week. The Hong Kong Trade Development Council (HKTDC), together with strategic partner the Hong Kong Economic and Trade Office in Brussels (Brussels ETO), and supporting organisations including Hong Kong Science and Technology Parks Corporation (HKSTP), The Hong Kong Polytechnic University, Hong Kong Productivity Council (HKPC), The Hong Kong University of Science and Technology, and Cyberport, hosted the Hong Kong Tech Pavilion to showcase innovative solutions from 24 local innovation and technology (I&T) enterprises and institutions to global investors and industry players. During the exhibition, a series of thematic seminars, start-up pitching sessions and networking events were held to facilitate industry exchanges and business matching, helping local start-ups seize opportunities in the European market and deepen their international collaboration networks. HKTDC’s Chris Lo, Regional Director, Europe, Central Asia & Israel, stated: “VivaTech 2026's Hong Kong Tech Pavilion has achieved excellent results once again this year, facilitating multiple cross-border collaborations. We are pleased to see that some of these outcomes have gradually come to fruition from connections and exchanges initiated last year. Through its participation in overseas promotional platforms, the HKTDC has been helping local start-ups build networks and increase their exposure in international markets, creating collaboration opportunities for them and supporting their expansion into global markets, thereby injecting sustained momentum into Hong Kong's innovation and technology development." The participating start-ups and institutions included Formwork IO, which specialises in developing carbon-negative construction materials and sustainable solutions, which was selected as one of the top 30 finalists for VivaTech's "Tech for Change" Award. Tech for Change recognises start-ups that leverage innovative technology to drive positive impact for the environment, society or health, with an emphasis on the parallel pursuit of impact and commercial value. The finalists were selected from exhibiting start-ups worldwide based on their high growth potential. Additionally, from numerous startups and institutions worldwide, the organiser selected two Hong Kong Tech Pavilion I&T companies including PointFit Technology, a developer of wearable health monitoring and smart sports solutions, and Robocore Technology Limited, which develops globally leading open-platform service robot solutions, to give live demonstrations at VivaTech's Discovery Stage to buyers and investors around the world. These achievements fully demonstrate the innovative capabilities and international competitiveness of Hong Kong startups in health technology, artificial intelligence, and other fields. Forging cross-regional collaborations with fruitful results Several participating companies successfully established connections with European investors, large enterprises and industry partners, and commenced business discussions, laying the groundwork for subsequent cooperation. Among them, Robocare Technology is in negotiations with JCDecaux, a France-based multinational outdoor advertising company, for a cooperation agreement that will provide 1,000 robots to JCDecaux for marketing campaigns. Robocore Technology first connected with JCDecaux at the Hong Kong Tech Pavilion at VivaTech last year. Its CEO, Lim Long-hei, said: "Leveraging the business connections we have built through the Hong Kong Tech Pavilion at VivaTech over the past two years, we hope to further deepen our collaboration with European multinational corporations, achieve greater market share, and attain rapid business growth in Europe and beyond." Additionally, LeafIoT Technology Limited signed a Memorandum of Understanding with the Lecco Campus of Politecnico di Milano to further advance their cooperation and accelerate the pace of expanding into the European market. LeafIoT Technology specialises in developing smart tree monitoring solutions. The two parties will collaborate in talent cultivation and technological innovation, jointly promoting the application and market expansion of AI algorithms and remote sensing technology in enhanced tree monitoring and health assessment. LeafIoT Technology's innovative solutions have successfully attracted international partnership interest. Its Managing Director, Chan Pak-kwan, said: "We hope to extend Hong Kong's industry-university-research model further into Europe, while promoting the R&D achievements of Hong Kong institutions, and deepening collaboration with European academic institutions, thereby achieving five- to ten-fold business growth." During VivaTech, the HKTDC hosted a series of seminars, start-up pitching sessions, and networking events to facilitate in-depth exchanges between investors and start-ups. The Special Representative for Hong Kong Economic & Trade Affairs to the European Union, Shirley Yung, attended the thematic seminar and networking event titled "Building Resilient Tech Ecosystems: Powering the Next Wave of International Tech Leadership from Hong Kong" on 19 June. In Yung’s speech, she said Hong Kong's innovation ecosystem brings together four powerful advantages: top-tier research and talent, deep pools of global capital, unparalleled access to the Guangdong-Hong Kong-Macao Greater Bay Area innovation cluster, and strong connectivity to global markets, providing businesses with a comprehensive platform to innovate, scale up and expand into the Asian and global markets. The subsequent discussion session revolved around the strengths of Hong Kong's innovation and technology ecosystem, and how to leverage Hong Kong as a springboard to explore international markets. Chief Executive Officer, Terry Wong from HKSTP shared that Hong Kong, with familiar frameworks in regulations, research and development excellence, enables a common ground for Europe companies to explore the vast market opportunities in the East; while Chief Innovation Officer, Yonghai Du from HKPC pointed out that Hong Kong possesses significant advantages in research capabilities and attracting international investment, including technical support to ensure that enterprise products meet international testing standards, thereby helping businesses successfully go global and expand into international markets. The HKTDC is actively working with local enterprises to participate in major international technology exhibitions, assisting start-ups to expand into overseas markets and increase opportunities to connect with international investors and buyers. Following the Consumer Electronics Show (CES 2026) in Las Vegas, USA in January this year, the Mobile World Congress (MWC), and ‘4 Years From Now’ (4YFN) exhibition dedicated to tech start-ups held in Barcelona, Spain in March, the HKTDC once again organised the Hong Kong Tech Pavilion at VivaTech, providing a platform for start-ups to showcase their innovative achievements and connect with international funding. The 10th VivaTech attracted participants from over 165 countries and regions worldwide, with more than 15,000 global start-ups and 200,000 visitors, making it one of the most important events in the global technology ecosystem. Hong Kong Tech Pavilion at VivaTech is a flagship initiative under the "Economic and Trade Express" in Europe, Brussels ETO, HKTDC and InvestHK also jointly organised a series of other promotional and networking events to provide targeted support to the participating Hong Kong tech start-ups in exploring the local market, including pitching sessions, thematic seminars, and other networking activities. List of 24 Start-ups and institutions at the Hong Kong Tech Pavilion: Category Company Name 1. Sustainable & Climate Technology Albacastor Technology Limited 2. AIGreen Limited 3. Asgard Group Limited 4. Formwork IO 5. Green Vigor Limited 6. Laputa Eco-Construction Material Company Limited 7. LeafIoT Technology Limited 8. Plasticvore Chain Ltd 9. AI and Software Solutions Cogniser Infotech Ltd 10. D-Engraver Limited 11. Midas Analytics Limited 12. OxGen Holdings Limited 13. Pantheon Lab Limited 14. SagaDigits Limited 15. Robotics and Microelectronics Technology Anlaseo Technology Limited 16. Bacbudy Limited 17. Cybercrystal Technology Co., Limited 18. Harmony SkyTech Limited 19. Oriental Materials Hong Kong Limited 20. Robocore Technology Limited 21. Health Technology Eieling Technology Limited 22. Hong Kong Bionic Beet Robotics Limited 23. PointFit Technology Limited 24. University The Hong Kong Polytechnic University Photo download: https://bit.ly/3SXwgb4 Websites: https://vivatech.com/exhibitors/hktdc-hong-kong-trade-development-council Media enquiries For enquiries, please contact HKTDC’s Communications & Public Affairs Department: Winnie Kan Tel: (852) 2584 4055 Email: winnie.wy.kan@hktdc.org Media Room: http://mediaroom.hktdc.com About HKTDC The Hong Kong Trade Development Council (HKTDC) celebrates its 60th anniversary this year. The HKTDC is a statutory body established in 1966 to promote, assist and develop Hong Kong's trade. With over 50 offices globally, including 13 in the Chinese Mainland, the HKTDC promotes Hong Kong as a two-way global investment and business hub. The HKTDC organises international exhibitions, conferences and business missions to create business opportunities for companies, particularly small and medium-sized enterprises (SMEs), in the mainland and international markets. The HKTDC also provides up-to-date market insights and product information via research reports and digital news channels. For more information, please visit: www.hktdc.com/aboutus.
EDEN PRAIRIE, MINN. - June 25, 2026 (NEWMEDIAWIRE) - NeuroOne Medical Technologies Corporation (Nasdaq: NMTC) ("NeuroOne" or the "Company"), a medical technology company dedicated to transforming the surgical diagnosis and treatment of neurological disorders, today announced that, effective June 24, 2026, its independent directors approved an equity award under NeuroOne’s 2021 Inducement Plan (the “Inducement Plan”), as a material inducement to an individual entering into employment with the Company. The equity award was approved in accordance with Nasdaq Listing Rule 5635(c)(4), which requires a public announcement of equity awards that are not made under a stockholder approved equity plan. In connection with entering into employment with NeuroOne, the individual, who was not a previous employee or director of NeuroOne, received an option to purchase 10,000 shares of the Company’s common stock. The option award has an exercise price of $3.27 per share, the closing price of NeuroOne’s common stock on June 24, 2026, the date of the grant. The option has a ten-year term and vests over a period of four years, with 25% vesting on June 24, 2027, and the remainder vesting in 12 equal quarterly installments thereafter, provided the new hire’s employment is continuing on each such date, and subject to acceleration or forfeiture upon the occurrence of certain events as set forth in the new hire's option agreement. About NeuroOne NeuroOne Medical Technologies Corporation is a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders. NeuroOne markets a minimally invasive and high-definition/high-precision electrode technology platform with four FDA-cleared product families: Evo® Cortical Electrodes, Evo® sEEG Electrodes, OneRF® Ablation System (for brain), and OneRF® Trigeminal Nerve Ablation System. These solutions offer the potential to reduce the number of hospitalizations and surgical procedures, lower costs, and improve patient outcomes by offering diagnostic and therapeutic functions. The Company is engaged in research and development for drug delivery, basivertebral nerve ablation and spinal cord stimulation programs. For more information, visit nmtc1.com. IR Contact MZ Group MZ North America NMTC@mzgroup.us
ZUG, SWITZERLAND - June 25, 2026 (NEWMEDIAWIRE) - LION E-Mobility AG (LION; ISIN: CH0560888270), a leading manufacturer of battery packs for electric mobility and energy storage solutions, published its audited annual report of the LION Group for the 2025 financial year today. The Group generated revenues of EUR 28.3 million, a 68% increase compared to EUR 16.9 million in 2024. EBITDA improved significantly to EUR 6.5 million* (2024: EUR -3.6 million) resulting in an EBITDA margin of 22.8%*. Net profit also improved from EUR -6.6 million to EUR 2.3 million. Growth was primarily driven by a strong recovery in market demand for batteries. Outlook 2026 Looking ahead to 2026, LION anticipates further revenue growth exceeding EUR 35 million, accompanied by a strongly positive EBITDA. The Company's new production lines will be dedicated to high-performance NMC+ battery pack technology, which means a substantial share of 2026 revenues is expected to be weighted towards the second half of the year. Beyond its core business, LION sees additional growth momentum in the BESS and defense sectors. In the defense space, the Company is actively engaged in a number of related inquiries. A recent example is the partnership with Mandrill Engineering, in which LION Smart's high-performance battery technology serves as the power source for an advanced unmanned ground vehicle (UGV) - delivering dependable performance and extended operational capabilities in challenging field conditions. The full annual report is available on the LION E-Mobility website here. The Annual General Meeting will take place on June 25, 2026 in Zug (Switzerland). *The audited EBITDA and EBITDA margin deviate from the preliminary EBITDA of EUR 7.5 million and the preliminary EBITDA margin of 26.4% published on April 1, 2026. About LION E-Mobility AG: LION E-Mobility AG is a manufacturer of lithium-ion battery packs. The company offers customized plug-and-play solutions for electric vehicles as well as for stationary and industrial applications. The company operates highly automated module assembly lines at its own production facility in Germany. LION's battery packs offer the highest standards in terms of safety, quality, and reliability. Founded in 2011, LION E-Mobility AG (ISIN: CH0560888270, WKN: A2QH 97) is listed on the stock exchanges in Munich, Frankfurt, and Hamburg. www.lionemobility.com LION E-Mobility Investor Relations: Kirchhoff Consult lion@kirchhoff.de ir@lionemobility.com | www.lionemobility.com Disclaimer: Statements that express or contain forecasts, expectations, views, plans, goals and assumptions regarding future events or performance are not considered historical facts and may therefore be forward-looking statements. Forward-looking statements are based on the expectations, estimates and plans at the time the statements were made, and therefore involve a number of risks and uncertainties that could cause actual results or events to differ materially from those currently anticipated become. LION E-Mobility AG is under no obligation to update the forward-looking statements in this press release. View the original release on www.newmediawire.com
GENEVA, SWITZERLAND - June 25, 2026 (NEWMEDIAWIRE) - MindMaze Therapeutics Holding SA (SIX: MMTX) (MindMaze Therapeutics or the Company), a global leader in scalable precision neurotherapeutics, today announced the results of its Annual General Meeting held earlier today. Shareholders approved all proposals submitted by the Board of Directors, except the proposed increase in conditional share capital, which did not obtain the required qualified majority. Shareholders re-elected Walid Hanna, Olaf Blanke and Martin Reiss to the Board of Directors and elected Brad Hollinger, Founder, Chairman and Chief Executive Officer of Vibra Healthcare, and Zach Henderson, Chief Executive Officer of MindMaze Therapeutics, as new members of the Board of Directors. In addition, shareholders approved the 2025 Annual Report and financial statements, the appropriation of available earnings, the discharge of the members of the Board of Directors and the Executive Committee, the re-election of Walid Hanna as Chairman of the Board of Directors, the elections to the Nomination and Compensation Committee, the re-election of the Independent Proxy and the statutory auditor, the compensation proposals for the Board of Directors and Executive Committee, and the consultative vote on the 2025 Compensation Report. Further information on the proposals submitted to shareholders is available in the AGM Invitation. Detailed voting results will be published on the Company’s website later today. About MindMaze Therapeutics MindMaze Therapeutics (SIX: MMTX) is a global leader in scalable, precision neurotherapeutics, dedicated to redefining the recovery trajectory for patients around the world. By integrating advanced software, proprietary sensors, and AI-driven data analytics, MindMaze Therapeutics provides a seamless continuum of care from the acute hospital phase to outpatient treatment to home-based therapy. The company’s FDA-cleared and CE-marked products are designed to address the systemic shortage of specialized clinicians, offering scalable, reimbursable solutions for stroke, Parkinson’s disease, and other neurological disorders. With an extensive library of rigorous clinical validation and a robust R&D pipeline, MindMaze Therapeutics is operationalizing the future of neurorestorative medicine. For more information, visit www.mindmazetherapeutics.com. Media & Investor Contacts Investor Relations: Jeremy Meinen, Chief Financial Officer ir@mindmazetherapeutics.com Media Inquiries: VSC for MindMaze Therapeutics mindmazetherapeutics@vsc.com DISCLAIMER This press release contains forward-looking statements, which may be identified by words such as "believe," "assume," "expect," "intend," "may," "could," "will," or similar expressions. These statements are based on current plans and assumptions and are subject to risks and uncertainties that could cause actual results, financial condition, performance, or achievements to differ materially from those expressed or implied. This communication is provided as of the date hereof, and MindMaze Therapeutics undertakes no obligation to update any forward-looking statements contained herein as a result of new information, future events or otherwise. Additional features: File: Press release_MindMaze_AGM 2026 Results View the original release on www.newmediawire.com
GARCHING, GERMANY - June 25, 2026 (NEWMEDIAWIRE) - Allane Mobility Group, a specialist for vehicle leasing and full-service solutions in Germany, successfully held its regular virtual Annual General Meeting 2026 today. The shareholders approved all proposed resolutions of the Management Board and Supervisory Board by a clear majority. In total, 93.54 percent of the voting share capital was represented. Eckart Klumpp, CEO of Allane SE: "2025 was an extremely successful financial year. We grew significantly and clearly improved profitability. Our contract portfolio reached a record level – driven above all by strong growth in Captive Leasing. The momentum in the first quarter of 2026 confirms that we are on the right track.“ Ignacio Barbadillo Llorens, Chairman of the Supervisory Board of Allane SE: "In 2025, the Management Board set clear priorities - profitability over volume, risk discipline, and the consistent expansion of OEM partnerships. The results validate this course, and the Supervisory Board fully supports it.“ Resolutions at a glance The Annual General Meeting granted discharge to the Management Board and Supervisory Board for the 2025 financial year. No dividend will be distributed for the 2025 financial year; the funds generated will primarily be used to strengthen the equity base and finance further growth. Four members were elected to the Supervisory Board for a term of office until the Annual General Meeting in 2030: Marcelo Antonio Brutti and Woo Jong Joo (both Hyundai Capital Services, Seoul), Andre Lorse (Santander Consumer Bank AG, Monchengladbach), and Dr. Axel Wieandt as an independent member. These Supervisory Board members had previously been appointed by the registry court. In addition, the Annual General Meeting elected BDO AG Wirtschaftsprufungsgesellschaft, Hamburg, as auditor for the 2026 financial year and also resolved to delete obsolete capital authorizations from the Articles of Association without replacement. The detailed voting results are available on the website of Allane SE. About Allane Mobility Group: Allane Mobility Group based in Garching near Munich is a multi-brand provider of comprehensive mobility solutions. In its business segments Online Retail, Fleet Leasing, Captive Leasing and Fleet Management, the Company offers a wide range of services and innovative solutions that make mobility easy in every way. Private and commercial customers use Allane’s online and offline platforms to lease new vehicles affordably or acquire used vehicles from a large stock. Corporate customers benefit from the cost-efficient full-service leasing of their vehicle fleet and from comprehensive fleet management expertise. Allane SE (ISIN: DE000A0DPRE6) is listed in the Prime Standard of the Frankfurt Stock Exchange. In the 2025 financial year, the Group generated consolidated revenue of around EUR 864 million. With around 92 percent, Hyundai Capital Bank Europe GmbH (HCBE), a joint venture of Santander Consumer Bank AG and Hyundai Capital Services Inc., is the largest shareholder of Allane SE. www.allane-mobility-group.com Contact: Allane Mobility Group Investor Relations +49 89 7080 81 610 ir@allane.com View the original release on www.newmediawire.com
BREMEN and GEROLSTEIN, GERMANY - June 25, 2026 (NEWMEDIAWIRE) - OHB Digital Connect GmbH, a subsidiary of OHB SE, has successfully completed the upgrade of military ground stations on behalf of the Federal Office of Bundeswehr Equipment, Information Technology and In-Service Support (BAAINBw). As part of the overall project, the existing technology of the mobile ground stations was progressively replaced with modern satellite communications hardware for the SATCOMBw system. This enabled the systems to be modernized step by step and subsequently returned to the Bundeswehr. With the handover of the final batch, consisting of four refurbished ground stations, the project has now been successfully completed during a closing ceremony at Eifelkaserne in Gerolstein. At the time the contract was awarded, Bremen-based OHB Digital Connect had expanded its capabilities through a merger with Mainz-based antenna manufacturer MT Mechatronics, which has since also become part of the OHB Group. The contract for the refurbishment of the ground stations thus marked the beginning of more intensive cross-site collaboration. Contact: Media representatives: Marianne Radel Corporate Communications Phone: +49 421 2020 9159 Email: marianne.radel@ohb.de Investors and analysts: Marcel Dietz Investor Relations Phone: +49 421 2020 6426 Email: ir@ohb.de View the original release on www.newmediawire.com
LOS ANGELES, CA - June 25, 2026 (NEWMEDIAWIRE) - HeartBeam (NASDAQ: BEAT) announced a strategic reorganization aimed at accelerating execution, expanding global market reach and improving capital efficiency as it advances commercialization of its cardiac monitoring technology. Under the new structure, Founder and President Branislav Vajdic, Ph.D., and Executive Chairman Rich Ferrari will lead focused implementation teams designed to streamline decision-making, improve accountability and reduce costs. As part of the transition, former CEO Robert Eno will move into a consulting role. The company said its strategy centers on leveraging its patented 3D ECG platform across multiple healthcare channels while advancing development beyond arrhythmia assessment toward heart attack detection. HeartBeam also plans to expand partnerships with governments, health systems, ECG manufacturers and wearable device companies, building on its December 2025 FDA clearance for its synthesized 12-lead ECG technology for arrhythmia assessment. To view the full press release, visit https://ibn.fm/CTxXi About HeartBeam, Inc. HeartBeam, Inc. is a medical technology company dedicated to transforming the detection and monitoring of critical cardiac conditions. The Company is creating the first-ever cable-free device capable of collecting ECG signals in 3D, from three non-coplanar directions, and synthesizing the signals into a 12-lead ECG. This platform technology is designed for portable devices that can be used wherever the patient is to deliver actionable heart intelligence. Physicians will be able to identify cardiac health trends and acute conditions and direct patients to the appropriate care – all outside of a medical facility, thus redefining the future of cardiac health management. HeartBeam’s 3D ECG technology received FDA clearance for arrhythmia assessment in December 2024 and the 12-lead ECG synthesis software in December 2025(1) . The Company holds over 20 issued patents related to technology enablement. Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://IBN.fm/Disclaimer The latest news and updates relating to BEAT are available in the company’s newsroom at https://ibn.fm/BEAT Forward Looking Statements Certain statements in this article are forward-looking, as defined in the Private Securities Litigation Reform Act of 1995. These statements involve risks, uncertainties, and other factors that may cause actual results to differ materially from the information expressed or implied by these forward-looking statements and may not be indicative of future results. These forward-looking statements are subject to a number of risks and uncertainties, including, among others, various factors beyond management's control, including the risks set forth under the heading "Risk Factors" discussed under the caption "Item 1A. Risk Factors" in Part I of the Company's most recent Annual Report on Form 10-K or any updates discussed under the caption "Item 1A. Risk Factors" in Part II of the Company's Quarterly Reports on Form 10-Q and in the Company's other filings with the SEC. Undue reliance should not be placed on the forward-looking statements in this article in making an investment decision, which are based on information available to us on the date hereof. All parties undertake no duty to update this information unless required by law
LOS ANGELES, CA - June 25, 2026 (NEWMEDIAWIRE) - Greenland Mines (NASDAQ: GRML) announced it has completed a three-day, multidisciplinary planning workshop for its Skaergaard Precious and Critical Metals Project in southeast Greenland, bringing together more than 15 international experts from GTK Mintec, the Geological Survey of Finland, SLR Consulting, WSP Denmark and other technical specialists. The June 22-24 sessions focused on advancing understanding of the orebody and processing pathways, planning 2026 drilling, sampling and environmental programs and establishing a roadmap toward an Initial Assessment (“IA”) or Preliminary Economic Assessment (“PEA”) and future development. The company said the workshop produced an integrated plan for the 2026 field campaign, a refined metallurgical testing strategy, a framework for incorporating geotechnical and environmental data into mine design and permitting and a long-term development roadmap extending toward a potential exploitation license. Greenland Mines said the workshop builds on its existing collaborations with GTK Mintec, WSP Denmark and SLR Consulting and reflects its strategy of engaging leading international technical experts to advance the Skaergaard project. To view the full press release, visit: https://ibn.fm/LP1cL About Greenland Mines Greenland Mines Ltd is a Nasdaq-listed company with two operating divisions: (1) Mining, focused on the exploration and development of the Skaergaard Project in southeast Greenland and, subject to closing of the previously announced transaction, the Sarfartoq neodymium-praseodymium (Nd-Pr) rare earths project in southwest Greenland; and (2) Biotech, including Klotho’s KLTO‑202 primary indication for ALS. The Company’s strategy is centered on building a multi-asset platform with exposure to rare earth magnet materials, precious metals and selected midstream processing opportunities, while advancing its broader North Atlantic Critical Metals Corridor vision linking Greenland resources with allied downstream jurisdictions and industrial infrastructure. Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://IBN.fm/Disclaimer The latest news and updates relating to GRML are available in the company’s newsroom at https://ibn.fm/GRML Forward Looking Statements Certain statements in this article are forward-looking, as defined in the Private Securities Litigation Reform Act of 1995. These statements involve risks, uncertainties, and other factors that may cause actual results to differ materially from the information expressed or implied by these forward-looking statements and may not be indicative of future results. These forward-looking statements are subject to a number of risks and uncertainties, including, among others, various factors beyond management's control, including the risks set forth under the heading "Risk Factors" discussed under the caption "Item 1A. Risk Factors" in Part I of the Company's most recent Annual Report on Form 10-K or any updates discussed under the caption "Item 1A. Risk Factors" in Part II of the Company's Quarterly Reports on Form 10-Q and in the Company's other filings with the SEC. Undue reliance should not be placed on the forward-looking statements in this article in making an investment decision, which are based on information available to us on the date hereof. All parties undertake no duty to update this information unless required by law View the original release on www.newmediawire.com
LOS ANGELES, CA - June 25, 2026 (NEWMEDIAWIRE) - VERAXA Biotech (NASDAQ: VRXA), an emerging leader in designing novel cancer therapies, has announced new in vitro proof-of-concept data supporting its BiTAC-ADC platform, a technology designed to improve the selectivity of antibody-drug conjugates in cancer treatment. The announcement comes as the company prepares to engage with potential pharmaceutical and biotechnology partners during the BIO International Convention 2026 in San Diego (https://nnw.fm/APy2D). VERAXA Biotech has reported new in vitro proof-of-concept data supporting its BiTAC-ADC technology, demonstrating selective activity against cancer cells while sparing healthy cells in early testing. The company is presenting its BiTAC-ADC and BiTAC-TCE platforms for potential strategic collaborations at the BIO International Convention 2026. VERAXA’s proprietary BiTAC approach is designed to improve the precision of antibody-based cancer therapies by activating therapeutic effects only in targeted tumor cells. The company maintains a diversified oncology pipeline of antibody-based formats including antibody-drug conjugates (“ADCs”), T-cell engagers (“TCEs”), and other antibody-based formats. VERAXA recently began trading on the NASDAQ Capital Market under the ticker symbol VRXA following the completion of its business combination with Voyager Acquisition Corp. The newly released data showed that VERAXA’s BiTAC-ADC technology was able to distinguish between breast cancer cells and healthy cells in laboratory studies and demonstrated dose-dependent destruction of three-dimensional tumor cell spheroids. While the platform remains in early development, the results… Read More Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://IBN.fm/Disclaimer The latest news and updates relating to VRXA are available in the company’s newsroom at https://ibn.fm/VRXA Forward Looking Statements Certain statements in this article are forward-looking, as defined in the Private Securities Litigation Reform Act of 1995. These statements involve risks, uncertainties, and other factors that may cause actual results to differ materially from the information expressed or implied by these forward-looking statements and may not be indicative of future results. These forward-looking statements are subject to a number of risks and uncertainties, including, among others, various factors beyond management's control, including the risks set forth under the heading "Risk Factors" discussed under the caption "Item 1A. Risk Factors" in Part I of the Company's most recent Annual Report on Form 10-K or any updates discussed under the caption "Item 1A. Risk Factors" in Part II of the Company's Quarterly Reports on Form 10-Q and in the Company's other filings with the SEC. Undue reliance should not be placed on the forward-looking statements in this article in making an investment decision, which are based on information available to us on the date hereof. All parties undertake no duty to update this information unless required by law View the original release on www.newmediawire.com
Companies to Integrate p-Chip’s Unclonable Micro-Transponder Technology Into SuperCloud’s GPOD Battery Platform, Beginning With Battery Traceability and Serialization and Building Toward EU Battery Passport Readiness BOCA RATON, FL and CHICAGO, IL - June 25, 2026 (NEWMEDIAWIRE) - SuperCloud Energy, a clean energy innovator advancing scalable on- and off-grid power solutions, and p-Chip® Corporation today announced that they have signed a Letter of Intent (LOI) to pursue a strategic partnership integrating p-Chip’s micro-transponder identity and traceability technology into SuperCloud Energy’s U.S.-built battery and energy storage systems. The collaboration will begin with battery traceability and serialization across SuperCloud’s Green Power on Demand (GPOD) platform and is designed to expand toward full-lifecycle identity and Battery Passport readiness. Under the LOI, the two companies will begin technical, operational, and commercial discussions on a phased implementation, starting with a focused battery-traceability engagement and scaling into deeper manufacturing and commissioning integration as value is proven. As battery manufacturers face rising expectations for secure identity, lifecycle traceability, manufacturing integrity, and future Battery Passport compliance, the durability of the underlying physical identifier is becoming a core requirement. Conventional labels and QR codes can wear off or be swapped, and standard RFID antennas can struggle in battery environments. A traceability record is only as trustworthy as the physical identifier it is anchored to. p-Chip’s light-activated micro-transponder delivers a hardware-unique, read-only silicon identity that cannot be copied, edited, or re-applied like a conventional label. The technology has demonstrated survivability under harsh battery conditions, including thermal cycling, electrolyte exposure, and extended charge/load cycling, and supports hierarchical identity from cell to module, pack, and system. Each verified scan can be captured as an auditable, enterprise-grade event through AuthiumTM, p-Chip’s traceability software on SAP Business Technology Platform. For SuperCloud, the partnership establishes a durable physical root of trust for its domestically manufactured energy storage systems, linking component provenance, manufacturing quality, commissioning sign-off, and dispatch verification to a single, unclonable identity that travels with each battery across its service life. “SuperCloud is building more than batteries or power systems. We are building a globally deployable distributed energy infrastructure,” said Jim Devericks, Founder, Chairman and CEO of SuperCloud Energy. “To do that at scale, every battery must carry a trusted, permanent identity. p-Chip gives us a secure and unclonable foundation for battery traceability, strengthening quality assurance, lifecycle intelligence, and supply chain integrity across our GPOD platform. This not only supports access to global markets like the EU as Battery Passport standards emerge, but positions us ahead of future U.S. regulatory requirements while giving customers greater confidence and visibility into the assets powering their operations.” “SuperCloud is exactly the kind of partner we built this platform for, a manufacturer that treats traceability as infrastructure, not an afterthought,” said Joe Wagner, CEO and Co-Founder of p-Chip Corporation. “Energy storage is one of the most demanding environments for any identity technology. Our micro-transponders have demonstrated survivability under thermal, electrochemical, and charge/load stress, and this partnership brings that durable, unclonable identity to American-made batteries, from the moment they are manufactured through their entire lifecycle.” The companies intend to advance the relationship along a phased path: an initial battery-traceability engagement across SuperCloud’s manufacturing, QA/commissioning, and dispatch checkpoints; deeper integration into manufacturing workflow and ERP/quality systems; and, over time, a broader identity layer supporting lifecycle intelligence, sustainability assurance, and EU Battery Passport readiness. About SuperCloud Energy, Inc. SuperCloud Energy, a division of SuperCloud Global Holdings, is pioneering the future of sustainable power with GPOD (Green Power On Demand), the world’s first fully integrated, zero-emission, off-grid energy platform. Built with a proprietary energy generation technology and paired with advanced sodium-ion battery storage, SuperCloud Energy delivers breakthrough solutions that are portable, scalable, and emission-free. From powering data centers and EV infrastructure to supporting remote communities, military operations, and disaster recovery, GPOD is redefining how and where reliable electricity can be generated. With numerous patents pending and a global team of partners and innovators, SuperCloud Energy is committed to making clean, affordable, and independent power available anywhere in the world. For more information, visit https://supercloudenergy.com/. About p-Chip Corporation p-Chip Corporation provides a physical-digital trust layer for regulated and high-value supply chains. Its light-activated micro-transponder delivers a hardware-unique, read-only silicon identity that cannot be copied, edited, or re-applied like a conventional label, paired with reader infrastructure and Authium, p-Chip’s traceability software on SAP Business Technology Platform. p-Chip technology has been validated across pharmaceutical, life sciences, diagnostics, industrial, and product-authenticity applications, including collaborations with Merck KGaA, Darmstadt, Germany, and Avantor. For more information, visit www.p-chip.com. Media Contacts SuperCloud Energy Kyle Porter EVP, Virgo PR (212) 584-4289 supercloud@virgo-pr.com p-Chip Corporation Investor & Media Relations: Lyda Guilfoyle 310‑906‑8368 lyda@p‑chip.com This announcement relates to a non-binding Letter of Intent. The Letter of Intent expresses the parties’ good-faith intent to pursue further technical, operational, and commercial discussions toward a potential strategic partnership and does not constitute a binding commercial agreement. Any resulting partnership is subject to further discussions and definitive agreements between the parties. View the original release on www.newmediawire.com
Energy, Oil & Gas Magazine Profiles CEO Robert Price as Company Prepares for October 2026 Exploration Campaign in East Greenland LOS ANGELES, CA - June 25, 2026 (NEWMEDIAWIRE) - Greenland Energy (NASDAQ: GLND) is advancing development of the Jameson Land Basin in East Greenland, an onshore petroleum basin that CEO Robert Price described as one of the world’s last largely undrilled frontier oil regions. In an interview with Energy, Oil & Gas Magazine, Price said the company holds rights to up to a 70% interest in the basin and is leveraging extensive seismic data originally collected by Atlantic Richfield Company (“ARCO”) during the 1970s and 1980s. Modern reprocessing of the historical data has helped refine potential drilling targets within a geological system the company believes shares characteristics with the North Sea. Price said independent evaluations have suggested upside potential of up to 13 billion barrels across the basin, with the first drill location estimated to contain approximately 2.9 billion barrels. He added that project preparations are underway, including refurbishment and transport of a drilling rig, road construction and logistics planning led by Halliburton, with initial drilling targeted for October 2026. According to Price, the project could play an important role in future energy security while also contributing to Greenland’s long-term economic development. Drawing comparisons to the impact of resource development in Norway and Denmark, he said stakeholders increasingly view the basin’s potential hydrocarbon resources as a possible catalyst for infrastructure investment, public revenue generation and broader economic growth. Source: Energy, Oil & Gas Magazine About Greenland Energy Company Greenland Energy Company is an energy exploration company focused on responsibly developing Greenland’s hydrocarbon resources, with an emphasis on the Jameson Land Basin. It aims to advance oil and gas exploration and create a publicly traded platform for Arctic energy development. Forward-Looking Statements This communication contains “forward-looking statements” within the meaning of the “safe harbor” provisions of the United States Private Securities Litigation Reform Act of 1995 and within the meaning of Section 27A of the Securities Act of 1933, as amended (the “Securities Act”), and Section 21E of the Securities Exchange Act of 1934, as amended. All statements contained herein other than statements of present or historical fact, including, without limitation, statements regarding Greenland Energy Company’s (the “Company”) future financial performance, business strategy, operations, financial position, estimated revenues and losses, projected costs, prospects, plans, objectives of management, and expected benefits of the Company’s recent business combination, are forward-looking statements. Forward-looking statements are generally identified by the use of words such as “believe,” “may,” “will,” “estimate,” “continue,” “anticipate,” “intend,” “expect,” “should,” “would,” “plan,” “project,” “forecast,” “potential,” “predict,” or the negative of these terms or similar expressions, although not all forward-looking statements contain such identifying words. These forward-looking statements are based on management’s current expectations, assumptions and beliefs regarding future events and are based on information currently available to the Company. These statements involve a number of risks and uncertainties, many of which are difficult to predict and are beyond the Company’s control, and actual results may differ materially from those expressed or implied by these forward-looking statements. Factors that could cause actual results to differ materially include, among others: (i) Exploration and Geological Risks, including the Company’s status as a development-stage company with no operating history, revenues, or proved reserves; the inherent uncertainty in prospective resource estimates, including that the 13 billion barrel estimate is based on undiscovered accumulations with no certainty of discovery or commercial viability; geological complexity arising from limited seismic data coverage, pervasive igneous intrusions, faulting patterns, and significant Tertiary uplift creating thermal maturity uncertainty; the fact that the basin has never produced a commercial discovery despite decades of study dating back to the 1970s, and a 2008 USGS report stating less than a 10% chance of containing a technically recoverable hydrocarbon accumulation; and high-cost frontier exploration with estimated well costs of $40 million for the first well and $20 million for subsequent wells; (ii) Operational and Environmental Risks, including the challenges of operating in a remote Arctic location with extreme climate, harsh weather, limited daylight, no existing infrastructure, and seasonal access windows for equipment and personnel; drilling hazards such as blowouts, equipment failures, well control events, environmental releases, and accidents inherent in oil and gas operations; reliance on third-party contractors; and climate change scrutiny, as operations in Greenland face increasing opposition from environmental groups and institutional investors due to Arctic drilling concerns; (iii) Regulatory and Political Risks, including the 2021 Greenland drilling moratorium, and while licenses are grandfathered, future regulatory changes could jeopardize operations; geopolitical tensions, including U.S. interest in acquiring Greenland and Greenland’s internal independence movements that could affect operations; permit requirements, as drilling requires Environmental Impact Assessment approval and Field Activities Application approval from Greenlandic authorities; and forfeiture risk, as failure to meet drilling milestones could result in loss of the Company’s right to earn working interests; (iv) Financial and Capital Risks, including significant capital requirements and the need for substantial funding beyond current resources to complete the drilling program; commodity price volatility, as oil, gas, and NGL prices are highly volatile and will heavily influence project viability; a long development timeline during which market conditions may change significantly before potential production, unlike short-cycle shale projects; going concern uncertainty and substantial doubt about the Company’s ability to continue as a going concern without additional financing; and energy transition risk, as global demand for oil may decline due to electric vehicle adoption, renewable energy policies, and changing consumer preferences; and other risks and uncertainties as set forth in the Company’s Prospectus filed with the Securities and Exchange Commission pursuant to Rule 424(b)(4) under the Securities Act on April 29, 2026, in the section titled “Risk Factors”. Forward-looking statements speak only as of the date they are made. The Company undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by applicable law. Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://IBN.fm/Disclaimer Forward Looking Statements Certain statements in this article are forward-looking, as defined in the Private Securities Litigation Reform Act of 1995. These statements involve risks, uncertainties, and other factors that may cause actual results to differ materially from the information expressed or implied by these forward-looking statements and may not be indicative of future results. These forward-looking statements are subject to a number of risks and uncertainties, including, among others, various factors beyond management's control, including the risks set forth under the heading "Risk Factors" discussed under the caption "Item 1A. Risk Factors" in Part I of the Company's most recent Annual Report on Form 10-K or any updates discussed under the caption "Item 1A. Risk Factors" in Part II of the Company's Quarterly Reports on Form 10-Q and in the Company's other filings with the SEC. Undue reliance should not be placed on the forward-looking statements in this article in making an investment decision, which are based on information available to us on the date hereof. All parties undertake no duty to update this information unless required by law View the original release on www.newmediawire.com
LOS ANGELES, CA - June 25, 2026 (NEWMEDIAWIRE) - Cardio Diagnostics Holdings (NASDAQ: CDIO), an AI-powered precision cardiovascular medicine company, announced that Atlas Healthcare Physicians, an independent physician association serving managed care populations across Los Angeles and Orange counties, will provide coverage for the company’s Epi+Gen CHD(TM) and PrecisionCHD(TM) tests for eligible members with prior authorization. The coverage expands access to physician-ordered blood tests designed to assess coronary heart disease risk and support diagnosis and personalized treatment planning. Cardio Diagnostics said Epi+Gen CHD(TM) evaluates a patient’s three-year risk of a coronary heart disease event, while PrecisionCHD(TM) helps diagnose coronary heart disease and identify its underlying molecular drivers. The company noted that both tests are noninvasive blood-based diagnostics that do not require fasting or radiation exposure, supporting broader adoption of precision cardiovascular medicine across community healthcare networks. To view the full press release, visit https://nnw.fm/EFQen About Cardio Diagnostics Cardio Diagnostics is an artificial intelligence-powered precision cardiovascular medicine company that makes cardiovascular disease prevention, detection, and management more accessible, personalized, and precise. The company was formed to further develop and commercialize clinical tests by leveraging a proprietary Artificial Intelligence (AI)-driven Integrated Genetic-Epigenetic Engine (“Core Technology”) for cardiovascular disease to become one of the leading medical technology companies for improving prevention, detection, and treatment of cardiovascular disease. Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://IBN.fm/Disclaimer The latest news and updates relating to CDIO are available in the company’s newsroom at https://ibn.fm/CDIO Forward Looking Statements Certain statements in this article are forward-looking, as defined in the Private Securities Litigation Reform Act of 1995. These statements involve risks, uncertainties, and other factors that may cause actual results to differ materially from the information expressed or implied by these forward-looking statements and may not be indicative of future results. These forward-looking statements are subject to a number of risks and uncertainties, including, among others, various factors beyond management's control, including the risks set forth under the heading "Risk Factors" discussed under the caption "Item 1A. Risk Factors" in Part I of the Company's most recent Annual Report on Form 10-K or any updates discussed under the caption "Item 1A. Risk Factors" in Part II of the Company's Quarterly Reports on Form 10-Q and in the Company's other filings with the SEC. Undue reliance should not be placed on the forward-looking statements in this article in making an investment decision, which are based on information available to us on the date hereof. All parties undertake no duty to update this information unless required by law
KELOWNA, BRITISH COLUMBIA - June 25, 2026 (NEWMEDIAWIRE) - Lexaria Bioscience Corp. (Nasdaq: LEXX) (the “Company” or “Lexaria”), a global innovator in drug delivery platforms, announces that dosing began on schedule on June 14th with Human Pilot Study #7 (GLP-1-H26-7) that is evaluating two oral DehydraTECH-semaglutide (“DHT-sema”) compositions against Novo Nordisk’s® (“Novo”) commercially available Wegovy® tablets, over a 5-week duration (the “Study”). Lexaria is seeking to preserve the superior safety and tolerability profiles evidenced in its previous glucagon-like peptide-1 (“GLP-1”) studies such as Human Study #4 (GLP-1-H24-4), combined with pharmacokinetic (“PK”) performance that matches or exceeds the Wegovy® tablet control. Previous Lexaria salcaprozate sodium (“SNAC”)-inclusive DHT-sema single dose studies such as Human Pilot Studies #1 and #2 (GLP-1-H24-1 and GLP-1-H24-2) evidenced PK performance that matched or exceeded the Rybelsus® control arm and also evidenced noteworthy safety and tolerability profiles. The results of this Study are expected to be carefully reviewed by the pharmaceutical industry in order to evaluate the possibility of entering into commercial relationships focused on Lexaria’s proprietary DehydraTECH™ technology. The Study is investigating three separate arms to assess safety & tolerability as well as PK properties that will compare SNAC-inclusive, DHT-sema compositions formulated in both tablet and capsule formats to commercially available Wegovy® tablets. The Study is being conducted under fasted pre-dose conditions similar to the advised administration criteria of Novo’s oral semaglutide products. The 5-week dosing duration was selected in order to allow for achievement of steady state concentration levels, meaning that the semaglutide blood quantities in each arm will be expected to reach an equilibrium level that balances drug input with natural bodily elimination. The Study is exploring several new DehydraTECH™ enhancements not previously evaluated, which include but are not limited to the following two main improvements: (1) First, an oral tablet DHT-sema composition will be used by Lexaria for the first time, as opposed to only the capsule compositions administered in all our previous DehydraTECH™ GLP-1 studies. Novo’s Rybelsus® and Wegovy® oral semaglutide medications use specially formulated tablets designed to temporarily adhere to the stomach lining and disintegrate and dissolve releasing agents in a focal manner that aids in optimizing absorption of semaglutide into the human body. For the first time ever, Lexaria has attempted to mimic and integrate certain physical properties of the Rybelsus® and Wegovy® SNAC-inclusive tablet delivery modality into its DHT-sema tablets to follow established industry standards and thereby increase the likelihood of subsequent commercial pharmaceutical relationships. (2) Second, both the Lexaria DHT-sema tablet and capsule test articles will be formulated with SNAC, which will be the first time these formulations will be evaluated over a multi-dose, multi-week time period in humans. The five-week dosing duration of the Study is expected to be long enough to reach so-called steady-state, which is when drug concentrations in the body reach a constant concentration. As noted above, Human Pilot Studies #1 and #2 (GLP-1-H24-1 and GLP-1-H24-2), conducted in 2024 and 2025 which incorporated SNAC (but did not use tablets), were limited by single-dose study designs and therefore of much shorter duration. The Study is fully funded from existing corporate resources. About Lexaria Bioscience Corp. & DehydraTECH™ DehydraTECH™ is Lexaria’s patented drug delivery formulation and processing platform technology which improves the way a wide variety of drugs enter the bloodstream, always through oral delivery. DehydraTECH(TM) has repeatedly evidenced the ability to increase bio-absorption, reduce side-effects, and deliver some drugs more effectively across the blood brain barrier. Lexaria operates a licensed in-house research laboratory and holds a robust intellectual property portfolio with 66 patents granted and additional patents pending worldwide. For more information, please visit www.lexariabioscience.com. CAUTION REGARDING FORWARD-LOOKING STATEMENTS This press release includes forward-looking statements. Statements as such term is defined under applicable securities laws. These statements may be identified by words such as "anticipate," "if," "believe," "plan," "estimate," "expect," "intend," "may," "could," "should," "will," and other similar expressions. Such forward-looking statements in this press release include, but are not limited to, statements by the Company relating to the Company’s ability to carry out research initiatives, receive regulatory approvals or grants or experience positive effects or results from any research or study. Such forward-looking statements are estimates reflecting the Company's best judgment based upon current information and involve a number of risks and uncertainties, and there can be no assurance that the Company will actually achieve the plans, intentions, or expectations disclosed in these forward-looking statements. As such, you should not place undue reliance on these forward-looking statements. Factors which could cause actual results to differ materially from those estimated by the Company include, but are not limited to, government regulation and regulatory approvals, managing and maintaining growth, the effect of adverse publicity, litigation, competition, scientific discovery, the patent application and approval process, potential adverse effects arising from the testing or use of products utilizing the DehydraTECH technology, the Company’s ability to maintain existing collaborations and realize the benefits thereof, delays or cancellations of planned R&D that could occur related to pandemics or for other reasons, and other factors which may be identified from time to time in the Company's public announcements and periodic filings with the US Securities and Exchange Commission on EDGAR. The Company provides links to third-party websites only as a courtesy to readers and disclaims any responsibility for the thoroughness, accuracy or timeliness of information at third-party websites. There is no assurance that any of Lexaria’s postulated uses, benefits, or advantages for the patented and patent-pending technology will in fact be realized in any manner or in any part. No statement herein has been evaluated by the Food and Drug Administration (FDA). Lexaria-associated products are not intended to diagnose, treat, cure or prevent any disease. Any forward-looking statements contained in this release speak only as of the date hereof, and the Company expressly disclaims any obligation to update any forward-looking statements or links to third-party websites contained herein, whether as a result of any new information, future events, changed circumstances or otherwise, except as otherwise required by law. INVESTOR CONTACT: George Jurcic - Head of Investor Relations ir@lexariabioscience.com Phone: 250-765-6424, ext 202 View the original release on www.newmediawire.com
VANCOUVER, BRITISH COLUMBIA - June 25, 2026 (NEWMEDIAWIRE) - Canary Gold Corp. (CSE: BRAZ; OTCQB: CNYGF; Frankfurt: K5D) (“Canary Gold” or the “Company”) is pleased to provide a follow-up to its June 10, 2026 news release and announce that it has received additional technical observations and recommendations from Clara Maria Lamus Molina, an internationally recognized geologist-engineer and specialist in the evaluation and sampling of alluvial gold deposits. The review supports the Company’s view that Rio Madeira represents a prospective large-scale alluvial exploration target where the next phase of technical advancement will depend on disciplined validation of paleochannel geometry, gravel continuity, recoverable gold content and volumetric grade. Ms. Molina’s work provides Canary with a practical roadmap to advance from preliminary geological observations toward systematic, representative and auditable technical data. The Company believes the review represents an important next step in positioning the Madeira River Project for future exploration milestones, evaluation of whether sufficient technical information can ultimately support a National Instrument 43-101 compliant mineral resource estimate subject to continued exploration success, additional drilling, representative sampling, QA/QC, recovery testing and geological modelling. Ms. Molina’s review highlights several positive indicators and technical priorities at the Madeira River Project, including: active alluvial gold mining observed within the Madeira River system; visible free gold observed during the inspection of active alluvial mining operations within the broader Madeira River system; these observations provide regional geological context only and are not necessarily indicative of mineralization on the Company’s property; favourable gravel intervals identified in areas of exploration interest; geomorphological features compatible with alluvial plains, terraces, paleochannels and high-energy channel environments; paleochannels and coarse-gravel systems identified as priority targets for alluvial gold concentration; sonic drilling recommended as a preferred validation tool in priority target areas; recovered-volume control recommended to evaluate gold content on a reliable volumetric basis; standardized logging, granulometry, gold-particle classification, QA/QC and chain-of-custody procedures recommended; and geological-volumetric modelling identified as a key step toward future resource-readiness. As announced on June 10, 2026, recent deeper drilling has intersected targeted mature coarse sediments, including gravels and sands, supporting the Company’s interpretation of a large-scale paleochannel system associated with the Madeira River. Mark Tommasi, President of Canary Gold, commented: “Rio Madeira exhibits several characteristics commonly associated with alluvial gold systems, including interpreted paleochannel targets, favourable gravel horizons and active alluvial mining within the broader Madeira River region. The next step is disciplined validation. Ms. Molina’s review gives us a clear technical pathway to test the project in a way that is systematic, auditable and meaningful for investors.” Mr. Tommasi continued: “Alluvial gold systems are different from conventional hard-rock deposits. They are generally evaluated on a volumetric basis, where the size and continuity of the paleochannel, the thickness of favourable gravels, recoverable gold content, stripping ratio, processing efficiency and throughput are all important. Our objective is to define the channel, measure the gravel, validate the grade, test recovery and build the database step by step.” Why the Alluvial Model Matters Alluvial, or placer, gold systems are formed when gold is naturally liberated from source rocks, transported by ancient or modern river systems and concentrated by hydraulic sorting within favourable sedimentary environments such as coarse gravels, sand bars, terraces, channel bases and paleochannels. Canary’s exploration model at the Madeira River Project is focused on identifying preserved paleochannel and high-energy gravel environments within the broader Madeira River system where gold may have been naturally concentrated and preserved. The Company believes the Madeira River Project is best understood through a staged alluvial-gold development pathway. Canary is currently in the early stages of this pathway. The Company has identified preliminary geological indicators and priority paleochannel-style targets. The next phase is intended to validate geometry, continuity, gravel thickness, representative grade and recovery characteristics. Technical Program Focus A central recommendation from Ms. Molina is the use of sonic drilling in priority target areas. Sonic drilling is considered well suited to unconsolidated alluvial environments because it can improve sample recovery, preserve stratigraphic relationships, reduce interval contamination, improve fine-material recovery and support more accurate measurement of recovered sample volume. These factors are critical in alluvial gold exploration, where gold distribution can be irregular and reliable evaluation depends on representative sampling, volume control and repeatable recovery methods. Future work is expected to focus on: systematic sonic drilling in priority areas; metre-by-metre geological logging; recovered-volume measurement by interval; controlled sample processing and gravity concentration; gold-particle recovery, classification and weighing; laboratory validation of selected samples; robust QA/QC and chain-of-custody procedures; and geological-volumetric modelling. Click to see Figure 2: Conceptual alluvial-gold development pathway showing the technical progression from discovery and paleochannel definition through drill delineation, bulk sampling, resource estimation, economic studies, reserves and potential production. Canary is currently focused on early-stage validation, and there is no assurance the Project will advance through all stages. Sampling, Processing and QA/QC Ms. Molina has recommended that future sampling programs incorporate a practical sample-processing workflow appropriate for alluvial gold environments. Under this approach, samples from target horizons may be screened through a 1/8-inch mesh, with the passing material washed and concentrated. Concentration may be completed through skilled panning or, where appropriate, calibrated modern gravity-concentration equipment. The process is expected to include experienced technical supervision, gold-particle classification and use of a deposit-specific particle-size-to-weight calibration chart to support consistent preliminary field estimates. The Company continues to review and refine its sampling and analytical procedures as exploration progresses. The objective is to establish a representative, repeatable and auditable technical workflow appropriate for alluvial gold and coarse gold environments. Learning from Mature Alluvial Systems Canary has also reviewed mature alluvial gold systems to better understand the technical pathway required to move an alluvial discovery toward resource definition and potential development. One relevant example is the Nechí alluvial gold system in Colombia, operated by Mineros S.A. Nechí is a long-running alluvial operation with NI 43-101 mineral resource and reserve disclosure, extensive drilling, production history and operating reconciliation. Canary cautions that Nechí is referenced solely as an educational and technical benchmark for how alluvial systems can be evaluated and advanced when sufficient drilling, volume control, recovery testing, mine planning and QA/QC have been completed. Nechí is not located on or adjacent to the Madeira River Project, is materially more advanced than the Madeira River Project, and no inference should be drawn that the Madeira River Project hosts comparable mineralization, grades, resources, reserves, recoveries, economics or mining conditions. Mr. Tommasi added: “Nechí is not a direct comparison to Rio Madeira. It is a useful example of the level of technical discipline required to move an alluvial system from concept to resource and operating model. Our objective is to apply that discipline early at Rio Madeira and build the technical foundation required for future decision-making.” Management’s View Canary believes the Madeira River Project represents an early-stage alluvial gold exploration project with multiple targets requiring further technical validation. The Company’s immediate objective is to advance from preliminary geological and field observationstoward representative, auditable data that can support future technical and investment decisions. The Company is now reviewing budgets, logistics, access and sequencing for a priority sonic-drilling and sample-processing program at the Madeira River Project. The Company cautions investors that exploration at the Madeira River Project remains at an early stage. No mineral resource has been defined, and there can be no assurance that continued exploration will result in the delineation of an economic mineral deposit. Geological interpretations, including interpreted paleochannel targets, remain subject to further drilling, sampling, testing and validation. Qualified Person and Technical Disclosure The scientific and technical information contained in this news release has been reviewed and approved by Andrew Lee Smith, P.Geo., a Qualified Person as defined by National Instrument 43-101 – Standards of Disclosure for Mineral Projects. Mr. Smith has previously visited the Company’s project areas in Brazil and is familiar with the regional geology and exploration activities. While not continuously present on site, Mr. Smith has reviewed drilling, sampling, QA/QC and geological information and is satisfied that the information has been collected and reported by site-based personnel in accordance with industry standard practices. Mr. Smith is not independent of the Company within the meaning of National Instrument 43-101, as he serves as Executive Chairman of Canary Gold Corp. About Canary Gold Corp. Canary Gold Corp. is a Canadian public exploration company focused on the acquisition and advancement of gold projects in Brazil. The Company holds an option to earn up to a 70% undivided interest in the Rio Madeira Project through a series of staged exploration expenditures and milestone payments. In August 2025, Canary further expanded its regional strategy by entering into a definitive agreement to acquire a 100% interest in ten additional mineral tenements totaling approximately 94,700 hectares from Talisman Venture Partners Ltd., a private British Columbia corporation. The total consideration of CAD $1.7 million has been satisfied through staged cash and share payments. Talisman retains a 1.0% net smelter return (NSR) royalty on future production from the acquired tenements, one-half of which (reducing the NSR to 0.5%) may be repurchased by the Company at any time for CAD $1.0 million. Together, these interests provide Canary Gold with a dominant and strategically consolidated land position in the Madeira River region of Rondonia State - a historically productive and underexplored gold region of Brazil. For Further Information, Please Contact: Canary Gold Corp. Mark Tommasi, President Tel: (604) 318-1448 www.canarygold.ca Cautionary Statement Regarding Forward-Looking Information This news release contains forward-looking statements within the meaning of applicable securities laws that are not historical facts. Forward-looking statements are often identified by terms such as “will”, “may”, “should”, “anticipates”, “expects”, “believes”, and similar expressions or the negative of these words or other comparable terminology. All statements, other than statements of historical fact, included in this release, including, without limitation, statements regarding the Company’s planned exploration programs and drill programs and potential significance of results, are forward-looking statements that involve risks and uncertainties. There can be no assurance that such statements will prove to be accurate and actual results and future events could differ materially from those anticipated in such statements. Important factors that could cause actual results to differ materially from the Company’s expectations include but are not limited to the risks detailed in the Company’s Prospectus and in the continuous disclosure filings made by the Company with securities regulations from time to time. The reader is cautioned that assumptions used in the preparation of any forward-looking information may prove to be incorrect. Events or circumstances may cause actual results to differ materially from those predicted, as a result of numerous known and unknown risks, uncertainties, and other factors, many of which are beyond the control of the Company. The reader is cautioned not to place undue reliance on any forward-looking information. Such information, although considered reasonable by management at the time of preparation, may prove to be incorrect and actual results may differ materially from those anticipated. Forward-looking statements contained in this news release are expressly qualified by this cautionary statement. The forward-looking statements contained in this news release are made as of the date of this news release and the Company will update or revise publicly any of the included forward-looking statements only as expressly required by applicable law. No securities exchange or commission has reviewed or accepts responsibility for the adequacy or accuracy of this release. Disclaimer This news release does not constitute an offer to sell or a solicitation of an offer to buy nor shall there be any sale of any securities in any jurisdiction in which such offer, solicitation, or sale would be unlawful. The securities of the Company have not been and will not be registered under the United States Securities Act of 1933, as amended (the “1933 Act”), or any state securities laws and may not be offered or sold in the “United States” or to “U.S. persons” (as such terms are defined in Regulation S under the 1933 Act) unless registered under the 1933 Act and applicable state securities laws, or an exemption from such registration requirements is available. View the original release on www.newmediawire.com
Total distribution of EUR 2.6 million Approval of anticipatory resolutions and all agenda items SCHWANDORF and AMBERG, GERMANY - June 24, 2026 (NEWMEDIAWIRE) - At today's Annual General Meeting, held in person in Amberg, the Management Board and Supervisory Board of Nabaltec AG once again received broad shareholder support for the company's operational direction and corporate strategy. Shareholders followed the joint profit appropriation proposal of the Management Board and Supervisory Board and resolved to distribute a dividend totaling EUR 2.6 million, or EUR 0.29 per share. The remaining distributable profit of EUR 66.6 million will be carried forward to new account and will continue to serve to strengthen the company's equity base. The dividend will be paid out on 29 June 2026. “Once again, we have received strong approval from our shareholders for the direction of Nabaltec AG. Against the backdrop of a challenging market environment – particularly in the chemical industry – this vote of confidence is of great importance,” said Johannes Heckmann, CEO of Nabaltec AG. “We are especially pleased to be able to give our shareholders a share in the company's success, particularly given the overall more cautious dividend policy across the chemicals sector.” In addition to the profit appropriation, shareholders approved the discharge of the Management Board and Supervisory Board, as well as the proposal for the election of the auditor for the 2026 Financial Year and various anticipatory resolutions. These include the authorization to acquire treasury shares, the creation of new authorized capital, and the option to issue convertible bonds and/or bonds with warrants, including the creation of new contingent capital. Note: The voting results of Nabaltec AG's 2026 Annual General Meeting will be available for download from the Investor Relations/Annual General Meeting section of www.nabaltec.de/en, shortly. About Nabaltec AG: Nabaltec AG, with registered office in Schwandorf, a chemicals business which has received multiple awards for innovativeness, manufactures, develops and distributes highly specialized products based on aluminum hydroxide and aluminum oxide on an industrial scale through its two product segments, “Functional Fillers” and “Specialty Aluminas.” The company's product range includes eco-friendly flame retardant fillers and functional additives for the plastics industry. Flame retardant fillers are used e.g. in cables in tunnels, airports, high-rise buildings and electronic devices, while additives have applications in catalysis and in electric vehicles. Nabaltec also produces specialty oxides for use in technical ceramics, the refractory and polishing industries. Nabaltec maintains production sites in Germany and the US and plans to continue to develop its market position by expanding capacity, further optimizing processes and quality and making strategic extensions to its product range. On the strength of its specialty products, the company strives to attain the market leadership in each segment. Contact: Heidi Wiendl-Schneller Nabaltec AG Phone: +49 9431 53-202 E-mail: InvestorRelations@nabaltec.de Vera Muller/Frank Ostermair IR4value GmbH Phone: +49 156 78409459 E-mail: Vera.Mueller@ir4value.de
Change on the Management Board Following the Scheduled end of Stefan Heidenreich’s Term of Office DUDERSTADT, GERMANY - June 24, 2026 (NEWMEDIAWIRE) - Ottobock SE & Co. KGaA, the listed global MedTech company, has appointed Dr. Katarzyna Mazur-Hofsaess to its Management Board effective 22 June 2026. She succeeds Stefan Heidenreich, whose regular five-year term on the Management Board has come to an end. “With Dr. Katarzyna Mazur-Hofsaess, we are gaining a proven expert in international medical technology and healthcare. Her experience in global companies and her medical background will be a valuable addition to our Board,” says Professor Hans Georg Nader, Chairman of the Management Board of Ottobock SE & Co. KGaA. Dr. Mazur-Hofsaess has many years of international experience in medical technology and healthcare. From 2018 to 2025, she was a member of the Management Board of Fresenius Medical Care and CEO of the company MedTech segment Care Enablement. Prior to that, she was responsible for the EMEA region at Zimmer Biomet, the US-based specialist in joint replacement solutions. Earlier in her career, she held positions at Abbott Diagnostics and Roche Polska. She is also currently active as an independent, non-executive Director at Smith & Nephew. A physician by training, Dr. Mazur-Hofsaess studied and earned her doctorate at the Medical University of Gdansk. She also completed management studies at the Warsaw School of Economics and the University of Minnesota. She began her professional career at the University Clinical Centre in Gdansk. Stefan Heidenreich is stepping down from the Management Board following the scheduled end of his regular five-year term of office. As Deputy Chairman of the Management Board, he played a key role in shaping the company’s strategic development. Ottobock expressly thanks him for his work and the expertise he contributed to the company’s development into a listed company. Contact Media contact: Ottobock SE & Co. KGaA Merle Florstedt Head of Corporate Communications Mobile +49 151 441 616 25 Merle.florstedt@ottobock.de Investor Relations contact: Ottobock SE & Co. KGaA Julia Hartmann VP Investor Relations Mobile +49 151 556 848 07 Julia.Hartmann@ottobock.de About Ottobock Listed global MedTech champion Ottobock combines more than 100 years of tradition with outstanding innovative strength in prosthetics, neuro-orthotics and exoskeletons. Ottobock develops innovative care solutions for people with limited mobility and is driving the digitalization of the industry. Founded in Berlin in 1919, the company now operates in 45 countries with almost 9,300 employees (FTE) and runs the world’s largest international patient care network with around 420 patient care centers worldwide. With a strong R&D ratio in its product and components business and more than 2,600 patents and patent applications, Ottobock is shaping the Human Bionics landscape of the future. The mission to improve people’s freedom of movement, quality of life and independence is deeply rooted in the company’s DNA - as is its social commitment: Ottobock has been a partner and supporter of the Paralympic Games since 1988. View the original release on www.newmediawire.com
Inclusion in an Index Following Rapid Success in the Capital Markets Just Three Months After the Initial Public Offering WEDEL, GERMANY - June 24, 2026 (NEWMEDIAWIRE) - VINCORION SE, a leading developer and manufacturer of energy and mechatronics solutions for defense platforms and advanced aviation systems, was officially listed on the SDAX of the Frankfurt Stock Exchange on June 22, 2026. This makes the company one of the 70 largest and most liquid publicly traded companies in Germany below the MDAX – just three months after it successfully began trading on March 20, 2026. Inclusion in one of Deutsche Borse’s prestigious indices underscores the extraordinary pace at which VINCORION has established itself as a capital-market-ready company. It reflects the high level of confidence that institutional and private investors have in the company’s business model and growth prospects. “With today’s inclusion in the SDAX, we are reaching another important milestone – and at a pace that fills us with pride,” says Dieter Holst, CFO of VINCORION. “As an SDAX member, we are now visible and relevant to a significantly broader circle of institutional and passive investors. This creates a stable foundation on which we will consistently expand our capital market presence and generate sustainable value for our shareholders.” The index inclusion is based on Deutsche Borse’s regulations and confirms VINCORION’s growing market capitalization. About VINCORION SE VINCORION SE is a leading developer and manufacturer of power and mechatronic solutions for defense platforms and advanced aviation systems. The company is specialized on innovative power systems, including generators, electric motors and drives, gensets, power electronics, and hybrid power systems. As a partner to the defense and aviation industries, VINCORION develops and manufactures solutions tailored to its customers’ specific requirements on the basis of an in-depth dialog. A high-performance customer support team provides assistance and service to users of the company’s own products and those from third parties throughout the entire product life cycle. With approximately 900 employees at sites in Germany and the United States, VINCORION generated revenues of approximately EUR 240 million in financial year 2025. For more information and the latest news, please visit www.vincorion.com and follow us on LinkedIn. Media Contact Frederike Gasa Head of Communications & Marketing VINCORION SE Feldstrasse 155 22880 Wedel, Germany E-Mail: media@vincorion.com IR Contact Felix Zander Head of Investor Relations VINCORION SE Feldstrasse 155 22880 Wedel, Germany E-Mail: ir@vincorion.com View the original release on www.newmediawire.com
Total distribution of EUR 2.6 million Approval of anticipatory resolutions and all agenda items SCHWANDORF and AMBERG, GERMANY - June 24, 2026 (NEWMEDIAWIRE) - At today's Annual General Meeting, held in person in Amberg, the Management Board and Supervisory Board of Nabaltec AG once again received broad shareholder support for the company's operational direction and corporate strategy. Shareholders followed the joint profit appropriation proposal of the Management Board and Supervisory Board and resolved to distribute a dividend totaling EUR 2.6 million, or EUR 0.29 per share. The remaining distributable profit of EUR 66.6 million will be carried forward to new account and will continue to serve to strengthen the company's equity base. The dividend will be paid out on 29 June 2026. “Once again, we have received strong approval from our shareholders for the direction of Nabaltec AG. Against the backdrop of a challenging market environment – particularly in the chemical industry – this vote of confidence is of great importance,” said Johannes Heckmann, CEO of Nabaltec AG. “We are especially pleased to be able to give our shareholders a share in the company's success, particularly given the overall more cautious dividend policy across the chemicals sector.” In addition to the profit appropriation, shareholders approved the discharge of the Management Board and Supervisory Board, as well as the proposal for the election of the auditor for the 2026 Financial Year and various anticipatory resolutions. These include the authorization to acquire treasury shares, the creation of new authorized capital, and the option to issue convertible bonds and/or bonds with warrants, including the creation of new contingent capital. Note: The voting results of Nabaltec AG's 2026 Annual General Meeting will be available for download from the Investor Relations/Annual General Meeting section of www.nabaltec.de/en, shortly. About Nabaltec AG: Nabaltec AG, with registered office in Schwandorf, a chemicals business which has received multiple awards for innovativeness, manufactures, develops and distributes highly specialized products based on aluminum hydroxide and aluminum oxide on an industrial scale through its two product segments, “Functional Fillers” and “Specialty Aluminas.” The company's product range includes eco-friendly flame retardant fillers and functional additives for the plastics industry. Flame retardant fillers are used e.g. in cables in tunnels, airports, high-rise buildings and electronic devices, while additives have applications in catalysis and in electric vehicles. Nabaltec also produces specialty oxides for use in technical ceramics, the refractory and polishing industries. Nabaltec maintains production sites in Germany and the US and plans to continue to develop its market position by expanding capacity, further optimizing processes and quality and making strategic extensions to its product range. On the strength of its specialty products, the company strives to attain the market leadership in each segment. Contact: Heidi Wiendl-Schneller Nabaltec AG Phone: +49 9431 53-202 E-mail: InvestorRelations@nabaltec.de Vera Muller/Frank Ostermair IR4value GmbH Phone: +49 156 78409459 E-mail: Vera.Mueller@ir4value.de View the original release on www.newmediawire.com
BERLIN - June 24, 2026 (NEWMEDIAWIRE) - The Annual General Meeting of Eckert & Ziegler SE (ISIN DE0005659700) today approved the proposal of the Executive Board and Supervisory Board and resolved to pay a dividend of EUR 0.22 per share (previous year: EUR 0.17) for the 2025 fiscal year. As in previous years, the Annual General Meeting was held as an in-person event, right next to the Eckert & Ziegler SE headquarters in Berlin. In total, 55.37 % of the company’s share capital was represented. The Annual General Meeting endorsed the members of the Executive Board and the Supervisory Board of Eckert & Ziegler SE for the 2025 fiscal year and approved all items on the agenda by a large majority. The detailed voting results of the Annual General Meeting and the CEO’s presentation are available on the Eckert & Ziegler SE website: https://www.ezag.com/investors/annual-general-meeting/ About Eckert & Ziegler Eckert & Ziegler SE with more than 1.000 employees is a leading specialist for isotope-related components in nuclear medicine and radiation therapy. The company offers a broad range of services and products for the radiopharmaceutical industry, from early development work to contract manufacturing and distribution. Eckert & Ziegler shares (ISIN DE0005659700) are listed in the TecDAX index of Deutsche Börse. Contributing to saving lives. Your contact: Eckert & Ziegler SE, Karolin Riehle, Investor Relations Robert-Rossle-Str. 10, 13125 Berlin, Germany Tel.: +49 (0) 30 / 94 10 84-138, karolin.riehle@ezag.de, www.ezag.com View the original release on www.newmediawire.com
BERLIN - June 24, 2026 (NEWMEDIAWIRE) - The Annual General Meeting of Eckert & Ziegler SE (ISIN DE0005659700) today approved the proposal of the Executive Board and Supervisory Board and resolved to pay a dividend of EUR 0.22 per share (previous year: EUR 0.17) for the 2025 fiscal year. As in previous years, the Annual General Meeting was held as an in-person event, right next to the Eckert & Ziegler SE headquarters in Berlin. In total, 55.37 % of the company’s share capital was represented. The Annual General Meeting endorsed the members of the Executive Board and the Supervisory Board of Eckert & Ziegler SE for the 2025 fiscal year and approved all items on the agenda by a large majority. The detailed voting results of the Annual General Meeting and the CEO’s presentation are available on the Eckert & Ziegler SE website: https://www.ezag.com/investors/annual-general-meeting/ About Eckert & Ziegler Eckert & Ziegler SE with more than 1.000 employees is a leading specialist for isotope-related components in nuclear medicine and radiation therapy. The company offers a broad range of services and products for the radiopharmaceutical industry, from early development work to contract manufacturing and distribution. Eckert & Ziegler shares (ISIN DE0005659700) are listed in the TecDAX index of Deutsche Börse. Contributing to saving lives. Your contact: Eckert & Ziegler SE, Karolin Riehle, Investor Relations Robert-Rossle-Str. 10, 13125 Berlin, Germany Tel.: +49 (0) 30 / 94 10 84-138, karolin.riehle@ezag.de, www.ezag.com View the original release on www.newmediawire.com
OSTFILDERN, GERMANY - June 24, 2026 (NEWMEDIAWIRE) - BOS GmbH & Co. KG (“BOS”) issued senior secured bonds in an aggregate amount of EUR 150,000,000 (the “Bonds”) (ISIN:NO0013515759) on 25 June 2025. The application for admission to trading of the Bonds on a regulated market has been made in accordance with the Bond terms. For this purpose, BOS prepared a listing prospectus, which has been approved by the Luxembourg Commission de Surveillance du Secteur Financier (CSSF). The Bonds have been admitted to trading on the Luxembourg Stock Exchange (LuxSE) as of today. The listing of the Bonds is available on the Luxembourg Stock Exchange’s website: https://www.luxse.com/security/NO0013515759/534057 The prospectus is available on the company’s website: https://www.bos.de/app/uploads/2026/06/BOS-GmbH-Co.-KG-Nordic-Bond-Prospectus-24-June-2026.pdf About BOS Founded in 1910, BOS GmbH & Co. KG is a global leader in kinematics and mechatronic systems for automotive interiors and exteriors. The company develops and produces innovative components that enhance vehicle comfort, safety, and functionality - fully independent of the powertrain. Along its 115-year history, BOS has been recognized for its strong innovation track record and market-making expertise, having repeatedly delivered first-to-market solutions that define new industry standards. With resilient supply chains and a best-cost production network that is strategically built for close proximity to major OEM hubs, BOS serves a diverse blue-chip customer base. Its longstanding partnerships with established automakers are complemented by growing ties to emerging OEMs across key markets. As of 31 March 2026, the BOS Group employed approximately 5,600 full-time equivalents (FTE). For more information, please visit www.bos.de. IR Contact Philipp Sander BOS GmbH & Co. KG Ernst-Heinkel-Strasse 2 73760 Ostfildern GERMANY E-Mail: ir@bos.de View the original release on www.newmediawire.com
PRATTELN, SWITZERLAND - June 24, 2026 (NEWMEDIAWIRE) - The Annual General Meeting of Highlight Event and Entertainment AG adopts all proposals of the Board of Directors. Highlight Event and Entertainment AG, Pratteln ("HLEE"), which is listed on the SIX Swiss Stock Exchange, held its Annual General Meeting today. All motions proposed by the Board of Directors were approved by the shareholders with a large majority in each case. Bernhard Burgener was re-elected as Chairman of the Board of Directors for another term of office, and Peter von Buren, Clive Ng, Edda Kraft and Stefan Wehrenberg were re-elected as members of the Board of Directors for another year. Edda Kraft and Stefan Wehrenberg were additionally re-elected as members of the Compensation Committee. Contact: Highlight Event und Entertainment AG Netzibodenstrasse 23b 4133 Pratteln Investor Relations Tel.: +41 41 226 05 97 info@hlee.ch www.hlee.ch View the original release on www.newmediawire.com
LOS ANGELES, CA - June 24, 2026 (NEWMEDIAWIRE) - Beeline Holdings (NASDAQ: BLNE), a fast-growing digital mortgage platform offering a quicker and easier path to home ownership, was added as a member of the Russell Microcap Index, marking a notable milestone for the digital mortgage company as it attempts to scale its technology-driven lending platform during one of the most challenging housing finance environments in years. Beeline’s AI-enabled underwriting and customer acquisition tools are designed to reduce friction in mortgage approvals, particularly for gig-economy borrowers. Shares of Beeline Holdings, Inc. are set to join the Russell Microcap Index effective June 29, increasing visibility among institutional investors. The company’s first-quarter 2026 revenue more than doubled year over year to $2.7 million, while loan originations rose to $85.6 million. Management is targeting younger real estate investors alongside older homeowners seeking access to home equity without refinancing. The company continues investing in automation and adjacent software capabilities as it pursues a broader housing finance technology strategy. The inclusion, effective June 29 following the annual Russell indexes reconstitution, places Beeline among a group of small-cap companies tracked by institutional investors and index-linked funds. According to FTSE Russell, approximately $12.2 trillion in assets are benchmarked against… Read More Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://IBN.fm/Disclaimer Forward Looking Statements Certain statements in this article are forward-looking, as defined in the Private Securities Litigation Reform Act of 1995. These statements involve risks, uncertainties, and other factors that may cause actual results to differ materially from the information expressed or implied by these forward-looking statements and may not be indicative of future results. These forward-looking statements are subject to a number of risks and uncertainties, including, among others, various factors beyond management's control, including the risks set forth under the heading "Risk Factors" discussed under the caption "Item 1A. Risk Factors" in Part I of the Company's most recent Annual Report on Form 10-K or any updates discussed under the caption "Item 1A. Risk Factors" in Part II of the Company's Quarterly Reports on Form 10-Q and in the Company's other filings with the SEC. Undue reliance should not be placed on the forward-looking statements in this article in making an investment decision, which are based on information available to us on the date hereof. All parties undertake no duty to update this information unless required by law
LOS ANGELES, CA - June 24, 2026 (NEWMEDIAWIRE) - Greenland Mines (NASDAQ: GRML) is focused on the exploration and development of mineral assets in Greenland. Through its mining division, the company is advancing the Skaergaard Project in southeast Greenland while also pursuing the acquisition of the Sarfartoq rare earth project in southwest Greenland. Together, these assets provide exposure to precious metals, critical metals and rare earth elements within a jurisdiction that has attracted growing interest as governments and industries seek to diversify strategic mineral supply chains. Greenland Mines’ flagship Skaergaard Project hosts an NI 43-101 Mineral Resource estimate containing 11.4 million ounces PdEq in the Indicated category and 14.1 million ounces PdEq in the Inferred category. The pending acquisition of the Sarfartoq Project would add an advanced rare earth asset with a historical resource estimate, extensive drilling history and exposure to magnet rare earth elements including neodymium and praseodymium. The company’s relationship with Neo Performance Materials includes an offtake arrangement covering up to 60% of future Sarfartoq production, subject to completion of the acquisition and future project development. Greenland Mines is pursuing a North Atlantic critical minerals strategy that includes resource development in Greenland and potential downstream processing and logistics initiatives in Iceland. Greenland Mines’ strategic investment in AnorTech provides exposure to sustainable alumina, high purity alumina and related midstream processing opportunities that complement the company’s broader critical minerals strategy. The company’s strategy centers on building a North Atlantic critical minerals platform that links resource development in Greenland with downstream processing, logistics infrastructure and industrial markets in Europe and North America. In June 2026, Greenland Mines expanded that strategy through a strategic… Read More Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://IBN.fm/Disclaimer The latest news and updates relating to GRML are available in the company’s newsroom at https://ibn.fm/GRML Forward Looking Statements Certain statements in this article are forward-looking, as defined in the Private Securities Litigation Reform Act of 1995. These statements involve risks, uncertainties, and other factors that may cause actual results to differ materially from the information expressed or implied by these forward-looking statements and may not be indicative of future results. These forward-looking statements are subject to a number of risks and uncertainties, including, among others, various factors beyond management's control, including the risks set forth under the heading "Risk Factors" discussed under the caption "Item 1A. Risk Factors" in Part I of the Company's most recent Annual Report on Form 10-K or any updates discussed under the caption "Item 1A. Risk Factors" in Part II of the Company's Quarterly Reports on Form 10-Q and in the Company's other filings with the SEC. Undue reliance should not be placed on the forward-looking statements in this article in making an investment decision, which are based on information available to us on the date hereof. All parties undertake no duty to update this information unless required by law.
LOS ANGELES, CA - June 24, 2026 (NEWMEDIAWIRE) - VERAXA Biotech (NASDAQ: VRXA), an emerging developer of novel cancer therapies, announced it has expanded its laboratory footprint at its existing research and development site in Heidelberg, Germany, under a previously executed long-term lease agreement. The additional space will support planned growth of the company’s R&D team, installation of new laboratory equipment and completion of infrastructure needed to advance future development activities. VERAXA said the expansion aligns with efforts to advance its growing portfolio of proprietary and partnered oncology programs from discovery-stage research toward early clinical development. The company’s pipeline is centered on its BiTAC platform, including BiTAC-TCE and BiTAC-ADC candidates, which are designed to enable tumor-restricted activation of cancer therapies through the use of complementary precursor molecules. To view the full press release, visit https://ibn.fm/n3t6U About VERAXA Biotech AG At VERAXA, we are building a premier engine for the discovery and development of next-generation antibody-based therapeutics, including bispecific T cell engagers, bispecific ADCs and other innovative formats. Powered by a suite of transformative technologies and guided by rigorous quality-by-design principles, we are rapidly advancing our pipeline of ADCs and proprietary BiTAC formats into clinical development and beyond. VERAXA was founded on scientific breakthroughs made at the European Molecular Biology Laboratory (EMBL), a world-renowned institution known for pioneering life science research and cutting-edge technology. Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://IBN.fm/Disclaimer The latest news and updates relating to VRXA are available in the company’s newsroom at https://ibn.fm/VRXA Forward Looking Statements Certain statements in this article are forward-looking, as defined in the Private Securities Litigation Reform Act of 1995. These statements involve risks, uncertainties, and other factors that may cause actual results to differ materially from the information expressed or implied by these forward-looking statements and may not be indicative of future results. These forward-looking statements are subject to a number of risks and uncertainties, including, among others, various factors beyond management's control, including the risks set forth under the heading "Risk Factors" discussed under the caption "Item 1A. Risk Factors" in Part I of the Company's most recent Annual Report on Form 10-K or any updates discussed under the caption "Item 1A. Risk Factors" in Part II of the Company's Quarterly Reports on Form 10-Q and in the Company's other filings with the SEC. Undue reliance should not be placed on the forward-looking statements in this article in making an investment decision, which are based on information available to us on the date hereof. All parties undertake no duty to update this information unless required by law
BEIJING - June 24, 2026 (NEWMEDIAWIRE) - LakeShore Biopharma Co., Ltd (“LakeShore Biopharma” or the “Company”) (OTCPK: LSBCF; OTCPK: LSBWF), a global biopharmaceutical company dedicated to discovering, developing, manufacturing, and delivering new generations of vaccines and therapeutic biologics for infectious diseases and cancer, today announced the completion of the merger (the “Merger”) with Oceanpine Merger Sub Inc. (“Merger Sub”), a wholly owned subsidiary of Oceanpine Skyline Inc. (“Parent”), pursuant to the previously announced Agreement and Plan of Merger, dated November 4, 2025, as amended by Amendment No. 1 to Agreement and Plan of Merger, dated April 29, 2026 (the “Merger Agreement”), by and among the Company, Parent and Merger Sub. As a result of the Merger, the Company became a wholly owned subsidiary of Parent and will cease to be a publicly traded company. Pursuant to the Merger Agreement, which was approved by the Company’s shareholders at an extraordinary general meeting on June 19, 2026, at the effective time of the Merger (the “Effective Time”), (i) each ordinary share, par value US$0.0002 per share, of the Company (each, a “Share”), issued and outstanding immediately prior to the Effective Time (other than the Excluded Shares (as defined in the Merger Agreement) and the Dissenting Shares (as defined in the Merger Agreement)) was cancelled and ceased to exist in exchange for the right to receive US$0.066 in cash per Share without interest and net of any applicable withholding taxes (the “Merger Consideration”), and (ii) each Excluded Share was cancelled and ceased to exist without payment of any consideration or distribution from the Company therefor. Registered holders of Shares immediately prior to the Effective Time who are entitled to the Merger Consideration will receive from the paying agent a letter of transmittal and instructions on how to surrender their Shares in exchange for the Merger Consideration in respect of each Share held thereby, and should wait to receive the letter of transmittal before surrendering their Shares. Payment of the Merger Consideration will be made to holders of Shares in respect of each such Share held thereby upon surrender of applicable Shares and delivery of the letter of transmittal and any other documents required by such letter of transmittal to be delivered in connection therewith. The Company intends to suspend its reporting obligations under the Securities Exchange Act of 1934, as amended, by promptly filing a Form 15 with the U.S. Securities and Exchange Commission (the “SEC”). The Company’s obligation to file with the SEC certain reports and forms, including Form 20-F and Form 6-K, will be suspended immediately as of the filing date of the Form 15 and will cease once the deregistration becomes effective. In connection with the Merger, the Company has filed with the Financial Industry Regulatory Authority, Inc. (“FINRA”), as required by FINRA Rule 6490, an Issuer Company-Related Action Notification Form. Upon the effectiveness of the Merger, FINRA is expected to remove the Company’s trading symbols from the OTC Pink tier of the OTC Markets. However, such removal may not be completed until one or more trading days after the consummation of the Merger. Any trades effectuated following the consummation of the Merger and prior to the removal of the trading symbols by FINRA will not be valid trades, as the securities subject to any such trades will no longer be outstanding as a result of the Merger. The Company is providing this information to help prevent trades from being effected that may subsequently be invalidated. The Company will not be responsible for any losses that may be incurred as a result of trades that occur from and after the completion of the Merger. Kroll, LLC is serving as the financial advisor to a committee of independent directors established by the board of directors of the Company (the “Special Committee”). Gibson, Dunn & Crutcher LLP is serving as U.S. legal counsel to the Special Committee. Maples and Calder (Hong Kong) LLP is serving as Cayman Islands legal counsel to the Special Committee. White & Case LLP is serving as U.S. legal counsel to the buyer group with respect to the Merger. About LakeShore Biopharma Co., Ltd LakeShore Biopharma, previously known as YS Biopharma, is a global biopharmaceutical company dedicated to discovering, developing, manufacturing, and delivering new generations of vaccines and therapeutic biologics for infectious diseases and cancer. It has developed a proprietary PIKA® immunomodulating technology platform and a new generation of preventive and therapeutic biologics targeting Rabies, Hepatitis B, Influenza, and other virus infections. The Company operates in China, Singapore, and the Philippines, and is led by a management team that combines rich local expertise and global experience in the biopharmaceutical industry. For more information, please visit https://investors.lakeshorebio.com/. Forward-Looking Statements This press release contains statements that may constitute “forward-looking” statements. These forward-looking statements include, without limitation, the Company’s business plans and development, which can be identified by terminology such as “may,” “will,” “expect,” “anticipate,” “aim,” “future,” “estimate,” “intend,” “plan,” “believe,” “potential,” “continue,” “is/are likely to” or other similar expressions. Statements that are not historical facts, including statements about LakeShore Biopharma’s beliefs, plans and expectations, are forward-looking statements. Forward-looking statements involve inherent risks and uncertainties. A number of factors could cause actual results to differ materially from those contained in any forward-looking statement, including but not limited to the following: uncertainties as to the expected benefits and costs of the Merger; the outcome of any legal proceedings that may be instituted against the Company related to the Merger; the amount of the costs, fees, expenses and charges related to the Merger; the Company’s expectation that its trading symbols will be removed from the OTC Pink tier of the OTC Markets; and other risks and uncertainties discussed in documents filed with the SEC by the Company. Further information regarding these and other risks, uncertainties or factors is included in the Company’s filings with the SEC. All information provided in this press release is as of the date of this press release, and the Company does not undertake any obligation to update any forward-looking statement as a result of new information, future events or otherwise, except as required under applicable law. For investor inquiries, please contact: IR Team Tel: +86 (10) 8920-2086 Email: ir@lakeshorebio.com View the original release on www.newmediawire.com
TULSA, OK - June 24, 2026 (NEWMEDIAWIRE) - Ladybug Resource Group, Inc. ("Ladybug" or the "Company") (OTC ID: LBRG) today announced the continued expansion of its strategic collaboration between its Jingdiao manufacturing division and Mino, a globally recognized provider of intelligent manufacturing and industrial automation solutions. The collaboration underscores Jingdiao’s growing role as a precision manufacturing partner supporting advanced automotive production systems. By combining Jingdiao’s engineering and fabrication capabilities with Mino’s large-scale integration expertise, the companies are contributing to the development and deployment of next-generation body-in-white (BIW) welding and assembly systems for electric vehicle manufacturers worldwide. Supporting Global Automotive Manufacturing Programs Through this relationship, Jingdiao supplies high-precision fixtures, robotic bases, structural assemblies, and specialized manufacturing components utilized in large-scale automation projects. These systems support production environments serving leading automotive manufacturers, including Tesla, Volkswagen, BMW, and other global OEMs. As vehicle manufacturers continue investing in electric vehicle production capacity and factory modernization, the ability to deliver precision-engineered components on schedule and to specification has become increasingly important. Jingdiao’s digital manufacturing systems, engineering processes, and quality-control standards help support Mino’s deployment requirements across multiple international markets. Integrated Manufacturing Capabilities Jingdiao operates a comprehensive manufacturing platform that includes advanced laser cutting, precision machining, welding, assembly, finishing, and environmentally certified painting operations. This integrated approach enables the Company to manage complex manufacturing projects from design through final delivery while maintaining quality and production consistency. By consolidating multiple manufacturing processes under one operation, Jingdiao helps reduce supply chain complexity and supports the delivery requirements of global industrial automation projects. Management Commentary "Our expanding relationship with Mino reflects the manufacturing capabilities and operational standards developed by our Jingdiao team," said Mr. Shicai Li, Chief Executive Officer of the Manufacturing Division. "As demand for advanced automation and EV production infrastructure continues to grow, we believe our engineering expertise, digital management systems, and integrated manufacturing capabilities position us to support some of the world's most sophisticated industrial projects. We look forward to further strengthening our collaboration with Mino and expanding our participation in the global automotive manufacturing sector." About Ladybug Resource Group, Inc. Ladybug Resource Group, Inc. is a US-listed company focused on the intersection of advanced manufacturing and industrial AI. Through its acquisition of Guangzhou JingDiao, the Company provides digitally managed supply chain solutions for the global automotive and precision engineering industries, led by a management team with deep roots in world-class manufacturing excellence. Stay connected: Website: Ladybug Resource Group Inc. OTC Markets: LBRG Stock Quote X (formerly Twitter) LinkedIn Instagram Media & Investor Relations Contact Warren Booth Ladybug Resource Group Inc. 1408 S. Denver Avenue, Tulsa, OK 74119 info@ladybuglbrg.com +1 918-727-7137 Safe Harbor Statement This news release contains forward-looking statements which are not statements of historical fact. Forward-looking statements include estimates and statements that describe the Company's future plans, objectives or goals, including words to the effect that the Company or management expects a stated condition or result to occur. Forward-looking statements may be identified by such terms as "believes," "anticipates", "expects", "estimates", "may", "could", "would", "will", or "plan". Since forward-looking statements are based on assumptions and address future events and conditions, by their very nature they involve inherent risks and uncertainties. Although these statements are based on information currently available to the Company, the Company provides no assurance that the actual results will meet management's expectations. Risks, uncertainties, and other factors involved with forward-looking information could cause actual events, results, performance, prospects, and opportunities to differ materially from those expressed or implied by such forward-looking information. Factors that could cause actual results to differ materially from such forward-looking information include but are not limited to changes in general economic and financial market conditions. Although the Company believes that the assumptions and factors used in preparing the forward-looking information in this news release are reasonable, undue reliance should not be placed on such information, which only applies as of the Date of this news release, and no assurance can be given that such events will occur in the disclosed time frames or at all. The Company disclaims any intention or obligation to update or revise any forward-looking information, whether as a result of new information, future events or otherwise, other than as required by law.
VANCOUVER, BC - June 24, 2026 (NEWMEDIAWIRE) - North Atlantic Titanium Corp. (CSE: NATO) (OTCQB: NATQF) (FSE: Y33) (“North Atlantic Titanium,” or the “Company”) is pleased to announce that its common shares have been approved for uplisting from the OTCPK to the OTCQB Venture Market (“OTCQB”), effective June 24, 2026, and that the Company has received DTC eligibility. The Company will continue to trade under the symbol “NATQF” on the OTC, “NATO” on the Canadian Securities Exchange and “Y33” on the Frankfurt Stock Exchange. The OTCQB serves as a premier trading platform for emerging companies, offering greater visibility, liquidity, and transparency to United States investors. Companies must meet stringent financial and regulatory requirements, including annual verification, management certification, and compliance with U.S. securities laws. The Company is also pleased to announce that its application for Depository Trust Company (DTC) eligibility has been received and approved. DTC eligibility simplifies the trading process by allowing U.S. investors to trade, settle, and transfer shares electronically, increasing liquidity, reducing transaction costs, and streamlining stock transfers for shareholders. Dwayne Yaretz, CEO and Director of North Atlantic Titanium, states “We are pleased to announce this important milestone as North Atlantic Titanium’s common shares begin trading on the OTCQB Market in the United States. This uplisting strengthens our ability to enhance liquidity, broaden our investor base, and significantly expand our presence in the U.S. capital markets as we continue to advance our Everett titanium-vanadium project in Quebec.” About North Atlantic Titanium Corp. North Atlantic Titanium Corp. is a Canadian publicly traded exploration company focused on advancing the Everett titanium-vanadium project in Quebec, targeting the production of high-quality titanium feedstocks with potential value-added vanadium and phosphate coproducts. The Company also holds a 100-per-cent interest in the Sleeping Giant South project, located in the Abitibi greenstone belt, approximately 75 kilometres south of Matagami, Quebec. For more information, please visit www.natitanium.com. ON BEHALF OF THE BOARD OF DIRECTORS For more information, please visit our website at www.natitanium.com. ON BEHALF OF THE BOARD OF DIRECTORS Dwayne Yaretz, CEO North Atlantic Titanium Corp. Phone: 778-709-3398 Email: info@natitanium.com Website: www.natitanium.com Neither the Exchange nor its Regulation Services Provider (as that term is defined in the policies of the Exchange) accepts responsibility for the adequacy or accuracy of this release. View the original release on www.newmediawire.com
GRANDE PRAIRIE, ALBERTA - June 24, 2026 (NEWMEDIAWIRE) - ANGKOR RESOURCES CORP. (TSXV: ANK) (“ANGKOR” OR “THE COMPANY”) announces that a total of 2,800 meters of diamond drilling is planned for the Andong Bor copper-gold target in Cambodia over the coming months. Drilling will focus on the Thmei North (“TN”) target, a one-square-kilometer copper anomaly. The program is staged around the Cambodian seasons: an initial 1,200 meters in three holes is starting June 24 2026 to be completed during the current dry-season window with the balance of the program to follow in early 2027 once the fields are dry and the crops have been harvested. DRILL PROGRAM AT A GLANCE Total program: 2,800 meters of diamond drilling planned at the Thmei North copper-gold target over the next 8 months. First phase: three 400-metre holes to be drilled starting June 24th 2026, before the heavy rains descend upon the Kingdom of Cambodia. Second phase: the remaining 1,600 meters to be drilled in early 2027, once the fields are dry and the crops have been harvested. Hole orientation: the three initial holes will be drilled to the east to better intersect the mineralized beds. Core will be logged, photographed, and sampled, with selected intervals dispatched for assay as the program progresses. THMEI NORTH - DRILLING TO THE EAST The Andong Bor license is 100.28 square kilometers and straddles Oddar Meanchey and Banteay Meanchey provinces. Drilling completed in 2025 showed that the main structures controlling mineralization are north-northwest (NNW) striking and steeply west dipping. These three holes will be drilled to the east in order to better intersect the mineralized beds. In this modified copper porphyry model, the best mineralization is found within potassic-altered sediments adjacent to feldspar porphyry diorite dikes of varying widths. The intrusive dikes vary in width from a few meters to tens of meters. By drilling to the east, the Company will maximize mineralized sedimentary rock interceptions as it drills through alternating lithologies of intrusive and sedimentary rocks. Dennis Ouellette, VP Exploration, comments: “Our 2025 drilling told us how this system is oriented. The structures controlling mineralization are north-northwest striking and steeply west dipping, so by drilling to the east we put the core across the mineralized beds rather than down them. The best copper sits in the potassic-altered sediments next to the feldspar porphyry diorite dikes, and an eastward orientation lets us cut the most of that favorable host as we pass in and out of the intrusive dikes.” THMEI SOUTH - NEXT STEPS Thmei South requires further auger soil geochemistry to extend the existing copper geochemical anomaly southward and determine its full extent. Thmei South will be the focus of subsequent drill programs. QUALIFIED PERSON: Dennis Ouellette, B.Sc., P.Geo., is a member of The Association of Professional Engineers and Geoscientists of Alberta (APEGA #104257) and a Qualified Person as defined by National Instrument 43-101 (“NI 43-101”). He is the Company’s VP Exploration on site and has reviewed and approved the technical disclosure in this document. ABOUT ANGKOR RESOURCES CORP. ANGKOR Resources Corp. is a public company, listed on the TSX-Venture Exchange, and is a leading resource explorer and developer in Cambodia working towards mineral and energy solutions across the country. The Company's mineral subsidiary, Angkor Gold Corp. Co., Ltd., currently holds two mineral exploration licenses in Cambodia with multiple prospects in copper and gold. Both licenses are in their first two-year renewal term. Angkor’s Cambodian energy subsidiary, EnerCam Resources Co., Ltd., was granted an onshore oil and gas license in the southwest quadrant of Cambodia called Block VIII. The original 7,300 km² license was reduced to approximately 4,300 km² upon voluntary removal of parks and protected areas, subsequently adjusted through government remapping directed by the Ministry of Mines and Energy, and then expanded by 220 km² with the addition of the Kirirom Basin in the northeast, resulting in the current area of approximately 4,095 km². EnerCam is actively advancing oil and gas exploration activities onshore to meet its mission to prove Cambodia as a nation with its own oil and gas resources. The Company completed 2D-seismic in 2025 and has identified multiple drill targets with multiple target zones. As it has completed an additional Environmental Impact Assessment on the drilling target areas, which is now submitted for approval by the Ministry of Environment, the Company plans to follow with drilling Cambodia’s first privately financed onshore exploratory oil and gas wells under a Production Sharing Contract. CONTACT: Delayne Weeks - CEO Email:- info@angkorresources.com Website:angkorresources.com Telephone: +1 (780) 831-8722 Please follow @AngkorResources on LinkedIn, Facebook, Twitter, Instagram and YouTube. Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release. Certain information set forth in this news release may contain forward-looking statements that involve substantial known and unknown risks and uncertainties. These forward-looking statements are subject to numerous risks and uncertainties, certain of which are beyond the control of the Company, including, but not limited to oil and gas risks of the seismic interpretation uncertainty and the preliminary nature of structural closure estimates; drilling risk and the absence of a drilled well on the Concession; reservoir and fluid uncertainty; PSC compliance obligations and the risk of relinquishment for non-performance; oil price exposure; and Cambodia-specific sovereign and regulatory risk. As well, additional uncertainties on the mineral projects exist regarding the potential for gold and/or other minerals at any of the Company’s properties, the prospective nature of any claims comprising the Company’s property interests, the impact of general economic conditions, industry conditions, dependence upon regulatory approvals, uncertainty of sample results, timing and results of future exploration, and the availability of financing. Readers are cautioned that the assumptions used in the preparation of such information, although considered reasonable at the time of preparation, may prove to be imprecise and, as such, undue reliance should not be placed on forward-looking statements. View the original release on www.newmediawire.com
CARACAS, VENEZUELA - June 24, 2026 (NEWMEDIAWIRE) - LataMed AI Corp. (OTC: LMED) (the “Company”), a development-stage digital health and artificial intelligence technology company focused on telehealth infrastructure, healthcare analytics, and care coordination solutions for emerging markets, today announced the execution of a strategic commercial and services agreement between its Venezuelan operating affiliate, LataMed AI VE, and Focus Fitness C.A., a fitness and wellness operator serving members in Caracas, Venezuela. The agreement represents an initial operational milestone in connection with the Company’s previously announced initiative to expand certain healthcare technologies and digital health services into fitness, wellness, and athletic performance environments. Management believes the agreement represents the first commercial implementation of the Company’s previously announced wellness market expansion strategy. Under the agreement, LataMed AI VE is expected to provide technology-enabled onboarding, appointment scheduling, and healthcare coordination capabilities designed to support preventative health evaluations and physical fitness assessments for new Focus Fitness members. The initiative is intended to utilize the Company’s web-based and mobile technology platforms to streamline scheduling workflows, improve accessibility to healthcare-related services, and support member onboarding activities. Management stated that the agreement is designed to support broader utilization of the LataMed AI platform while introducing fitness and wellness participants to certain healthcare technologies and services currently being developed within the Company’s healthcare ecosystem. The Company further noted that Focus Fitness intends to promote the use of the LataMed AI platform and mobile application among its member base and support adoption of certain healthcare-related services available through the Company’s developing healthcare ecosystem. Management believes the agreement demonstrates a practical application of the Company’s broader wellness market strategy and may provide valuable operational insights as the Company continues evaluating opportunities within the fitness, wellness, and preventative healthcare sectors. The Company believes that the growing convergence of healthcare, wellness, and digital technologies continues to create opportunities for innovative approaches to preventative health management, patient engagement, healthcare accessibility, and technology-enabled care coordination. Dr. Kevin Rodan Levy, Chief Executive Officer of LataMed AI Corp., stated: “This agreement represents an important milestone in the execution of our wellness market strategy. We believe fitness and wellness environments represent a natural extension of our broader healthcare ecosystem, providing opportunities to engage individuals who are actively focused on preventative health, wellness, and personal health management. Through this relationship, we expect to gain valuable operational experience while continuing to evaluate opportunities to expand the reach and utility of our healthcare technology platform.” The agreement has an initial term of twelve months and may be renewed in accordance with its terms. The Company believes this relationship may serve as a foundation for evaluating additional opportunities within the broader fitness and wellness sector as it continues to expand its healthcare technology ecosystem throughout Latin America. For additional information, please visit https://latamed.ai, follow the Company’s official social media channels, or review the Company’s filings with the U.S. Securities and Exchange Commission at www.sec.gov. About LataMed AI Corp. LataMed AI Corp. (OTC: LMED) is a development-stage digital health and artificial intelligence technology company focused on building telehealth infrastructure, healthcare coordination tools, analytics capabilities, and AI-enabled healthcare solutions for emerging markets. The Company’s strategy is centered on developing technology platforms designed to support healthcare access, patient engagement, provider coordination, emergency medical response, pharmacy integration, and data-driven healthcare operations, with an initial regional focus on Latin America. Forward-Looking Statements This press release contains forward-looking statements. Forward-looking statements include, but are not limited to, statements regarding the Company’s business strategy, fitness and wellness initiatives, healthcare technology initiatives, telehealth infrastructure development, artificial intelligence applications, commercialization initiatives, platform deployment, operational execution, strategic commercial relationships, market opportunities, regional expansion plans, and future operations. These statements are based on current expectations and assumptions and are subject to significant risks and uncertainties that could cause actual results to differ materially from those expressed or implied. Investors are cautioned not to place undue reliance on forward-looking statements, which speak only as of the date of this press release. Actual results may differ materially due to various factors, including but not limited to: the Company’s ability to successfully implement its business plan; the availability of financing; the Company’s ability to obtain required regulatory authorizations; operational execution risks; technology deployment risks; risks associated with operations in emerging markets, including Venezuela; the Company’s ability to successfully implement strategic commercial relationships and fitness-sector initiatives; and general economic and market conditions. The Company undertakes no obligation to update any forward-looking statements except as required by applicable law. Disclaimer This press release is provided for informational purposes only and does not constitute an offer to sell or the solicitation of an offer to buy any securities of the Company. Any investment decision should be made solely on the basis of information contained in the Company's filings with the U.S. Securities and Exchange Commission and other publicly available documents. The Company's securities involve a high degree of risk. Prospective investors are urged to carefully review all risk factors and disclosures contained in the Company's SEC filings before making any investment decision. No representation or warranty, express or implied, is made as to the accuracy or completeness of the information contained herein. Investor Relations Contact LataMed AI Corp. ir@latamed.ai +1 (787) 476-2350 https://latamed.ai View the original release on www.newmediawire.com
Venue Managed Services (VMS) Deployment Extends the Company’s Live Event Technology Footprint Across Gulf Coast Markets Two-Day Festival Confirmed for September 25-26, 2026 HOUSTON, TX and BOGALUSA, LA - June 24, 2026 (NEWMEDIAWIRE) - PickleJar Entertainment Group, Inc. (OTC Pink: PKLE) (“PickleJar” or the “Company”), a music and entertainment technology company, today announced that it has been selected to provide ticketing services for the Bogalusa Blues & Heritage Festival, a leading blues festival in the Gulf Coast region. The engagement is a new commercial deployment of the Company’s Venue Managed Services (VMS) platform and adds to PickleJar’s growing presence in live event technology. Held annually in Bogalusa, Louisiana, the Bogalusa Blues & Heritage Festival has built a regional reputation as a cornerstone destination for blues music in the Gulf South. The 2026 festival is scheduled for September 25 and 26, with a full artist lineup to be announced in the coming weeks. A New Channel in PickleJar’s Live Event Strategy PickleJar will power ticketing for the Bogalusa Blues & Heritage Festival through its Venue Managed Services platform, helping festival organizers streamline ticket sales, improve attendee access, and capture audience data. The deployment reflects PickleJar’s strategy of building single-event engagements into longer-term platform relationships through its integrated suite of venue and fan-engagement tools. Through the PickleJar platform, the festival will have access to: Flexible ticketing fee structures designed to support organizer margins Direct-to-consumer ticket sales with integrated pre-event fan engagement Data capture tools that provide audience insights for future marketing and retention Year-round attendee communication tools to build loyalty and lower audience-acquisition costs for future events This engagement is consistent with management’s stated strategy of deploying VMS technology across regional festival markets - with the goal of converting single-event engagements into multi-year platform relationships alongside the Company’s nationally syndicated radio and artist-promotion businesses. Management and Partner Commentary “We’re excited to partner with the Bogalusa Blues & Heritage Festival to support their continued growth,” said Kristian Barowsky, President and Co-Founder of PickleJar Entertainment Group. “Our platform is designed to help organizers better serve their attendees through competitive ticketing, while giving them the tools to stay connected with fans year-round and build momentum for future events. Each VMS deployment like Bogalusa adds to the live event model we’re building.” “We are excited to partner with PickleJar to help us grow the festival and understand our patrons in greater detail, so we can serve them better as we grow bigger and better each year,” said Michelle Goode, Executive Chair of the Bogalusa Blues & Heritage Festival. Strategic Context for Investors The Bogalusa engagement reflects the continued commercial buildout of PickleJar’s three-pillar revenue model: (1) nationally syndicated radio through PickleJar Up All Night, now airing across more than 82 affiliate stations; (2) artist promotion and fan engagement through its integrated technology platform; and (3) live event services and ticketing through Venue Managed Services. Each business unit is designed to complement the others, capturing fan data at multiple touchpoints while supporting diversified revenue. Regional festivals such as the Bogalusa Blues & Heritage Festival represent an underserved market for modern, integrated ticketing and fan-engagement solutions. PickleJar’s platform is built to serve this segment - offering organizers capable tools at accessible price points while allowing the Company to build audience-data assets and longer-term client relationships. For investor inquiries, contact investors@picklejar.com or visit otcmarkets.com/stock/PKLE. ABOUT PICKLEJAR ENTERTAINMENT GROUP, INC. (OTC Pink: PKLE) PickleJar unlocks the potential of shared entertainment experiences through an integrated suite of software and services. Developed for an era of social commerce, the Company builds tools that connect fan engagement with emerging artists, mid-sized venues, and brands. By embedding secure payment technology, data intelligence, and content distribution, PickleJar’s artist-promotion programs, Venue Managed Services, and mobile apps create a 360° view of how fans connect with the music and moments that matter most. For more information, visit www.picklejar.com. Follow PickleJar: X | Facebook | Instagram | YouTube ABOUT BOGALUSA BLUES & HERITAGE FESTIVAL The Bogalusa Blues & Heritage Festival is one of the Gulf Coast’s leading live music events, held annually in Bogalusa, Louisiana. The festival has earned a reputation as a cornerstone destination for blues music in the region and draws audiences from across the Gulf South. The 2026 festival is scheduled for September 25–26. For more information, visit https://www.bogalusablues.com/info. Forward-Looking Statements This press release contains “forward-looking statements” within the meaning of the federal securities laws, including statements regarding expected financial performance, growth, and future events. Forward-looking statements involve known and unknown risks, uncertainties, and other factors that may cause actual results to differ materially from those expressed or implied. Important factors that could cause differences include, but are not limited to: the inability to gain or maintain licenses, reliance on unaudited financial statements, the Company’s need for additional funding, the impact of competitive products and pricing, and the demand for the Company’s products and services. PickleJar undertakes no obligation to publicly update or revise its forward-looking statements except as required by law. For a more detailed description of the risk factors affecting PickleJar (PKLE), please refer to the Company’s OTC Markets filings, available at otcmarkets.com/stock/PKLE/overview. Contact: Anna Benson anna@picklejar.com View the original release on www.newmediawire.com
VANCOUVER, BRITISH COLUMBIA - June 24, 2026 (NEWMEDIAWIRE) - Andina Copper Corporation (TSX-V: ANDC | FSE: FIR | OTCQB: PMMCF) is pleased to report further outstanding drill intercepts from the Cobrasco Project in Choco, Colombia. Drillhole CDH009 was drilled northwesterly from the same drill pad as CDH006, CDH007 and CDH008 (refer 13 May 2026 News Release) to a final depth of 954m. Results confirm a significant northwesterly extension of near-surface mineralization, with grades notably increasing from 38m downhole. Two additional drillholes, CDH010 and CDH011, have been completed from this same platform, with assays pending. Wide spaced scout drilling designed to assess the overall scale potential of the Cobrasco mineralized system is ongoing from a new platform located approximately 350m northwest of the previous drill site. HIGHLIGHTS: CDH009 further confirms a significant northwesterly extension of the Cobrasco Central Cu-Mo mineralized system, returning: 502m @ 0.40% Cu, 73ppm Mo, 1.22g/t Ag from 38m Incl. 388m @ 0.44% Cu, 36ppm Mo, 1.28g/t Ag from 38m Incl 186m @ 0.50% Cu, 22ppm Mo, 1.48g/t Ag from 38m Results expand the drillhole-defined mineralized footprint at Cobrasco Central to approximately 1,200m by 550m, with the footprint continuing to grow through successive step-out drilling. Mineralization remains open in all directions. Mineralization persists to the end of CDH009 at 954m; however, copper grade decreases at depth as the intensity of overprinting sericite alteration and associated chalcopyrite–bornite mineralization progressively transitions to a lower-grade potassic-altered domain. Additional step-out drillholes CDH010 and CDH011 have been completed from the same platform to further extend the Cobrasco Central mineralized system. Geological logging indicates the mineralized system extends into both holes with assay results pending. Preparations underway for introduction of second drill rig. Multiple drill targets and ongoing step-outs planned in the near-term. Joseph van den Elsen, Andina Copper President and CEO, stated: “Andina Copper continues to systematically advance its scout drilling programme in a northwesterly direction with wide spaced fans of holes aimed at expanding the envelope of porphyry Cu-Mo mineralization. The results of hole CDH009 validate this approach, significantly extending shallow, near-surface copper-molybdenum mineralization 350m to the northwest. Incredibly, all nine drill holes reported to-date have returned wide intervals of high-grade, near-surface Cu-Mo mineralization. The current drill defined footprint of the Cobrasco mineralized porphyry system is approximately 1,200m x 550m and remains open in all directions. Mobilization of a second diamond drilling rig will expedite continued systematic and aggressive exploration and evaluation of the Cobrasco Central system and enable simultaneous testing of potential new porphyry centers.” Geology and Mineralization - Drillhole CDH009 Hole CDH009 was collared from the same drill pad as CDH006 - CDH008 (and subsequent holes CDH010 - CDH011) and drilled NW to test for the continuation of shallow mineralization previously intersected from this collar position, bisecting a wide untested area between drill holes CDH006 and CDH008. All holes completed thus far from this pad have intersected consistent intervals of shallow continuous moderate - high-grade Cu-Mo mineralization commencing immediately below the oxidized profile, which averages approximately 40m in thickness. Hole CDH009 (Az: 292o Dip: -55º Depth: 954m) was the fourth hole to be drilled from this drill pad, oriented NW at a relatively shallow dip designed to test approximately 545m horizontally and 780m vertically. Click to see Figure 2: Cobrasco Central long section (looking E-NE) showing CDH009 and previously reported drillholes with downhole copper grades. CDH009 extends mineralization to the northwest; the system remains open. The hole intersected a leached cap with supergene oxidation developed to a depth of approximately 41m. Minor chalcocite coatings on chalcopyrite occur immediately below the base of oxidation but are of negligible volumetric significance. Below the base of oxidation and extending to a depth of approximately 350m downhole, significant chalcopyrite mineralization occurs as disseminations and hairline veinlets affecting several phases of felsic rhyolite and intermediate daci-andesite porphyries, as well as magmatic-hydrothermal breccias. Below 350m, copper and molybdenum mineralization is principally associated with halo veins and alteration fronts comprising silica, white and green sericite, and molybdenite-bearing B-type veins respectively; darker Early Dark Micaceous (EDM) halo veins also carry chalcopyrite-bornite mineralization. Although not pervasive, chalcopyrite-bornite mineralization associated with green and white sericite halo veins remains locally abundant within a preserved potassic (biotite–K-feldspar) altered domain and persists to the end of the hole at 954m. Copper grades decrease with depth (Figure 3, right-hand photo) as the intensity and abundance of the sericitic overprint progressively diminish within an increasingly dominant potassic-altered domain. The rhyolite porphyry suite commonly displays flow banding (often convolute) supporting the dome complex affiliation for the felsic rhyolite “family” of porphyries. In broad terms, the rhyolite porphyries intrude the intermediate-composition daci-andesitic porphyries. The highest grades are found in the upper 300m of the hole and are closely associated with intensive white to green sericite alteration. This interval also contains two magmatic-hydrothermal breccias associated with rhyolite porphyries between 150 - 250m downhole. Although mineralized, these breccias do not attain the very high copper grades observed elsewhere in the system. Click to see Figure 3: Left - CDH009, 263m: Chalcopyrite zone in green and white sericite (phyllosilicate) alteration without early quartz veining; chalcopyrite (Cp) locally replaced by bornite (Bn). Sample interval grading 1.78% Cu, 10 ppm Mo, and 5.7 g/ Middle - CDH009, 305m: Rhyolite (quartz-eye) porphyry with intense white and green sericite alteration and disseminated chalcopyrite partially replaced by bornite. Sample interval grading 1.17% Cu, 18ppm Mo, and 3.6 g/t Ag (304–306 m). Right - CDH009, 810m: Rhyolite (quartz-eye) porphyry affected by quartz–potassium feldspar (potassic) alteration, partially overprinted by green and white sericite alteration carrying chalcopyrite and bornite mineralization, demonstrating that copper mineralization is lower grade but persists to depth. Sample interval grading 0.13% Cu, 42ppm Mo, and 0.8 g/t Ag (810–812 m). The Company’s Corporate Presentation is available at: Andina Copper Corporate Presentation Interested parties can subscribe to our mailing list and follow our social media channels in the links below: Mailing List | Andina Copper LinkedIn | Andina Copper X ON BEHALF OF THE BOARD Joseph van den Elsen President & Chief Executive Officer joseph@andinacopper.com Jordan Webster VP – Technical Communications jordan@andinacopper.com QUALIFIED PERSON Francisco Montes, a consultant of Andina Copper Corp and a “qualified person” (“QP”) within the definition of that term in National Instrument 43-101, Standards of Disclosure for Mineral Projects, has reviewed and approved the technical information contained in this news release. Francisco Montes is a member of Australian Institute of Geoscientists (MAIG #4160). QAQC CDH009 was collared with a PQ size drill string to a depth of 169.10m and continued with HQ/HQ3 to a final depth of 954.00m. In all cases the drill core was extracted from the core barrel by the drill contractor under the supervision of Andina Copper personnel and placed in core boxes with appropriate depth markers (core blocks) and padding added for extra protection during transport. Full core boxes were then strapped closed before being transported by helicopter and pickup truck to the Cobrasco core cutting facility in Quibdó. The drill core was cleaned where required, marked-up and photographed, prior to undergoing geotechnical and geological logging. All core segments were cut by diamond saw by Andina Copper technicians, other than the top saprolite intervals that could be cut and sampled using hand tools. All sampling was conducted in nominal 2m intervals with cut-lines marked by the supervising geologists to ensure representative sampling. Samples were placed in plastic bags with non-repeatable sample tags and bagged in polyweave sacks ready for transport. The core trays with the remaining half-core are stored at the Andina Copper facility in Quibdó for ongoing geotechnical (Terraspec spectral analysis, magnetic susceptibility readings, rock density measurements) and follow-up detailed geological logging. From Quibdó, core samples were sent to the ALS sample preparation facility in Medellin, an accredited laboratory which is independent of the Company. Prepared sample pulps were then forwarded to the ALS laboratory in Lima, Peru for gold (Au-AA23), multi-elements (ME-MS61), and “overlimits” analysis (ME-OG62 including copper Cu-OG62). Coarse and fine rejects are routinely returned by ALS Medellin for storage at the Andina Copper storage facility. Click to see Table 1: Cobrasco Project – Significant Drill Intercepts Note 1: The 502m @ 0.40% Cu, 73ppm Mo interval is constrained to maximum 10m less than 0.2% Cu. Note 2: Interval widths are measured down-hole and uncorrected. They do not necessarily represent true widths of mineralization. Click to see Table 2: Cobrasco Project – Drill Collar Parameters (WGS84, UTM Zone 18N) ABOUT ANDINA COPPER Andina Copper Corporation is a unique South America-focused copper explorer listed on the TSX Venture Exchange (TSXV:ANDC), Frankfurt (FSE: FIR), and OTC (OTCQB: PMMCF) exchanges. The Company holds two significant discoveries along the world’s premier copper producing Andean porphyry belt in Argentina and Colombia, and a compelling undrilled copper-gold target in the prolific copper production district of the Coastal Cordillera of Chile. FORWARD-LOOKING STATEMENT This news release contains certain statements that may be deemed "forward-looking statements". All statements in this release, other than statements of historical fact, that address events or developments that Andina Copper expects to occur, are forward-looking statements. Forward-looking statements are statements that are not historical facts and are generally, but not always, identified by the words "expects" and similar expressions, or that events or conditions "will" or "may" occur. These statements are subject to various risks. Although Andina Copper believes the expectations expressed in such forward-looking statements are based on reasonable assumptions, such statements are no guarantee of future performance, and actual results may differ materially from those in forward-looking statements. Neither the TSXV nor the Canadian Investment Regulatory Organization accepts responsibility for the adequacy or accuracy of this release. View the original release on www.newmediawire.com
Statement Highlights: Current evidence indicates that nearly 1 in 4 women 20-44 years of age currently has some type of cardiovascular disease, and heart disease is now one of the leading causes of pregnancy-related death in the U.S. Heart failure symptoms, such as shortness of breath, fatigue and swelling, often resemble common symptoms experienced during pregnancy and after delivery, which can delay heart failure diagnosis and treatment. This can have life-threatening consequences for both mother and baby. The first year after delivery is a high-risk time for women to develop heart failure, and postpartum women need ongoing follow-up care after delivery. Standard screening, prompt treatment and coordinated care between obstetricians and heart specialists may help improve maternal health and save lives. DALLAS - June 24, 2026 (NEWMEDIAWIRE) - Early detection and timely treatment of heart failure in pregnant or postpartum women are crucial to prevent serious complications, such as irregular heartbeat, stroke and death, according to a new American Heart Association scientific statement, “Heart Failure Occurring in the Perinatal Period.” Heart failure is a serious condition in which the heart cannot pump enough blood well enough to meet the body’s needs. The true prevalence of heart failure during pregnancy and the postpartum period is unknown. However, according to a 2026 American Heart Association scientific statement Forecasting the Burden of Cardiovascular Disease and Stroke in Women, nearly 1 in 4 women 20-44 years of age currently have some type of cardiovascular disease. Data from the U.S. Centers for Disease Control and Prevention’s Pregnancy Mortality Surveillance System indicates that heart disease is now one of the leading causes of pregnancy-related death in the U.S. A new scientific statement, published today in the American Heart Association’s flagship peer-reviewed scientific journal Circulation, highlights the challenges of recognizing heart failure in pregnant and postpartum women and emphasizes the need for prompt treatment as well as continued monitoring after delivery. “Heart failure affects more than just the heart - it can affect the lungs, kidneys, brain and more,” said Demilade A. Adedinsewo, M.D., M.P.H., chair of the volunteer scientific statement writing group and an assistant professor in the department of cardiovascular medicine at the Mayo Clinic in Jacksonville, Florida. “Because blood flow is reduced and fluid builds up, it can lead to breathing difficulties, kidney issues, irregular heartbeats and increased risk of stroke and death.” What are the symptoms of heart failure during pregnancy and postpartum? Symptoms of heart failure include shortness of breath, labored breathing, fatigue and weight gain with swelling in the legs and feet. Since these symptoms are also common in otherwise healthy pregnancies, heart failure in women who are pregnant or have recently given birth often goes unrecognized. Peripartum cardiomyopathy (PPCM), also known as postpartum cardiomyopathy, is a form of heart muscle failure that can develop late in pregnancy or months after delivery. Women who develop PPCM may experience and report various heart failure symptoms due to fluid retention. “Heart failure during and after pregnancy is often hiding in plain sight. By recognizing symptoms earlier and initiating appropriate treatment, especially in the postpartum period, clinicians and health systems have a powerful opportunity to prevent serious complications and save mothers’ lives,” said Adedinsewo. What are the risk factors for heart failure? Heart failure in the perinatal period can affect women who already have cardiovascular disease and those who do not. Risk factors for heart failure in general include high blood pressure, Type 2 diabetes, abnormal cholesterol, overweight/obesity or metabolic syndrome. During the perinatal period, unique risk factors include known heart disease prior to pregnancy, older maternal age, multiple gestation, known genetic variants for heart failure, use of assisted reproductive technology and prolonged use of tocolytic agents (medications used to suppress premature labor). Among women with known heart disease, heart failure is the most common complication, affecting 11% of women during pregnancy and in the postpartum period. However, significant disparities exist in perinatal heart failure risk and outcomes in the U.S.: Black adults have about a 19% higher risk of developing heart failure than white adults. Black women and Native American women were more frequently diagnosed with PPCM than white women. Black women with PPCM were also more likely to be diagnosed later compared to other racial groups. Heart failure or abnormal cardiac function contributed to 14.5% of pregnancy-related deaths among American Indian/Alaska Native women and 14.2% among Black women. What are the risks if heart failure is not diagnosed and treated promptly? Heart failure poses substantial risks to the health of a mother and baby. Delays in recognizing and diagnosing heart failure during the perinatal period can be life-threatening. Data from a national database found that women who are pregnant and have heart failure are about 32 times more likely to die around the time of delivery compared to pregnant women who do not have heart failure. Other risks for the mother include irregular heartbeat, stroke, worsening cardiac function, preterm delivery, caesarean delivery, postpartum hemorrhage, poor mental health and poor quality of life. Heart failure in the mother during pregnancy increases the risk of restricted fetal growth, premature birth, low birth weight, a prolonged stay in the pediatric intensive care unit, stillbirth or death in the first four weeks of an infant’s life. How is heart failure diagnosed in pregnant and postpartum women? Knowing the signs and symptoms of heart failure, as well as prompt medical evaluation and testing, are crucial first steps in improving women’s health. The statement emphasizes that it is important for clinicians to evaluate patients with any heart symptoms during pregnancy, particularly if they have other cardiovascular risk factors. Diagnostic testing, such as electrocardiograms (ECG), blood tests for cardiac biomarkers and echocardiograms, can help clinicians distinguish between normal pregnancy changes and warning signs of heart failure. How is heart failure managed during pregnancy? Although there is no cure for heart failure, it can be managed with medications and healthy lifestyle. Many women with new onset of heart failure in the perinatal period recover heart function with appropriate care. Treatment is guided by the severity of the disease. Medications to treat heart failure that may be considered safe in pregnancy include beta blockers, diuretics, vasodilators and anticoagulants (when appropriate). The priorities are to stabilize maternal heart function and ensure the fetus is receiving adequate blood flow. A multidisciplinary cardio-obstetrics team to provide continuous monitoring and treatment is critical for optimal care. Achieving optimal cardiovascular health, as outlined by the American Heart Association’s Life’s Essential 8 metrics, is increasingly recognized as important before, during and after pregnancy. People with heart failure who follow a healthy eating plan, engage in regular physical activity and get support from family and friends often report greater improvement in managing symptoms and emotional well-being. Why is the postpartum period critical? The postpartum period, which extends through the first year after delivery, is a particularly high-risk time for women to develop heart failure. Some women first experience symptoms within the first few days after childbirth, while others develop symptoms weeks or months after delivery. Referrals from obstetric care/maternal-fetal medicine specialists to other health care professionals, whether cardiology or primary care, are an essential component of high-quality postpartum care beyond the traditional 6-week postpartum period. Continued monitoring during the first year after delivery may include home visits and alternatives to in-person appointments, such as telemedicine and using digital technologies for remote monitoring and symptom assessments. Counseling about contraception is also an important consideration for postpartum women. Long-acting reversible contraceptives (LARCs), specifically hormonal intrauterine devices, are the preferred method of contraception for women with cardiovascular disease including heart failure. Estrogen-containing methods are not recommended for women with moderate or severe heart failure due to the increased risk for thrombosis (blood clots in the veins and arteries). “Improving postpartum care is essential to protecting maternal health. Standardized screening, listening carefully to patient concerns and improved access to care are crucial to help improve outcomes for mothers and their families,” said Adedinsewo. This scientific statement was prepared by the volunteer writing group on behalf of the American Heart Association’s Women’s Health Science Committee of the Council on Clinical Cardiology, the Council on Cardiovascular Surgery and Anesthesia, and the Council on Cardiovascular and Stroke Nursing. American Heart Association scientific statements promote greater awareness about cardiovascular diseases and stroke issues and help facilitate informed health care decisions. Scientific statements outline what is currently known about a topic and what areas need additional research. While scientific statements inform the development of guidelines, they do not make treatment recommendations. American Heart Association guidelines provide the Association’s official clinical practice recommendations. Co-authors are Vice Chair Nosheen Reza, M.D, M.S., Haywood L. Brown, M.D.; Afshan B. Hameed, M.D., M.B.A..; Dennis McNamara, M.D.; Mulubrhan F. Mogos, Ph.D., M.Sc., FAHA; Jenna Skowronski, M.D.; Arthur Vaught, M.D; Marie-Louise Meng, M.D.; and Modele O. Ogunniyi, M.D., M.P.H., FAHA. Authors’ disclosures are listed in the manuscript. The Association receives more than 85% of its revenue from sources other than corporations. These sources include contributions from individuals, foundations and estates, as well as investment earnings and revenue from the sale of our educational materials. Corporations (including pharmaceutical, device manufacturers and other companies) also make donations to the Association. The Association has strict policies to prevent any donations from influencing its science content and policy positions. Overall financial information is available here. Additional Resources: Available multimedia is on right column of release link After June 24, 2026, view the manuscript online. American Heart Association scientific statement news release: 6 in 10 U.S. women projected to have at least one type of cardiovascular disease by 2050 (Feb. 2026) American Heart Association news release: Risk factors for cardiovascular disease negatively impact health during, after pregnancy (Oct. 2025) American Heart Association news release: New postpartum care recommendations target CVD risk (May 2024) American Heart Association scientific statement news release: Heart disease risk factors in women highlight need for increased awareness, prevention (Feb. 2024) American Heart Association/ACC Guideline: 2022 Guideline for the Management of Heart Failure (May 2022) American Heart Association Policy Statement: Call to Action: Maternal Health and Saving Mothers (Aug. 2021) American Heart Association health information: Pregnancy and Maternal Health American Heart Association health initiative: Advancing Maternal Health Initiative Follow American Heart Association/American Stroke Association news on X @HeartNews Follow news from the American Heart Association’s Circulation journal @CircAHA About the American Heart Association The American Heart Association is a relentless force for a world of longer, healthier lives. Dedicated to ensuring equitable health in all communities, the organization has been a leading source of health information for more than one hundred years. Supported by more than 35 million volunteers globally, we fund groundbreaking research, advocate for the public’s health, and provide critical resources to save and improve lives affected by cardiovascular disease and stroke. By driving breakthroughs and implementing proven solutions in science, policy, and care, we work tirelessly to advance health and transform lives every day. Connect with us on heart.org, Facebook, X or by calling 1-800-AHA-USA1. For Media Inquiries: 214-706-1173 Amanda Ebert: Amanda.Ebert@heart.org For Public Inquiries: 1-800-AHA-USA1 (242-8721) heart.org and stroke.org View the original release on www.newmediawire.com
Company Highlights Recent Progress Across Its U.S.-focused Tungsten Platform and Introduces Stocktwits as a Supplemental Channel for Public Company Updates VANCOUVER, BC - June 24, 2026 (NEWMEDIAWIRE) - Western Star Resources Inc. (CSE: WSR) (OTC: WSRIF) (FRA: 4K2) (the "Company" or "Western Star") is pleased to provide shareholders with a corporate update following a period of significant activity across the Company's critical minerals platform. Western Star would like to thank its shareholders for their continued support. The Company has issued a number of recent updates, and management believes this is an appropriate time to help shareholders and interested investors better understand how these developments tie together, what has been accomplished, and where the Company is focused as it moves forward. Over the past several months, Western Star has advanced its strategy of building a U.S.-focused tungsten platform at a time when tungsten continues to receive increased attention as a critical mineral for defense, aerospace, energy, and advanced manufacturing applications. The Company's recent progress includes: Closing an oversubscribed private placement and flow-through financing to support exploration, development, working capital, and market awareness initiatives; - Expanding and advancing the Rowland Tungsten Property in Elko County, Nevada, including the completion of Phase 1 exploration and a modern UAV magnetic geophysical survey; - Initiating drill-permitting work at Rowland through the engagement of KC Harvey Environmental, LLC; - Acquiring and outlining an exploration program for the White Star Tungsten Project, located adjacent to Rowland, creating a broader district-scale exploration opportunity in the Jarbidge-Charleston tungsten area of Nevada; - Acquiring a 100% interest in the past-producing Eagle Point Tungsten Mine in New Mexico, further expanding the Company's growing portfolio of past-producing U.S. tungsten assets; and - Submitting an application in response to a solicitation from the U.S. Defense Industrial Base Consortium related to the supply of strategic critical minerals. Blake Morgan, President and CEO of Western Star, stated, "Western Star has had a very active period, and we believe the recent developments are connected by one clear strategy: building a meaningful U.S.-focused tungsten platform around past-producing assets, modern exploration, and the growing need for reliable domestic critical mineral supply. We appreciate the continued support of our shareholders as we advance this strategy. The company will have news regarding its drill permits, maiden drill programs and assays from current explorations programs over the next few weeks." At Rowland, the Company recently completed Phase 1 exploration, including UAV geophysics, soil geochemistry, rock-chip sampling, and field checking of historical workings. The Company also reported results from its high-resolution UAV magnetic survey, which will be integrated with pending Phase 1 assay results to support the design of a Phase 2 exploration program and refine potential drill targets. The acquisition of the White Star Tungsten Project adds an adjacent property with historical tungsten-molybdenum skarn mineralization and allows the Company to evaluate Rowland and White Star as part of a broader district-scale exploration model. Western Star believes the proximity of the two projects may provide advantages related to logistics, exploration efficiency, and future drill targeting. The Company's recent acquisition of the past-producing Eagle Point Tungsten Mine in New Mexico further expands Western Star's U.S. tungsten portfolio. Eagle Point provides exposure to another historical tungsten district with documented past production, surface mineralization, and untested exploration targets. Mr. Morgan continued, "Our goal is to move beyond isolated announcements and help shareholders see the larger picture. We are building a portfolio of past-producing tungsten assets in the United States, advancing modern exploration datasets, preparing for drill targeting, and positioning Western Star within the broader critical mineral’s discussion." Official Stocktwits Account Western Star is also pleased to announce the launch of its official Stocktwits account as a supplemental communication channel for shareholders and interested investors. Shareholders and interested investors are encouraged to follow Western Star Resources on Stocktwits at @WesternStarResources. The Company intends to use Stocktwits to share links to company news releases, public updates, interviews, investor awareness content, and other publicly available information. The Company's Stocktwits account is intended to supplement, and not replace, Western Star's formal disclosure channels, including news releases, regulatory filings, and the Company's website. The Company does not intend to provide investment advice, price targets, or recommendations to buy or sell securities through Stocktwits. Investors should continue to review the Company's official news releases, filings, and its website for complete information regarding Western Star's business, exploration activities, risks, and corporate updates. About Western Star Resources Western Star Resources is an emerging junior mineral exploration company focused on revitalizing North America's tungsten supply. The Company is advancing its entry into the U.S. market through past-producing tungsten assets in historically important mining districts and is positioning itself to participate in the growing need for secure domestic critical mineral supply. For more information, please visit www.westernstarresources.com. Contact Information Blake Morgan President, CEO and Director Email: blake@acvc.vc Forward-Looking Information Certain statements contained in this news release may constitute forward-looking information within the meaning of applicable securities laws. Forward-looking information may include, but is not limited to, statements regarding the Company's exploration plans, permitting activities, future work programs, potential drill targets, critical minerals strategy, use of social media platforms, and expectations regarding the development of the Company's properties. Forward-looking information is based on management's current expectations, estimates, projections, and assumptions and is subject to a number of risks and uncertainties. Actual results may differ materially from those expressed or implied by such forward-looking information. Readers are cautioned not to place undue reliance on forward-looking information. Except as required by applicable securities laws, the Company undertakes no obligation to update or revise any forward-looking information. Neither the Canadian Securities Exchange nor its Regulation Services Provider accepts responsibility for the adequacy or accuracy of this release. View the original release on www.newmediawire.com
Total dividend of EUR 1.60 per share approved, including a special dividend of EUR 0.95 per share All agenda items approved by a large majority Successful con-pearl exit and Janoschka acquisition mark the beginning of the next growth phase Strong liquidity position continues to provide flexibility for value-enhancing acquisitions MUNICH, GERMANY - June 23, 2026 (NEWMEDIAWIRE) - At today’s Annual General Meeting, the shareholders of Blue Cap AG (“Blue Cap”) approved all proposals submitted by the Management Board and Supervisory Board with a large majority. In total, 64.7% of the company’s voting share capital was represented. Record dividend following successful value realization Shareholders approved the distribution of a total dividend of EUR 1.60 per share (previous year: EUR 1.10 per share). The dividend consists of a base dividend of EUR 0.65 per share and a special dividend of EUR 0.95 per share. The distribution is primarily based on the successful sale of portfolio company con-pearl during the 2025 financial year. “The renewed record dividend reflects the strength of our business model. We are allowing our shareholders to participate directly in the value realized from the sale of con-pearl while still maintaining sufficient financial resources to actively shape Blue Cap’s next phase of growth,” said Dr. Henning von Kottwitz, CEO of Blue Cap AG. Part of the Exit proceeds invested in Janoschka – significant financial flexibility remains In its report to the Annual General Meeting, the Management Board looked back on an eventful year 2025. With the sale of con-pearl, Blue Cap once again demonstrated the successful execution of its Buy-Transform-Sell strategy. The company achieved an attractive exit proceeds and further strengthened its balance sheet. In addition, the acquisition of Janoschka AG in early 2026 marked an important milestone in Blue Cap’s growth strategy. The internationally active provider of prepress solutions for the packaging industry expands the investment portfolio with an established company that has a global presence and attractive development opportunities. “The sale of con-pearl once again demonstrated how we create and realize sustainable value through active transformation. At the same time, with Janoschka we have acquired an investment that is an excellent strategic fit and offers significant value creation potential,” said Henning Eschweiler, COO of Blue Cap AG. The detailed voting results of the Annual General Meeting and the Management Board presentation will be published at www.blue-cap.de/annual-general-meeting. About Blue Cap AG Blue Cap AG is a publicly listed investment company headquartered in Munich, Germany, founded in 2006. The company acquires medium-sized B2B companies in special situations and actively supports their operational development with the aim of selling them profitably at a later stage. The acquired companies are headquartered in the DACH region, generate revenues between EUR 20 million and EUR 200 million, and operate sustainable and resilient core businesses. Blue Cap generally holds majority stakes in six companies operating in the industries of Adhesives & Coating Technology, Plastics Technology, Prepress, Life Sciences, and Business Services. The Group currently employs around 2,000 people in Germany and other countries. Blue Cap AG is listed on the Open Market (Scale segment of the Frankfurt Stock Exchange and m of the Munich Stock Exchange; ISIN: DE000A0JM2M1; Stock ticker: B7E). www.blue-cap.de Contact: Blue Cap AG Annika Kuppers Corporate Affairs Manager Tel. +49 89 288909-24 akueppers@blue-cap.de View the original release on www.newmediawire.com
Shareholders approve all resolutions on the agenda brought forward by Delivery Hero. Strong Supervisory Board with the re-election of Roger Rabalais and Scott Ferguson. BERLIN - June 23, 2026 (NEWMEDIAWIRE) - Delivery Hero SE (“Delivery Hero”, the “Company”, or the “Group”), the world’s leading local delivery platform, has concluded its ordinary 2026 Annual General Meeting (AGM) in Berlin today. In alignment with the proposals of the Management Board and the Supervisory Board, the Company’s shareholders voted to approve all resolutions on the agenda. Strengthening of the Supervisory Board During the meeting, shareholders voted on the scheduled elections to the Supervisory Board. Scott Ferguson was re-elected as a shareholder representative for a term running until the conclusion of the 2027 AGM. Roger Rabalais was re-elected to the Supervisory Board as a shareholder representative and independent member of the Board, following his court appointment in April 2026. His term will run until the conclusion of the 2029 AGM. Following his election, the Delivery Hero Supervisory Board intends to re-elect Roger Rabalais as Chairman of the Audit Committee, securing deep expertise in financial and risk oversight for the global Group. Kristin Skogen Lund, Chair of the Supervisory Board, commented: “Scott’s investor perspective and Roger’s deep experience in corporate finance and the delivery sector are key assets for Delivery Hero. Together with the other experienced members of the Supervisory Board, we maintain high-caliber independent oversight capabilities that align closely with our commitment to robust corporate governance.” Niklas Ostberg, CEO and Co-Founder of Delivery Hero, added: "The clear approval of today's resolutions demonstrates our shareholders' strong support of Delivery Hero's strategy. We remain focused on our transition to the Everyday App, executing on our Strategic Review, maintaining our very strong operational momentum, and working towards our financial goals with discipline to create long-term value." Approval of new compensation system and auditor transition Shareholders additionally ratified the modernized Management Board Compensation System 2026. The new, simplified compensation system for members of the Management Board was developed in consideration of the Company’s long-term strategic objectives, regulatory requirements and investor expectations. It provides a more stringent incentive structure with an even stronger capital market focus, as well as increased transparency. To guarantee planning certainty and a seamless transition for the Group, PricewaterhouseCoopers GmbH was appointed as the new auditor for the Group starting in the 2027 financial year, in accordance with regulatory rotation guidelines. KPMG AG was ratified as the auditor for the Group for the current 2026 financial year. Additionally, the AGM formally approved the discharges of all members of the Management Board and the Supervisory Board in office during the 2025 financial year. The complete and detailed voting results for all agenda items will be published on Delivery Hero’s Investor Relations website shortly. ABOUT DELIVERY HERO Delivery Hero is the world’s leading local delivery platform, operating its service in around 65 countries across Asia, Europe, Latin America, the Middle East and Africa. The Company started as a food delivery service in 2011 and today runs its own delivery platform on four continents. Additionally, Delivery Hero is pioneering quick commerce, the next generation of e-commerce, aiming to bring groceries and household goods to customers in under one hour and often in 20 to 30 minutes. Headquartered in Berlin, Germany, Delivery Hero has been listed on the Frankfurt Stock Exchange since 2017 and is part of the MDAX stock market index. For more information, please visit www.deliveryhero.com MEDIA CONTACT Corporate Communications press@deliveryhero.com INVESTOR RELATIONS CONTACT Investor Relations ir@deliveryhero.com DISCLAIMER This release may contain forward looking statements, estimates, opinions and projections with respect to anticipated future performance of Delivery Hero SE (“forward-looking statements”). These forward-looking statements can be identified by the use of forward-looking terminology, including the terms “believes,” “estimates,” “anticipates,” “expects,” “intends,” “may,” “will” or “should” or, in each case, their negative, or other variations or comparable terminology. These forward-looking statements include all matters that are not historical facts. Forward-looking statements are based on the current views, expectations and assumptions of the management of Delivery Hero SE and involve significant known and unknown risks and uncertainties that could cause actual results, performance or events to differ materially from those expressed or implied in such statements. Forward-looking statements should not be read as guarantees of future performance or results and will not necessarily be accurate indications of whether or not such results will be achieved. Any forward-looking statements included herein only speak as at the date of this release. We undertake no obligation, and do not expect to publicly update, or publicly revise, any of the information, forward-looking statements or the conclusions contained herein or to reflect new events or circumstances or to correct any inaccuracies which may become apparent subsequent to the date hereof, whether as a result of new information, future events or otherwise. We accept no liability whatsoever in respect of the achievement of such forward-looking statements and assumptions. View the original release on www.newmediawire.com
All agenda items approved by a large majority 2026 Annual General Meeting elects Jack Yefei Ling as new member of the Supervisory Board LADENBURG, GERMANY - June 23, 2026 (NEWMEDIAWIRE) - Heidelberg Pharma AG (FSE: HPHA), a clinical-stage biotech company developing innovative Antibody Drug Conjugates (ADCs), today announced that the company's shareholders approved the management proposals with a large majority (between 98.67% and 98.72%) at today's ordinary virtual Annual General Meeting. All members of the Management Board and Supervisory Board formally approved for the 2024/2025 financial year Auditors for the 2025/2026 financial year appointed Remuneration report for the Management Board approved Election of Mr. Jack Yefei Ling as new member of the Supervisory Board Resolution on the amendment to the Articles of Association regarding the reduction in the size of the Supervisory Board from seven to five members Attendance (incl. postal votes cast) at the 2026 Annual General Meeting corresponded to 80.55% of the current capital stock. For more information on the Annual General Meeting, including the voting results, please visit: https://heidelberg-pharma.com/en/agm. About Heidelberg Pharma Heidelberg Pharma is the first company to develop cancer therapies using Amanitin, a compound derived from the green death cap mushroom. The biological mechanism of action of the toxin represents a new therapeutic modality and is used as a compound in the Amanitin-based ADC technology, the so-called ATAC technology. The lead candidate HDP-101 (INN: pamlectabart tismanitin) is a BCMA ATAC in clinical development for multiple myeloma. The candidate has been granted Orphan Drug Designation and Fast Track Designation from the FDA. A second ATAC candidate, HDP-102 is in clinical development stage in Non-Hodgkin Lymphoma. HDP-103 against metastatic castration-resistant prostate cancer and HDP-104 targeting gastrointestinal tumors such as colorectal cancer have completed preclinical development. These programs are available for partnering. The company is based in Ladenburg, Germany, and is listed on the Frankfurt Stock Exchange: ISIN DE000A11QVV0 / WKN A11QVV / Symbol HPHA. More information is available at www.heidelberg-pharma.com ATAC® is a registered trademark of Heidelberg Pharma Research GmbH. Contact Heidelberg Pharma AG Sylvia Wimmer Senior Director Corporate Communications Tel.: +49 6203 1009 1004 E-Mail: investors@hdpharma.com Gregor-Mendel-Str. 22, 68526 Ladenburg IR/PR-Support MC Services AG Katja Arnold (CIRO) Managing Director & Partner Tel.: +49 89 210 228-40 E-Mail: katja.arnold@mc-services.eu This communication contains certain forward-looking statements relating to the Company's business, which can be identified by the use of forward-looking terminology such as "estimates", "believes", "expects", "may", "will”, "should”, "future", "potential" or similar expressions or by a general discussion of the Company's strategy, plans or intentions. Such forward-looking statements involve known and unknown risks, uncertainties and other factors, which may cause our actual results of operations, financial condition, performance, achievements, or industry results, to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. Given these uncertainties, prospective investors and partners are cautioned not to place undue reliance on such forward-looking statements. We disclaim any obligation to update any such forward-looking statements to reflect future events or developments. View the original release on www.newmediawire.com
BIRKENFELD, GERMANY - June 23, 2026 (NEWMEDIAWIRE) - Shareholders at today’s Annual General Meeting of STRATEC SE (Frankfurt: SBS; Prime Standard) approved all agenda items submitted for resolution for resolution with clear majorities. As proposed, STRATEC will enable its shareholders to participate in the company’s performance by distributing a dividend of EUR 0.60 per share for the past 2024 financial year (previous year’s dividend: EUR 0.60 per share). The distribution total amounts to EUR 7.3 million and will be paid to shareholders via their depositing banks on June 26, 2026. Furthermore, shareholders also approved the actions of the Board of Management and the Supervisory Board and elected PricewaterhouseCoopers GmbH Wirtschaftsprüfungs-gesellschaft (PwC), Frankfurt and Main, as auditor for the 2026 financial year. In addition, the remuneration report was approved. Overall, 70.1 percent of the company’s registered share capital was represented at the Annual General Meeting. Further information about the Annual General Meeting can be found at www.stratec.com/agm, where details of voting results have also been published. ABOUT STRATEC STRATEC SE (www.stratec.com) designs and manufactures fully automated analyzer systems for its partners in the fields of clinical diagnostics and life sciences. Furthermore, the company offers complex consumables for diagnostic and medical applications. For its analyzer systems and consumables, STRATEC covers the entire value chain – from development to design and production through to quality assurance. The partners market the systems, software, and consumables, in general together with their own reagents, as system solutions to laboratories, blood banks and research institutes around the world. STRATEC develops its products on the basis of patented technologies. Shares in the company (ISIN: DE000STRA555) are traded in the Prime Standard segment of the Frankfurt Stock Exchange. FURTHER INFORMATION IS AVAILABLE FROM: STRATEC SE Jan Keppeler, CFA | Investor Relations, Sustainability & Corporate Communications Tel: +49 7082 7916-6515 ir@stratec.com www.stratec.com View the original release on www.newmediawire.com
CALGARY, ALBERTA - June 23, 2026 (NEWMEDIAWIRE) - Voyageur Pharmaceuticals Ltd. (TSX.V: VM) (OTC Pink: VYYRF) (“Voyageur” or the “Company”), a Canadian developer of pharmaceutical-grade barium and iodine contrast media for medical imaging, is pleased to announce that it has engaged Fluor Corporation (“Fluor”), a leading global engineering, procurement, construction and maintenance firm, to complete comprehensive feasibility studies for two strategic projects that will advance the Company’s vertically integrated North American supply chain for radiology contrast drugs. The engagement covers: An Iodine Project as part of a collaboration with Bayer – a feasibility study for a proposed iodine extraction and production facility in Oklahoma, USA using Voyageur's previously announced patent pending Meuller process (see news release dated Jan 12, 2026), developed in collaboration with Bayer AG (“Bayer”) under the milestone-based funding agreement announced on February 23, 2026. This project aims to produce high-purity iodine from iodine-rich oilfield brine for use in contrast media drugs. Voyageur’s Integrated Iodine and Barium Contrast Drug Manufacturing Facility – a feasibility study for the Company’s planned pharmaceutical manufacturing plant that management of Voyageur expects will produce finished barium and iodine-based contrast media products. This facility is expected to integrate Voyageur’s high-purity barite from its 100%-owned Frances Creek barium deposit in British Columbia, with domestically sourced iodine, creating the first fully integrated “Earth-to-Bottle” contrast media platform in North America. Voyageur has budgeted US$2,350,000 for completion of the Bayer project feasibility study and will create a final budget for the integrated iodine and barium drug facility feasibility study, after completion of the testing of Voyageur's proprietary Streamline iodine drug manufacturing process. Fluor’s world-class expertise in process engineering, project economics, and large-scale industrial facility design will ensure both studies meet the highest technical, environmental, and economic standards required for project financing and regulatory approvals. The studies are expected to be completed in early 2027, paving the way for a potential construction decision in 2027. “We are thrilled to partner with Fluor to de-risk and accelerate these projects,” said Brent Willis, CEO of Voyageur Pharmaceuticals. “With the iodine initiative and Fluor’s technical expertise, we are moving decisively toward securing North America’s supply chain for critical medical imaging drugs. These feasibility studies represent a major milestone in our strategy to become the first fully integrated producer of both barium and iodine contrast agents on the continent.” The dual feasibility studies build on Voyageur’s recent progress, including its Health Canada-approved barium contrast products already generating commercial sales (see news release dated Aug 21, 2025) and the ongoing Bayer collaboration. Subject to successful completion of the feasibility study and further agreement of the parties, Voyageur and Bayer may consider advancing the project into a subsequent phase under an offtake-linked production financing arrangement. In a potential subsequent phase, Bayer may provide capital financing for the project, while Voyageur would operate and manage the project, subject to definitive agreements. About Voyageur Pharmaceuticals Ltd. Voyageur Pharmaceuticals (TSXV: VM) is a Canadian company focused on becoming a low-cost, vertically integrated producer of barium and iodine Active Pharmaceutical Ingredients (APIs) and finished imaging contrast agents. The Company has already developed five barium contrast products that hold Health Canada licenses and are currently generating revenue in Canada. Voyageur is positioned to become North America’s first vertically integrated, low-cost manufacturer of both barium and iodine contrast media, a significant competitive advantage. By owning 100% of the high-grade, metal-free Frances Creek barite project, the Company controls its own secure, domestic source of pharmaceutical-grade barium sulfate. In parallel, Voyageur’s patent-pending Mueller process enables low-cost extraction of iodine from mineral brine water. Combined with its proprietary Streamline manufacturing technology, the Company plans to process that iodine directly into finished iodine contrast drugs within a single, integrated production chain. This end-to-end ownership from raw material extraction through proprietary processing to finished pharmaceutical products, is expected to deliver materially lower operating costs than competitors who purchase intermediates on the open market. At the same time, it is anticipated to create a reliable, North American-based supply chain for critical medical imaging agents, significantly reducing geopolitical, logistics, and shortage risks for hospitals and patients in the United States and Canada. This strategy embodies Voyageur’s motto, “From Earth to Bottle,” reflecting its commitment to responsible, traceable, and secure sourcing and manufacturing from North American resources. For Further Information: Brent Willis, CEO Brent@vpharma.ca, 403-923-5944 info@vpharma.ca Albert Deslauriers, CFO Albert@vpharma.ca https://voyageurpharmaceuticals.ca Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this news release. Cautionary Statement Regarding “Forward-Looking” Information This news release may contain certain forward-looking statements and forward-looking information (collectively, "forward-looking statements"), including without limitation: the successful completion of the feasibility studies for the proposed iodine extraction and production facility in Oklahoma, USA and the Company’s planned pharmaceutical manufacturing plant; the testing, refining, market launch, manufacturing, sales and revenue from Voyageur's barium and iodine contrast products; entering into an offtake agreement with Bayer; the Company's aim to become a key player in the barium and iodine contrast markets; the Company's plan to transition into a high-margin manufacturer of radiology drugs; the Company's belief that the Frances Creek Project's mineral will replace the current synthetic products in the pharmaceutical marketplace with higher quality imaging products; and the Company's belief that it can ensure quality and cost efficiency by controlling all primary input costs. Forward-looking statements normally contain words like "will", "intend", "anticipate", "could", "should", "may", "might", "expect", "estimate", "forecast", "plan", "potential", "project", "assume", "contemplate", "believe", "shall", "scheduled", and similar terms. Forward-looking statements are not guarantees of future performance, actions, or developments and are based on expectations, assumptions, and other factors that management currently believes are relevant, reasonable, and appropriate in the circumstances. Although management believes that the forward-looking statements herein are reasonable, actual results could be substantially different due to the risks and uncertainties associated with and inherent to Voyageur's business. Additional material risks and uncertainties applicable to the forward-looking statements herein include, without limitation, the impact of general economic conditions, and unforeseen events and developments. This list is not exhaustive of the factors that may affect the Company's forward-looking statements. Many of these factors are beyond the control of Voyageur. All forward-looking statements included in this news release are expressly qualified in their entirety by these cautionary statements. The forward-looking statements contained in this news release are made as at the date hereof, and Voyageur undertakes no obligation to update publicly or to revise any of the included forward-looking statements, whether as a result of new information, future events, or otherwise, except as may be required by applicable securities laws. Risks and uncertainties about the Company's business are more fully discussed under the heading "Risk Factors" in its most recent filings. They are otherwise disclosed in its filings with securities regulatory authorities available on SEDAR+ at www.sedarplus.ca. View the original release on www.newmediawire.com
LOS ANGELES, CA - June 23, 2026 (NEWMEDIAWIRE) - Quantum BioPharma (NASDAQ: QNTM) (CSE: QNTM) was featured in a BioMedWire editorial highlighting its development of Lucid-MS, a patented, first-in-class drug candidate designed to directly protect the myelin sheath damaged by multiple sclerosis. Unlike conventional MS treatments that primarily target the immune system, Lucid-MS is being developed as a non-immunomodulatory neuroprotective therapy and is preparing to enter Phase 2 clinical trials following successful Phase 1 safety and tolerability studies. The editorial notes that Lucid-MS has demonstrated the ability to prevent and reverse myelin degradation in preclinical studies and is supported by more than a decade of scientific research. Quantum BioPharma is also advancing a collaboration with researchers at Massachusetts General Hospital to validate a novel PET imaging technique that may enable direct measurement of myelin integrity in MS patients. To view the full press release, visit https://ibn.fm/iZmx1 About Quantum BioPharma Ltd. Quantum is a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions for the treatment of challenging neurodegenerative and metabolic disorders and alcohol misuse disorders with drug candidates in different stages of development. Through its wholly owned subsidiary, Lucid Psycheceuticals Inc. (“Lucid”), Quantum is focused on the research and development of its lead compound, Lucid-MS. Lucid-MS is a patented new chemical entity shown to prevent and reverse myelin degradation, the underlying mechanism of multiple sclerosis, in preclinical models. Quantum invented UNBUZZD(TM) and spun out its OTC version to a company, Unbuzzd Wellness Inc. (“Unbuzzd”) (formerly, Celly Nutrition Corp.), led by industry veterans. Quantum retains ownership of 19.84% (as of March 31, 2026) of Unbuzzd at www.unbuzzd.com. The agreement with Unbuzzd also includes royalty payments of 7% of sales from unbuzzd(TM) until payments to Quantum total $250 million. Once $250 million is reached, the royalty drops to 3% in perpetuity. Quantum retains 100% of the rights to develop similar products or alternative formulations specifically for pharmaceutical and medical uses. Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://IBN.fm/Disclaimer The latest news and updates relating to QNTM are available in the company’s newsroom at https://ibn.fm/QNTM Forward Looking Statements Certain statements in this article are forward-looking, as defined in the Private Securities Litigation Reform Act of 1995. These statements involve risks, uncertainties, and other factors that may cause actual results to differ materially from the information expressed or implied by these forward-looking statements and may not be indicative of future results. These forward-looking statements are subject to a number of risks and uncertainties, including, among others, various factors beyond management's control, including the risks set forth under the heading "Risk Factors" discussed under the caption "Item 1A. Risk Factors" in Part I of the Company's most recent Annual Report on Form 10-K or any updates discussed under the caption "Item 1A. Risk Factors" in Part II of the Company's Quarterly Reports on Form 10-Q and in the Company's other filings with the SEC. Undue reliance should not be placed on the forward-looking statements in this article in making an investment decision, which are based on information available to us on the date hereof. All parties undertake no duty to update this information unless required by law View the original release on www.newmediawire.com
LOS ANGELES, CA - June 23, 2026 (NEWMEDIAWIRE) - Datavault AI (NASDAQ: DVLT), through its Acoustic Sciences division’s WiSA Technologies, announced that its WiSA E Enterprise wireless audio module has been integrated into Goldhorn’s new Goho LS7 2.0 and 5.1 home audio and karaoke systems. The systems feature 4K Ultra HD projectors and are designed to deliver high-definition stereo and immersive 5.1 surround sound using WiSA’s wireless audio transmission technology, with products now available in China. The launch expands WiSA’s presence beyond its traditional markets and highlights the scalability of its wireless audio platform. Datavault AI said its WiSA E technology is designed to provide secure, low-latency, high-definition multi-channel audio connectivity and is positioned for use across home entertainment, robotics, holographic systems, drones and other emerging applications requiring synchronized wireless audio distribution and control. To view the full press release, visit https://nnw.fm/vOOwD About Datavault AI Inc. Datavault AI(TM) is leading the way in AI-driven data experiences, valuation and monetization of assets in the Web 3.0 environment. The Company’s cloud-based platform provides comprehensive solutions with a collaborative focus in its Acoustic Sciences and Data Sciences divisions. Datavault AI’s Acoustic Sciences division features WiSA(R), ADIO(R) and Sumerian(R) patented technologies and industry-first foundational spatial and multichannel wireless, high-definition sound transmission technologies with intellectual property covering audio timing, synchronization and multi-channel interference cancellation. The Data Science division leverages the power of Web 3.0 and high-performance computing to provide solutions for experiential data perception, valuation and secure monetization. Datavault AI’s platform serves multiple industries, including high-performance computing software licensing for sports & entertainment, events & venues, biotech, education, fintech, real estate, healthcare, energy and more. The Information Data Exchange(R) enables Digital Twins and the licensing of name, image and likeness by securely attaching physical real-world objects to immutable metadata, fostering responsible AI with integrity. The Company’s technology suite is fully customizable and offers AI- and machine-learning-based automation, third-party integration, detailed analytics and data, marketing automation and advertising monitoring. The Company is headquartered in Philadelphia, PA. Learn more about Datavault AI at https://dvlt.ai. Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://IBN.fm/Disclaimer Forward Looking Statements Certain statements in this article are forward-looking, as defined in the Private Securities Litigation Reform Act of 1995. These statements involve risks, uncertainties, and other factors that may cause actual results to differ materially from the information expressed or implied by these forward-looking statements and may not be indicative of future results. These forward-looking statements are subject to a number of risks and uncertainties, including, among others, various factors beyond management's control, including the risks set forth under the heading "Risk Factors" discussed under the caption "Item 1A. Risk Factors" in Part I of the Company's most recent Annual Report on Form 10-K or any updates discussed under the caption "Item 1A. Risk Factors" in Part II of the Company's Quarterly Reports on Form 10-Q and in the Company's other filings with the SEC. Undue reliance should not be placed on the forward-looking statements in this article in making an investment decision, which are based on information available to us on the date hereof. All parties undertake no duty to update this information unless required by law. View the original release on www.newmediawire.com
LOS ANGELES, CA - June 23, 2026 (NEWMEDIAWIRE) - Greenland Energy (NASDAQ: GLND) is positioning itself at the intersection of one of the Arctic’s most compelling economic opportunities. Through the company’s Jameson Project in East Greenland, it is pursuing resource exploration in an area that has long attracted geological interest but has seen only limited development. As Greenland seeks to improve its economic future and cut down dependence on external financial support, projects like Jameson highlight the critical role responsible resource development can play in building long-term prosperity. GLND is advancing exploration at the Jameson Project, one of Greenland’s most prospective yet historically underexplored resource regions The company is focused on unlocking economic opportunities that could support job creation, infrastructure development, and long-term revenue generation These developments align with a broader vision: empowering Greenland’s path toward greater economic independence through responsible resource development The company’s focus on the Jameson Basin highlights a broader opportunity emerging across Greenland. Despite having significant natural resource potential, much of the country’s resource base is still underexplored relative to other energy-producing regions globally. Advances in exploration… Read More Forward-Looking Statements This communication contains “forward-looking statements” within the meaning of the “safe harbor” provisions of the United States Private Securities Litigation Reform Act of 1995 and within the meaning of Section 27A of the Securities Act of 1933, as amended (the “Securities Act”), and Section 21E of the Securities Exchange Act of 1934, as amended. All statements contained herein other than statements of present or historical fact, including, without limitation, statements regarding Greenland Energy Company’s (the “Company”) future financial performance, business strategy, operations, financial position, estimated revenues and losses, projected costs, prospects, plans, objectives of management, and expected benefits of the Company’s recent business combination, are forward-looking statements. Forward-looking statements are generally identified by the use of words such as “believe,” “may,” “will,” “estimate,” “continue,” “anticipate,” “intend,” “expect,” “should,” “would,” “plan,” “project,” “forecast,” “potential,” “predict,” or the negative of these terms or similar expressions, although not all forward-looking statements contain such identifying words. These forward-looking statements are based on management’s current expectations, assumptions and beliefs regarding future events and are based on information currently available to the Company. These statements involve a number of risks and uncertainties, many of which are difficult to predict and are beyond the Company’s control, and actual results may differ materially from those expressed or implied by these forward-looking statements. Factors that could cause actual results to differ materially include, among others: (i) Exploration and Geological Risks, including the Company’s status as a development-stage company with no operating history, revenues, or proved reserves; the inherent uncertainty in prospective resource estimates, including that the 13 billion barrel estimate is based on undiscovered accumulations with no certainty of discovery or commercial viability; geological complexity arising from limited seismic data coverage, pervasive igneous intrusions, faulting patterns, and significant Tertiary uplift creating thermal maturity uncertainty; the fact that the basin has never produced a commercial discovery despite decades of study dating back to the 1970s, and a 2008 USGS report stating less than a 10% chance of containing a technically recoverable hydrocarbon accumulation; and high-cost frontier exploration with estimated well costs of $40 million for the first well and $20 million for subsequent wells; (ii) Operational and Environmental Risks, including the challenges of operating in a remote Arctic location with extreme climate, harsh weather, limited daylight, no existing infrastructure, and seasonal access windows for equipment and personnel; drilling hazards such as blowouts, equipment failures, well control events, environmental releases, and accidents inherent in oil and gas operations; reliance on third-party contractors; and climate change scrutiny, as operations in Greenland face increasing opposition from environmental groups and institutional investors due to Arctic drilling concerns; (iii) Regulatory and Political Risks, including the 2021 Greenland drilling moratorium, and while licenses are grandfathered, future regulatory changes could jeopardize operations; geopolitical tensions, including U.S. interest in acquiring Greenland and Greenland’s internal independence movements that could affect operations; permit requirements, as drilling requires Environmental Impact Assessment approval and Field Activities Application approval from Greenlandic authorities; and forfeiture risk, as failure to meet drilling milestones could result in loss of the Company’s right to earn working interests; (iv) Financial and Capital Risks, including significant capital requirements and the need for substantial funding beyond current resources to complete the drilling program; commodity price volatility, as oil, gas, and NGL prices are highly volatile and will heavily influence project viability; a long development timeline during which market conditions may change significantly before potential production, unlike short-cycle shale projects; going concern uncertainty and substantial doubt about the Company’s ability to continue as a going concern without additional financing; and energy transition risk, as global demand for oil may decline due to electric vehicle adoption, renewable energy policies, and changing consumer preferences; and other risks and uncertainties as set forth in the Company’s Prospectus filed with the Securities and Exchange Commission pursuant to Rule 424(b)(4) under the Securities Act on April 29, 2026, in the section titled “Risk Factors”. Forward-looking statements speak only as of the date they are made. The Company undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by applicable law. Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://IBN.fm/Disclaimer Forward Looking Statements Certain statements in this article are forward-looking, as defined in the Private Securities Litigation Reform Act of 1995. These statements involve risks, uncertainties, and other factors that may cause actual results to differ materially from the information expressed or implied by these forward-looking statements and may not be indicative of future results. These forward-looking statements are subject to a number of risks and uncertainties, including, among others, various factors beyond management's control, including the risks set forth under the heading "Risk Factors" discussed under the caption "Item 1A. Risk Factors" in Part I of the Company's most recent Annual Report on Form 10-K or any updates discussed under the caption "Item 1A. Risk Factors" in Part II of the Company's Quarterly Reports on Form 10-Q and in the Company's other filings with the SEC. Undue reliance should not be placed on the forward-looking statements in this article in making an investment decision, which are based on information available to us on the date hereof. All parties undertake no duty to update this information unless required by law
LOS ANGELES, CA - June 23, 2026 (NEWMEDIAWIRE) - Heart disease has held the grim distinction of being the leading cause of death in the United States for decades, and despite advances in medicine, the problem is getting worse, not better. According to the American Heart Association (“AHA”), cardiovascular disease accounted for more than 940,000 deaths in the United States in 2022, maintaining its position as the nation’s number one killer. Into that persistent and costly healthcare burden steps Cardio Diagnostics Holdings (NASDAQ: CDIO), a Chicago-based precision cardiovascular medicine company that is applying artificial intelligence, epigenetics and genetics to a problem that traditional diagnostic tools have never fully solved: detecting coronary heart disease, including forms that standard methods routinely miss, from a simple blood draw. For cardiovascular conditions, annual health care costs are forecasted to increase from $393 billion in 2020 to $1.4 trillion by 2050, almost quadrupling in size. What makes Cardio Diagnostics’ approach distinct, and what gives the company a defensible clinical position, is its ability to detect coronary heart disease earlier and with high sensitivity. The company’s recent commercial and regulatory milestones give additional shape to the investment thesis. The scale of the problem that Cardio Diagnostics is working to address is difficult to overstate. According to the AHA, cardiovascular disease remains the leading cause of death across men, women, and most racial and ethnic groups in the nation, with one person dying every 34 seconds from the… Read More Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://IBN.fm/Disclaimer The latest news and updates relating to CDIO are available in the company’s newsroom at https://ibn.fm/CDIO Forward Looking Statements Certain statements in this article are forward-looking, as defined in the Private Securities Litigation Reform Act of 1995. These statements involve risks, uncertainties, and other factors that may cause actual results to differ materially from the information expressed or implied by these forward-looking statements and may not be indicative of future results. These forward-looking statements are subject to a number of risks and uncertainties, including, among others, various factors beyond management's control, including the risks set forth under the heading "Risk Factors" discussed under the caption "Item 1A. Risk Factors" in Part I of the Company's most recent Annual Report on Form 10-K or any updates discussed under the caption "Item 1A. Risk Factors" in Part II of the Company's Quarterly Reports on Form 10-Q and in the Company's other filings with the SEC. Undue reliance should not be placed on the forward-looking statements in this article in making an investment decision, which are based on information available to us on the date hereof. All parties undertake no duty to update this information unless required by law
LOS ANGELES, CA - June 23, 2026 (NEWMEDIAWIRE) - Greenland Mines (NASDAQ: GRML) announced it has awarded a diamond drilling contract to Nordisk Fundering A/S for the 2026 field campaign at its 80%-owned Skaergaard precious and critical metals project in southeast Greenland. The planned program will include approximately 7,500 meters of helicopter-supported diamond core drilling aimed at advancing resource categories, collecting additional metallurgical material and supporting geotechnical studies for potential future open-pit development scenarios. Greenland Mines said the integrated campaign will utilize three helicopter-portable drill rigs and will generate geological, metallurgical and engineering data to support mine planning and broader development studies. The company noted that Nordisk Fundering’s Arctic and geotechnical drilling experience is expected to enhance execution of the program, which will run alongside ongoing metallurgical and processing work being conducted with GTK Mintec to support future economic evaluations of the Skaergaard project. To view the full press release, visit: https://ibn.fm/9uyEs About Greenland Mines Greenland Mines Ltd is a Nasdaq-listed company with two operating divisions: (1) Mining, focused on the exploration and development of the Skaergaard Project in southeast Greenland and, subject to closing of the previously announced transaction, the Sarfartoq neodymium-praseodymium (Nd-Pr) rare earths project in southwest Greenland; and (2) Biotech, including Klotho’s KLTO‑202 primary indication for ALS. The Company’s strategy is centered on building a multi-asset platform with exposure to rare earth magnet materials, precious metals and selected midstream processing opportunities, while advancing its broader North Atlantic Critical Metals Corridor vision linking Greenland resources with allied downstream jurisdictions and industrial infrastructure. Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://IBN.fm/Disclaimer The latest news and updates relating to GRML are available in the company’s newsroom at https://ibn.fm/GRML Forward Looking Statements Certain statements in this article are forward-looking, as defined in the Private Securities Litigation Reform Act of 1995. These statements involve risks, uncertainties, and other factors that may cause actual results to differ materially from the information expressed or implied by these forward-looking statements and may not be indicative of future results. These forward-looking statements are subject to a number of risks and uncertainties, including, among others, various factors beyond management's control, including the risks set forth under the heading "Risk Factors" discussed under the caption "Item 1A. Risk Factors" in Part I of the Company's most recent Annual Report on Form 10-K or any updates discussed under the caption "Item 1A. Risk Factors" in Part II of the Company's Quarterly Reports on Form 10-Q and in the Company's other filings with the SEC. Undue reliance should not be placed on the forward-looking statements in this article in making an investment decision, which are based on information available to us on the date hereof. All parties undertake no duty to update this information unless required by law View the original release on www.newmediawire.com
LOS ANGELES, CA - June 23, 2026 (NEWMEDIAWIRE) - Coronary artery disease remains one of the most urgent and widespread health threats worldwide, contributing to millions of deaths each year and often progressing silently until a major cardiac event occurs. As healthcare providers search for faster and more accessible ways to identify high-risk patients earlier, HeartBeam (NASDAQ: BEAT) has launched a new pilot study designed to evaluate its technology - a proprietary on-demand 12-lead ECG patch - in detecting coronary artery disease and inadequate blood flow and oxygen supply to tissue, or ischemia. The seriousness of coronary artery disease continues to intensify as populations age and cardiovascular risk factors become more common. HeartBeam announced the launch of a pilot study focused on evaluating its on-demand 12-lead ECG patch in detecting coronary artery disease and inadequate blood flow and oxygen supply to tissue, or ischemia. The study represents a significant step in the development of the HeartBeam patch, which has the potential to disrupt the $2 billion long-term continuous monitor and mobile cardiac telemetry (“MCT”) markets. “Ischemia detection has not been possible on patch-based ambulatory monitors, and they do not provide clinical-grade insights over an extended period of time,” said HeartBeam CEO Robert Eno. “The HeartBeam patch is designed to change that. A device capable of generating an on-demand… Read More Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://IBN.fm/Disclaimer The latest news and updates relating to BEAT are available in the company’s newsroom at https://ibn.fm/BEAT Forward Looking Statements Certain statements in this article are forward-looking, as defined in the Private Securities Litigation Reform Act of 1995. These statements involve risks, uncertainties, and other factors that may cause actual results to differ materially from the information expressed or implied by these forward-looking statements and may not be indicative of future results. These forward-looking statements are subject to a number of risks and uncertainties, including, among others, various factors beyond management's control, including the risks set forth under the heading "Risk Factors" discussed under the caption "Item 1A. Risk Factors" in Part I of the Company's most recent Annual Report on Form 10-K or any updates discussed under the caption "Item 1A. Risk Factors" in Part II of the Company's Quarterly Reports on Form 10-Q and in the Company's other filings with the SEC. Undue reliance should not be placed on the forward-looking statements in this article in making an investment decision, which are based on information available to us on the date hereof. All parties undertake no duty to update this information unless required by law View the original release on www.newmediawire.com
By Meg Flippin, Benzinga DETROIT, MICHIGAN - June 23, 2026 (NEWMEDIAWIRE) - As investors search for the next major technology trend beyond AI, quantum computing is attracting growing attention for its potential to reshape industries ranging from drug discovery and transportation to cybersecurity. In fact, the technology is increasingly being seen by some as a complementary technology to AI that could grow alongside it. At the same time, when it comes to investing in the technology that makes all this possible, investors have historically focused on a small group of publicly traded quantum computing companies, assigning them multi-billion-dollar valuations. However, there are also players in the space that haven’t tapped the public markets yet. Move Over Big Caps One such player is IQM Quantum Computers, the European quantum computing company, which plans to list publicly soon through a SPAC merger with Real Asset Acquisition Corp. (RAAQ). RAAQ shareholders will vote to approve the deal on June 25, and the transaction is expected to close as soon as possible thereafter, subject to satisfaction or waiver of the applicable closing conditions. Upon closing of the transaction, all shares in RAAQ will convert, on a one-for-one basis, into American depositary shares of IQM. Once the transaction closes, IQM is expected to have an implied valuation of about $1.9 billion and will have pro forma cash of up to $477 million, prior to giving effect to any exercises of redemption rights for cash by RAAQ shareholders. IQM ADSs will trade on the Nasdaq Global Market under the symbol IQMX. IQM is already well-established in the market, having already sold 23 quantum computers, built more than 30 and delivered 18 computers globally. In 2025, IQM reports that it generated about $36 million in revenue, growing significantly from the past year. IQM’s customers include four of the world's top ten supercomputing centers and leading research institutions, including Oak Ridge National Laboratory in the U.S. That’s a big deal because one of the biggest questions surrounding quantum computing is whether customers are willing to pay for the technology today. These factors may explain why institutional investors were willing to invest $146 million in IQM’s upsized PIPE transaction conducted concurrently with the SPAC merger. Willing To Spend Top-tier institutions also appear willing to bet on IQM, given that many have chosen the company after evaluating multiple technologies before making long-term infrastructure commitments. That, says the company, provides powerful third-party validation that quantum computing is moving beyond research and into real-world deployment. As CEO Jan Goetz recently told CNBC, "Many people think quantum is still a technology thing and it's not clear which technology wins and how to build a quantum computer. We think we are far beyond that. It's actually about the adoption and putting quantum computing to use." Plus, IQM reports that it had about $77 million in revenue backlog as of December 31, 2025, which shows that it has customers who are willing to pay for quantum computing, locking in future revenue. For investors, the backlog highlights commercial momentum, provides visibility into future revenue and reflects a runway of future system deployments. But interested individuals don’t have to rely on IQM for evidence that the quantum computing market is poised for growth. The opportunity extends well beyond the quantum computing market itself, with McKinsey estimating the technology could unlock up to $2.7 trillion in economic value by 2035. AI & Quantum Computing: Better Together While AI has become the defining technology investment theme of the decade, many leading supercomputing centers and research institutions are investing in both AI and quantum computing as they prepare for the next generation of computing. IQM systems are already deployed in advanced computing environments where researchers are exploring how quantum technologies can complement future AI workloads. As AI models become larger and computational challenges become more complex, quantum computing is increasingly viewed as a complementary capability rather than a competing technology. For investors looking beyond today's AI cycle, quantum computing is among the areas being watched by some as a potential next-generation opportunity. Instead of competing with AI for investment dollars, quantum computing is increasingly complementing the technology, a trend which could bode well for IQM, given it is an established leader with a proven track record, top-tier customers and $77 million in backlog. Goetz also shared with CNBC that he believes the timing is right: "The technology is ready. The adoption is coming. We have successful sales cases around the world.” Featured image from Shutterstock. This content was originally published on Benzinga. Read further disclosures here. This post contains sponsored content and was created in collaboration with a third-party partner. Benzinga is a publisher and does not provide personalized investment advice or act as a broker or dealer. This content is for informational purposes only and is not intended to be investing advice or an offer or solicitation to buy or sell any security. View the original release on www.newmediawire.com
Potentially Valuable Novel Compositions Being Investigated Lexaria Also Receives Additional New Granted Patent KELOWNA, BRITISH COLUMBIA - June 23, 2026 (NEWMEDIAWIRE) - Lexaria Bioscience Corp. (Nasdaq: LEXX) (the “Company” or “Lexaria”), a global innovator in drug delivery platforms, provides the following update on Animal Study #1 (GLP-1-A26-1) that is evaluating a number of formulation enhancements using both DehydraTECH-semaglutide (“DHT-sema”) glucagon-like peptide-1 (“GLP-1”) compositions and DehydraTECH-CBD (“DHT-CBD”) compositions to explore the potential for additional improved performance as well as stake new intellectual property (“IP”) claims (the “Study”). The Study is on schedule and dosing began on June 10, 2026, as planned. Barring any unforeseen interruptions, Study results are currently expected by early September. One of the novel objectives of this Study is to evaluate innovative alternative formulations to SNAC (salcaprozate sodium) which is currently in use by Novo Nordisk® with their oral Rybelsus® and Wegovy® tablet products. If Lexaria is able to scientifically evidence novel new formulations with similarity or superiority to SNAC performance enhancements, we may be able to establish valuable new proprietary IP and an industry alternative to SNAC that could be of value within the keenly competitive GLP-1 sector. To this end, Lexaria is pleased to report that we have already filed 3 new patent applications that anticipate our latest technological improvements in this area. The Study is utilizing Sprague-Dawley rats with 11 separate Study arms evaluating a number of different novel compositions. Blood samples are being taken at multiple timepoints through an 8-24 hour post-dosing period to quantify the pharmacokinetic performance of each composition. In addition, the Study will also measure drug concentrations in the brain since DehydraTECH has, in the past, evidenced apparent superior absorption of active ingredients into brain tissue, an area of intense interest due to the fact that GLP-1 drug performance is increasingly understood to include or even depend upon involvement of brain neurochemistry, thus making brain biodistribution vital. There will be one reference arm using an existing DHT-sema composition and another reference arm using an existing DHT-CBD composition. Lexaria will leverage the wealth of study data that we have amassed from previous work by utilizing our proprietary historical data and the reference arms as baseline comparators to the current Study results as we search for areas of improvement. The Study is fully funded from existing corporate resources. Lexaria is also pleased to report that on June 11, 2026 we received our first Australian patent grant (#2023302884) in our Family #21 - Pharmaceutical Compositions and Methods for Treating Hypertension. This patent represents our 7th patent in this family with 3 others previously granted in the US, 1 in Europe and 2 in Japan. The term of this patent is until April 25, 2043. About Lexaria Bioscience Corp. & DehydraTECH™ DehydraTECH™ is Lexaria’s patented drug delivery formulation and processing platform technology which improves the way a wide variety of drugs enter the bloodstream, always through oral delivery. DehydraTECHTM has repeatedly evidenced the ability to increase bio-absorption, reduce side-effects, and deliver some drugs more effectively across the blood brain barrier. Lexaria operates a licensed in-house research laboratory and holds a robust intellectual property portfolio with 66 patents granted and additional patents pending worldwide. For more information, please visit www.lexariabioscience.com. CAUTION REGARDING FORWARD-LOOKING STATEMENTS This press release includes forward-looking statements. Statements as such term is defined under applicable securities laws. These statements may be identified by words such as "anticipate," "if," "believe," "plan," "estimate," "expect," "intend," "may," "could," "should," "will," and other similar expressions. Such forward-looking statements in this press release include, but are not limited to, statements by the Company relating to the Company’s ability to carry out research initiatives, receive regulatory approvals or grants or experience positive effects or results from any research or study. Such forward-looking statements are estimates reflecting the Company's best judgment based upon current information and involve a number of risks and uncertainties, and there can be no assurance that the Company will actually achieve the plans, intentions, or expectations disclosed in these forward-looking statements. As such, you should not place undue reliance on these forward-looking statements. Factors which could cause actual results to differ materially from those estimated by the Company include, but are not limited to, government regulation and regulatory approvals, managing and maintaining growth, the effect of adverse publicity, litigation, competition, scientific discovery, the patent application and approval process, potential adverse effects arising from the testing or use of products utilizing the DehydraTECH technology, the Company’s ability to maintain existing collaborations and realize the benefits thereof, delays or cancellations of planned R&D that could occur related to pandemics or for other reasons, and other factors which may be identified from time to time in the Company's public announcements and periodic filings with the US Securities and Exchange Commission on EDGAR. The Company provides links to third-party websites only as a courtesy to readers and disclaims any responsibility for the thoroughness, accuracy or timeliness of information at third-party websites. There is no assurance that any of Lexaria’s postulated uses, benefits, or advantages for the patented and patent-pending technology will in fact be realized in any manner or in any part. No statement herein has been evaluated by the Food and Drug Administration (FDA). Lexaria-associated products are not intended to diagnose, treat, cure or prevent any disease. Any forward-looking statements contained in this release speak only as of the date hereof, and the Company expressly disclaims any obligation to update any forward-looking statements or links to third-party websites contained herein, whether as a result of any new information, future events, changed circumstances or otherwise, except as otherwise required by law. INVESTOR CONTACT: George Jurcic - Head of Investor Relations ir@lexariabioscience.com Phone: 250-765-6424, ext 202 View the original release on www.newmediawire.com
TULSA, OK - June 23, 2026 (NEWMEDIAWIRE) - Ladybug Resource Group, Inc. ("Ladybug" or the "Company") (OTC ID: LBRG) today announced a strategic expansion of its market focus, leveraging the proven high-precision manufacturing model of its JingDiao division to capture high-margin opportunities beyond the automotive sector. Following the successful deployment of JingDiao’s proprietary operational intelligence in the Electric Vehicle (EV) supply chain, the Company is now scaling these capabilities to serve the surging global demand in medical instrumentation, aerospace structural components, and advanced semiconductor packaging infrastructure. The Portability of JingDiao’s Operational Intelligence across Global Sectors The Company’s strategic move beyond the automotive sector is driven by the demonstrated portability of JingDiao’s digital management models. The same high-efficiency systems that manage complex EV production lines at the JingDiao facility have shown exceptional performance when applied to other precision-intensive industries that require zero-defect integrity. By utilizing its Smart Supply Chain Hub, JingDiao can now rapidly re-allocate its 5-axis CNC capacity and AI-driven inspection systems to fulfill orders for high-end medical device frames and aerospace components, providing the same level of auditable transparency and precision that has made it a leader in the automotive world. Capitalizing on Global Manufacturing Trends through JingDiao’s Scalability As Western economies prioritize the reshoring of critical manufacturing and the building of resilient supply chains, there is a substantial global deficit in facilities capable of delivering both extreme precision and large-scale output. JingDiao is filling this void by acting as a decentralized manufacturing partner for global technology firms that require rapid prototyping and localized production of high-precision automation hardware. This diversification strategy, powered by JingDiao’s engineering expertise, significantly increases the Company’s Total Addressable Market (TAM), reducing exposure to any single industry’s cyclicality while ensuring a consistent pipeline of high-value engineering contracts throughout 2026 and beyond. Management Commentary "JingDiao’s technological moat is fundamentally industry-agnostic," stated Mr. Shicai Li, CEO of the manufacturing division. "While the global transition to sustainable transportation remains a core pillar of our growth, the precision and digital transparency perfected at JingDiao are universal requirements for the next generation of intelligent industry. By expanding JingDiao’s footprint into the medical and aerospace automation sectors, we are unlocking new high-margin revenue streams and demonstrating the immense scalability of the Ladybug model. We are building an industrial ecosystem designed for long-term capital appreciation across multiple global growth sectors." About Ladybug Resource Group, Inc. Ladybug Resource Group, Inc. is a US-listed company focused on the intersection of advanced manufacturing and industrial AI. Through its acquisition of Guangzhou JingDiao, the Company provides digitally managed supply chain solutions for the global automotive and precision engineering industries, led by a management team with deep roots in world-class manufacturing excellence. Stay connected: Website: Ladybug Resource Group Inc. OTC Markets: LBRG Stock Quote X (formerly Twitter) LinkedIn Instagram Media & Investor Relations Contact Warren Booth Ladybug Resource Group Inc. 1408 S. Denver Avenue, Tulsa, OK 74119 info@ladybuglbrg.com +1 918-727-7137 Safe Harbor Statement This news release contains forward-looking statements which are not statements of historical fact. Forward-looking statements include estimates and statements that describe the Company's future plans, objectives or goals, including words to the effect that the Company or management expects a stated condition or result to occur. Forward-looking statements may be identified by such terms as "believes," "anticipates", "expects", "estimates", "may", "could", "would", "will", or "plan". Since forward-looking statements are based on assumptions and address future events and conditions, by their very nature they involve inherent risks and uncertainties. Although these statements are based on information currently available to the Company, the Company provides no assurance that the actual results will meet management's expectations. Risks, uncertainties, and other factors involved with forward-looking information could cause actual events, results, performance, prospects, and opportunities to differ materially from those expressed or implied by such forward-looking information. Factors that could cause actual results to differ materially from such forward-looking information include but are not limited to changes in general economic and financial market conditions. Although the Company believes that the assumptions and factors used in preparing the forward-looking information in this news release are reasonable, undue reliance should not be placed on such information, which only applies as of the Date of this news release, and no assurance can be given that such events will occur in the disclosed time frames or at all. The Company disclaims any intention or obligation to update or revise any forward-looking information, whether as a result of new information, future events or otherwise, other than as required by law.
Partnership Will Enable US Distribution of Archax’s Tokenized Short-Term Treasuries Product via tZERO’s SEC- and FINRA-Regulated Broker-Dealer Ecosystem NEW YORK, NY - June 23, 2026 (NEWMEDIAWIRE) - tZERO Group, Inc., a leader in blockchain-based financial infrastructure, and Archax, the UK/EU-regulated digital asset platform, today announced that Archax’s $GOVY tokenized US Treasury Bill product will be available for distribution to US qualified purchasers through tZERO’s SEC-registered and FINRA-member broker-dealer and custodial infrastructure for tokenized assets later this year. The collaboration will mark the first time $GOVY – which provides direct, legally enforceable entitlement to short-term treasuries with embedded on-chain settlement, custody and delivery functionality – will be available to US qualified purchasers. Distribution will be facilitated through tZERO’s regulated brokerage ecosystem, providing a compliant pathway for US institutional investors to access government yield via tokenized infrastructure, subject to tZERO’s due diligence and final approval. The announcement builds on the recent Archax launch of $GOVY, as well as on the strategic partnership between Archax and tZERO announced last year, which established a framework for distributing digital securities and tokenized real-world assets across both platforms in the US, UK and EU. “The US represents the largest addressable market for tokenized government securities, and working with tZERO gives $GOVY a regulated, institutional-grade route into that market,” said Graham Rodford, CEO and co-founder of Archax. “tZERO’s infrastructure – including their SEC- and FINRA-regulated broker-dealer and digital custody capabilities – is ideally suited to distribute $GOVY to US institutional investors who want direct exposure to T-Bills without the friction of traditional settlement cycles.” “$GOVY is exactly the kind of product our platform was built to support – an institutional-quality tokenized asset that delivers real yield with operational simplicity,” said Alan Konevsky, Chairman and Chief Executive Officer of tZERO. “By distributing $GOVY through our infrastructure, we will give US institutional investors seamless exposure to a tokenized treasuries product while demonstrating the power of cross-border collaboration between regulated venues that is at the heart of the global convergence promise of financial asset tokenization. This is the follow-the-sun model in action.” The $GOVY token provides US qualified purchasers continuous exposure to short-term treasuries removing the operational complexity of managing, rolling and settling short-term treasury positions. Investors may redeem $GOVY for stablecoins or the underlying T-Bill at any time. Key Features for US Institutional Investors Dual-Regulated Infrastructure Archax is authorised by the UK Financial Conduct Authority; tZERO operates an SEC-registered and FINRA-member broker-dealer, SEC-regulated ATS and is a qualified custodian for digital assets. Operational Simplicity Continuous exposure to short-term treasuries via a single token, with no manual roll management required. Subscriptions and redemptions are processed on-chain. Institutional-Grade Custody tZERO’s digital asset broker-dealer providing US-regulated custodial capabilities. 24/7 Subscriptions and Redemptions $GOVY is issued initially on Ethereum, Hedera and Stellar, with support for other blockchains to follow. The US distribution of $GOVY will represent a significant milestone in the Archax–tZERO partnership and demonstrates how regulated venues in different jurisdictions can collaborate to expand investor access to tokenized real-world assets. Further product launches across additional currencies – including £GOVY (GBP) and €GOVY (EUR) – are planned. For more information on GOVY visit https://govy.finance/. Media Contacts: tZERO Group, Inc. Julie Ros, Head of Marketing & Communications jros@tzero.com About Archax Archax is a UK/EU regulated digital asset platform, targeted at professionals and institutions. Founded by experts from traditional capital markets, Archax supports all types of digital assets – from unregulated cryptocurrencies through to regulated tokenized real-world assets (RWAs). Archax also covers the full digital lifecycle from token issuance and fundraising through to trading and custody. Archax provides the global, regulated on-chain capital markets infrastructure that allows traditional financial markets participants to bridge into the digital/crypto/DeFi space. For more information, visit www.archax.com or contact media@archax.com. About tZERO Group, Inc. tZERO Group, Inc. (tZERO) and its broker-dealer subsidiaries provide an innovative liquidity platform for private companies and assets. We offer institutional-grade solutions for issuers looking to digitize their capital table through blockchain technology, and make such equity available for trading on an alternative trading system. tZERO, through its broker-dealer subsidiaries, democratizes access to private assets by providing a simple, automated, and efficient trading venue to broker-dealers, institutions, and investors. All technology services are offered through tZERO Technologies, LLC. For more information, please visit our website. About tZERO Digital Asset Securities, LLC tZERO Digital Asset Securities, LLC is a broker-dealer registered with the SEC and a member of FINRA and SIPC. It is the broker-dealer custodian of all digital asset securities offered on tZERO’s online brokerage platform. Digital asset securities may not be “securities” as defined under the Securities Investor Protection Act (SIPA)-and in particular, digital asset securities that are “investment contracts” under the Howey test but are not registered with the Securities and Exchange Commission are excluded from SIPA’s definition of “securities”-and thus the protections afforded to securities customers under SIPA may not apply. More information about tZERO Digital Asset Securities may be found on FINRA’s BrokerCheck. About tZERO Securities, LLC tZERO Securities, LLC is a broker-dealer registered with the SEC and a member of FINRA and SIPC. It is the operator of the tZERO Securities ATS. More information about tZERO Securities may be found on FINRA’s BrokerCheck. Investor Notice Digital asset securities, as well as any particular investment, may not be suitable or appropriate for everyone. Investors should note that investing or trading in securities could involve substantial risks, including no guarantee of returns, costs associated with selling and purchasing, and no assurance of liquidity which could impact their price and investors’ ability to sell, and possible loss of principal invested. There is always the potential of losing money when you invest in securities. There are also unique risks specific to digital asset securities, including, without limitation, fraud, manipulation, theft, and loss. No Offer, Solicitation, Investment Advice or Recommendations This release is for informational purposes only and does not constitute an offer to sell, a solicitation to buy, or a recommendation for any security, nor does it constitute an offer to provide investment advisory or other services by tZERO, Bed Bath & Beyond, Inc., or any of their respective affiliates, subsidiaries, officers, directors or employees. No reference to any specific security constitutes a recommendation to buy, sell, or hold that security or any other security. Nothing in this release shall be considered a solicitation or offer to buy or sell any security, future, option or other financial instrument or to offer or provide any investment advice or service to any person in any jurisdiction. Nothing contained in this release constitutes investment advice or offers any opinion with respect to the suitability of any security, and the views expressed in this release should not be taken as advice to buy, sell or hold any security. In preparing the information contained in this release, we have not taken into account the investment needs, objectives, and financial circumstances of any particular investor. This information has no regard to the specific investment objectives, financial situation, and particular needs of any specific recipient of this information and investments discussed may not be suitable for all investors. Any views expressed in this release by us were prepared based upon the information available to us at the time such views were written. Changed or additional information could cause such views to change. All information is subject to possible corrections. Information may quickly become unreliable for various reasons, including changes in market conditions or economic circumstances. Forward-Looking Statements by tZERO This release contains forward-looking statements. In addition, from time to time, tZERO, its subsidiaries, or its representatives may make forward-looking statements orally or in writing. These forward-looking statements are based on expectations and projections about future events, which is derived from currently available information. Such forward-looking statements relate to future events or future performance, including financial performance and projections; growth in revenue and earnings; and business prospects and opportunities. You can identify forward-looking statements by those that are not historical in nature, particularly those that use terminology such as “may,” “should,” “expects,” “anticipates,” “contemplates,” “estimates,” “believes,” “plans,” “projected,” “predicts,” “potential,” or “hopes” or the negative of these or similar terms. In evaluating these forward-looking statements, you should consider various factors, including, without limitation: the ability of tZERO and its subsidiaries to change the direction; tZERO’s ability to keep pace with new technology and changing market needs; performance of individual transactions; regulatory developments and matters; and competition. These and other factors may cause actual results to differ materially from any forward-looking statement. Forward-looking statements are only predictions. The forward-looking events discussed in this release and other statements made from time to time by tZERO, its subsidiaries or their respective representatives, may not occur, and actual events and results may differ materially and are subject to risks, uncertainties and assumptions. tZERO, its subsidiaries, and its representatives are not obligated to publicly update or revise any forward-looking statement, whether as a result of uncertainties and assumptions, the forward-looking events discussed in this release and other statements made from time to time by tZERO, its subsidiaries or its representatives might not occur. This press release is for informational purposes only and does not constitute an offer to sell, a solicitation of an offer to buy, or a recommendation to purchase any security. The securities described herein are subject to qualification by the U.S. Securities and Exchange Commission under Regulation A+ (Tier 2) and have not yet been so qualified. No money or other consideration is being solicited, and if sent in response, will not be accepted. No offer to buy the securities can be accepted and no part of the purchase price can be received until the offering statement is qualified, and any such offer may be withdrawn or revoked, without obligation or commitment of any kind, at any time before notice of its acceptance given after the date of qualification. A person's indication of interest involves no obligation or commitment of any kind. For more information, visit www.tzero.com. View the original release on www.newmediawire.com
CARACAS, VENEZUELA - June 23, 2026 (NEWMEDIAWIRE) - LataMed AI Corp. (OTC: LMED) (the “Company”), a development-stage digital health and artificial intelligence technology company focused on telehealth infrastructure, healthcare analytics, and care coordination solutions for emerging markets, today announced that its Venezuelan operating affiliate, LataMed AI VE, will be featured in an interview in ES Salud Magazine, a healthcare-focused publication covering healthcare businesses, medical innovation, and developments within the healthcare sector. According to the Company, the feature is expected to be published in the July 2026 edition of ES Salud Magazine and will include an editorial profile and interview discussing the Company’s healthcare technology initiatives, digital healthcare ecosystem strategy, and ongoing efforts to improve healthcare accessibility throughout Latin America. The Company further noted that it has received a formal invitation from the publisher to participate in a broader editorial feature package expected to include coverage through both ES Salud Magazine and Eva’s Magazine. According to the invitation, the feature is anticipated to be distributed through multiple print, digital, social media, and online publication channels. Management stated that the publication is expected to provide an opportunity to discuss LataMed AI’s evolving healthcare platform while increasing visibility of the Company’s healthcare ecosystem among healthcare professionals, industry participants, and other stakeholders throughout the healthcare sector. The feature is expected to discuss the Company’s telehealth infrastructure, healthcare coordination technologies, payment accessibility initiatives, insurance integration opportunities, pharmacy-related services, and artificial intelligence-driven healthcare solutions currently under development. The Company noted that the feature is expected to highlight its broader vision of developing an integrated healthcare ecosystem designed to improve accessibility, coordination, and engagement for patients, healthcare providers, and other healthcare stakeholders across emerging markets, while further increasing awareness of the Company’s developing healthcare technology initiatives. Management believes that healthcare-focused industry publications provide valuable opportunities to increase awareness of healthcare innovation initiatives, share perspectives regarding evolving healthcare technologies, and engage with healthcare professionals, industry participants, and other stakeholders interested in the future of healthcare delivery. Dr. Kevin Rodan Levy, Chief Executive Officer of LataMed AI Corp., stated: “We appreciate the opportunity to share our vision for technology-enabled healthcare solutions and discuss the initiatives we are currently advancing throughout Latin America. We believe healthcare accessibility, coordination, and patient engagement remain important challenges across many markets, and we welcome opportunities to participate in industry discussions regarding the role of technology in addressing those challenges. We also believe opportunities to engage with healthcare-focused audiences help increase awareness of our broader healthcare ecosystem strategy and the technologies we are developing to support patients and providers throughout Latin America.” The Company expects the feature to be published during July 2026 and intends to provide additional updates once publication details have been finalized, including information regarding publication dates, online availability, print distribution, and access through the publication's online digital channels. For additional information, please visit https://latamed.ai, follow the Company’s official social media channels, or review the Company’s filings with the U.S. Securities and Exchange Commission at www.sec.gov. About LataMed AI Corp. LataMed AI Corp. (OTC: LMED) is a development-stage digital health and artificial intelligence technology company focused on building telehealth infrastructure, healthcare coordination tools, analytics capabilities, and AI-enabled healthcare solutions for emerging markets. The Company’s strategy is centered on developing technology platforms designed to support healthcare access, patient engagement, provider coordination, emergency medical response, pharmacy integration, and data-driven healthcare operations, with an initial regional focus on Latin America. Forward-Looking Statements This press release contains forward-looking statements. Forward-looking statements include, but are not limited to, statements regarding the Company's business strategy, industry engagement initiatives, healthcare technology initiatives, telehealth infrastructure development, artificial intelligence applications, commercialization initiatives, platform deployment, operational execution, strategic relationships, potential collaboration opportunities, market opportunities, regional expansion plans, and future operations. These statements are based on current expectations and assumptions and are subject to significant risks and uncertainties that could cause actual results to differ materially from those expressed or implied. Investors are cautioned not to place undue reliance on forward-looking statements, which speak only as of the date of this press release. Actual results may differ materially due to various factors, including but not limited to: the Company's ability to successfully implement its business plan; the availability of financing; the Company's ability to obtain required regulatory authorizations; operational execution risks; technology deployment risks; risks associated with operations in emerging markets, including Venezuela; the Company's ability to successfully develop and execute strategic relationships, collaboration opportunities, and other business initiatives arising from industry engagement activities; and general economic and market conditions. The Company undertakes no obligation to update any forward-looking statements except as required by applicable law. Disclaimer This press release is provided for informational purposes only and does not constitute an offer to sell or the solicitation of an offer to buy any securities of the Company. Any investment decision should be made solely on the basis of information contained in the Company's filings with the U.S. Securities and Exchange Commission and other publicly available documents. The Company's securities involve a high degree of risk. Prospective investors are urged to carefully review all risk factors and disclosures contained in the Company's SEC filings before making any investment decision. No representation or warranty, express or implied, is made as to the accuracy or completeness of the information contained herein. Investor Relations Contact LataMed AI Corp. ir@latamed.ai +1 (787) 476-2350 https://latamed.ai View the original release on www.newmediawire.com
Issuers Receptive to Less Frequent Reporting, Respondents Suggest LOS ANGELES, CA - June 23, 2026 (NEWMEDIAWIRE) - Seventy-seven percent of investors say companies should continue reporting quarterly results, according to a survey conducted by PondelWilkinson, an investor relations and strategic public relations consultancy. By contrast, 18% of investors believe public companies should report results semi-annually, while 5% support semi-annual reporting supplemented by select key metrics in non-reporting quarters. The online survey comes as the SEC seeks public comment by July 6, 2026 on its proposed semi-annual reporting rule, which would allow public companies to report results twice a year rather than four times. A smaller group of public company management respondents was more divided on the proposal, with a slight majority expressing support for either less frequent reporting or reporting only key metrics in alternating quarters. “Our survey results highlight investors’ strong demand for timely, transparent information,” said Roger Pondel, CEO at PondelWilkinson. “At the same time, issuers pointed to reduced regulatory burdens and lower compliance costs as key reasons why shifting to semi-annual reporting could be beneficial.” Click here or visit https://youtu.be/NRuRilrigEo to view Roger Pondel's video commentary on the survey findings. In addition to structured survey questions, participants were asked to provide commentary on the potential benefits, drawbacks and alternative reporting frameworks. Feedback centered around three core themes: Investors Strongly Favor Transparency and Frequent Disclosure Investors emphasized the importance of timely financial information for valuation and market efficiency, expressing concern that reduced reporting frequency could increase uncertainty, risk and volatility. “Efficient markets require more information, not less.” “Six months is an eternity in business these days and is too long to be dealing with stale financials.” “Less information ⇒ more risk. More risk ⇒ lower valuation.” Issuers Seek Relief from Reporting Burdens Company executives, particularly at smaller issuers, highlighted the operational and cost burden of quarterly reporting. “Quarterly encourages short-sighted decisions to ensure quarters look good.” “As long as corporations have to report quarterly, they will want to show profit each quarter, which will reduce incentive to invest in R&D.” "Earnings releases should be quarterly, but full 10-Q's and disclosures should be semiannually." Support for a Hybrid or Compromise Approach Some investor respondents supported middle-ground solutions that balance transparency with flexibility. "If it were semi-annual, I think at least revenue should be reported quarterly.” “Why twice or quarterly? Three times a year is a good compromise.” "For some industries, semi-annual reporting would be adequate; industries containing more volatile metrics should report quarterly." The SEC officially proposed the amendment on May 5, 2026, marking the first time in 55 years that firms may have the flexibility to switch from Form 10-Q reporting. Under the proposed framework, public companies that want to report on a half-year cadence would file their results on a new Form 10-S, while annual filings on Form 10-K would remain unchanged About the survey PondelWilkinson conducted its online survey May - June 2026. Investor respondents included institutional investors, buy-side analysts, sell-side analysts, wealth managers, family office investors, individual investors and investment bankers. Among investor respondents, institutional investors comprised the largest share of participants, followed by individual investors and sell-side analysts. Public company respondents included comments from chief executive officers and chief financial officers. About PondelWilkinson Trusted advisors in investor relations and strategic public relations for more than 50 years, PondelWilkinson helps established and emerging publicly traded, pre-public and private companies navigate Wall Street and Main Street with narratives that inform, inspire and influence. The firm has offices in New York, Connecticut, and Los Angeles, serving companies in multiple sectors worldwide. More information on PondelWilkinson can be found by visiting https://www.pondel.com/ or following the company on LinkedIn and X. FOR MORE INFORMATION, CONTACT: Michael Wichman PondelWilkinson mwichman@pondel.com 917-526-0855 www.pondel.com View the original release on www.newmediawire.com
SILICON VALLEY, CA - June 23, 2026 (NEWMEDIAWIRE) - ABVC BioPharma, Inc. (NASDAQ: ABVC) (“ABVC” or the “Company”), a clinical-stage biopharmaceutical company focused on botanical-derived therapeutics and commercial ingredient platforms, today announced the planned spin-off of BioKey (Cayman), Inc. (“BioKey”) and a related dividend distribution of BioKey shares to ABVC shareholders. Subject to completion of the remaining administrative and regulatory steps, including the effectiveness of the Registration Statement on Form 10 by June 25, 2026, related to the shares to be issued in the distribution, ABVC intends to distribute approximately 15% of BioKey's outstanding Ordinary Shares, which the Company owns, as a pro rata dividend to ABVC shareholders of record as of the close of business on July 24, 2026 (the “Share Distribution” and the "Record Date", respectively). The Share Distribution is expected to be effective as of 11:59 p.m., New York City time, on August 3, 2026. BioKey is a nutraceutical and functional-supplement research, development, and manufacturing company operating as a fully integrated CRO and CDMO platform. Through its subsidiary BioKey, Inc. (California), BioKey offers contract research, formulation development, cGMP manufacturing, regulatory documentation support, and commercial supply services to partners across Asia and North America. BioKey also hopes to integrate burgeoning artificial intelligence technology for its services in the future. ABVC intends to distribute to eligible ABVC shareholders, as a pro rata dividend, approximately 4,500,000 Ordinary Shares, representing approximately 15% of BioKey's current issued and outstanding Ordinary Shares. Additional details regarding distribution mechanics, including fractional share treatment and the role of VStock Transfer, LLC as distribution agent, are set forth in the Information Statement accompanying the Form 10, as filed with the U.S. Securities and Exchange Commission on June 22, 2026. ABVC shareholders are not required to vote on or take any other action to approve the spin-off of BioKey or the Share Distribution. No consideration is required, and shareholders will not be required to surrender or exchange any shares of ABVC common stock to receive their pro rata portion of BioKey Ordinary Shares. The Share Distribution will be made in book-entry form through the facilities of VStock Transfer, LLC, as distribution agent. No public trading market for BioKey Ordinary Shares currently exists. Following completion of the Share Distribution, BioKey intends to apply to have its Ordinary Shares quoted on the OTC Markets. However, there can be no assurance as to the timing of such quotation or that an active trading market will ever develop. Until BioKey's Ordinary Shares are quoted on the OTC Markets, holders of BioKey Ordinary Shares will not be able to sell or transfer their shares in the public market. ABVC Common Stock will continue to trade on the Nasdaq Stock Market under the symbol "ABVC." "We believe the BioKey transaction provides an opportunity to highlight the underlying value of our businesses while maintaining our commitment to long-term shareholder value creation," said Dr. Uttam Patil, ABVC's Chief Executive Officer. "We remain focused on executing our growth strategy and exploring additional opportunities that may benefit our shareholders over time." The planned BioKey spin-off represents an important milestone in ABVC's long-term strategy to unlock the value of its subsidiaries, technology platforms, and strategic investments, while providing ABVC shareholders with direct participation in BioKey's future. Management believes this distribution not only rewards existing shareholders with direct participation in BioKey's future growth, but also demonstrates ABVC's broader commitment to creating shareholder value through the development, commercialization, strategic monetization, and potential separation of subsidiary businesses and technology platforms. The Company continues to evaluate opportunities across its biotechnology, artificial intelligence, healthcare, and commercial services portfolio that may generate additional value-enhancing transactions for shareholders. About ABVC BioPharma & Its Industry ABVC BioPharma is a clinical-stage biopharmaceutical company with an active pipeline of six drugs and one medical device (ABV-1701/Vitargus®) under development. For its drug products, the Company utilizes in-licensed technology from its network of world-renowned research institutions to conduct proof-of-concept trials through Phase II of clinical development. The Company's network of research institutions includes Stanford University, University of California at San Francisco, and Cedars-Sinai Medical Center. For Vitargus®, the Company intends to conduct pivotal clinical trials (Phase III) through global partnerships. About BioKey (Cayman), Inc. BioKey (Cayman), Inc. is a wholly owned subsidiary of ABVC BioPharma established to serve as a holding company for BioKey, Inc., a California corporation, a nutraceutical and functional-supplement research, development, and manufacturing company. Through its California subsidiary, BioKey, Inc., operates as a fully integrated Contract Research and Development and Manufacturing Organization (CRDMO), offering contract research services for preclinical and clinical trials, active pharmaceutical ingredient analysis, drug formulation and analytical method development, clinical trial material production under cGMP conditions, and FDA-compliant regulatory filing support. BioKey holds four FDA-approved Abbreviated New Drug Applications (ANDAs) and operates a cGMP-certified facility in Fremont, California. Following the planned distribution, BioKey intends to pursue independent growth opportunities, strategic acquisitions, technology partnerships, and expansion of its service offerings. Management believes that establishing BioKey as a separate entity will provide greater visibility into its operations, create strategic flexibility, and enhance its ability to pursue future financing and business development initiatives. Forward-Looking Statements This press release contains "forward-looking statements." Such statements may be preceded by the words "intends," "may," "will," "plans," "expects," "anticipates," "projects," "predicts," "estimates," "aims," "believes," "hopes," "potential," or similar words. Forward-looking statements are not guarantees of future performance, are based on certain assumptions, and are subject to various known and unknown risks and uncertainties, many of which are beyond the Company's control, and cannot be predicted or quantified, and, consequently, actual results may differ materially from those expressed or implied by such forward-looking statements. None of the outcomes expressed herein are guaranteed. Such risks and uncertainties include, without limitation, risks and uncertainties associated with (i) our inability to manufacture our product candidates on a commercial scale on our own, or in collaboration with third parties; (ii) difficulties in obtaining financing on commercially reasonable terms; (iii) changes in the size and nature of our competition; (iv) loss of one or more key executives or scientists; and (v) difficulties in securing regulatory approval to proceed to the next level of the clinical trials or to market our product candidates. More detailed information about the Company and the risk factors that may affect the realization of forward-looking statements is set forth in the Company's filings with the Securities and Exchange Commission (SEC), including the Company's Annual Report on Form 10-K, its Quarterly Reports on Form 10-Q, and the Registration Statement on Form 10 relating to the BioKey’s spin-off (including the Information Statement filed as Exhibit 99.1 thereto). Investors are urged to read these documents free of charge on the SEC's website at http://www.sec.gov. The Company assumes no obligation to publicly update or revise its forward-looking statements as a result of new information, future events or otherwise. This press release does not constitute an offer to sell, or the solicitation of an offer to buy any of the Company's securities, nor shall such securities be offered or sold in the United States absent registration or an applicable exemption from registration, nor shall there be any offer, solicitation or sale of any of the Company's securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of such state or jurisdiction. Contact: Uttam Patil Email: uttam@ambrivis.com View the original release on www.newmediawire.com
VANCOUVER, BC - June 23, 2026 (NEWMEDIAWIRE) - Generation Uranium Inc. (TSXV: GEN, OTCQB: GENRF, FRA: W85) (“Generation” or the “Company”) is pleased to provide an update on exploration planning for the 2026 field season. As the Company awaits approval of its drill permit and prepares for the upcoming field program, Generation is focused on refining and recalibrating historic targets through integration of the 2024 MMT survey results and the evaluation of artificial intelligence as an additional target ranking and optimization tool. 2024–2025 MMT Survey Integration In 2025, Generation received the results of the Expert Geophysics Mobile Magnetotellurics (MMT) survey completed on the Yath Project. The survey covered the majority of the property, with only a small block left incomplete due to deteriorating weather conditions. In total, 810 line kilometres were flown over an area of approximately 120 km2. (see Figure 1 below) MMT surveys targeting unconformity style uranium systems focus on three key elements: - Graphitic Conductor Fault Zones - High grade unconformity uranium deposits globally are associated with basement fault zones enriched in graphite, which is highly conductive. - Hydrothermal Alteration Halos - Uranium bearing acidic fluids alter surrounding sandstone or host rocks, producing conductivity highs (clay alteration) or resistivity highs (silicification). - Deep Structural Controls - Understanding the architecture of deep structures helps identify pathways for uranium bearing fluid migration. Integration of conductive and resistive MMT corridors with historic mapping and sampling has significantly narrowed the footprint of known targets and, importantly, improved the understanding of structural orientations beneath overburden. Targets historically defined at the scale of hundreds of metres can now be constrained to zones only tens of metres wide. The MMT data has refined the interpreted orientation of key uranium targets including BOG, VGR, Embryo, FOX, and Lucky Break, revealing that conductive and resistive trends are oblique to earlier interpretations. Advancing Toward Drill‑Ready Targets The Company continues to integrate the MMT dataset with historic results from the Yath Project, including: - Surface samples up to 9.8% U3O8 at the Embryo target - 1.0 m at 0.224% U3O8 from 25.5 m in drillhole BOG‑8‑80 This work is advancing the definition and prioritization of the most prospective drill targets for discovery. AI Target generation and Ranking Generation recognizes that Yath is a target‑rich project with a substantial volume of both historic and modern data. To enhance target ranking and improve discovery success, the Company has engaged several AI‑driven geological service providers and is evaluating which group is best suited to support advanced target analysis on the project. CEO Michael Collins stated: “The MMT data represents a major leap forward for buried uranium targeting. This exploration concept has already been validated by Atha Energy’s five new discoveries(*) in 2025 on their Angilak Project to the south. Generation has a real opportunity to shorten the discovery cycle at Yath while maximizing exploration dollars and drilling effectiveness.” * Atha Energy press release, May 5, 2026. Mineralization hosted on an adjacent property is not necessarily indicative of mineralization hosted on Generation’s property. Figure 1 Conductors and Resistors derived from Mobile Magnetotellurics survey conducted in 2024 by Expert Geophysics Qualified Person Michael Collins, P. Geo., President, CEO and Director of Generation Uranium, and a Qualified Person as defined by National Instrument 43‑101 (Standards of Disclosure for Mineral Projects), has reviewed and approved the scientific and technical information contained in this news release. About Generation Uranium Generation Uranium is a Canadian exploration company focused on advancing high‑quality uranium assets in premier jurisdictions. Its flagship Yath Project is located in Nunavut’s Angilak district, one of Canada’s most active and rapidly emerging uranium camps. With a growing portfolio of high‑priority targets in a well‑understood uranium district, Generation is well positioned to make discoveries that contribute meaningfully to the future global supply of clean nuclear energy. For Further Information Michael Collins, P.Geo., CEO +1(778) 819-7881 admin@generationuranium.com Roger Leschuk, VP Corporate Development rleschuk@generationuranium.com +1(604) 720-4544 Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release. The TSX Venture Exchange has neither approved nor disapproved of the contents of this news release. Uranium Outlook 2026 The uranium market in 2026 continues to strengthen, supported by a widening structural supply deficit and accelerating global demand. Spot prices surpassed US$100/lb early in the year as mine production struggles to keep pace with reactor requirements. Demand growth is being driven by the rapid expansion of AI‑powered data centers, alongside significant increases in nuclear generation capacity in China, India, and the United States. Long‑term contract prices have now moved above spot, reflecting a healthy and sustained trend as utilities secure supply in an increasingly competitive environment. A comprehensive sector report(2) released by Shaw and Partners in February 2026 forecasts the potential for a multi‑year uranium price spike toward US$200/lb. The report highlights tightening fuel contracting cycles, accelerating nuclear demand, and persistent supply shortfalls as the foundation for a powerful re‑rating across the uranium sector. The report also underscores a growing disconnect between uranium supply and long‑term reactor demand. Global nuclear capacity currently consumes approximately 180 million pounds (Mlb) of U3O8 annually, while existing mine production delivers only about 150 Mlb. According to the World Nuclear Association’s reference scenario(3), global nuclear capacity could expand significantly by 2040, pushing annual uranium consumption toward 390 Mlb. Shaw and Partners’ modelling further indicates: New mine supply requirements this decade could exceed 350 Mlb, once depletion of existing operations is included. Structural supply deficits could surpass 200 Mlb per year in the coming decades unless new large‑scale uranium projects are brought into production. Overall, the uranium market is expected to remain tight, with low inventories and rising demand driving utilities toward increasingly aggressive long‑term contracting strategies. This environment continues to strengthen the outlook for exploration‑stage companies positioned in proven and emerging uranium districts. References 1 https://athaenergy.com/atha-energy-completes-mobilization-commences-diamond-drilling-operations-as-part-of-the-2026-angilak-exploration-program-fully-funded-and-largest-to-date-at-the-project/ 2 https://widget.medianet.com.au/uranium-super-cycle-emerging-as-shaw-and-partners-lifts-price-forecast-to-us200lb/1044683?WebsiteId=104 3 https://world-nuclear.org/our-association/publications/global-trends-reports/world-nuclear-fuel-report-2025#:~:text=The%20World%20Nuclear%20Association's%20biennial%20report%20on,including%20targets%20to%20achieve%20net%2Dzero%20carbon%20emissions View the original release on www.newmediawire.com
Two Founding Author Spots Remaining MIAMI, FL - June 23, 2026 (NEWMEDIAWIRE) - Wisdom Bridge Authors, LLC today announces its official launch as a full-service publishing and course creation company dedicated exclusively to bringing high-impact, transformational books to Spanish-speaking readers around the world. The company has already secured its first Founding Author and is now opening the two remaining spots, a unique opportunity for conscious leaders ready to share their wisdom across languages. A Bridge That Has Been Missing More than 500 million people speak Spanish across 20+ countries and Latino communities worldwide. The vast majority of transformational books on consciousness, personal development, leadership, wellness, and finance have been written in English, leaving hundreds of millions of potential readers without access to the wisdom they are actively seeking. Wisdom Bridge Authors was founded to close that gap. “I did not set out to build a translation company. I set out to make sure that the books most needed in the world had every possible chance to reach the Latino community translated into their language, published for their hands, and taught through courses built from the very wisdom each author wrote,” Dr. Carmen Delia Ortiz, Founder. More Than Translation - A Complete Spanish-Language Presence Wisdom Bridge Authors delivers a full journey for each author: a professionally translated and published Spanish edition in print and digital formats, a four-module online course in Spanish developed by a certified instructional designer, a four-week digital launch campaign, and a comprehensive marketing strategy for the U.S. Latino, Latin American, and Spanish markets. The entire process from manuscript to market is completed in four to six months. Authors retain 100% of all revenue generated by their Spanish edition and course. Wisdom Bridge Authors, LLC takes no royalties, ever. The Founding Author Invitation With one Founding Author already underway, two spots remain. Founding Authors receive: Permanent Founding Author recognition across all Wisdom Bridge Authors, LLC promotional materials Priority production in 2026 A co-created launch strategy built personally with each author Six-month full satisfaction guarantee a complete refund of the full investment, in writing, within 30 days, if not fully satisfied “The Founding Author experience is a genuine co-creation. We build the launch strategy together. It is a deeply personalized approach that cannot be replicated at scale and that is exactly why only two spots remain,” Dr. Carmen Delia Ortiz. About Wisdom Bridge Authors, LLC Wisdom Bridge Authors, LLC is a Miami-based publishing services company founded by Dr. Carmen Delia Ortiz, CFP®, PhD, MBA a four-decade practitioner at the intersection of financial empowerment, education, and human transformation. The company exists on the conviction that language should never be the barrier between a seeker and the wisdom they need. Every soul deserves wisdom in their own language. To learn more or begin a private conversation about the remaining Founding Author spots, visit https://wisdombridgeauthors.com/. Media Contact: Carmen D. Ortiz Founder, CEO Wisdom Bridge Authors, LLC carmen@transcendentfinancialliving.com 352-609-8055 https://wisdombridgeauthors.com/ View the original release on www.newmediawire.com
Survey Highlights: 95% of U.S. employees are actively trying to improve their health and well-being. 50% report healthcare costs have made it difficult to pay for day-to-day expenses, including food, childcare and rent. 47% are reducing or stopping retirement contributions to afford healthcare costs and maintain a healthy lifestyle. DALLAS - June 22, 2026 (NEWMEDIAWIRE) - U.S. employees[1] are highly motivated to improve their health, but are limited by finances, time and work structure, according to a recent survey conducted by The Harris Poll on behalf of the American Heart Association, a relentless force changing the future of health for everyone, everywhere. The rising cost of healthcare is a particularly pressing concern. Half (50%) of survey respondents agree that healthcare costs have made it difficult to afford day-to-day expenses, including food, childcare and rent. Nearly as many (47%) say they have stopped or decreased their retirement contributions to afford healthcare costs and maintain a healthy lifestyle. For employees already stretched thin by limited wage growth and inflation, healthcare costs represent a larger percentage of take-home pay, leaving even less room to absorb price increases or unexpected expenses. “No one should have to skip buying groceries or halt their retirement savings to cover medical expenses,” said Nancy Brown, chief executive officer of the American Heart Association. “The American Heart Association is committed to addressing healthcare affordability in our efforts to build a world of longer, healthier lives. Employers are important allies in this work - their influence is critical to prioritizing more affordable, accessible care for all.” According to a 2026 Business Group on Health survey, large employers anticipate a median 9% increase in healthcare costs this year before cost-reduction measures. In response, business leaders are increasingly focused not only on lowering costs, but on how they can strengthen comprehensive support and drive systems-level change for the well-being of the workforce. A recent Presidential Advisory from the American Heart Association warns that healthcare affordability in the U.S. has reached crisis levels. The advisory outlines five core principles to guide policymakers and stakeholders toward a more affordable and sustainable healthcare system, including: Access to high-quality care without financial hardship. Minimal or no-cost-sharing for high-value, cost-effective care, including preventive services. Shared accountability across the healthcare ecosystem for advancing a more efficient, transparent and cost-conscious healthcare system. Strategic investments in the healthcare workforce, infrastructure and data. Strengthen the public health infrastructure and address health inequities. In addition to healthcare costs (21%), the recent Harris Poll survey found managing work-life balance (36%), finding the time (30%), and parenting and caregiving responsibilities (23%) are key barriers for employees in managing their health. The vast majority of U.S. employees agree that employee health and well-being should be supported in how they work day-to-day, not just through policies or program offerings (92%), and a similar proportion want company leaders to set a good example for employees when it comes to work-life balance (93%). Survey Methodology The Harris Poll conducted research among 2,001 employees (defined as U.S. adults age 18+ who are employed full or part time (not self-employed) by a company with 25+ employees, are enrolled in a health plan offered by their employer and whose health coverage is provided by their employer). The survey was conducted February 26 – March 12, 2026. Data was weighted where necessary by age, gender, race/ethnicity, region, education, marital status, household size, employment and household income, as well as company size, in order to bring them in line with their actual proportions in the population. Respondents to this survey were selected from among those who have agreed to participate in Harris Poll surveys. For this study, the sample data is accurate to within ± 2.8 percentage points using a 95% confidence level. This credible interval will be wider among subsets of the surveyed population of interest. All sample surveys and polls, whether or not they use probability sampling, are subject to other multiple sources of error that are most often not possible to quantify or estimate, including, but not limited to coverage error, error associated with nonresponse, error associated with question wording and response options, and post-survey weighting and adjustments. More than 8 in 10 (82%) U.S. adults say they are confident in the American Heart Association to provide trustworthy information related to public health, according to a recent poll by the University of Pennsylvania’s Annenberg Public Policy Center. About the American Heart Association The American Heart Association is a relentless force for a world of longer, healthier lives. Dedicated to ensuring equitable health in all communities, the organization has been a leading source of health information for more than one hundred years. Supported by more than 35 million volunteers globally, we fund groundbreaking research, advocate for the public’s health, and provide critical resources to save and improve lives affected by cardiovascular disease and stroke. By driving breakthroughs and implementing proven solutions in science, policy, and care, we work tirelessly to advance health and transform lives every day. Connect with us on heart.org, Facebook, X or by calling 1-800-AHA-USA1. For Media Inquiries: 214-706-1173 Steve Weiss - steve.weiss@heart.org For Public Inquiries: 1-800-AHA-USA1 (242-8721) heart.org and stroke.org [1] U.S. adults age 18+ who are employed full or part time (not self-employed) with a company with 25+ employees, are enrolled in a health plan offered by their employer, and their coverage is provided by their employer (i.e., they did not receive a stipend). View the original release on www.newmediawire.com
NORTH BERGEN, NEW JERSEY - June 22, 2026 (NEWMEDIAWIRE) - Just over a quarter of U.S. youth ages 6-11 and 14% of youth ages 12-17 meet the recommendation of at least 60 minutes of physical activity every day, according to the American Heart Association’s 2026 Heart Disease and Stroke Statistics Update. That’s why the American Heart Association and the NFL (National Football League) are helping students build healthier habits early through NFL PLAY 60. Today’s more than 100 sixth-grade students from Robert Fulton Elementary School in North Bergen, New Jersey participated in today’s NFL PLAY 60 event at North Bergen Recreation Center, where New York Giants quarterback Jameis Winston joined in a series of interactive drills, supported by USA Football, designed to make movement engaging and accessible. Students rotated through activity stations focused on movement, teamwork and skill-building, reinforcing how physical activity can be both fun and foundational to lifelong wellness. “This summer the World Cup is bringing people together, and we want to multiply that energy by collaborating both football communities for maximum impact,” said Winston, a Heisman Trophy winner, national champion and former No. 1 overall NFL draft pick. “ Through NFL PLAY 60, this initiative is about helping kids stay active, build healthy habits and see how sports can unite and inspire the next generation.” What is the NFL Play 60? The NFL PLAY 60 initiative encourages children to get at least 60 minutes of physical activity each day to support both immediate and long-term physical and mental health. “Programs like NFL PLAY 60 help us meet young people where they are - with experiences that make physical activity engaging and sustainable,” said Nancy Brown, chief executive officer of the American Heart Association. “Together with the NFL, we are helping build healthier futures by making daily movement a priority for every child.” The National Football League and the American Heart Association have partnered since 2006 to bring physical activity to life for young people through school and community-based programming. The initiative is rooted in the Heart Association’s physical activity guidelines, which recommend at least 60 minutes of moderate-to-vigorous activity daily for children. Research shows that regular movement supports cardiovascular health while also improving focus, stress management and classroom performance. To help overcome common barriers such as limited time, space or weather, NFL PLAY 60 also offers the NFL PLAY 60 Exercise Library, featuring short, on-demand videos from all 32 NFL teams. These resources make it easier for educators, families and caregivers to incorporate physical activity throughout the day - whether in the classroom, at home or in the community. Today’s event is part of the broader NFL PLAY 60 movement, which reaches millions of youth nationwide through school programs, community events and digital tools - reinforcing the importance of daily physical activity for lifelong health. More information, including resources and grant opportunities, is available at heart.org/NFLPLAY60. About the American Heart Association The American Heart Association is a relentless force for a world of longer, healthier lives. The organization has been a leading source of health information for more than one hundred years. Supported by more than 35 million volunteers globally, we fund groundbreaking research, advocate for the public’s health, and provide critical resources to save and improve lives affected by cardiovascular disease and stroke. By driving breakthroughs and implementing proven solutions in science, policy, and care, we work tirelessly to advance health and transform lives every day. Connect with us on heart.org, Facebook, X, or by calling 1-800-AHA-USA1 About NFL PLAY 60 NFL PLAY 60 is the league’s national youth health and wellness platform. Now in its 20th season, the initiative empowers millions of youth to get physically active for at least 60 minutes a day, supporting programs and resources so that kids everywhere can lead a healthy lifestyle. Alongside the NFL’s 32 clubs and partners, the PLAY 60 movement will continue to serve and motivate the next generation of youth to get active and PLAY 60. For more information, visit NFL.com/PLAY60. For Media Inquiries: American Heart Association: Linzy Cotaya: linzy.cotaya@heart.org National Football League: Ian Martin, Ian.Martin@nfl.com For Public Inquiries: 1-800-AHA-USA1 (242-8721) heart.org and stroke.org
LOS ANGELES, CA - June 22, 2026 (NEWMEDIAWIRE) - VERAXA Biotech (NASDAQ: VRXA) is highlighting partnering opportunities for its proprietary BiTAC(TM)-ADC and BiTAC-TCE technology platforms ahead of the BIO International Convention, taking place June 22-25 in San Diego. The company recently reported new proof-of-concept data supporting its BiTAC-ADC platform, which is designed to improve cancer treatment precision through tumor-restricted activation of therapeutic agents while minimizing off-target toxicity. VERAXA said the findings, together with previously presented BiTAC-TCE data unveiled at the American Association for Cancer Research Annual Meeting in April 2026, support the potential of two differentiated cancer therapy platforms that may be applicable across multiple solid tumor indications. Management plans to discuss partnering opportunities for both technologies at the BIO International Convention, scheduled for June 22-25, 2026, in San Diego. To view the full press release, visit https://ibn.fm/r8zEz About VERAXA Biotech AG At VERAXA, we are building a premier engine for the discovery and development of next-generation antibody-based therapeutics, including bispecific T cell engagers, bispecific ADCs and other innovative formats. Powered by a suite of transformative technologies and guided by rigorous quality-by-design principles, we are rapidly advancing our pipeline of ADCs and proprietary BiTAC formats into clinical development and beyond. VERAXA was founded on scientific breakthroughs made at the European Molecular Biology Laboratory (EMBL), a world-renowned institution known for pioneering life science research and cutting-edge technology. Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://IBN.fm/Disclaimer The latest news and updates relating to VRXA are available in the company’s newsroom at https://ibn.fm/VRXA Forward Looking Statements Certain statements in this article are forward-looking, as defined in the Private Securities Litigation Reform Act of 1995. These statements involve risks, uncertainties, and other factors that may cause actual results to differ materially from the information expressed or implied by these forward-looking statements and may not be indicative of future results. These forward-looking statements are subject to a number of risks and uncertainties, including, among others, various factors beyond management's control, including the risks set forth under the heading "Risk Factors" discussed under the caption "Item 1A. Risk Factors" in Part I of the Company's most recent Annual Report on Form 10-K or any updates discussed under the caption "Item 1A. Risk Factors" in Part II of the Company's Quarterly Reports on Form 10-Q and in the Company's other filings with the SEC. Undue reliance should not be placed on the forward-looking statements in this article in making an investment decision, which are based on information available to us on the date hereof. All parties undertake no duty to update this information unless required by law View the original release on www.newmediawire.com
Research Highlights: In a study that spanned 25 years, people who drank more sugary beverages and fruit juice beginning in childhood had a higher risk of developing high blood pressure than those drinking less. Substituting one serving per day of sugary beverages with whole fruit, milk or water was associated with a lower risk of high blood pressure. Also, replacing fruit juice with whole fruit was associated with a lower risk. DALLAS - June 22, 2026 (NEWMEDIAWIRE) - Drinking fruit juice and sugar-sweetened beverages from childhood through adulthood may be linked to an increased risk of developing high blood pressure as an adult, according to new research published today in the American Heart Association’s flagship journal Circulation. “Dietary habits in early life can have lasting health consequences,” said senior study author Vasanti Malik, Sc.D., M.Sc., an associate professor and Canada Research Chair in Nutrition and Chronic Disease Prevention in the department of nutritional sciences at Temerty Faculty of Medicine at the University of Toronto, and an adjunct faculty member in the department of nutrition at the Harvard T.H. Chan School of Public Health in Boston. ”High blood pressure is also emerging earlier in life, with growing rates being seen in younger adults, in children and adolescents, which highlights the importance of early detection and prevention,” she said. High blood pressure can lead to other serious health conditions or events, such as heart attack and stroke. While some risk factors for blood pressure such as family history, age, gender and race cannot be changed, unhealthy lifestyle factors, such as lack of physical activity, smoking and poor diet, can increase the risk of high blood pressure. The analysis included more than 25,000 participants from a study of U.S. youths. Participants reported how often, on average, they consumed sugar-sweetened beverages, including sodas, punches, lemonades, teas and sports drinks; fruit juice and whole fruits. They also reported their intake of other foods and beverages typically consumed and their body measurements and habits, such as physical activity and smoking, via questionnaires completed every 1 to 4 years. Researchers estimated the associations of total fructose and sugar-sweetened beverages, fruit juice and whole fruit intake with self-reported high blood pressure diagnoses. They also developed models of the effect of substituting sugar-sweetened beverages or fruit juice with whole fruit, milk and water. Participants were followed for up to 25 years. What are the key results of the analysis?: Participants who drank two or more servings of sugar-sweetened beverages per day had a 52% higher risk of later developing high blood pressure compared to those who consumed less than three servings a week. A typical serving was defined as a 12-ounce can or glass. Among sugary drink subtypes, each daily serving of soda and sports drinks was associated with a 23% and 36% higher risk of high blood pressure, respectively. Those who drank 1.5 or more servings of fruit juice per day had a 35% higher risk of developing high blood pressure compared to those who said they drank less than one serving a week. One serving was defined as an 8-ounce glass. For subtypes of fruit juice, each daily serving of orange juice was associated with a 20% higher risk of high blood pressure, while apple and other juices were not. However, the researchers noted the potential for misclassification, as orange-flavored drinks with added sugars may have been misreported as orange juice. The substitution analysis suggested that replacing a daily serving of sugary beverage with whole fruit could be associated with a 22% lower risk of developing high blood pressure. Similarly, replacing fruit juice with whole fruit could result in a 19% lower risk of developing high blood pressure. Substituting sugar-sweetened beverages with milk or water in the model analysis was associated with up to a 13% lower risk of developing high blood pressure, whereas no significant association was found for replacing fruit juice with milk or water. This link between sugary drinks/fruit juice and high blood pressure was independent of overall diet quality, physical activity and other factors. “Sugar-sweetened beverages, such as soda and sports drinks, which are often marketed as somewhat healthy, should be limited,” Malik said. “Fruit juice intake may be harmless at low levels yet harmful at higher intake levels. They should always be 100% fruit juice, and even so, consumed only in moderation. Whole fruit should be emphasized over sugary beverages.” A 2026 Dietary Guidance to Improve Cardiovascular Health scientific statement from the American Heart Association notes that added sugar in beverages and foods should be minimized. American Heart Association volunteer expert Amit Khera, M.D., FAHA, vice-chair of the dietary guidance writing committee, said that while the association between sugar-sweetened beverages and increased hypertension and cardiovascular risk is generally consistent across studies, these findings add several new insights: “First, the focus on childhood and the importance of health behaviors in childhood with adult risk factor development provides a critical opportunity for prevention. As has been seen in adults, the total amount of fructose seems less important for the development of hypertension than the type of food where it is consumed, so sugar-sweetened beverages and fruit juice relate to increased risk, while whole fruit does not. “Secondly, there has been a misconception about fructose in general being harmful for cardiovascular health regardless of the source, and that fruit juices are beneficial for health. This study demonstrates that neither seems to be correct,” added Khera, the director of preventive cardiology and clinical chief of cardiology at the University of Texas Southwestern Medical Center in Dallas. He also noted this study’s population was mostly white children and adults; “however, non‑Hispanic Black and Hispanic American populations have the highest sugar-sweetened beverages intake, so these findings may be even more relevant for those groups.” The American Heart Association advocates for science-based policies that reduce consumption of sugary drinks. These policies include: Establishing taxes on sugary drinks to decrease consumption. Improving nutrition standards in school meals. Enhancing “informed dining” in restaurants. Improving diet quality in the Supplemental Nutrition Assistance Program (SNAP). What are the details, background, design and limitations of the study? The participants were from the Growing Up Today Study (GUTS), which included the GUTS I study initiated in 1996 and the GUTS II, which was initiated in 2004. The offspring of participants in the Nurses’ Health Study II were recruited for GUTS nationwide. The study followed 25,749 participants, ages 9 to 16, (about 55% female and 96% non-Hispanic white participants) for up to 25 years. The median age of the participants by the end of the follow-up period was 36 years. Participants completed 132-item food frequency questionnaires, administered annually from 1996 to 1998, then in 2001, 2004, 2006, 2008, 2011 and 2015. Children with high blood pressure or with missing dietary information at baseline were not included in this analysis. The food frequency that was used to assess diet asked how often, on average, they consumed a standard serving of a food or beverage, ranging from “never or less than once per month” to “6 or more per day”. A serving was specified as a 12-ounce can or glass of sugar-sweetened beverages and an 8-ounce glass of fruit juice. Sugar-sweetened beverages were defined as sodas, fruit punches, lemonades, iced teas, sports drinks and non-carbonated fruit drinks. Fruit juice included orange juice, apple juice and other 100% fruit juice drinks. Whole fruits included apples, oranges, bananas, mangos, grapes, pears, melons, strawberries and peaches. Substitution analyses were conducted by contrasting one serving per day of sugar-sweetened beverages or fruit juice with a serving of fruit juice, milk (1%, 2% and whole milk but not chocolate or flavored milk), water or whole fruit. Blood pressure was self-reported through the 2010 to 2021 questionnaires. Participants were asked if they had ever been diagnosed by a healthcare professional with high blood pressure. In the 2010 questionnaire, the earliest response option for the year of diagnosis was “before 1996” and ranged until “2010+”. Limitations of the study include the inability to prove cause and effect because it was based on questionnaires and self-reports and some factors not included in this analysis may have affected the results. In addition, the findings may not apply to other groups not included in this study. Co-authors, disclosures and funding sources are listed in the manuscript. Studies published in the American Heart Association’s scientific journals are peer-reviewed. The statements and conclusions in each manuscript are solely those of the study authors and do not necessarily reflect the Association’s policy or position. The Association makes no representation or guarantee as to their accuracy or reliability. The Association receives more than 85% of its revenue from sources other than corporations. These sources include contributions from individuals, foundations and estates, as well as investment earnings and revenue from the sale of our educational materials. Corporations (including pharmaceutical, device manufacturers and other companies) also make donations to the Association. The Association has strict policies to prevent any donations from influencing its science content and policy positions. Overall financial information is available here. Additional Resources: Multimedia is available on the right column of release link. After June 22, view the manuscript online. American Heart Association news release: Following 9 key steps for a lifetime of eating well can support heart health (March 2026) American Heart Association health information: Rethink Your Drink: How to Reduce Sugary Drinks American Heart Association health information: Sip Smarter Infographic Follow American Heart Association/American Stroke Association news on X @HeartNews Follow news from American Heart Association’s flagship journal Circulation @CircAHA About the American Heart Association The American Heart Association is a relentless force for a world of longer, healthier lives. Dedicated to ensuring equitable health in all communities, the organization has been a leading source of health information for more than one hundred years. Supported by more than 35 million volunteers globally, we fund groundbreaking research, advocate for the public’s health, and provide critical resources to save and improve lives affected by cardiovascular disease and stroke. By driving breakthroughs and implementing proven solutions in science, policy, and care, we work tirelessly to advance health and transform lives every day. Connect with us on heart.org, Facebook, X or by calling 1-800-AHA-USA1. For Media Inquiries and American Heart Association Expert Perspective: 214-706-1173 Bridgette McNeill: Bridgette.McNeill@heart.org For Public Inquiries: 1-800-AHA-USA1 (242-8721) heart.org and stroke.org
VANCOUVER, BC - June 22, 2026 (NEWMEDIAWIRE) - Western Star Resources Inc. (CSE: WSR) (OTC: WSRIF) (the “Company” or “Western Star”) is pleased to announce that field crews have mobilised to the Company’s 100% owned White Star Tungsten Project in Elko County, Nevada, USA, to commence the planned 2026 exploration program. The White Star Project is located in the Charleston Mining District, adjacent to the Company’s Rowland Tungsten Property, and was recently acquired by Western Star. Key Highlights: - Field crews have mobilised to the White Star Tungsten Project to commence the first modern exploration program on the property and surrounding the past producing Mission Cross Mine workings. - Initial activities include a property-wide high-resolution UAV magnetic geophysical survey, and a systematic soil geochemistry survey. - UAV magnetic survey results expected over the coming weeks; rock-chip and soil samples will be submitted to the laboratory for certified assay. Figure 1: Drone being deployed at the White Star Tungsten Project. Blake Morgan, the CEO and President of Western Star, stated, “Mobilising to White Star, with the Rowland program already underway and Eagle Point just acquired in New Mexico, gives Western Star three active U.S. tungsten projects on the ground in 2026. White Star sits in the same skarn setting as Rowland and similar to Rowland, largely under-explored. Running an integrated drone magnetic survey and a focused soil and rock-chip program across the White Star workings is the fastest path to defining drill targets and matching what we have already done at Rowland.” Program at White Star The initial White Star program will mirror the integrated workflow being applied at Rowland and comprises the following core workstreams; 1. A property-wide UAV magnetic survey, providing the first modern high-resolution geophysical dataset across the project 2. Systematic mapping and ground-truthing of the historical Mine workings, including open-pit and underground workings, surface trenches, shafts, adits, and waste dumps. 3. Reconnaissance soil sampling across the broader White Star claim package, including ground between the White Star workings and the adjoining Rowland Property. Next Steps The Company expects to receive preliminary processed geophysical products from the contractor over the coming weeks. Soil samples will be submitted for certified laboratory analysis, with assay results to be released once received and interpreted. The combined White Star and Rowland datasets are intended to support a single, district-scale geological model spanning the consolidated Jarbidge–Charleston tungsten footprint. Qualified Person The scientific and technical information contained in this news release has been reviewed and approved by intendant Geologist Jasper Mowatt, MIMMM (Membership No. 0486653) and MAusIMM (Membership No. 3178851), a Qualified Person as defined by National Instrument 43-101 – Standards of Disclosure for Mineral Projects. About Western Star Resources Western Star Resources is an emerging junior mineral exploration company focused on revitalizing North America's tungsten supply. The company is advancing its entry into the U.S. market through the acquisition of a past-producing tungsten mine in Nevada -- one of America's most important historic tungsten districts. With this strategic move, Western Star is positioning itself to play a leading role in re-establishing a secure, domestic source of this critical mineral. The company also owns nine non-surveyed contiguous mineral claims totalling 4,740 hectares, which are located within the Revelstoke mining division of British Columbia. The Western Star property group is located approximately 50 kilometres southeast of Revelstoke, B.C., and roughly 10 kilometres north of the abandoned community of Camborne. Contact Information: Blake Morgan Director, President and CEO blake@acvc.vc Neither the Canadian Securities Exchange nor its Regulation Services Provider (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this press release. Certain of the statements made and information contained herein may constitute “forward-looking information”. In particular references to the acquisition, future work programs or expectations on the quality or results of such work programs are subject to risks associated with operations on the property, exploration activity generally, equipment limitations and availability, as well as other risks that we may not be currently aware of. Accordingly, readers are advised not to place undue reliance on forward-looking information. Except as required under applicable securities legislation, the Company undertakes no obligation to publicly update or revise forward-looking information, whether as a result of new information, future events or otherwise. View the original release on www.newmediawire.com
LOS ANGELES, CA - June 19, 2026 (NEWMEDIAWIRE) - Greenland Mines (NASDAQ: GRML) announced the engagement of Tetra Tech Canada Inc. and GeoSim Services Inc. to prepare an updated SEC S-K 1300-compliant mineral resource estimate for its Sarfartoq neodymium-praseodymium rare earth project in southwest Greenland. The updated resource estimate, expected to be substantially completed this summer, will incorporate historical NI 43-101 resource work along with drilling and technical studies completed by Neo Performance Materials between 2023 and 2025, and is intended to support an updated preliminary economic assessment and future development studies. GeoSim, led by Ronald G. Simpson, P.Geo., has been appointed as the qualified person for the resource estimate, providing continuity from earlier Sarfartoq resource and economic studies completed in 2011 and 2012. Tetra Tech will provide engineering, mine planning and metallurgical support, including optimization studies evaluating open-pit, underground and hybrid development scenarios. Greenland Mines also reappointed WSP Danmark A/S to continue environmental baseline work at the project as the company advances Sarfartoq, which it believes is distinguished by a strong neodymium-praseodymium component and strategic relevance to Western rare earth supply chains. To view the full press release, visit: https://ibn.fm/eIurP About Greenland Mines Greenland Mines Ltd is a Nasdaq-listed company with two operating divisions: (1) Mining, focused on the exploration and development of the Skaergaard Project in southeast Greenland and, subject to closing of the previously announced transaction, the Sarfartoq neodymium-praseodymium (Nd-Pr) rare earths project in southwest Greenland; and (2) Biotech, including Klotho’s KLTO‑202 primary indication for ALS. The Company’s strategy is centered on building a multi-asset platform with exposure to rare earth magnet materials, precious metals and selected midstream processing opportunities, while advancing its broader North Atlantic Critical Metals Corridor vision linking Greenland resources with allied downstream jurisdictions and industrial infrastructure. Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://IBN.fm/Disclaimer The latest news and updates relating to GRML are available in the company’s newsroom at https://ibn.fm/GRML Forward Looking Statements Certain statements in this article are forward-looking, as defined in the Private Securities Litigation Reform Act of 1995. These statements involve risks, uncertainties, and other factors that may cause actual results to differ materially from the information expressed or implied by these forward-looking statements and may not be indicative of future results. These forward-looking statements are subject to a number of risks and uncertainties, including, among others, various factors beyond management's control, including the risks set forth under the heading "Risk Factors" discussed under the caption "Item 1A. Risk Factors" in Part I of the Company's most recent Annual Report on Form 10-K or any updates discussed under the caption "Item 1A. Risk Factors" in Part II of the Company's Quarterly Reports on Form 10-Q and in the Company's other filings with the SEC. Undue reliance should not be placed on the forward-looking statements in this article in making an investment decision, which are based on information available to us on the date hereof. All parties undertake no duty to update this information unless required by law.
LOS ANGELES, CA - June 19, 2026 (NEWMEDIAWIRE) - VERAXA Biotech (NASDAQ: VRXA) announced new in vitro proof-of-concept data supporting its novel BiTAC(TM)-ADC technology platform, which is designed to improve precision in cancer treatment through tumor-restricted activation of therapeutic agents. The company reported that BiTAC-ADCs demonstrated the ability to distinguish between breast cancer and healthy cells and achieved dose-dependent killing of 3D tumor cell spheroids while minimizing toxicity through the use of separately delivered, systemically inactive precursor components. VERAXA said the findings further validate the potential of its BiTAC-ADC platform and complement its BiTAC-TCE technology, providing the company with two differentiated cancer therapy platforms that may be applicable across multiple solid tumor indications. Management plans to discuss partnering opportunities for both platforms at the BIO International Convention in San Diego from June 22-25, 2026. To view the full press release, visit https://ibn.fm/QiPhH About VERAXA Biotech AG At VERAXA, we are building a premier engine for the discovery and development of next-generation antibody-based therapeutics, including bispecific T cell engagers, bispecific ADCs and other innovative formats. Powered by a suite of transformative technologies and guided by rigorous quality-by-design principles, we are rapidly advancing our pipeline of ADCs and proprietary BiTAC formats into clinical development and beyond. VERAXA was founded on scientific breakthroughs made at the European Molecular Biology Laboratory (EMBL), a world-renowned institution known for pioneering life science research and cutting-edge technology. Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://IBN.fm/Disclaimer The latest news and updates relating to VRXA are available in the company’s newsroom at https://ibn.fm/VRXA Forward Looking Statements Certain statements in this article are forward-looking, as defined in the Private Securities Litigation Reform Act of 1995. These statements involve risks, uncertainties, and other factors that may cause actual results to differ materially from the information expressed or implied by these forward-looking statements and may not be indicative of future results. These forward-looking statements are subject to a number of risks and uncertainties, including, among others, various factors beyond management's control, including the risks set forth under the heading "Risk Factors" discussed under the caption "Item 1A. Risk Factors" in Part I of the Company's most recent Annual Report on Form 10-K or any updates discussed under the caption "Item 1A. Risk Factors" in Part II of the Company's Quarterly Reports on Form 10-Q and in the Company's other filings with the SEC. Undue reliance should not be placed on the forward-looking statements in this article in making an investment decision, which are based on information available to us on the date hereof. All parties undertake no duty to update this information unless required by law.
MONTEREY PARK, CA - June 19, 2026 (NEWMEDIAWIRE) - Focus Universal Inc. (Nasdaq: FCUV) today introduced a formal definition of Deterministic AI as a distinct category of enterprise artificial intelligence systems designed for execution of complex, compliance-driven business workflows with consistent, verifiable, and repeatable outcomes. While every US public company is required to file annual reports (10-K), quarterly reports (10-Q), proxy statements, and numerous other SEC-mandated disclosures within strict regulatory deadlines, regardless of market conditions, economic uncertainty, or management priorities. In addition, SEC filings must be prepared in XBRL (eXtensible Business Reporting Language), a standardized machine-readable format that enables investors, regulators, and analysts to automatically extract, analyze, and compare financial information across companies and reporting periods. Because XBRL is based on XML programming language and requires specialized technical expertise, most CPAs, CFOs, auditors, and securities attorneys do not perform this work themselves. As a result, many issuers rely on specialized EDGAR filing agents to handle Edgarization and XBRL tagging. The current process is often expensive, labor-intensive, and time-consuming. To meet filing deadlines, issuers frequently must deliver their draft reports to filing agents several days in advance, creating additional pressure on management teams and reducing flexibility during the reporting process. Now imagine a different approach. An issuer or filing agent simply uploads a collection of raw Word documents, including 10-Ks, 10-Qs, and 8-Ks. The system automatically identifies each filing type, determines the appropriate workflow, converts the documents into SEC-compliant HTML, performs Edgarization, applies XBRL tagging, validates the output, and generates SEC-ready filings - all with minimal or no human intervention. What traditionally requires days of manual effort can be completed in minutes per filing. The system can process multiple heterogeneous filings simultaneously, operating 24 hours a day, seven days a week. Productivity does not slow down when staff are unavailable, working remotely, or on vacation. This vision is now becoming reality through the Deterministic AI technology developed by the Focus Universal team. By combining rule-based intelligence, domain expertise, and automated workflow execution, Deterministic AI has the potential to fundamentally transform how SEC filings are prepared, Edgarized, and tagged in XBRL. The Company believes Deterministic AI represents a fundamentally different approach from both traditional automation systems and generative AI models, introducing an execution-focused architecture designed to transform unstructured business documents directly into completed, compliance-ready workflows. A New Class of AI Distinct from Automation and Generative Models Focus Universal stated that Deterministic AI differs fundamentally in algorithm, purpose, structure, and output behavior from existing categories of enterprise AI systems: Traditional automation systems rely on predefined rules, structured inputs, templates, and manually programmed workflows, and are limited to processes explicitly designed in advance. Generative AI systems operate on probabilistic models trained on large datasets and produce variable outputs based on prompts and context. While flexible, their outputs are non-deterministic and often require human review and iterative refinement. Deterministic AI systems, as defined by the Company, are designed to acquire domain knowledge and apply that knowledge to execute complete business workflows with consistent outcomes. Given identical inputs and conditions, the system produces identical outputs, enabling auditability and regulatory reliability. Minimal Input Design: Document-Only Execution A defining characteristic of Deterministic AI is its minimal input requirement. Unlike traditional automation, which relies on predefined rules and structured inputs, Deterministic AI acquires and applies domain-specific knowledge to perform tasks that have historically required trained professionals. Unlike generative AI, which produces probabilistic outputs that may vary from one execution to another, Deterministic AI produces the same output when provided with the same input and operating conditions, making it particularly suitable for regulatory, compliance, financial, legal, and other mission-critical applications. One of the most significant advantages of Deterministic AI is its ability to perform complex tasks with minimal user input. Traditional automation systems generally require users to provide structured data, predefined workflows, mapping instructions, templates, or prior-period information before a task can be completed. Generative AI systems often require detailed prompts, extensive context, supporting documents, and multiple rounds of user interaction to achieve acceptable results. Deterministic AI operates differently. The knowledge necessary to perform the task resides within the system itself. As a result, users only need to provide the primary business document, while the system supplies the domain knowledge required to complete the work. For example, a public company's SEC filing may contain more than 1,000 financial facts and footnote disclosures requiring XBRL tagging. The Word document provided by the company contains no XBRL tags, taxonomy mappings, EDGAR formatting instructions, or guidance regarding which financial concepts should be associated with specific XBRL taxonomy elements. Traditionally, financial reporting professionals must manually review hundreds of pages of disclosures, identify reporting concepts, select appropriate taxonomy elements, perform EDGARization, and validate the filing. Existing automation solutions often depend on prior-year tagged filings and roll-forward methodologies that simply carry forward historical tagging decisions. Deterministic AI requires only the Word document. Using knowledge acquired from large numbers of financial filings and reporting patterns, the system can identify financial reporting concepts, determine appropriate taxonomy elements, perform EDGARization, and generate compliant outputs with little or no human intervention. Unlike traditional roll-forward approaches, Deterministic AI continuously improves the quality of its decisions as additional filings are processed. For example, the system can increasingly identify opportunities to replace company-specific custom tags with standard GAAP taxonomy elements, improving consistency, comparability, and data quality across filings. At the same time, the system remains deterministic, ensuring that identical inputs produce identical outputs. The system is designed to: Interpret unstructured documents Identify relevant business or regulatory context Execute required workflows end-to-end Produce structured, compliance-ready outputs SEC Financial Reporting as a Representative Use Case As a sample application, SEC financial reporting illustrates the complexity that Deterministic AI is designed to address. A typical SEC filing may contain more than 1,000 financial facts and footnote disclosures requiring XBRL tagging and EDGAR compliance formatting. The source Word document provided by public companies generally contains no XBRL tags, taxonomy mappings, or structured reporting instructions. Traditionally, financial professionals must manually review extensive disclosures, identify reporting concepts, apply EDGARization processes, determine appropriate XBRL taxonomy elements, and validate compliance across filings. Many existing solutions rely on prior-year roll-forward approaches that simply carry forward previous tagging decisions. Focus Universal stated that Deterministic AI is designed to eliminate this dependency on manual interpretation and roll-forward logic by directly processing the source document and generating compliant outputs from learned domain knowledge. Automated EDGARization and XBRL Tagging from Raw Documents Deterministic AI is designed to process SEC filings using only the Word document as input. Leveraging accumulated domain knowledge from large volumes of filings, the system is designed to: Identify financial reporting concepts within disclosures Determine appropriate XBRL taxonomy elements Perform EDGARization formatting Generate structured, compliance-ready outputs Improve consistency of taxonomy selection over time The Company noted that as additional filings are processed, the system refines its ability to align disclosures with standard GAAP taxonomy elements and reduce reliance on company-specific custom tags, while maintaining deterministic output behavior. Autonomous Task Recognition and Batch Processing Focus Universal also highlighted the platform’s ability to process diverse document types and workflows without user configuration. Traditional automation systems require users to select workflows in advance, with separate processes typically required for different SEC filings such as Form 10-K, 10-Q, and 8-K. Generative AI systems may assist with classification but typically require prompts, context, and human validation to determine appropriate execution steps. Deterministic AI operates differently. Users provide documents directly, and the system automatically: Identifies document type (e.g., 10-K, 10-Q, 8-K) Determines required workflow Applies relevant domain knowledge Executes appropriate processing steps This enables batch processing of heterogeneous documents, where a single batch may contain multiple filing types across multiple companies. The system independently processes each document, performs EDGARization and XBRL tagging, and generates compliant outputs without requiring user-specified workflow selection. Continuous Knowledge Acquisition with Deterministic Output Unlike traditional automation systems constrained by static rules, Deterministic AI is designed to continuously refine its domain knowledge as additional filings are processed. This includes improved identification of opportunities to replace company-specific custom tags with standard GAAP taxonomy elements, enhancing comparability and consistency across filings. Importantly, the Company emphasized that despite ongoing knowledge refinement, the system remains deterministic - ensuring identical inputs always produce identical outputs. Efficient Learning and Computational Model Generative AI systems typically require large-scale datasets and substantial computational resources to learn probabilistic relationships across vast data distributions. Deterministic AI addresses a different class of enterprise problems, where outcomes are governed by established standards, regulations, and verifiable rules. Because correct outputs are constrained and objectively definable in domains such as financial reporting, tax preparation, medical billing, logistics, and compliance workflows, Deterministic AI is designed to acquire and refine domain knowledge with substantially lower computational overhead compared to large-scale generative models. Broad Enterprise Applications Beyond SEC Reporting While SEC financial reporting is a primary application, Focus Universal believes Deterministic AI is broadly applicable across labor-intensive, document-driven enterprise workflows, including: Tax preparation and accounting services Freight forwarding and logistics documentation Medical billing and healthcare claims processing Insurance claims administration Regulatory compliance reporting Legal document preparation and review Banking and financial operations General back-office administrative workflows requiring structured execution Data entry The Company believes these industries share a common challenge: transforming unstructured documents into structured, compliant, and auditable outputs with high accuracy requirements and minimal tolerance for error. "We believe Deterministic AI represents a new category of enterprise artificial intelligence focused on execution rather than content generation," said Dr. Desheng Wang, CEO of Focus Universal. "While generative AI can create text, images, and code, Deterministic AI is designed to complete complex business workflows with consistent and verifiable outcomes. By combining domain knowledge with autonomous workflow execution, we believe technology can significantly reduce manual labor while improving speed, accuracy, and scalability across many industries. SEC reporting is only one example of the broader opportunities we see for this platform." About Focus Universal: Focus Universal Inc. is a provider of patented hardware and software design technologies for Internet of Things (IoT) and 5G. The company has developed five disruptive patented technology platforms with 26 patents and patents pending in various phases and 8 trademarks pending in various phases to solve the major problems facing hardware and software design and production within the industry today. These technologies combined to have the potential to reduce costs, product development timelines and energy usage while increasing range, speed, efficiency, and security. Focus currently trades on the Nasdaq Capital Markets. Forward-Looking Statements: Statements in this press release about future expectations, plans and prospects, as well as any other statements regarding matters that are not historical facts, may constitute "forward-looking statements" within the meaning of The Private Securities Litigation Reform Act of 1995. The words "anticipate," "believe," "continue," "could," "estimate," "expect," "intend," "may," "plan," "potential," "predict," "project," "should," "target," "will," "would" and similar expressions are intended to identify forward-looking statements, although not all forward-looking statements contain these identifying words. Actual results may differ materially from those indicated by such forward-looking statements as a result of various important factors, including: the uncertainties related to market conditions and the completion of the public offering on the anticipated terms or at all, and other factors discussed in the "Risk Factors" section of the preliminary prospectus filed with the SEC. Any forward-looking statements contained in this press release speak only as of the date hereof and Focus Universal specifically disclaims any obligation to update any forward-looking statement, whether because of new information, future events or otherwise. For investor and media inquiries, please contact: Investor Relations 626-272-3883 ir@focusuniversal.com
BEIJING, CHINA - June 19, 2026 (NEWMEDIAWIRE) - LakeShore Biopharma Co., Ltd (“LakeShore Biopharma” or the “Company”) (OTCPK: LSBCF; OTCPK: LSBWF), a global biopharmaceutical company dedicated to discovering, developing, manufacturing, and delivering new generations of vaccines and therapeutic biologics for infectious diseases and cancer, today announced that at an extraordinary general meeting of shareholders (the “EGM”) held today, the Company’s shareholders voted in favor of the proposal to authorize and approve the previously announced Agreement and Plan of Merger, dated November 4, 2025, as amended by Amendment No. 1 to Agreement and Plan of Merger, dated April 29, 2026 (the “Merger Agreement”), by and among the Company, Oceanpine Skyline Inc. (“Parent”) and Oceanpine Merger Sub Inc. (“Merger Sub”), a wholly owned subsidiary of Parent, pursuant to which, at the effective time of the merger, Merger Sub will merge with and into the Company and cease to exist, with the Company continuing as the surviving company and becoming a wholly owned subsidiary of Parent, the plan of merger required to be filed with the Registrar of Companies of the Cayman Islands (the “Plan of Merger”) and the transactions contemplated thereby, including the merger. Approximately 92.3% of the Company’s total outstanding ordinary shares, par value US$0.0002 each (each, a “Share”), as of 5 p.m. Cayman Islands time on the share record date of May 27, 2026 voted in person or by proxy at the EGM. The Merger Agreement, the Plan of Merger and the transactions contemplated thereby, including the merger, were approved by approximately 86.2% of the total votes cast at the EGM. Completion of the merger is subject to the satisfaction or waiver of the conditions set forth in the Merger Agreement. The Company will work with the other parties to the Merger Agreement towards completing the merger in due course. If consummated, the merger will result in the Company becoming a privately held company, and its Shares and warrants to purchase Shares (the “Company Warrants”) will no longer be listed for quotation on any public market place or quotation system, including the OTC Pink tier of the OTC Markets. In addition, the Company’s Shares and Company Warrants will cease to be registered under Section 12 of the Securities Exchange Act of 1934 following the consummation of the merger. About LakeShore Biopharma Co., Ltd LakeShore Biopharma, previously known as YS Biopharma, is a global biopharmaceutical company dedicated to discovering, developing, manufacturing, and delivering new generations of vaccines and therapeutic biologics for infectious diseases and cancer. It has developed a proprietary PIKA® immunomodulating technology platform and a new generation of preventive and therapeutic biologics targeting Rabies, Hepatitis B, Influenza, and other virus infections. The Company operates in China, Singapore, and the Philippines, and is led by a management team that combines rich local expertise and global experience in the biopharmaceutical industry. For more information, please visit https://investors.lakeshorebio.com/. Forward-Looking Statements This press release contains statements that may constitute “forward-looking” statements. These forward-looking statements include, without limitation, the Company’s business plans and development, which can be identified by terminology such as “may,” “will,” “expect,” “anticipate,” “aim,” “future,” “estimate,” “intend,” “plan,” “believe,” “potential,” “continue,” “is/are likely to” or other similar expressions. Statements that are not historical facts, including statements about LakeShore Biopharma’s beliefs, plans and expectations, are forward-looking statements. Forward-looking statements involve inherent risks and uncertainties. A number of factors could cause actual results to differ materially from those contained in any forward-looking statement, including but not limited to the following: the possibility that the merger will not occur as planned if events arise that result in the termination of the Merger Agreement; the possibility that financing may not be available; the possibility that various closing conditions for the transaction may not be satisfied or waived; and other risks and uncertainties discussed in documents filed with the U.S. Securities and Exchange Commission (the “SEC”) by the Company, as well as the Schedule 13E-3 and the proxy statement filed by the Company; the Company’s goals and strategies; the Company’s future business development, financial condition and results of operations; its ability to provide efficient services and compete effectively; its ability to maintain and enhance the recognition and reputation of its brands; general economic and business conditions globally and in China and assumptions underlying or related to any of the foregoing. Further information regarding these and other risks, uncertainties or factors is included in the Company’s filings with the SEC. All information provided in this press release is as of the date of this press release, and the Company does not undertake any obligation to update any forward-looking statement as a result of new information, future events or otherwise, except as required under applicable law. For investor inquiries, please contact: IR Team Tel: +86 (10) 8920-2086 Email: ir@lakeshorebio.com View the original release on www.newmediawire.com
HONG KONG - June 19, 2026 (NEWMEDIAWIRE) - In the latest World Competitiveness Yearbook (WCY) 2026 published by the International Institute for Management Development, Hong Kong's global competitiveness has continued to rise, with the city ranking second globally this year. Hong Kong has performed strongly across a wide range of indicators. It tops the charts in "Tax policy" and "Business legislation"; ranks second in "Finance"; and third in "International trade", "International investment", "Management practices" and "Education”, underscoring the city’s clear institutional strengths and market efficiency. Prof Frederick Ma, Chairman of the Hong Kong Trade Development Council, said: “The WCY 2026 reaffirms Hong Kong’s competitiveness and business advantages. Together with a number of recent international reports showing that Hong Kong has become the world’s fifth-largest trading entity, overtaken Switzerland to rank first globally in cross-border wealth management, and remained among the top global destinations for IPO fundraising, these positive developments highlight Hong Kong’s competitive advantages as the ‘Four Centres and One Hub’. They also demonstrate that Hong Kong is the premier two-way springboard connecting the Chinese Mainland and international markets.” Prof Ma added that HKTDC will continue to actively support the Hong Kong Special Administration Region government, to proactively align with the national 15th Five-Year Plan and Hong Kong’s Five-Year Plan. Leveraging the city’s unique strengths as a superconnector and super value-adder, the HKTDC will help Hong Kong better integrate into and contribute to the nation’s overall development. HKTDC Media Room: https://mediaroom.hktdc.com/en Media enquiries Please contact the HKTDC’s Communications & Public Affairs Department: Sam Ho Tel: (852) 2584 4569 Email: sam.sy.ho@hktdc.org About HKTDC The Hong Kong Trade Development Council (HKTDC) celebrates its 60th anniversary this year. The HKTDC is a statutory body established in 1966 to promote, assist and develop Hong Kong's trade. With over 50 offices globally, including 13 in the Chinese Mainland, the HKTDC promotes Hong Kong as a two-way global investment and business hub. The HKTDC organises international exhibitions, conferences and business missions to create business opportunities for companies, particularly small and medium-sized enterprises (SMEs), in the mainland and international markets. The HKTDC also provides up-to-date market insights and product information via research reports and digital news channels. For more information, please visit: www.hktdc.com/aboutus. View the original release on www.newmediawire.com
CALGARY, ALBERTA - June 18, 2026 (NEWMEDIAWIRE) - Voyageur Pharmaceuticals Ltd. (TSX-V: VM) (OTC Pink: VYYRF) (“Voyageur” or the “Company”), a Canadian developer of pharmaceutical-grade barium and iodine contrast media for medical imaging, is pleased to announce it is evaluating three potential locations in the United States for its planned integrated iodine and barium contrast drug manufacturing facility. The Company is completing a comprehensive technical, regulatory, economic, and logistical analysis of candidate sites. Key evaluation criteria include proximity to iodine brine sources (expected to support an estimated +70% of future revenue), logistics, infrastructure, access to skilled labour, and the strength of government incentive packages. Voyageur is actively engaging with economic development authorities across multiple U.S. jurisdictions. The final site will be selected based on the most attractive overall combination of factors, with a strong emphasis on the incentive and support packages offered. This competitive process is designed to optimize project economics and accelerate development timelines. Strategic Advantages of Shortlisted Jurisdictions Strong candidate locations have been identified in the States of Oklahoma and Texas due to their compelling attributes, including: Proximity to Voyageur’s iodine extraction initiatives in Oklahoma’s Anadarko Basin Robust transportation infrastructure (rail, major highways, and port access) for efficient North American and global distribution Access to skilled labour and abundant municipal water supply Reliable infrastructure and a competitive business climate with low taxes, cost-effective land and energy Strong local, state, and federal incentives supporting advanced manufacturing, pharmaceutical and API production, critical minerals processing, and strategic supply chain onshoring. Facility Overview and Vertical Integration The pharmaceutical manufacturing facility will receive concentrated iodine liquor produced through Voyageur’s proprietary closed-loop Streamlined Iodine Process directly from its Oklahoma brine operations, together with high-purity barite from the Frances Creek project. Unlike conventional contrast media manufacturers that depend on imported iodine flakes or intermediates and energy-intensive synthetic precipitated barium sulfate, this integrated GMP campus will combine on-site iodine-to-API synthesis with barite upgrading into USP-grade material and sterile injectable manufacturing, which management believes will deliver the first fully domestic, vertically integrated supply chain for both iodinated and barium contrast agents at materially lower cost, with superior sustainability and supply security for U.S. hospitals, government customers and for international distribution. Key Anticipated Project Highlights: Cost leadership: Vertical integration is expected to deliver industry-leading production costs. Funding & incentives: Significant opportunities for U.S. federal and state support. Employment: 150–250 direct high-skilled positions in manufacturing, engineering, quality assurance, laboratory, and operations, plus substantial indirect jobs through construction and suppliers. Economic contribution: Once at full scale, the facility is expected to generate significant annual economic activity, major local tax revenue, and support for regional supply chains. Workforce development: Planned collaboration with post-secondary institutions to establish pharmaceutical training programs, co-op placements, and talent pipelines in chemical engineering, pharmaceutical sciences, and related fields. Market access: Centrally located to serve the North American contrast media market with excellent logistics for domestic and international distribution. Supply chain security: Expected to enable efficient management of iodine and barium contrast production while supporting iodine supply for the Company’s collaboration with Bayer on the Oklahoma iodine prill project. Brent Willis, CEO of Voyageur Pharmaceuticals, stated: “This location decision optimizes logistics between our Oklahoma iodine sources and Canadian barite resources while providing the infrastructure required for GMP-compliant manufacturing. We are evaluating multiple strong jurisdictions and will select the site that delivers the most compelling overall package, including the strongest incentive support. The jurisdiction that provides Voyageur with the most significant incentive package will secure this transformative project and its substantial long-term economic benefits.” Site preparation and detailed engineering are targeted to commence in late 2026, with first production expected in Q4 2028–2029, subject to financing, regulatory approvals, and other customary conditions. This announcement builds on Voyageur’s ongoing collaboration with Bayer and recent advancements in its barium contrast portfolio, including Health Canada-approved products already in commercial use. The Company continues to work closely with economic development corporations and state/federal partners to advance incentives and permitting. Management believes the project aligns with U.S. priorities for domestic critical and strategic minerals, pharmaceutical onshoring of strategic drugs, and rural economic development. About Voyageur Pharmaceuticals Ltd. Voyageur Pharmaceuticals (TSXV: VM) is a Canadian company focused on becoming a low-cost, vertically integrated producer of barium and iodine Active Pharmaceutical Ingredients (APIs) and finished imaging contrast agents. The Company has already developed five barium contrast products that hold Health Canada licenses and are currently generating revenue in Canada. Voyageur is positioned to become North America’s first vertically integrated, low-cost manufacturer of both barium and iodine contrast media, a significant competitive advantage. By owning 100% of the high-grade, metal-free Frances Creek barite project, the Company controls its own secure, domestic source of pharmaceutical-grade barium sulfate. In parallel, Voyageur’s patent-pending Mueller process enables low-cost extraction of iodine from mineral brine water. Combined with its proprietary Streamline manufacturing technology, the Company plans to process that iodine directly into finished iodine contrast drugs within a single, integrated production chain. This end-to-end ownership from raw material extraction through proprietary processing to finished pharmaceutical products, is expected to deliver materially lower operating costs than competitors who purchase intermediates on the open market. At the same time, it is anticipated to create a reliable, North American-based supply chain for critical medical imaging agents, significantly reducing geopolitical, logistics, and shortage risks for hospitals and patients in the United States and Canada. This strategy embodies Voyageur’s motto, “From Earth to Bottle,” reflecting its commitment to responsible, traceable, and secure sourcing and manufacturing from North American resources. For Further Information: Brent Willis, CEO Brent@vpharma.ca, 403-923-5944 info@vpharma.ca Albert Deslauriers, CFO Albert@vpharma.ca https://voyageurpharmaceuticals.ca Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this news release. Cautionary Statement Regarding “Forward-Looking” Information This news release may contain certain forward-looking statements and forward-looking information (collectively, "forward-looking statements"), including without limitation: the completion of the analysis and choosing the location for its drug manufacturing facility; the realization of the advantages of the location chosen; the timing, successful construction and operation of the drug manufacturing facility; obtaining Health Canada, FDA and other international regulatory approvals with reasonable timelines; the testing, refining, market launch, manufacturing, sales and revenue from Voyageur's barium and iodine contrast products; the Company’s business plan and the Company successfully raising additional financing to support the business plan including the construction of the drug manufacturing facility the Company's aim to become a key player in the barium and iodine contrast markets; the Company's plan to transition into a high-margin manufacturer of radiology drugs; the Company's belief that the Frances Creek Project's mineral will replace the current synthetic products in the pharmaceutical marketplace with higher quality imaging products; and the Company's belief that it can ensure quality and cost efficiency by controlling all primary input costs. Forward-looking statements normally contain words like "will", "intend", "anticipate", "could", "should", "may", "might", "expect", "estimate", "forecast", "plan", "potential", "project", "assume", "contemplate", "believe", "shall", "scheduled", and similar terms. Forward-looking statements are not guarantees of future performance, actions, or developments and are based on expectations, assumptions, and other factors that management currently believes are relevant, reasonable, and appropriate in the circumstances. Although management believes that the forward-looking statements herein are reasonable, actual results could be substantially different due to the risks and uncertainties associated with and inherent to Voyageur's business. Additional material risks and uncertainties applicable to the forward-looking statements herein include, without limitation, the impact of general economic conditions, and unforeseen events and developments. This list is not exhaustive of the factors that may affect the Company's forward-looking statements. Many of these factors are beyond the control of Voyageur. All forward-looking statements included in this news release are expressly qualified in their entirety by these cautionary statements. The forward-looking statements contained in this news release are made as at the date hereof, and Voyageur undertakes no obligation to update publicly or to revise any of the included forward-looking statements, whether as a result of new information, future events, or otherwise, except as may be required by applicable securities laws. Risks and uncertainties about the Company's business are more fully discussed under the heading "Risk Factors" in its most recent filings. They are otherwise disclosed in its filings with securities regulatory authorities available on SEDAR+ at www.sedarplus.ca. View the original release on www.newmediawire.com
GLENDALE, CA - June 18, 2026 (NEWMEDIAWIRE) - Every single day, communities lose pieces of their soul when the institutions built to protect their heritage quietly vanish. While iconic, city-funded Los Angeles landmarks like the La Brea Tar Pits and the Natural History Museum enjoy secure financial futures, unique independent treasures are left to fight for survival entirely on their own. Today, the Martial Arts History Museum in Glendale issues a heartfelt appeal to the public as it launches a critical $5 million campaign to help continue its journey moving forward. The museum’s core mission goes far beyond showcasing stunning artifacts designed by a Disney artist; it serves as a vital sanctuary for stories that cannot be allowed to die. It is an educational haven that teaches the world about the immense, positive contributions of the Asian American community and the profound cross-cultural impact of martial arts in the West. If we allow independent institutions like this to crumble, we are actively letting go of the profound sacrifices made by those who came before us. To let this museum stall is to permanently silence a number of memories of the historic 442nd American Japanese military regiment, and to erase the devastating yet resilient stories of how martial arts preserved dignity and hope inside Japanese Internment camps. It means letting the world forget the heroism of Filipino Kali icon Jack Santos, who stood fearlessly alone before an angry, swelling crowd with just two sticks in his hands, to stop them from destroying Little Tokyo as the war with Japan broke out. It means abandoning the legacy of a young Latino man, Benny Urquidez, from the barrio who overcame the heavy gravity of gang influence to transform into one of the greatest world champions of all time. These are not just exhibits; they are a testament to the human spirit, and they will be entirely lost if we stand by and do nothing. To ensure these vital pieces of cultural history survive for future generations, the museum has launched a GoFundMe crowdfunding site (https://gofund.me/e0e28705f) as the initial step toward its incremental $5 million fundraising goal. This campaign is a direct invitation to look closely at what is at stake and take action before it is too late. Keeping history alive requires more than appreciation; it demands active community guardianship to help us keep moving forward. “History, the internment camps, the 442nd, the heavy pressure of Asian-Hate in America - all these items are addressed in the museum through our rotating exhibits,” says Michael Matsuda, museum president. “These are important, heavy facts that we now have a precious opportunity to educate others about. The martial arts serves as our connection, our common denominator across so many diverse cultures. But the simple, painful truth is that we can only continue forward with your financial support.” Donations of any size can be made to the museum's official crowdfunding page or directly to the museum at MAmuseum.com, where every contribution goes directly toward sustaining rotating exhibits, funding educational outreach, and keeping the doors open. We owe it to the generations before us, and the children ahead of us, to ensure this invaluable light is kept moving forward. About the Martial Arts History Museum: The museum is a non-profit organization and is located at 201 N. Brand Blvd, B100, Glendale, CA, 91203, the Martial Arts History Museum is an independent, educational facility dedicated to promoting the benefits of diversity, artistry, and cultural history. By connecting Asian American heritage with the global impact of martial arts, the museum serves as a critical bridge of understanding and education for visitors from around the world. For info, visit MAmuseum.com or email info@MAmuseum.com.
tonies publishes mid-term ambition, targets to more than double group revenue to greater than EUR 1.4bn (by FY 2030) and aims to achieve an adj. EBITDA margin between 16-18% (mid-term) Global expansion is planned to continue with at least two additional market launches in 2027 and presence in all major regions of the world by 2030 New Global Advisory Group brings together leading childhood development experts to provide science-backed guidance on product and content development LUXEMBOURG and LONDON - June 18, 2026 (NEWMEDIAWIRE) - tonies SE (“tonies”), the globally leading interactive audio platform for children, today will host its first-ever Capital Markets Day. After creating an entirely new category at the intersection of technology, toys, content, and gaming while building an increasingly profitable global enterprise in less than a decade, tonies now sets out its financial ambitions and the strategic roadmap that will shape the years ahead. Tobias Wann, CEO of tonies, says: “tonies has global appeal and a market opportunity far beyond our current size. We are building a global icon around a platform model that drives subscription-like behavior. Three priorities will drive value over the coming years: building a multi-device ecosystem that compounds value, leveraging our global product-market fit, and extending our story of reliable, profitable growth. The opportunity in front of us is greater than anything we have delivered so far – and we have the demand, the team, and the plan to capture it.” tonies' growth ambition is anchored in three mutually reinforcing pillars. First, building an ecosystem designed to shape the future of childhood, generating recurring cohort revenue. Second, winning internationally, with the US representing the single largest near-term opportunity alongside upcoming launches in new markets. And third, building on a proven resilient financial model, by scaling a platform that does not need to be rebuilt market by market, but generates operating leverage fueling margin expansion. Across all three, tonies is deploying AI to accelerate localization, compress development cycles, and increase output without proportionate cost over time. Midterm ambition underscores potential for profitable growth in years ahead By 2030, the company targets revenues exceeding EUR 1.4 billion. Topline growth is expected to be primarily driven by expanding current activities, with additional contributions from new device developments and new market launches. tonies aims to achieve an adjusted EBITDA margin in the range of 16–18% mid-term. This target reflects the natural evolution toward higher-margin attach revenue over time, together with a growing installed base, alongside improved operating leverage stemming from structural improvements across cost of goods, fulfillment, and the broader cost base – including SG&A. Hansjorg Müller, CFO of tonies, explains: “Our financial model is built on an ecosystem flywheel: a growing installed base and a compounding relationship drive recurring and predictable revenue, and operating leverage improves with every market we roll out and scale. What makes this model particularly sustainable is the underlying resilience: We have delivered on our guidance every year since our IPO, recording profitable growth while facing supply chain disruption, geopolitical instability, consumer restraint, and even a historic tariff environment. Our ambition to grow tonies far beyond the billion-mark while significantly increasing our profitability in the coming years reflects us continuing this proven trajectory.” International expansion continues in new and established markets tonies aims to more than double its topline by 2030 as the global opportunity remains largely untapped. With significant penetration headroom in existing markets – in the US, tonies serves only ~12% of target households, compared to ~58% in DACH – and more than 570 million addressable households(1) around the world overall, international growth is and remains one of tonies’ most powerful value drivers. In addition, tonies follows an omnichannel strategy to drive revenue, continuously growing and scaling its retail footprint: Since 2019, tonies has grown its number of points of sale by more than 30% annually (CAGR) to more than 25,000 worldwide. Christoph Frehsee, CRO of tonies, says: “We have built a proven and repeatable global growth engine. Every market launch strengthens our data, our operating playbook, our retail partnerships, our localization capabilities, and our content ecosystem – making each successive launch more effective than the last. With significant growth potential still ahead of us, we are preparing to enter at least two new markets in 2027 and establish tonies across all major regions of the world by 2030.” Growing and engaging the world’s leading audio platform with a commitment to a good childhood tonies today announces the launch of its Global Advisory Group, a panel of leading experts across childhood development, education, neuroscience, pediatrics, and family wellbeing. Developmental research has long informed how tonies designs products and curates content. The Global Advisory Group formalizes that commitment as the company scales globally, ensuring innovation continues to be informed by trusted, independent expertise. Founding members include Michael Levine, Chrissy Lawler, Dr. Ellen Wartella, Dr. Katharina Meier-Batrakow, and Meredith Halpern-Ranzer, whose backgrounds span leading research institutions, and independent practice. Ginny McCormick, CXO of tonies, says: “At tonies, we are not building products for a moment. We are building relationships with families that grow across childhood. That requires more than beloved content, it requires trust. We believe the best childhood experiences are grounded in a deep understanding of how children learn, listen, and develop. Our Global Advisory Group reflects our commitment to bringing that expertise into everything we create.” The strength of tonies’ unique portfolio is visible in the pace of what the company is bringing to the market: within just a few weeks, tonies has launched Hasbro flagship games on Tonieplay, announced bringing Bluey to the Toniebox, and will shortly launch the first products from its collaboration with Pokémon – three of the world's most beloved children's brands, arriving in rapid succession. Tonies’ content portfolio now represents a large chunk of the world’s leading children's IPs, a breadth that reflects both the platform's reach and the trust the industry places in it. (1)Indicative estimate of households with at least one child aged 0–9 across all markets worldwide About tonies tonies® is the globally leading interactive audio platform for children redefining how children aged 1 to 9+ play, learn, and grow independently without screens. Since its founding in Germany in 2014, around 12.2 million Tonieboxes and over 165 million Tonies have been sold worldwide. On average, children engage with tonies for ~280 minutes per week, making it a trusted everyday companion that brings the joy and magic of interactive audio entertainment and education into family life worldwide. The intuitive and award-winning system – centered around Toniebox 2 – offers a portfolio of around 1,500 Tonies figurines and about 20 Tonieplay games and more than 3,500 digital titles via mytonies (library and app) – ranging from tonies Originals® to licensed content from around 350 partners including Disney, Warner Bros., NBC Universal, Mattel, Marvel, Paramount, Hasbro, Universal, Sony Music. tonies is rapidly expanding its platform globally. Besides DACH, central growth regions include tonies’ largest market, North America, the United Kingdom and Ireland, France, Australia and New Zealand, with Tonieboxes now active in over 100 countries. tonies employs more than 630 people, achieved EUR 630 million in group revenue in fiscal year 2025 (+31% yoy), and is listed in the SDAX segment of Frankfurt Stock Exchange (tonies SE). This document contains forward-looking statements Certain statements included in this document are forward-looking statements. Forward-looking statements can typically be identified by the use of words such as "expects", "may", "will", "could", "should", “target”, "intends", "plans", "predicts", "envisages" or "anticipates" or other words of similar meaning. These forward-looking statements are based upon current expectations and assumptions regarding anticipated developments and other factors affecting the tonies SE, incl. a flat memory chip cost development and that current tariff regimes remain stable. They are not historical or current facts, nor are they guarantees of future performance. Disclaimer By their nature, forward-looking statements involve several risks, uncertainties and assumptions that could cause actual results or events to differ materially from those expressed or implied by the forward-looking statements. These risks, uncertainties and assumptions could adversely affect the outcome and financial effects of the plans and events described in this document. These forward-looking statements speak only as of the date of this announcement. Except as required by any applicable mandatory law or regulation, tonies SE expressly disclaims any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements contained in this document to reflect any change in tonies SE's expectations with regard thereto or any change in events, conditions, or circumstances on which any such forward-looking statements are based. Neither tonies SE nor any other person accepts any responsibility for the accuracy of the opinions expressed in this document or the underlying assumptions. For the definition of the alternative performance measures used, please refer to the published Annual Report as of December 31, 2025 or by using the following link to our website: APM Media Contact: tonies: Christian Steinhof Head of Global Corporate Communications Phone: +49 171 121 0279 Mail: christian.steinhof@tonies.com Investor Relations Contact: tonies: Moritz Verleger Head of Investor Relations Phone: +49 151 5784 6012 Mail: ir@tonies.com View the original release on www.newmediawire.com
Once again high approval for all agenda items Dividend unchanged at 10 cents per share MUNICH, GERMANY - June 18, 2026 (NEWMEDIAWIRE) - Ringmetall SE (ISIN: DE000A3E5E55), a leading international specialist supplier in the packaging industry, held its Annual General Meeting in virtual form in Munich on June 16th. At the time of the vote, 75.94 percent of the company's share capital of EUR 29,069,040.00 was represented (previous year: 70.7 percent). Against the backdrop of a persistently challenging economic environment, the company increased its consolidated revenue by 7.3 percent to EUR 187.7 million in the 2025 financial year, mainly due to the acquisitions made in the previous year and in the financial year. At EUR 23.0 million, earnings before interest, taxes, depreciation and amortization (EBITDA) were 3.1 percent below the previous year's figure of EUR 23.7 million; this reflects in particular a one-off effect included in the previous year, the weak US dollar and subdued bag-in-box business. Due to the overall solid development of the company in the previous year, the Annual General Meeting voted in favour of a dividend payment of EUR 0.10 per outstanding share, unchanged compared to the previous year. In addition to the agenda items regularly voted on at the Annual General Meetings on the appropriation of the retained profit, the discharge of the Management Board and the Supervisory Board, the election of the auditor and the approval of the remuneration report, the creation of new authorized capital in 2026 for cash and non-cash capital increases with the option of excluding subscription rights was put to the vote. In this context, the existing authorized capitals for 2018 and 2021 were abolished at the same time and the Articles of Association were amended accordingly. In detail, the percentage approval of the agenda items to be voted on was as follows: Agenda item 2 99.90 percent Agenda item 3a 98.29 percent Agenda item 3b 97.80 percent Agenda item 4 98.61 percent Agenda item 5 99.90 percent Agenda item 6 92.07 percent Agenda item 7 95.23 percent "2025 was a year of significant strategic steps for us, especially in the Liner business unit, which we have significantly strengthened through several acquisitions," says Christoph Petri, CEO of Ringmetall SE. "We will continue on this path in 2026. Even though the market environment remains challenging, we remain confident about the further development." Further information on the agenda items of the Annual General Meeting as well as on the Ringmetall Group and its affiliated subsidiaries can be found at www.ringmetall.de. Contact: David Stakemeier Ringmetall SE Phone: +49 (0) 89 45 220 98 0 E-mail: ir@ringmetall.de About the Ringmetall Group Ringmetall is a leading international specialist supplier of industrial packaging. The company produces highly secure closure systems and inner sleeves for industrial drums in the chemical, pharmaceutical and food processing industries. In addition, Ringmetall offers innovative packaging solutions for the beverage industry. With products that are highly recyclable, the company contributes to strengthening the circular economy and the sustainability of its end customers. In addition to its headquarters in Munich, the group of companies is represented by worldwide production and sales offices in Germany, France, Great Britain, Spain, Italy, Poland, Turkey, the Netherlands, Finland as well as China and the USA. View the original release on www.newmediawire.com
Lenzing Group at CIDPEX China, TECHTEXTIL Frankfurt and INDEX Geneva INDEX™ 26 Award for LENZING™ DualWipe LENZING™ Nonwoven Technology as platform for scalable, bio-based nonwoven solutions LENZING, AUSTRIA - June 18, 2026 (NEWMEDIAWIRE) - From CIDPEX in China to Techtextil in Frankfurt and INDEX in Geneva, the Lenzing Group showcases ready-for-market, bio-based nonwoven solutions and receives industry recognition for LENZING™ Nonwoven Technology. The Lenzing Group, a leading global producer of regenerated cellulose fibers for the nonwovens and textiles industries, further strengthened the positioning of its nonwovens business during a series of major international industry fairs in the first half of 2026. From CIDPEX in China to Techtextil in Frankfurt and INDEX in Geneva, Lenzing demonstrated how its nonwovens fiber portfolio and LENZING™ Nonwoven Technology (LNT) enable scalable, bio-based alternatives to fossil-based nonwoven materials. Global presence across key nonwovens markets The year began with CIDPEX 2026 in Nanjing, China, the world’s largest exhibition for tissue and disposable hygiene products. As a key industry platform in Asia, CIDPEX played an important role in strengthening Lenzing’s regional presence and increasing the global visibility of VEOCEL™ branded fibers, particularly for absorbent hygiene and wipes applications. At Techtextil 2026 in Frankfurt and INDEX 2026 in Geneva, Lenzing further engaged with European and international customers. At both events, LENZING™ Nonwoven Technology was presented through interactive touch and feel stations that attracted strong industry interest. These hands-on demonstrations allowed visitors to experience the performance, versatility, and material benefits of Lenzing’s cellulosic nonwoven solutions in an application-oriented context. INDEX™ 26 Award for LENZING™ DualWipe A central highlight was the recognition of LENZING™ DualWipe with the prestigious INDEX™ Award in the Nonwovens Roll Goods category at the INDEX fair in Geneva. This innovative wipe, enabled by the LENZING™ Nonwoven Technology, integrates two functional surfaces within a single wipe: an abrasive side for effective removal of dirt and residues, and a soft, highly absorbent side for wiping and finishing. DualWipe contains no synthetic fibers, binders, or finishing chemicals, eliminating the risk of microplastic shedding typically associated with conventional synthetic wipes. Patricia Sargeant, Executive Vice President Commercial Nonwovens at Lenzing Group says: “We would like to thank EDANA and the independent INDEX Award jury for recognizing LENZING™ DualWipe with the INDEX™ 26 Award. This underlines the relevance of cellulose based, fossil free technologies for the future of the nonwovens industry. With LENZING™ Nonwoven Technology, we provide a scalable, high-performance alternative to fossil-based materials by combining renewable raw materials and advanced fiber and web technologies. Lenzing supports customers in meeting increasing regulatory, brand, and consumer expectations and enables the industry’s transition toward more sustainable products.” Lenzing’s nonwovens solutions are aligned with the EU Bioeconomy Strategy, which emphasizes the use of bio-based materials to reduce dependence on fossil resources and strengthening sustainable industrial value chains. Lenzing translates these strategic ambitions into industrial-scale solutions that are already available for applications in hygiene, wipes and technical nonwovens. Innovation partner for the nonwovens industry Across all fairs, Lenzing demonstrated how its fibers and technologies add value to diverse end applications, with a particular focus on absorbent hygiene products and advanced nonwoven solutions. By combining fiber innovation, application expertise, and close collaboration along the value chain, Lenzing is well-positioned as an innovation and solution provider to the global nonwovens industry. Photo download: CELUM Content Your contact for Media Relations: Corporate Communications PR & Media Team Lenzing Aktiengesellschaft WerkstraBe 2, 4860 Lenzing, Austria Phone +43 664 6112534 E-mail media@lenzing.com Web www.lenzing.com About the Lenzing Group The Lenzing Group stands for the responsible production of specialty and premium fibers based on regenerated cellulose. As an innovation leader, Lenzing is a partner of global textile and nonwoven manufacturers and drives many new technological developments. The Lenzing Group’s high-quality fibers are the raw material for a wide range of textile applications – ranging from functional, comfortable, and fashionable clothing through to durable and sustainable home textiles. TUV-certified biodegradable and compostable Lenzing fibers are also ideal for demanding use in everyday hygiene applications. The Lenzing Group’s business model extends far beyond that of a traditional fiber producer. Together with its customers and partners, Lenzing develops innovative products along the value chain, adding value for consumers. The Lenzing Group strives for efficient utilization and processing of all raw materials and offers solutions for the transition of the textile industry from the current linear economic system to a circular economy. In order to align its commitment to limiting man-made climate change with the goals of the Paris Agreement, Lenzing has a clear, science-based climate action plan that provides for a significant reduction in greenhouse gas emissions (Scopes 1, 2, and 3) by 2030 and a net-zero target by 2050. Key Facts & Figures Lenzing Group 2025 Revenue: EUR 2.60 bn Nominal capacity (fibers): 1,110,000 tonnes Employees (full-time equivalents): 7,738 TENCEL™, LENZING™ ECOVERO™, VEOCEL™, LENZING™, and REFIBRA™ are trademarks of Lenzing AG. View the original release on www.newmediawire.com
Performance: Q3 business performance so far behind expectations. Customer confidence and willingness to buy significantly under pressure due to ongoing macroeconomic uncertainties and price sensitivity. Strategy: Focus on strategic priorities in new market reality: Re-allocation of investments, sharper differentiation and exclusivity, pricing, and digital acceleration. FY guidance 2025/26 adjusted: Net sales growth of 0-1% (corresponds to 4.58-4.63 billion euros, previously “at the lower end of 4.65 - 4.80 billion euros”) Adj. EBITDA margin of around 15.0% (previously “around 16.0%”) Net leverage of 3.0x to 3.5x as of 30/09/26 (previously “at the upper end of 2.5x to 3.0x”) DUSSELDORF, GERMANY - June 18, 2026 (NEWMEDIAWIRE) - In light of the Q3 business performance so far, the DOUGLAS Group adjusts its guidance for the Financial Year 2025/26. At the same time, the company is driving forward its strategic measures in order to safeguard profitable growth. These include, in particular, that investments are being reallocated, differentiation and exclusivity will be further fostered and digitalization accelerated. Sander van der Laan, CEO of the DOUGLAS Group, said: “Consumer behavior and market dynamics have changed significantly. In this challenging environment, we fully focus on our strategic priorities: we shift investments from our store to our online business; we are investing in competitive pricing, while further strengthening our differentiation and exclusivity; and we are continuing to drive digitalization forward. Some of these measures will deliver short-term benefits, while others will take longer to materialize. We act swiftly, with focus and purpose – we are guided by a sustainable medium- to long-term approach.” Driven by a changed customer behavior and consumer spending, the European premium beauty market continues to shift: Due to ongoing geopolitical and macroeconomic uncertainty, many customers remain very price-sensitive, and often delay their purchases in anticipation of promotions. E-Com grows faster than stores and with a solid profitability on Ebit-level, while like-for-like store sales develop negative. Channel-mix, category-mix, and overall spending patterns vary across markets, cross-channel services such as Click-and-Collect perform very strong. As the market trend in general weighs on revenues and profitability, the DOUGLAS Group changed its guidance for the financial year 2025/26 and now forecasts a sales growth of 0-1% (corresponding to a range of 4.58 - 4.63 billion euros, previously “at the lower end of 4.65 - 4.80 billion euros”) while the adjusted EBITDA margin is seen at around 15.0% (previously “around 16.0%”). Net leverage is expected at 3.0x to 3.5x as of 30 September 26 (previously “at the upper end of 2.5x to 3.0x”). Strongly positioned Omnichannel Business Model Supported by its leading omnichannel business model, its strong brand, and its trusted partnerships with premium beauty suppliers, the DOUGLAS Group remains strong positioned. The company has already addressed many of today’s challenges through its transformation in recent years into a true omnichannel retailer, giving it a clear head start, and benefits from a healthy financial profile that provides flexibility to act. “In the current market environment, both differentiation and pricing matter more than ever. Our omnichannel model, our curated premium assortment, an attractive pricing and our excellent brand name give us a clear competitive edge and we are executing on this with focus and discipline,” said van der Laan. “The management and all colleagues in the company are highly motivated and firmly committed to take on these challenges. We have a clear plan of action, and we are confident that this will put our company the path to profitable growth.” Further details and an update on strategic measures will be published at the DOUGLAS Group quarterly reporting on 12 August 2026. About the DOUGLAS Group The DOUGLAS Group, with its commercial brands DOUGLAS, NOCIBE, Parfumdreams and Niche Beauty, is the number one omnichannel premium beauty destination in Europe. The DOUGLAS Group is inspiring customers to live their own kind of beauty by offering a unique assortment online and in around 1,970 stores. With unparalleled size and access to customers, the DOUGLAS Group is the partner of choice for brands and offers a premium range of selective and exclusive brands as well as own corporate brands. The assortment includes fragrances, color cosmetics, skin care, hair care, accessories as well as beauty services. Strengthening its successful omnichannel positioning while consistently developing superior customer experience is at the heart of the DOUGLAS Group strategy “Let it Bloom”. The winning business model is underpinned by the Group’s omnichannel proposition, leading brands, and data capabilities. In the financial year 2024/25, the DOUGLAS Group generated sales of 4.58 billion euros and employed more than 19,900 people across Europe. The DOUGLAS Group (Douglas AG) is listed at the Frankfurt Stock Exchange. For further information please visit the DOUGLAS Group Website. Press Contact Peter Wübben SVP Group Communications & Sustainability Phone: +49 211 16847 6644 Mail: newsroom@douglas.de Investor Contact Dafne Sanac Director / Senior Principal Investor Relations Phone: +49 151 55675545 Mail: ir@douglas.de View the original release on www.newmediawire.com
GLENDALE, CA - June 18, 2026 (NEWMEDIAWIRE) - This Father’s Day, give your dad an unforgettable experience by taking him to the Martial Arts History Museum. Located in the heart of Glendale, California, the museum is opening its doors to honor fathers everywhere, offering free admittance for all dads on Father's Day, June 21, 2026 from 11:00 AM to 6:00 PM. Designed by a Disney artist, the Martial Arts History Museum is the only facility of its kind in the world. Spanning 8,000 square feet, the museum offers an immersive journey through Asian cultural history, the birth of MMA, and the artistic evolution of martial arts. Dads and their families can explore an incredible collection of martial arts movie props, scary ninjas, Japanese samurai artifacts, a history of anime, and even an authentic workout item used by the legendary icon Bruce Lee. The museum has become a cultural landmark in the Los Angeles area, drawing high-profile visitors and celebrity guests such as Keanu Reeves, Danny Trejo, Marisa Tomei, Steve Oedekerk, and Duff McKagan. While navigating other Los Angeles museums often means dealing with heavy traffic and expensive parking fees, the Martial Arts History Museum offers an easy, stress-free alternative for a special Father’s Day outing. The event runs from 11:00 AM to 6:00 PM on Father’s Day at 201 N. Brand Blvd., B100, Glendale, CA 91203. Convenient parking is located at 222 N. Orange, with the first 90 minutes free in the tower. Admission is completely free for fathers, $12 for adults, and $5 for children. For more information about the museum or to plan your visit, please visit MAmuseum.com. About the Martial Arts History Museum: The Martial Arts History Museum is an educational and cultural facility dedicated to preserving the history, art, and legacy of martial arts. Through unique exhibits, media, and historical artifacts from China, Japan, Korea, the Philippines, and beyond, the museum highlights the profound positive influence martial arts has had on global culture and film.
LOS ANGELES, CA - June 18, 2026 (NEWMEDIAWIRE) - Cardio Diagnostics Holdings (NASDAQ: CDIO) is focused on personalized, data-driven cardiovascular care powered by artificial intelligence, epigenetics and genetic insights. “Through its proprietary platform and expanding testing capabilities, the company is pursuing a future in which prevention becomes more accessible, scalable and actionable before life-threatening cardiac events occur,” reads a recent article. “The company’s vision reflects a broader shift taking place across the healthcare industry toward predictive and precision medicine. Cardio Diagnostics envisions a healthcare system where every patient receives individualized care informed by their unique molecular insights and where heart disease is no longer the world’s leading killer. Achieving that goal requires a combination of scientific expertise, advanced technology, scalable testing, and improved accessibility, all areas the company has identified as foundational pillars of its strategy.” To view the full article, visit https://ibn.fm/gHSrl About Cardio Diagnostics Holdings Inc. Cardio Diagnostics is an artificial intelligence-powered precision cardiovascular medicine company that makes cardiovascular disease prevention, detection, and management more accessible, personalized, and precise. The company was formed to further develop and commercialize clinical tests by leveraging a proprietary artificial intelligence (“AI”)-driven Integrated Genetic-Epigenetic Engine (“Core Technology”) for cardiovascular disease to become one of the leading medical technology companies for improving prevention, detection, and treatment of cardiovascular disease. Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://IBN.fm/Disclaimer The latest news and updates relating to CDIO are available in the company’s newsroom at https://ibn.fm/CDIO Forward Looking Statements Certain statements in this article are forward-looking, as defined in the Private Securities Litigation Reform Act of 1995. These statements involve risks, uncertainties, and other factors that may cause actual results to differ materially from the information expressed or implied by these forward-looking statements and may not be indicative of future results. These forward-looking statements are subject to a number of risks and uncertainties, including, among others, various factors beyond management's control, including the risks set forth under the heading "Risk Factors" discussed under the caption "Item 1A. Risk Factors" in Part I of the Company's most recent Annual Report on Form 10-K or any updates discussed under the caption "Item 1A. Risk Factors" in Part II of the Company's Quarterly Reports on Form 10-Q and in the Company's other filings with the SEC. Undue reliance should not be placed on the forward-looking statements in this article in making an investment decision, which are based on information available to us on the date hereof. All parties undertake no duty to update this information unless required by law View the original release on www.newmediawire.com
LOS ANGELES, CA - June 18, 2026 (NEWMEDIAWIRE) - With a 2026 drilling window fast approaching and $70 million in fresh capital already secured, Greenland Energy (NASDAQ: GLND) is making a compelling argument that the Jameson Land Basin in East Greenland, one of the largest undeveloped Arctic hydrocarbon positions in the world, is no longer a story about geological potential but about execution. In an updated investor presentation, the Houston-based energy exploration company outlines in detail its proposed strategy to advance exploration of the Jameson Land Basin through modern technology, a clearly defined earn-in structure and a set of near-term drilling catalysts that management believes are achievable within the current calendar year. The centerpiece of Greenland Energy’s investment thesis is the Jameson Land Basin itself. The earn-in structure is a key feature of Greenland Energy’s model. The company’s capital position is equally central to the near-term execution story. The centerpiece of Greenland Energy’s investment thesis is the Jameson Land Basin itself, a roughly 2.1-million-acre position in East Greenland covered by three exclusive exploration and exploitation licenses. According to the company, an independent engineering estimate places the basin’s gross unrisked… Read More Forward-Looking Statements This communication contains “forward-looking statements” within the meaning of the “safe harbor” provisions of the United States Private Securities Litigation Reform Act of 1995 and within the meaning of Section 27A of the Securities Act of 1933, as amended (the “Securities Act”), and Section 21E of the Securities Exchange Act of 1934, as amended. All statements contained herein other than statements of present or historical fact, including, without limitation, statements regarding Greenland Energy Company’s (the “Company”) future financial performance, business strategy, operations, financial position, estimated revenues and losses, projected costs, prospects, plans, objectives of management, and expected benefits of the Company’s recent business combination, are forward-looking statements. Forward-looking statements are generally identified by the use of words such as “believe,” “may,” “will,” “estimate,” “continue,” “anticipate,” “intend,” “expect,” “should,” “would,” “plan,” “project,” “forecast,” “potential,” “predict,” or the negative of these terms or similar expressions, although not all forward-looking statements contain such identifying words. These forward-looking statements are based on management’s current expectations, assumptions and beliefs regarding future events and are based on information currently available to the Company. These statements involve a number of risks and uncertainties, many of which are difficult to predict and are beyond the Company’s control, and actual results may differ materially from those expressed or implied by these forward-looking statements. Factors that could cause actual results to differ materially include, among others: (i) Exploration and Geological Risks, including the Company’s status as a development-stage company with no operating history, revenues, or proved reserves; the inherent uncertainty in prospective resource estimates, including that the 13 billion barrel estimate is based on undiscovered accumulations with no certainty of discovery or commercial viability; geological complexity arising from limited seismic data coverage, pervasive igneous intrusions, faulting patterns, and significant Tertiary uplift creating thermal maturity uncertainty; the fact that the basin has never produced a commercial discovery despite decades of study dating back to the 1970s, and a 2008 USGS report stating less than a 10% chance of containing a technically recoverable hydrocarbon accumulation; and high-cost frontier exploration with estimated well costs of $40 million for the first well and $20 million for subsequent wells; (ii) Operational and Environmental Risks, including the challenges of operating in a remote Arctic location with extreme climate, harsh weather, limited daylight, no existing infrastructure, and seasonal access windows for equipment and personnel; drilling hazards such as blowouts, equipment failures, well control events, environmental releases, and accidents inherent in oil and gas operations; reliance on third-party contractors; and climate change scrutiny, as operations in Greenland face increasing opposition from environmental groups and institutional investors due to Arctic drilling concerns; (iii) Regulatory and Political Risks, including the 2021 Greenland drilling moratorium, and while licenses are grandfathered, future regulatory changes could jeopardize operations; geopolitical tensions, including U.S. interest in acquiring Greenland and Greenland’s internal independence movements that could affect operations; permit requirements, as drilling requires Environmental Impact Assessment approval and Field Activities Application approval from Greenlandic authorities; and forfeiture risk, as failure to meet drilling milestones could result in loss of the Company’s right to earn working interests; (iv) Financial and Capital Risks, including significant capital requirements and the need for substantial funding beyond current resources to complete the drilling program; commodity price volatility, as oil, gas, and NGL prices are highly volatile and will heavily influence project viability; a long development timeline during which market conditions may change significantly before potential production, unlike short-cycle shale projects; going concern uncertainty and substantial doubt about the Company’s ability to continue as a going concern without additional financing; and energy transition risk, as global demand for oil may decline due to electric vehicle adoption, renewable energy policies, and changing consumer preferences; and other risks and uncertainties as set forth in the Company’s Prospectus filed with the Securities and Exchange Commission pursuant to Rule 424(b)(4) under the Securities Act on April 29, 2026, in the section titled “Risk Factors”. Forward-looking statements speak only as of the date they are made. The Company undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by applicable law. Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://IBN.fm/Disclaimer Forward Looking Statements Certain statements in this article are forward-looking, as defined in the Private Securities Litigation Reform Act of 1995. These statements involve risks, uncertainties, and other factors that may cause actual results to differ materially from the information expressed or implied by these forward-looking statements and may not be indicative of future results. These forward-looking statements are subject to a number of risks and uncertainties, including, among others, various factors beyond management's control, including the risks set forth under the heading "Risk Factors" discussed under the caption "Item 1A. Risk Factors" in Part I of the Company's most recent Annual Report on Form 10-K or any updates discussed under the caption "Item 1A. Risk Factors" in Part II of the Company's Quarterly Reports on Form 10-Q and in the Company's other filings with the SEC. Undue reliance should not be placed on the forward-looking statements in this article in making an investment decision, which are based on information available to us on the date hereof. All parties undertake no duty to update this information unless required by law View the original release on www.newmediawire.com
ABU DHABI, UNITED ARAB EMIRATES - June 18, 2026 (NEWMEDIAWIRE) - Falcon Energy Materials plc (TSX-V: FLCN) (“Falcon” or the “Company”) today announces that all nominees listed in the management proxy circular were elected as directors of the Company at its annual general meeting of shareholders (“AGM”) held on Thursday, June 18, 2026. A total of 38,944,710 ordinary shares or 22.90 % of the Company’s issued and outstanding ordinary shares as of the record date were represented in person or by proxy at the AGM. 1. Election of Directors The eight nominees listed in the Management Proxy Circular dated May 7, 2026, were elected as directors of the Company for the ensuing year, receiving the following votes: Table 1 2. Appointment of External Auditors In addition, Pricewaterhouse Coopers LLP, chartered accountants, in accordance with applicable Canadian legal requirements, and Grant Thornton Audit and Accounting Limited in accordance with Abu Dhabi Global Market legal requirements, were approved as External Auditors of the Company for the ensuing year and authorized the Directors to fix their respective remuneration for the next year. Table 2 3. Ratification and Approval of Security Based Compensation Plans Shareholders passed an ordinary resolution to ratify and approve the Company’s Amended and Restated Security Based Compensation Plans which provides for the number of ordinary shares reserved being increased from 22,764,466 ordinary shares to 34,016,078 ordinary shares issuable under Amended and Restated Stock Option Plan, Amended and Restated Deferred Share Units Plan and Amended and Restated Restricted Units Plan combined. The information circular disclosing the terms of the amendments have been filed on SEDAR+ under the Company’s profile. The Amended and Restated Security Based Compensation Plans are subject to the final approval of the TSX Venture Exchange. Table 3 About Falcon Falcon Energy Materials (TSX-V: FLCN, OTCQB: FLCNF) is aiming to be the premier provider of natural Coated Spheroidized Purified Graphite (“CSPG”), a critical component for energy storage solutions. As a dedicated chemical refiner of natural graphite concentrate, Falcon is working diligently towards the development of a state-of-the-art 26 ktpa CSPG production facility in Morocco. Strategically partnered with leading Chinese technology firms and Tier One Moroccan partners, Falcon benefits from advanced technological expertise, access to high-quality raw materials and chemicals, and a prime geographical location, factors that will enable it to deliver consistent, high-quality supply to global markets. With a clear focus on sustainable growth and innovation, Falcon aims to become the go-to producer of natural CSPG, supporting widespread adoption in energy storage and other emerging industries. For additional information, please visit Falcon’s website at www.falconem.net. Contact: Matthieu Bos Matt Johnston President & CEO IR Advisor Email: m.bos@falconem.net Email: m.johnston@falconem.net Telephone: +971 2307 4013 Neither the TSX-V nor its Regulation Services Provider (as that term is defined in the policies of the TSX-V) accepts responsibility for the adequacy or accuracy of this release. Forward-Looking Statements This press release contains "forward-looking information" within the meaning of Canadian securities legislation and other statements that are not historical facts. Forward-looking statements are included to provide information about management’s current expectations and plans that allows investors and others to have a better understanding of the Company’s business plans and financial performance and condition. All information contained herein that is not clearly historical in nature may constitute forward-looking information. Generally, such forward-looking information can be identified by the use of forward-looking terminology such as ““advancement”, “position”, “directed”, “continued”, “working”, “towards”, “development”, “enable”, “aims” or variations of such words and phrases or state that certain actions, events or results "may", "could", “will”, "would" or "might". In particular and without limitation, this news release contains forward-looking statements pertaining to (i) its aim to become the premier provider of natural CSPG; (ii) the development of a CSPG production facility in Morocco; (iii) factors that will enable it to deliver consistent, high-quality supply to global markets, including having partnered with leading Chinese technology firms and Tier One Moroccan partners and; (iv) its aim to become the go-to producer of natural CSPG that will support widespread adoption in energy storage and other emerging industries. . Forward-looking information is based upon certain assumptions and other important factors that, if untrue, could cause the actual results, performance or achievements of the Company to be materially different from future results, performance or achievements expressed or implied by such information or statements. There can be no assurance that such information or statements will prove to be accurate. Key assumptions upon which the Company’s forward-looking information is based include, without limitation: (i) the Company’s ability to successfully advance the development and construction of its proposed production facility; (ii) the availability of financing and other resources necessary for the construction and operation of the proposed facility on acceptable terms; (iii) the continued availability and performance of technology partners, suppliers and other strategic counterparties; (iv) the ability of the Company to obtain all necessary regulatory approvals, permits and authorizations in a timely manner for the financing, construction and operation of the proposed production facility; (v) anticipated demand for the CSPG in energy storage and other emerging industries; (vi) favourable market conditions; (vii) the ability to achieve projected production capacity, operational efficiencies and product quality standards; and (viii) general economic, market and industry conditions. . Readers are cautioned that the foregoing list is not exhaustive of all factors and assumptions which may have been used. Forward-looking information is subject to known and unknown risks, uncertainties and other factors that may cause the actual results, level of activity, performance or achievements of the Company to be materially different from those expressed or implied by such forward-looking information, including but not limited to: (i) volatile stock price; (ii) the general global markets and economic conditions; (iii) the possibility of write-downs and impairments; (iv) the risk associated with exploration, development and operations of mineral deposits and mine plans for the Company’s mining operations; (v) the risk associated with establishing title to mineral properties and assets including permitting, development, operations and production from the Company’s operations being consistent with expectations and projections; (vi) fluctuations in commodity prices, finding offtake takers and potential clients or enforcing such agreements against same, (vii) prices for diesel, process reagents, fuel oil, electricity and other key supplies being approximately consistent with current levels; (viii) production and cost of sales forecasts meeting expectations; (ix) the accuracy of the mineral reserve and mineral resource estimates of the Company; (x) labour and materials costs increasing on a basis consistent with the Company's current expectations; (xi) there being no significant disruptions affecting the operations of the Company whether due to artisanal miners, access to water, extreme weather events and other or related natural disasters, labour disruptions, supply disruptions, power disruptions, damage to equipment or otherwise; (xii) asset impairment (or reversal) potential, being consistent with the Company's current expectations; (xiii) risks associated to the accuracy of projections provided in a preliminary economic study which are preliminary in nature and which include significant of uncertainties; (xiv) risks associated with the availability and performance of strategic partners, suppliers and contractors; and (xv) other risks and uncertainties described or referred to in the section entitled “Risk and Uncertainties” in the Company’s management’s discussion and analysis for the year ended December 31, 2025, as updated from time to time in the Company’s interim management’s discussion and analysis for its quarterly financial periods, each of which is filed on SEDAR+ at www.sedarplus.ca. Although the Company believes its expectations are based upon reasonable assumptions and has attempted to identify important factors that could cause actual actions, events or results to differ materially from those described in forward-looking statements, there may be other factors that cause actions, events or results not to be as anticipated, estimated or intended. There can be no assurance that such forward-looking information will prove to be accurate, as actual results and future events could differ materially from those anticipated in such forward-looking information. Such forward-looking information has been provided for the purpose of assisting investors in understanding the Company's business, operations and exploration plans and may not be appropriate for other purposes. Accordingly, readers should not place undue reliance on forward-looking information. Forward-looking information is given as of the date of this press release, and the Company does not undertake to update such forward-looking information except in accordance with applicable securities laws. The Company qualifies all of its forward-looking statements by these cautionary statements. View the original release on www.newmediawire.com
Where Technology Creators, Open-Source Innovators, Infrastructure Leaders, and Builders Come Together to Shape What's Next SYDNEY, NOVA SCOTIA and WILMINGTON, NC - June 18, 2026 (NEWMEDIAWIRE) - 45Drives today announced the return of Creator Summit, its annual gathering of technology creators, infrastructure professionals, developers, engineers, and open-source advocates. The Fourth Annual Creator Summit will take place October 20-22, 2026, in Wilmington, North Carolina, at the Skyline Center and other venues. What began in 2023 as a small cohort of creators and customers has evolved into a unique forum where some of the most influential voices in open-source computing, content creation, homelab communities, and enterprise infrastructure come together to share ideas, challenge conventional thinking, and help shape the future of the industry. At a time when many industry events have become increasingly transactional, Creator Summit has established a reputation for something different: direct access. Attendees spend time engaging with engineers, creators, and industry leaders who are building, deploying, and documenting the systems that power modern organizations and creative workflows. The conversations are candid, technical, and often consequential. Many of the ideas, product improvements, partnerships, and initiatives that have emerged across the 45Drives ecosystem over the past several years can trace their origins to discussions that began at Creator Summit. Previous Summits have featured some of the most respected voices in the industry, including Jeff Geerling, Wendell Wilson, Tom Lawrence, Techno Tim, Craft Computing, Raid Owl, Jay LaCroix, and deadmau5, alongside other creators whose work collectively reaches millions of technology professionals worldwide. This year's Summit will feature two dedicated programming tracks designed to reflect the increasingly connected worlds of enterprise infrastructure and digital creation. The Enterprise Track will focus on the technologies powering modern organizations, including on-premises artificial intelligence, enterprise storage, cybersecurity, open-source infrastructure, virtualization, data sovereignty, and high-performance computing. Designed for IT leaders, infrastructure architects, systems administrators, engineers, developers, and technical decision-makers, sessions will explore the practical realities of deploying and managing modern infrastructure while maintaining control over data, security, performance, and cost. The Creative Track will focus on the future of digital creation and the tools transforming creative workflows. Built for creators, streamers, filmmakers, editors, designers, developers, and digital artists, sessions will examine how local compute, creator-owned infrastructure, open platforms, and emerging technologies are changing the way content is produced, distributed, and monetized. Discussions will explore workflow innovation, creative ownership, production efficiency, audience growth, and the evolving role of new technologies in the creative process. Together, the two tracks reflect a broader convergence between enterprise infrastructure and digital creation. The same advances in AI, compute, storage, and self-hosted platforms that are transforming organizational operations are also reshaping creative work. Creator Summit brings those communities together under one roof, creating opportunities for collaboration, learning, and innovation that rarely happen at traditional industry events. A central theme across both tracks will be the growing impact of on-premises artificial intelligence, data sovereignty, and private AI deployments. Attendees will gain practical insights into how organizations and creators are leveraging local AI to improve operations, accelerate innovation, maintain control of their data, and unlock new opportunities without sacrificing ownership, privacy, or flexibility. Discussions will explore both the technical and strategic implications of building AI systems closer to the data they depend on, reflecting a growing shift toward self-hosted and enterprise-controlled infrastructure. In addition to technical sessions and presentations, attendees can expect product workshops, facility tours, networking events, community-led discussions, creator meetups, live demonstrations, and a variety of uniquely 45Drives experiences that have become a hallmark of the Summit. "Most conferences are designed around presentations. Creator Summit is designed around participation," said Dr. Doug Milburn, President and Co-Founder of 45Drives. "The people in this room aren't spectators. They're builders. They're the people running production environments, creating educational content, developing software, and solving difficult technical problems every day. When you bring those people together for several days, remarkable things happen. Products improve. Partnerships form. New ideas emerge. That's why we keep doing this. Every year we leave Creator Summit with a better understanding of where the industry is going and how we can build better solutions for the people who rely on them." The event reflects 45Drives' longstanding belief that the best solutions are built in close collaboration with the people who use them. As the company continues to expand its presence across enterprise storage, self-hosted infrastructure, homelab computing, and creative workflows, Creator Summit remains a cornerstone of that philosophy. Additional speakers, programming details, and special guests will be announced in the coming weeks. Registration is now open at 45Drives.com/creator-summit. About 45Drives 45Drives provides open-source storage, server, and data infrastructure solutions to organizations around the world. The company helps enterprises, educational institutions, government agencies, research organizations, and creative professionals build scalable infrastructure while maintaining ownership and control of their data. Contact: Jonathan Phillips 45Drives@Phillcomm.Global View the original release on www.newmediawire.com
Portable Fuel-Free Batt Pack Pro Units Deployed for Specialized Mobile Systems in European Defense Program TORONTO, ONTARIO - June 18, 2026 (NEWMEDIAWIRE) - Hybrid Power Solutions Inc. (CSE: HPSS) (OTC: HPSIF) (FSE: E092) (“Hybrid” or the “Company”), an emerging leader in the delivery of fuel-free clean power solutions, is pleased to announce it has received a purchase order valued at C$560,000 for dozens of Batt Pack Pro units. The units will be deployed in specialized mobile electronics systems for a European defense customer. This order represents a significant milestone for Hybrid, marking its first meaningful defense-related win within its current pipeline of $12.5 million in active, quoted opportunities across four primary verticals. The Batt Pack Pro series delivers reliable, high-performance power without fossil fuels, making it ideal for demanding defense applications such as powering systems in field service, surveillance, emergency response, and remote operations. “We are excited to see a world-class organization adopt our Batt Pack Pro technology for their mobile systems,” said Francois Byrne, CEO and Founder of Hybrid Power Solutions Inc. “This purchase order validates the strong demand for our portable, fuel-free power solutions in specialized and highly exacting defense applications, establishing our credentials in this vertical. This win also marks a key step in our geographic growth strategy as we expand into large-scale fleet and equipment markets across Europe.” The selection of the Batt Pack Pro underscores the product's robust design, portability, silent operation, and zero emission performance. These are critical requirements for powering sensitive electronics equipment while supporting sustainability and operational efficiency goals. About Hybrid Power Solutions Hybrid Power Solutions Inc. is a Canadian clean energy innovator listed on the Canadian Securities Exchange under the symbol "HPSS." The Company specializes in developing portable power systems that eliminate the need for fossil fuels in off-grid and remote applications. With a focus on environmental responsibility and technological innovation, Hybrid Power Solutions is committed to leading the clean energy transition. On Behalf of the Company, Francois Byrne, CEO and Director For further information, inquiries, or media opportunities, please contact: Hybrid Power Solutions E: invest@hybridps.ca T: 866-549-2743 www.investhps.com Investor Relations Dean Stuart E: dean@boardmarker.net T: 403-617-7609 Sophic Capital Sean Peasgood E: Sean@SophicCapital.com T: 437-836-8862 Forward-Looking Statements Certain information contained herein constitutes "forward-looking information" under Canadian securities legislation. Generally, forward-looking information can be identified by terminology such as "will," "expects," "anticipates," or variations of such words and phrases, or by statements that certain actions, events, or results "will" occur. Forward-looking statements are based on management’s estimates as of the date such statements are made and are subject to risks, uncertainties, and other factors that may cause actual results to differ materially from those expressed or implied by such statements. The Canadian Securities Exchange does not accept responsibility for the adequacy or accuracy of this release. View the original release on www.newmediawire.com
More Than Three-Quarters of Those Surveyed Expect to Invest Within Six Months, While Digital Asset Securities Rank Ahead of Several Traditional Alternative Asset Classes Despite Limited Investor Familiarity NEW YORK, NY - June 18, 2026 (NEWMEDIAWIRE) - VerifyInvestor.com, powered by tZERO Group, Inc., today released The Accredited Investor Outlook 2026, a new research report that examines how accredited investors are deploying capital, evaluating opportunities, and thinking about the future of private markets. The report draws on survey responses from more than 200 verified accredited investors across the United States collected in April 2026. The key findings underscore the active and self-directed nature of today's accredited investor, while highlighting a meaningful and growing openness to digital asset securities, an asset class in which tZERO has built regulated, end-to-end blockchain-based financial infrastructure over more than a decade. Capital Is Ready to Be Deployed The survey reveals a market in motion. More than three-quarters of respondents (77%) plan to make an investment within the next six months, with nearly half anticipating investment activity within three months. Real estate (66%) and private equity/venture capital (61%) led investment category interest, respectively, while digital asset securities attracted interest from 27% of respondents, exceeding several traditional alternative categories including infrastructure, hedge funds, and energy-focused investments. Fundamentals and Trust Drive Allocations While expected returns ranked as the top evaluation criterion (70%), the survey reveals a more nuanced decision-making framework. Management quality (50.5%), downside protection and risk mitigation (49%), and sponsor track record (48.5%) all ranked nearly as highly as projected returns, suggesting investors are conducting increasingly sophisticated due diligence, prioritizing credibility and execution capability alongside financial performance. Liquidity potential ranked among the lowest evaluation criteria at 18%, indicating that many investors remain willing to commit capital to longer-duration opportunities when the underlying fundamentals are compelling. Tokenized Securities at an Inflection Point While only 11% of respondents described themselves as very familiar with tokenized securities, 27% expressed interest in digital asset securities as an investment category, a gap that points to education as the primary barrier to broader adoption rather than a lack of demand. The report identifies investor awareness as progressing through three stages: curiosity, education, and adoption, with many investors currently transitioning from the first to the second. "tZERO has pioneered the regulated end-to-end infrastructure, issuance, trading, custody, and settlement, that makes digital asset securities accessible to investors in a compliant, institutional-grade way," said Alan Konevsky, Chairman and Chief Executive Officer of tZERO. "Reports like this one reflect what we're seeing on the ground: accredited investors are actively looking to deploy readily available capital, and interest in digital asset securities is growing. Our platform exists to connect that demand with the infrastructure to act on it." To support that transition, VerifyInvestor.com is hosting a live webinar on June 23, 2026, at 1:00 p.m. EST, titled The New SEC Direction on Digital Assets: What Accredited Investors Need to Know. The event will feature expert panelists discussing recent SEC guidance on tokenized securities and its implications for private markets. Registration is available at https://lnkd.in/g8DeCXzg. "VerifyInvestor.com is one of the most established accredited investor verification platforms. Our latest report highlights that as private markets continue to evolve, having a verified, trusted investor base is foundational, for issuers, for platforms, and for the integrity of the market," said Jenny Shields, VP of Operations at VerifyInvestor.com. "VerifyInvestor.com exists to make that compliance seamless, so that when investors are ready to act, there are no barriers to participation." The Accredited Investor Outlook 2026 is available for download here. Media Contacts: tZERO Group, Inc. Julie Ros, Head of Marketing & Communications jros@tzero.com VerifyInvestor.com Jenny Shields, VP of Operations jennyl@verifyinvestor.com KCSA Strategic Communications tzero@kcsa.com About VerifyInvestor.com VerifyInvestor.com provides a fast, easy, and cost-effective method of compliance for companies seeking to verify their investors as accredited investors under Reg D, Rule 506(c). Through years of servicing issuers, funds, platforms, and investors across the private markets ecosystem, VerifyInvestor.com has likely built one of the largest databases of verified accredited investors in the United States. Constantly referred by top law firms, their clients have successfully navigated audits and investigations. They also offer AML/KYC services, custom verifications, qualified purchaser and qualified client verifications, as well as true and correct certification of key documents, such as government IDs, passports, and proof of address. About tZERO Group, Inc. tZERO Group, Inc. (tZERO) and its broker-dealer subsidiaries provide an innovative liquidity platform for private companies and assets. We offer institutional-grade solutions for issuers looking to digitize their capital table through blockchain technology, and make such equity available for trading on an alternative trading system. tZERO, through its broker-dealer subsidiaries, democratizes access to private assets by providing a simple, automated, and efficient trading venue to broker-dealers, institutions, and investors. All technology services are offered through tZERO Technologies, LLC. For more information, please visit our website. About tZERO Digital Asset Securities, LLC tZERO Digital Asset Securities, LLC is a broker-dealer registered with the SEC and a member of FINRA and SIPC. It is the broker-dealer custodian of all digital asset securities offered on tZERO’s online brokerage platform. Digital asset securities may not be “securities” as defined under the Securities Investor Protection Act (SIPA)-and in particular, digital asset securities that are “investment contracts” under the Howey test but are not registered with the Securities and Exchange Commission are excluded from SIPA’s definition of “securities”-and thus the protections afforded to securities customers under SIPA may not apply. More information about tZERO Digital Asset Securities may be found on FINRA’s BrokerCheck. About tZERO Securities, LLC tZERO Securities, LLC is a broker-dealer registered with the SEC and a member of FINRA and SIPC. It is the operator of the tZERO Securities ATS. More information about tZERO Securities may be found on FINRA’s BrokerCheck. About tZERO Transfer Services, LLC tZERO Transfer Services, LLC is a transfer agent registered with the SEC. More information about tZERO Transfer Services may be found on the SEC's Edgar: https://www.sec.gov/search-filings. About tZERO Capital Partners, LLC tZERO Capital Partners, LLC is an Exempt Reporting Advisor. More information about tZERO Capital Partners may be found on FINRA’s BrokerCheck. Investor Notice Digital asset securities, as well as any particular investment, may not be suitable or appropriate for everyone. Investors should note that investing or trading in securities could involve substantial risks, including no guarantee of returns, costs associated with selling and purchasing, and no assurance of liquidity which could impact their price and investors’ ability to sell, and possible loss of principal invested. There is always the potential of losing money when you invest in securities. There are also unique risks specific to digital asset securities, including, without limitation, fraud, manipulation, theft, and loss. No Offer, Solicitation, Investment Advice or Recommendations This release is for informational purposes only and does not constitute an offer to sell, a solicitation to buy, or a recommendation for any security, nor does it constitute an offer to provide investment advisory or other services by tZERO or any of tits affiliates, subsidiaries, officers, directors or employees. No reference to any specific security constitutes a recommendation to buy, sell, or hold that security or any other security. Nothing in this release shall be considered a solicitation or offer to buy or sell any security, future, option or other financial instrument or to offer or provide any investment advice or service to any person in any jurisdiction. Nothing contained in this release constitutes investment advice or offers any opinion with respect to the suitability of any security, and the views expressed in this release should not be taken as advice to buy, sell or hold any security. In preparing the information contained in this release, we have not taken into account the investment needs, objectives, and financial circumstances of any particular investor. This information has no regard to the specific investment objectives, financial situation, and particular needs of any specific recipient of this information and investments discussed may not be suitable for all investors. Any views expressed in this release by us were prepared based upon the information available to us at the time such views were written. Changed or additional information could cause such views to change. All information is subject to possible corrections. Information may quickly become unreliable for various reasons, including changes in market conditions or economic circumstances. Forward-Looking Statements by tZERO This release contains forward-looking statements. In addition, from time to time, tZERO, its subsidiaries, or its representatives may make forward-looking statements orally or in writing. These forward-looking statements are based on expectations and projections about future events, which is derived from currently available information. Such forward-looking statements relate to future events or future performance, including financial performance and projections; growth in revenue and earnings; and business prospects and opportunities. You can identify forward-looking statements by those that are not historical in nature, particularly those that use terminology such as “may,” “should,” “expects,” “anticipates,” “contemplates,” “estimates,” “believes,” “plans,” “projected,” “predicts,” “potential,” or “hopes” or the negative of these or similar terms. In evaluating these forward-looking statements, you should consider various factors, including, without limitation: the ability of tZERO and its subsidiaries to change the direction; tZERO’s ability to keep pace with new technology and changing market needs; performance of individual transactions; regulatory developments and matters; and competition. These and other factors may cause actual results to differ materially from any forward-looking statement. Forward-looking statements are only predictions. The forward-looking events discussed in this release and other statements made from time to time by tZERO, its subsidiaries or their respective representatives, may not occur, and actual events and results may differ materially and are subject to risks, uncertainties and assumptions. tZERO, its subsidiaries, and its representatives are not obligated to publicly update or revise any forward-looking statement, whether as a result of uncertainties and assumptions, the forward-looking events discussed in this release and other statements made from time to time by tZERO, its subsidiaries or its representatives might not occur. This press release is for informational purposes only and does not constitute an offer to sell, a solicitation of an offer to buy, or a recommendation to purchase any security. The securities described herein are subject to qualification by the U.S. Securities and Exchange Commission under Regulation A+ (Tier 2) and have not yet been so qualified. No money or other consideration is being solicited, and if sent in response, will not be accepted. No offer to buy the securities can be accepted and no part of the purchase price can be received until the offering statement is qualified, and any such offer may be withdrawn or revoked, without obligation or commitment of any kind, at any time before notice of its acceptance given after the date of qualification. A person's indication of interest involves no obligation or commitment of any kind. View the original release on www.newmediawire.com
New Offering Enables Rapid, Consistent Execution Across Hundreds of Store Locations in Days, not Months MIAMI, FL - June 18, 2026 (NEWMEDIAWIRE) - The Revenue Optimization Companies (T-ROC Global), the leading managed retail service provider of people and technology solutions for the global retail market, today announced the expansion of its Assembly Services, a scalable, nationwide solution designed to support large-scale retail rollouts with speed, precision, and consistency. As retailers face increasing pressure to execute complex in-store initiatives across multiple markets, T-ROC Global’s Assembly Services deliver a streamlined solution for fixture assembly, display setup, and merchandising implementation. The solution for launching a new product line, executing a seasonal reset, or opening multiple locations at once. Built to operate at scale, T-ROC Global’s trained teams can complete assembly and setup across hundreds of stores within days or weeks, dramatically reducing time-to-market while maintaining strict quality standards. The service is powered by a centralized project management model, standardized processes, and real-time reporting, ensuring consistent execution across every location. “Retail today moves fast, and our clients need partners who can keep up without sacrificing quality,” said Brett Beveridge, CEO and Founder of T-ROC Global. “Our Assembly Services are designed to deliver speed and consistency at scale, whether it’s 50 stores or 500. We’re helping brands and retailers launch faster, operate more efficiently, and create a seamless experience for their customers from day one.” Assembly Services support a wide range of retail environments, including big-box stores, specialty retail, and emerging formats. By combining experienced field teams with advanced logistics coordination, the company ensures that each project is executed on time, on brand, and on budget. Key benefits of T-ROC Global’s Assembly Services include: Rapid Deployment: Nationwide coverage enables completion of large-scale projects in compressed timelines Consistent Execution: Standardized training and processes ensure uniformity across all locations End-to-End Support: From delivery coordination to final setup, T-ROC Global manages every phase Scalable Solutions: Flexible resources to support projects of any size or complexity With this expanded offering, T-ROC Global continues to strengthen its position as a trusted partner for retailers seeking agile, high-impact solutions in an increasingly competitive landscape. For more information about T-ROC Global’s Assembly Services, visit: https://trocglobal.com/assembly-services/ To learn more about T-ROC Global, visit www.trocglobal.com and follow on Facebook, X, Instagram, and LinkedIn. About The Revenue Optimization Companies (T-ROC Global) T-ROC Global is a retail branding and consulting partner that supports companies in navigating through today's retail shopping experience, redefining the power of people and technology. T-ROC Global offers a unique combination of people-based services, applications, technology management, mystery shopping programs, actionable market research and competitive insights that support the complex needs of assisted selling. T-ROC Global's expertise and next-generation technology is delivered by a team that’s all in to drive sales, optimize performance and deliver measurable ROI for businesses every single day. Contact: Tyler Sminkey tyler@jwipr.com View the original release on www.newmediawire.com
Company Profitability Now Extending to 7 Straight Quarters Fiscal 2026 Second Quarter Sales Significantly Exceed Same Period in 2025. Profitability Now Extending for Seven (7) Trailing Quarters. Independent Lab Testing Program Proceeding On-Track for High Level Product Certifications to Qualify Insultex House Wrap® for Much Wider Applications. Production Increases Underway to Meet Rising Demand. PITTSBURGH, PA - June 18, 2026 (NEWMEDIAWIRE) - Innovative Designs, Inc. (OTCQB: IVDN) has now filed its fiscal second quarter financial report with continued revenue growth that now extends the Company’s profitability across seven (7) trailing quarters. Total revenues for the period ending on April 30, 2026 reached $808,666, significantly exceeding the 2025 second quarter total. This result is the second highest in Company history and only the 2nd time breaking the $800K level in a single quarter. Sales accelerated towards the end of the second quarter due to better weather for national building projects. As of today, IVDN has reached almost the $2 million revenue level for the 2026 fiscal year which puts the Company on pace to set an all time new record for annual sales and revenue growth with increasing profitability. IVDN is also maintaining a strong cash position with no long term or convertible debt on the books. The IVDN outstanding share count is still only about 38 million, reflecting management's commitment to supporting and enhancing long term shareholder value. Additionally, progress is proceeding on track for the new Insultex® independent laboratory testing program with BRC Laboratories, a qualified independent laboratory testing company, to complete the process of obtaining renewed high level product certifications for Insultex House Wrap®. The purpose of the updated testing and certification program is to allow our advanced Insultex® product to qualify for the needs of a much wider customer base and projects of significantly larger scope. Increasing numbers and also multiple larger building industry companies have indicated to us that attainment of the new certifications will be very important for their plans for using Insultex House Wrap® in their own major projects and marketing programs. Currently, Insultex House Wrap® is already fulfilling a key role in the homebuilding market because it meets or exceeds new government building codes specifying continuous insulation and exterior R-Value requirements. For new construction, our patented and unique evacuated cell Insultex House Wrap®, adds an R-6 moisture barrier membrane that does not need additional insulation boards or other support as with other products from competitors. This makes Insultex House Wrap®, the best overall insulation house wrap choice available on the market today. For full product specifications and details visit: http://www.insultexhousewrap.com. Joseph A. Riccelli Jr., CEO of Innovative Designs, commented, "Our entire team at IVDN deserves congratulations for putting the Company on the increasingly positive path of success that is now extended to seven straight quarters of profitability with the filing of our fiscal second quarter financial report. Our top performing sales agent, Built Link Solutions, is doing an outstanding job of introducing Insultex House Wrap® at key building industry trade shows and other events as well as ongoing direct meetings with a wide range of building professionals including some of the most important names in the industry. The result is that we have become busier than ever in selling and shipping our products. We are also continuing to work on expanding production of Insultex House Wrap® for the anticipated demand surge after the current new certification program is completed.” Randy Kimbler, Director of Business Development for Built Link Solutions and distributor for Insultex House Wrap®, commented on the 2nd quarter, “Now that the building season has ramped up following a late start due to very harsh winter weather, we are seeing multiple new building material suppliers coming on board this year and even more showing high interest in using Insultex House Wrap® as they learn about its distinct advantages. This, along with a significant increase in repeat orders from our existing clients, has given us a great start to the 2026 building season which is in full swing now.” About Innovative Designs, Inc. Innovative Designs, Inc. manufactures the Insultex House Wrap® and Arctic Armor® Line, under the "i.d.i.gear" label featuring INSULTEX®. Patented INSULTEX® is the thinnest, lightest and warmest insulator in the market today. For more information, please visit: http://www.insultexhousewrap.com and http://www.idigear.com Disclaimer Certain statements in this press release constitute "forward-looking" statements as defined by federal law. Such statements are based on assumptions, but there is no assurance that actual outcomes will not be materially different as those implied. Any such statements are made in reliance on the "Safe Harbor" protections provided under the Private Securities Reform Act of 1995 and are subject to various factors, including the risks and matters discussed in the Company's SEC filings available at http://www.sec.gov. CONTACT: Innovative Designs, Inc. Joseph A. Riccelli Jr., CEO 412-799-0350 Riccellijjr@insultexhousewrap.com http://www.insultexhousewrap.com Built Link Solutions, LLC Randy Kimbler, Director of Business Development 616-443-3200 RandyK@BuiltLinkSolutions.com View the original release on www.newmediawire.com
Subscription Revenue mix Grows 27% as Company Continues the Accelerated Shift to Recurring Revenue Model; Solid Cash Position Funds AI Initiative Advancing on Schedule With Agent Harness Development for Industrial Deployments MISSISSAUGA, ON - June 18, 2026 (NEWMEDIAWIRE) - Skkynet Cloud Systems, Inc. (“Skkynet” or “the Company”) (OTCQB: SKKY), a global leader in industrial software for secure, real-time data connectivity and edge processing, today announced financial results for the second quarter and six-month period ended April 30, 2026. Q2 FY2026 Financial Highlights Q2 Revenue Growth: Revenue for the second quarter was $606,106, an increase of approximately 4% over $585,712 in Q2 FY2025. Subscription Revenue Mix: Subscription revenue as a percentage of sales grew to 15% for the six-month period, up from 11.8% in the same period of FY2025 - an increase of approximately 27% in subscription mix. Deferred Revenue Surge: Deferred revenue increased 37% to $476,797 from $347,686 at fiscal year-end, reflecting the build-up of subscription contracts that will drive future recognized revenue. Solid Cash Position: Cash and cash equivalents of $1,339,191 and working capital of $1,003,773 - providing a strong financial foundation to execute the Company’s strategic plans. Q2 Loss Improvement: Net loss for Q2 improved by approximately 52% to $(109,392) compared to $(227,723) in Q2 FY2025. Six-Month Revenue: Revenue for the six-month period was $1,155,499 compared to $1,414,764 in the same period of FY2025, a decrease of approximately 18% attributable to the shift from perpetual to subscription license models. “The decline in our six-month reported revenue is the expected result of a deliberate and strategic shift,” said Gary Tillery, CEO of Skkynet. “When customers choose subscription licenses over perpetual licenses, the same total contract value is recognized over two or three years rather than immediately. This temporarily reduces reported revenue, but it builds a higher-quality, predictable, recurring revenue base. The 27% growth in our subscription mix and the 37% increase in deferred revenue confirm that this strategy is gaining traction. At the same time, we are investing from a position of financial strength - with over $1.3 million in cash and working capital above $1 million, we have the runway to execute our plans without compromise.” AI Initiative Advancing with Agent Harness for Industrial Deployments Skkynet’s C$2.6 million Industrial AI product development initiative, supported by FedDev Ontario, is progressing on schedule. The project is advancing in step with improvements in AI model capabilities, as the Company develops an agent harness specifically designed for the strict requirements of industrial customers. Industrial environments demand security, reliability, real-time performance, and deterministic behavior that consumer AI solutions do not address. Skkynet’s secure-by-design architecture and over 25 years of industrial data connectivity experience uniquely position the Company to build the data backbone for the AI-driven industrial future. The agent harness being developed will enable industrial AI agents to operate within the rigorous constraints that Skkynet’s customers require - security, auditability, and real-time determinism. Investing Now for a Platform of Future Growth The operating loss for the period reflects deliberate investment in leadership, product development, and market expansion. During the period, the Company expanded its executive team and advisory board, increased go-to-market activities including presence at AVEVA World, CSIA Conference, Hannover Messe, EXPONOR, SPS Italia and ProveIT, and granted stock options to 19 individuals to align the team with long-term value creation. Working capital declined only $23,942 over the six-month period despite this investment spending, demonstrating the Company’s ability to fund its strategy while the subscription revenue base builds. “Solid cash and working capital give us the foundation to invest confidently in the platform that will drive our future growth,” concluded Tillery. “We are building the secure data backbone to provide clean, secure, real-time OT data to wherever it needs to go, securely so that every other application you've invested in, like AI, can actually work - and we are doing it from a position of industry thought leadership, financial discipline and strength.” About Skkynet Skkynet has been helping organizations securely share real-time data for more than 25 years. We offer secure, real-time data connectivity and edge processing for industrial systems of all types. Skkynet’s technologies bridge plant systems, cloud platforms, and AI, enabling safe, intelligent, and resilient operations across all industrial verticals. Skkynet’s solutions empower organizations to optimize operations, enhance efficiency, and drive innovation by connecting, monitoring, and controlling their systems in real time while maintaining robust security and data privacy standards. For more information, visit skkynet.com. Forward-Looking Statements This press release contains statements that may constitute forward-looking statements, which can be identified by terminology such as “may,” “will,” “expect,” “believe,” “anticipate,” “estimate,” “approximate,” or “continue,” or the negative thereof. These statements speak only as of the date made and are based on management’s current expectations and assumptions. Actual results could differ materially due to risks including the Company’s ability to obtain necessary capital, meet anticipated development timelines, protect its proprietary technology and knowhow, establish a global market, successfully consummate future acquisitions, and other risk factors identified in the Company’s reports filed with the Securities and Exchange Commission. The Company disclaims any obligation to revise any forward-looking statement to reflect events or circumstances after the date thereof. Contact Skkynet Cloud Systems, Inc. Paul E. Thomas, President Tel: (888) 702-7851 Web: https://skkynet.com Email: ir@skkynet.com
RANCHO CORDOVA, CA - June 18, 2026 (NEWMEDIAWIRE) - iMD Companies, Inc. (OTC: ICBU) today announced it is in advanced due diligence to acquire a company in the mining sector and is simultaneously in active negotiations to purchase a target in the medical health space. These opportunities align with iMD’s strategy of acquiring revenue-generating businesses in established and high-potential industries. The mining target represents continued expansion in natural resources, while the medical health acquisition would further strengthen the Company’s presence in the healthcare sector. “We are pleased with the progress on both fronts,” said Richard Wilson, CEO of iMD Companies, Inc. “These potential acquisitions reflect our disciplined approach to identifying assets that can deliver long-term value and sustainable growth for our shareholders.” The Company expects to complete due diligence and negotiations in the coming weeks and will provide further updates as material developments occur. iMD remains committed to transparency and timely communication with its shareholders. For more on iMD: Visit imdcompaniesinc.com or OTC Markets. Follow @imd_inc on X for real-time updates. About iMD Companies, Inc. iMD Companies, Inc. (OTC: ICBU) is a Florida corporation focused on strategic acquisitions and growth across the mining, medical/health, and technology sectors. The Company seeks to build shareholder value through targeted acquisitions in industries with strong fundamentals and long-term demand. Forward-Looking Statements: Certain statements made in this press release constitute forward-looking statements that are based on management's expectations, estimates, projections and assumptions. Words such as "expects," "anticipates," "plans," "believes," "scheduled," "estimates" and variations of these words and similar expressions are intended to identify forward-looking statements. Forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995, as amended. These statements are not guarantees of future performance and involve certain risks and uncertainties, which are difficult to predict. Therefore, actual future results and trends may differ materially from what is forecast in forward-looking statements due to a variety of factors. All forward-looking statements speak only as of the date of this press release and the company does not undertake any obligation to update or publicly release any revisions to forward-looking statements to reflect events, circumstances or changes in expectations after the date of this press release. Media Contact: info@imdcompaniesinc.com View the original release on www.newmediawire.com
By Meg Flippin, Benzinga DETROIT, MICHIGAN - June 18, 2026 (NEWMEDIAWIRE) - Move over, Peru and Chile – when it comes to mining for gold and copper, Ecuador is proving to be the next bastion of growth. For good reasons. Only about 10% of the South American country’s territory has been explored despite being home to some of the world’s largest undeveloped gold and copper assets. Plus, the country is rapidly moving from a mining concept to a proven jurisdiction. After all, Ecuador is home to some major mining projects, including Lundin Gold's Fruta del Norte gold mine, which is one of the most lucrative gold mines in the world, and the Mirador copper mine, which is a large-scale open-pit operation and a cornerstone of the country’s copper export strategy. A Lot To Like About Ecuador It doesn’t hurt that its location makes logistics significantly easier than its bigger rivals in Peru and Chile. After all, Ecuador’s deposits sit at much lower elevations closer to the Pacific coast, which means heavy equipment and personnel don’t have to be transported to remote areas. Plus, it provides easier access to the water supply. The country also built out its hydropower infrastructure in order to give miners access to renewable energy at low rates, reducing their operational costs and carbon footprint. Then there’s the U.S dollar, which has been Ecuador’s official currency since 2000. International miners don’t have to worry about foreign exchange exposure or about the local currency fluctuating when dealing in the U.S. dollar. With mining exports growing, the government has been incentivizing companies to mine in Ecuador by offering streamlined environmental permitting and investment protection agreements. M&A Heating Up The efforts on the part of the Ecuadorian government seem to be paying off. Beyond the incumbents, there is a new wave of projects underway that promises to continue to transform the country into a premier mining destination. Silvercorp's El Domo copper-gold mine, which is under construction and targeting initial production next year, is one. The Condor gold project, which is under permitting and development as a low-cost underground operation, is another. Then there’s Solaris' Warintza porphyry, which is an undeveloped copper-gold-molybdenum mining project progressing toward final development after securing its key Environmental Impact Assessment (EIA) technical approval. Further validation of Ecuador's standing in the mining world is the M&A that has been taking place. Take Jiangxi Copper's $1.2 billion acquisition of SolGold for one example. In the deal, which took place in March 2026, the Chinese copper giant acquired SolGold, driven by a desire to secure long-term access to the tier-one copper-gold porphyry deposit and rapidly scale up China's industrial mineral reserves. Then there’s CMOC Group’s $420 million deal to acquire Lumina Gold in June 2025. CMOC said the deal was designed to mark its strategic entry into the global gold market by securing 100% control of the project, which happens to be the largest primary gold asset in Ecuador. Both transactions underscore growing major-company conviction in Ecuadorian porphyry assets. Auro Metals Steps Up To The Plate Building on that is Auro Metals Inc. (OTC: AURFF), a Canadian mineral exploration company. The company’s recent acquisition of the Santa Barbara project from Silvercorp transformed it from an early-stage explorer into a serious player in Ecuador. Located in the Zamora Copper-Gold Belt of southeastern Ecuador, the Santa Barbara Gold-Copper Project is a large-scale porphyry system that the company says holds a high-confidence indicated resource of 29.8 million tonnes containing 697,000 ounces of gold and 68 million pounds of copper. It also holds a much larger inferred resource of 205.7 million tonnes, adding 3.4 million ounces of gold and 426 million pounds of copper to the asset's total scale, reports Auro Metals. “The closing of this acquisition marks the beginning of a new chapter for Auro. Santa Barbara is a large-scale, gold-copper porphyry system with an existing resource and significant exploration upside in one of the world's most prolific gold-copper metallogeny belts,” said Victor Feng, CEO of Auro. “With our financing in place and technical team mobilized, we are fully focused on unlocking the potential of this asset for our shareholders.” Auro is paying a total of $13.5 million for the project, in a series of staged cash payments. Drilling Already Underway As part of the phase 1 program, drilling at Santa Barbara already commenced in April and is being executed by four drill rigs on site, reports Auro. Five holes have been completed to date, with the core currently being cut and prepared for shipment to the laboratory. Assay results will be reported as they become available. The phase 1 program is designed to confirm historical drill results, complete infill drilling to upgrade the existing mineral resources and obtain fresh drill core to further the company's understanding of the mineralization controls and metallurgy. A subsequent phase 2 program, which will kick off once phase 1 is complete, will focus on step-out drilling and resource extension, including testing targets at depth. All of it is aimed at eventually moving to full-scale development. As major companies continue to lock down Ecuador’s premier porphyry assets, the race is on to secure the region’s remaining territory. With its phase 1 drilling underway at Santa Barbara, Auro is positioning itself at the forefront of this next mining explosion. For investors watching South America's evolving mining landscape, eyes are now on Auro’s upcoming assay results to see just how large this investment’s potential is. To learn more about Auro Metals, click here. Featured image from Shutterstock. This content was originally published on Benzinga. Read further disclosures here. This post contains sponsored content and was created in collaboration with a third-party partner. Benzinga is a publisher and does not provide personalized investment advice or act as a broker or dealer. This content is for informational purposes only and is not intended to be investing advice or an offer or solicitation to buy or sell any security.
ANDERSON, SC - June 18, 2026 (NEWMEDIAWIRE) - Ideal Group of Companies, Inc. (OTC: IDGR) today confirmed the completion of its strategic acquisition of the El Quizer Mining Administrative Contract - a fully permitted, 675-hectare gold concession located within Bolivia's Precambrian Shield in the Nuflo de Chavez Province, Santa Cruz Department. The transaction establishes IDGR as an emerging participant in the global precious metals sector at a time when gold and platinum group metals (PGMs) have become structurally indispensable to the world's fastest-growing technology industries. About the Acquisition The El Quizer Mining Administrative Contract (Contract No. AJAM/DDSC/CAM/00023/2017, Unique Code 1000974) was issued by the Autoridad Jurisdiccional Administrativa Minera (AJAM), Bolivia's official governmental mining authority. The contract grants the holder full mining rights over a 30-year term - renewable for an additional 30 years - across 27 grids covering 675 hectares (approximately 1,668 acres) in the Municipality of San Ramon. The concession is readily accessible: 185 kilometers of paved highway from Santa Cruz de la Sierra, Bolivia's largest commercial hub, followed by approximately 11 kilometers of gravel road - roughly 3.5 hours total travel time. All required permits, environmental licenses, and mining registrations are current and in force. A World-Class Geological Setting El Quizer sits within one of the most underexplored gold-bearing geological terranes on earth. Bolivia's Precambrian Shield - geologically larger than Canada's Abitibi Greenstone Belt, which has yielded more than 170 million ounces of gold from over 100 mines since 1901 - has produced fewer than 10 million ounces to date. That disparity reflects decades of limited capital investment, not a shortage of mineral endowment. Gold mineralization within El Quizer is of the orogenic greenstone type, comparable to prolific deposits in Canada, West Africa, and Western Australia. The property sits directly adjacent to the historically producing Puquio Norte Mine, which yielded more than 300,000 ounces of gold from surface saprolite alone between 1996 and 2001. Recent field sampling of newly identified veins within the El Quizer boundary has returned assay values of 4.98 and 8.61 grams of gold per tonne - grades consistent with economically significant hard-rock deposits. Mineral Resources and Stockpile Inventory (2022 Estimates) Independent analysis and field assessment have identified the following mineral resource categories within the El Quizer concession: - Primary Oxide Stockpiles: Approximately 8 million metric tonnes at an average grade of 1.0 g/t gold, representing an estimated 210,000 ounces of contained gold. Left in place by former Compania Minera del Sur (COMSUR) operations, these stockpiles are fully accessible and represent a near-term, low-capital production opportunity with an estimated 12-year mine life at a processing rate of 2,000 tonnes per day. - Sulfide Stockpiles: Approximately 2 million metric tonnes at an average grade of 0.7 g/t gold in sulfide matrix, with additional potential for platinum group metals and base metals. - Virgin Primary Formations: An estimated 10 million metric tonnes in unworked primary geological formations at an average grade of 2.5 g/t gold, pending systematic drilling and reserve definition. - New Vein Discovery: Recently mapped gold-bearing veins measuring approximately 4 meters in width across a 2-kilometer strike length, assaying between 4.98 and 8.61 g/t gold. Preliminary XRF and cupellation analyses also indicate the presence of platinum group metals - including palladium (Pd), iridium (Ir), and rhodium (Rh) - within the concession boundary. These preliminary values remain subject to formal laboratory confirmation but are consistent with PGM occurrences documented in the region by the British Geological Survey, and materially enhance the Company's view of long-term resource potential. Why Precious Metals Are More Critical Than Ever The global economy is undergoing a structural transformation driven by artificial intelligence, high-performance computing, electric mobility, and next-generation communications infrastructure - all of which are significant consumers of precious and specialty metals. - AI Data Centers & Semiconductors: Gold's unmatched electrical conductivity and corrosion resistance make it irreplaceable in advanced semiconductor packaging, CPU bonding wires, and high-frequency connectors. As hyperscale AI data centers proliferate globally - with projected capital expenditure exceeding $1 trillion over the next five years - demand for high-purity gold in microelectronics continues to accelerate. - Central Bank Demand: Global gold demand reached 4,740 tonnes in 2022 - the highest level since 2011 - driven by record central bank purchases as sovereign institutions worldwide diversify reserves amid persistent inflation and currency volatility (World Gold Council). - PGMs in Clean Technology: Palladium, rhodium, and iridium are essential catalysts in hydrogen fuel cells, automotive catalytic converters, and electrochemical systems. Iridium is a critical input for proton exchange membrane (PEM) electrolyzers used to produce green hydrogen. Rhodium and palladium underpin virtually all global emissions-control systems. - Defense & Aerospace: High-purity gold and PGMs are used extensively in satellite systems, avionics, radar equipment, and electronic warfare systems - markets expanding alongside rising defense budgets worldwide. The convergence of AI infrastructure build-out, energy transition demand, and monetary safe-haven buying has created a structural supply deficit for precious and specialty metals expected to persist for decades. El Quizer's polymetallic potential - with gold as its anchor and PGMs as a potential co-product - positions Ideal Group at an advantageous point in this emerging supply chain. Commitment to Responsible Green Mining Ideal Group is committed to operating El Quizer under the highest international environmental and social standards. MetalPro SRL, the Bolivian operating entity within the El Quizer contract structure, has developed a comprehensive green mining framework that includes: - Elimination of mercury and cyanide from all processing circuits - Closed-loop water recycling and reuse systems - Use of renewable energy sources to minimize carbon emissions - Prohibition of indiscriminate deforestation - Active community engagement with residents of the Nuflo de Chavez Province to ensure positive socioeconomic outcomes The Company believes that responsible mining and superior financial returns are complementary, not competing, objectives. Management Commentary “The El Quizer acquisition puts us in the right place at the right time,” said Charles Cardona, Chief Executive Officer. “We hold a permitted, legally contracted, geologically compelling gold asset in a jurisdiction actively seeking responsible foreign investment - at the precise moment when the metals this property contains have become indispensable to AI infrastructure, clean energy, and advanced manufacturing. We intend to be a meaningful part of that supply chain, and to do so in a way that creates lasting value for Bolivia, our shareholders, and the communities where we operate.” About El Quizer El Quizer is a 675-hectare mining administrative contract in the Municipality of San Ramon, Nuflo de Chavez Province, Santa Cruz Department, Bolivia. The contract (Unique Code 1000974) is held under Bolivian Mining Law No. 535 and was formally approved by the Plurinational Legislative Assembly under Law No. 1022 on December 27, 2017. All mining patent payments are current; the property carries an active environmental license (EMAP), a Mining Identification Number (NIM), and registration with Bolivia's national mineral commercialization authority (SENARECOM). Geological studies of the broader San Ramón district have been conducted by the British Geological Survey, SERGEOTECMIN, and independent researchers since 1976. About Ideal Group of Companies, Inc. Ideal Group of Companies, Inc. (OTC: IDGR) is a dynamic and growing enterprise focused on strategic acquisitions and operational excellence across multiple sectors. Through its Oxygen Mortgage division, Hospitality Development Group subsidiary, and an expanding portfolio of commercial real estate, mining, and technology holdings, IDGR is committed to creating sustainable shareholder value through disciplined capital deployment and operational execution. Headquartered in Anderson, South Carolina, IDGR pursues opportunities that deliver immediate financial leverage and long-term growth potential. For more information, visit idealgroupcorp.com. Investor & Media Contacts Ideal Group of Companies, Inc. Charles Cardona, CEO ccardona@idealgroupcorp.com +1-864-345-8698 Hospitality Development Group, Inc. Jerrold R. Krystoff, Chairman & CEO info@hdgusa.com Forward-Looking Statements Certain statements contained herein are "forward-looking" statements as defined in the Private Securities Litigation Reform Act of 1995. Such statements include risks and uncertainties and actual results may differ materially from those expressed or implied. All statements other than statements of historical fact are forward-looking, including but not limited to the viability of the Company's business plans, the effect of acquisitions on profitability, the availability of working capital and financing, and the effectiveness and marketability of the Company's products. The Company undertakes no obligation to update forward-looking statements except as required by law. This press release does not constitute an offer to sell or the solicitation of an offer to buy any securities. View the original release on www.newmediawire.com
GRAND RAPIDS, MI - June 17, 2026 (NEWMEDIAWIRE) - Benchmark has appointed James Wesseldyk as Vice President of Communications, the company announced today, as it continues expanding its investor communications and capital formation initiatives. Wesseldyk brings a background in real estate investing, mortgage origination, and residential construction to the role, offering firsthand industry experience as Benchmark continues growing its investor base and increasing awareness around passive private real estate investment opportunities. “James brings something most communications hires don’t have, firsthand knowledge and experience in the field,” said Matthew Fox, Chief Executive Officer of Benchmark Companies. “He’s been on job sites, he’s written mortgages, he’s invested his own capital, and he understands what it takes to create value in this asset class. That perspective matters when communicating with investors.” Benchmark’s continued communications expansion comes as the company focuses on strengthening investor engagement and supporting future growth initiatives tied to passive real estate investment and capital raising activities. Benchmark is currently conducting a Regulation A+ capital raise of up to $50 million, with a minimum investment of $1,000. The Offering is currently open to both accredited and non-accredited investors. “This hire reflects where Benchmark is headed,” said Todd Harding, Chief Financial Officer of Benchmark. “We’re continuing to grow our investor relationships, and we want our communications to reflect the same rigor, clarity, and professionalism we bring to our investment strategy.” Before joining Benchmark, Wesseldyk spent several years as a loan originator, investing in real estate and building residential homes throughout the Grand Rapids area. About Benchmark Companies Benchmark is a West Michigan-based real estate investment company focused on providing qualified investors access to professionally managed real estate opportunities. The company specializes in real estate investment strategies designed to create long-term value and current income through disciplined acquisition, development, and asset management. Media Contact: James Wesseldyk Vice President of Communications Benchmark Companies james@benchmarkmi.com View the original release on www.newmediawire.com
Two Days of Presentations Across Biotechnology, Diagnostics, Medical Devices, and Digital Health Direct Access to Management Teams Through Live Presentations, Real-Time Q&A, and One-on-One Meetings NEW YORK, NY - June 17, 2026 (NEWMEDIAWIRE) - B2i Digital, Inc. invites investors to the Life Sciences Virtual Investor Forum, a B2i Digital Featured Conference, taking place over two days on June 24 and 25, 2026, and co-hosted by Virtual Investor Conferences and Zacks Small-Cap Research. B2i Digital, as the Official Marketing Partner, brings the forum into its ecosystem, anchored by a powerful distribution and media engine that drives qualified investors to the presentations and the one-on-one meetings that follow. Before, during, and after the two days, B2i amplifies the event across its platform, putting these life sciences companies in front of a proprietary network of more than 1.7 million retail and institutional market participants. The same visibility engine has carried more than 115 investor conferences. From Marketing to Meetings℠. Zacks Small-Cap Research, a preferred provider in the OTC Markets Group's Research Marketplace, prepares independent company-sponsored research and related content for distribution across investor and media channels. Its team of life sciences analysts supports the forum as co-host. The two-day lineup spans clinical-stage biotechnology, rare-disease and oncology therapeutics, molecular diagnostics, medical devices, veterinary medicine, nutrition science, and AI-powered digital health. Each company has 30 minutes for a live presentation and Q&A. One-on-one meeting requests are available through the VIC site, with replays available on B2i Digital and OTC Markets YouTube channels. “Life sciences investors want efficient, direct access to management teams developing the therapies and technologies that matter and pairing that access with independent research from Zacks makes the forum more valuable on both sides. Over two days, investors can meet companies across biotech, diagnostics, devices, and digital health, and reach their own conclusions,” said David Shapiro, Chief Executive Officer of B2i Digital. To request one-on-one meetings with management: https://app.axleaccess.com/public/events/636943bb-55cb-4a39-81b5-f658175de392?token=7b91921e-7b44-4da7-be93-ea5c37a5ed76 For more details: https://b2idigital.com/vic-june-25th-life-sciences-virtual-investor-forum Presenting Companies as of June 17, 2026 (subject to change): Day One – Wednesday, June 24 9:30 AM ET: Protalix BioTherapeutics, Inc. 10:30 AM ET: MetaVia Inc. 11:30 AM ET: CytoSorbents Corporation 12:00 PM ET: PetVivo Holdings Inc. 1:00 PM ET: Jaguar Health, Inc. 1:30 PM ET: Reviva Pharmaceuticals Holdings, Inc. 3:00 PM ET: 4DMedical Ltd. Day Two – Thursday, June 25 9:30 AM ET: Prostatype Genomics AB 10:00 AM ET: Abingdon Health plc 10:30 AM ET: Innovotech, Inc. 11:00 AM ET: Lakewood-Amedex Biotherapeutics Inc. 11:00 AM ET: Nasus Pharma Ltd. 11:30 AM ET: Kelyniam Global, Inc. 12:00 PM ET: IMUNON, Inc. 12:30 PM ET: Promino Nutritional Sciences Inc. 1:00 PM ET: Envoy Medical Inc. 1:30 PM ET: Coiled Therapeutics plc 2:00 PM ET: Aspire Biopharma Holdings Inc. 2:30 PM ET: Rocket Doctor AI Inc. 3:00 PM ET: Phio Pharmaceuticals Corp. 3:30 PM ET: aTyr Pharma, Inc. 4:00 PM ET: NuFarm Ltd. For registration and company profiles, please visit: https://www.virtualinvestorconferences.com/wcc/eh/4814904/category/149532/june-24th-25th-life-sciences-virtual-investor-forum?utm_source=b2i&utm_medium=marketing&utm_campaign=0624LifeSciencesForumVIC Throughout the year, Virtual Investor Conferences feature public companies from exchanges worldwide, including NYSE, Nasdaq, TSX, TSXV, CSE, ASX, LSE, and the OTC Markets. Virtual Investor Conferences is an OTC Markets Group Inc. property. About B2i Digital, Inc. B2i Digital, Inc. partners with investor conferences, public companies, and capital markets advisors through its Featured Conference, Featured Company, and Featured Expert programs. Acting as The Capital Markets Matchmaker℠, B2i Digital connects investors and companies through digital marketing, investor conferences, and direct meetings, supported by a proprietary network of more than 1.7 million market participants and a track record as the marketing partner for over 115 investor conferences. Its mantra, From Marketing to Meetings℠, reflects this integrated approach. The firm was founded in 2021 by David Shapiro, a former Maxim Group investment banker and Chief Marketing Officer. B2i Digital Contact Information David Shapiro Chief Executive Officer B2i Digital, Inc. https://b2idigital.com 212.579.4844 Office david@b2idigital.com https://www.linkedin.com/in/davidshapironyc B2i Digital Social Media https://www.linkedin.com/company/b2i-digital https://x.com/b2idigital https://www.facebook.com/b2idigital https://www.instagram.com/b2i_digital https://www.youtube.com/@b2idigital https://www.tiktok.com/@b2idigital https://stocktwits.com/B2iDigital https://www.reddit.com/user/b2idigital/ https://www.pinterest.com/b2idigital https://www.threads.net/@davidshapironyc https://bsky.app/profile/b2idigital.bsky.social About Zacks Small-Cap Research Zacks Small-Cap Research is a preferred provider in the OTC Markets Group's Research Marketplace, preparing independent company-sponsored research and related content for distribution through a range of investor and media channels, both traditional and social. Its team of life sciences-qualified analysts develops in-depth company research aimed at building awareness among long-term investors. Zacks Small-Cap Research Contact Information Richard Hantke Zacks Small-Cap Research 312.265.9448 rhantke@zacks.com https://scr.zacks.com About Virtual Investor Conferences Virtual Investor Conferences is the proprietary investor conference series that provides an interactive forum for publicly traded companies to meet directly with investors online. VIC offers companies efficient access to a broad investor audience through live presentations, Q&A sessions, and one-on-one meetings. Investors benefit from direct access to executive management teams and the ability to view presentations live or on demand. Virtual Investor Conferences Contact Information Greg Young VP Corporate Services OTC Markets Group (212) 652-5958 greg@otcmarkets.com Disclosure & Disclaimer B2i Digital, Inc. is the Official Marketing Partner of Virtual Investor Conferences. Content related to any specific company referenced in this release was provided by that company, approved by that company, or obtained from publicly available sources. B2i Digital, Inc. has not independently verified the accuracy or completeness of such information, and no representation or warranty, express or implied, is made as to its accuracy. This content is provided for informational purposes only and does not constitute an offer to sell or a solicitation of an offer to buy any security, nor should it be relied upon as the basis for any investment decision. B2i Digital, Inc. is not a registered broker-dealer, investment adviser, or financial adviser, and nothing herein should be construed as investment, legal, tax, or accounting advice. Readers should consult their own advisers and conduct their own due diligence before making any investment decision. View the original release on www.newmediawire.com
EMMEN, SWITZERLAND - June 17, 2026 (NEWMEDIAWIRE) - Europe’s AI market is entering a phase of rapid expansion, with AI spending expected to reach USD 144 billion by 2028, according to IDC. To help channel partners capture this opportunity, ALSO has become a trusted AI marketplace for the European channel. The offering includes a curated catalog of agentic AI building blocks from an increasing number of leading vendors, combining proven AI tools, AI-ready infrastructure, AI PCs, cybersecurity, vertical AI applications, and partner enablement into a scalable recurring-revenue platform. It also includes AI solutions successfully deployed within ALSO’s own operations, allowing partners and customers to benefit from proven real-world use cases. To accelerate adoption, the company is launching its AI Elite Partner Program to equip more than 140,000 resellers across more than 30 European countries with the capabilities to turn AI demand into practical customer solutions. Building on this foundation, ALSO has already delivered more than 1,000 training sessions and trained over 30,000 participants. Full platform functionality is scheduled to go live by August 2026. As companies move from experimenting with AI to deploying AI agents that act within business processes, four questions become critical: Execution quality: how to ensure reliable outcomes and governance Cost control: how to manage usage and compute economics Data access: which data agents can access and under what policies Deployment model: where AI workloads should run – locally or in the cloud ALSO’s approach is designed to help partners answer these questions and enable tailored solutions for individual customer requirements. Sensitive and routine tasks can run locally on the customer’s own device or infrastructure, while tasks requiring external AI can be routed to the cloud. This helps customers protect confidential data, manage cost, and deploy AI agents with the appropriate balance of performance, security, and control. Jan Bogdanovich, Chief Technology Officer of ALSO Holding AG (SIX: ALSN): "Major technology shifts need competent partners who enable adoption – that has always been the channel's job, and it is no different with agentic AI. The companies that will benefit most from AI won't be the ones with the most agents, but the ones who learn and adapt to new technology fastest without losing control. Our AI Elite Partner Program gives our resellers the expertise, tools, and ecosystem they need to turn AI opportunities into real customer outcomes." Contact ALSO Holding AG Kilian Maier Email: kilian.maier@also.com ALSO Holding AG (ALSN.SW) (Emmen/Switzerland) is Europe’s largest technology provider for the ICT industry, currently active in 31 European countries and in many countries worldwide via PaaS partners. The ALSO ecosystem comprises a total potential of more than 140,000 resellers, to whom we offer hardware, software and IT services from more than 800 vendors in over 1,680 product categories. In the spirit of the circular economy, the company provides all services from provision to remanufacturing from a single source. The business activities comprise the areas of Supply, Solutions and Service. Supply stands for the transactional provisioning of hardware and software. Solutions supports customers in the development of customised IT solutions. Subscription-based cloud offerings as well as digital platforms for IoT, cybersecurity, virtualisation and AI are at the heart of the Service division. The main shareholder is the Droege Group, Dusseldorf, Germany. Further information can be found at https://also.com. The Droege Group (founded in 1988) is an independent investment and consulting firm under full family ownership. The company acts as a specialist for tailor-made transformation programs aiming to enhance corporate value. Droege Group combines its corporate family-run structure and capital strength into a family-equity business model. The group invests its own equity in “special opportunities” with a focus on medium-sized companies and spin-offs as well as strategically in buy & build transactions. With the guiding principle "execution - following the rules of art", the group is a pioneer in execution-oriented corporate development. Droege Group follows a focused investment strategy based on long-term oriented megatrends. Enthusiasm for quality, innovation and speed determines the company’s actions. In recent years Droege Group has successfully positioned itself in domestic and international markets and operates in 30 countries. Further information can be found at https://droege-group.com. Disclaimer This press release contains forward-looking statements which are based on current assumptions and forecasts of the ALSO management. Known and unknown risks, uncertainties, and other factors could lead to material differences between the forward-looking statements made here and the actual development, in particular the results, financial situation, and performance of our Group. The Group accepts no responsibility for updating these forward-looking statements or adapting them to future events or developments. Additional features: File: 2026-06-17 - Agentic AI - EN View the original release on www.newmediawire.com
HomeToGo Originals Highlights the Trusted Local Service of Interhome and Kraushaar, Enhanced by HomeToGo’s Marketplace Distribution and Advanced Travel Technology LUXEMBOURG - June 17, 2026 (NEWMEDIAWIRE) - HomeToGo SE (Frankfurt Stock Exchange: HTG), Europe’s leading vacation rental group, today announced the launch of HomeToGo Originals, a new umbrella brand for its property management companies, Interhome, a leading holiday home rental management specialist with Europe’s largest local service network, and Kraushaar, a leading vacation rental agency at the German Baltic Sea. HomeToGo Originals highlights homes that are largely managed directly within the HomeToGo Group in partnership with owners, ensuring the highest quality service standards and professional, hands-on care across every stay. The new co-branding makes Interhome’s and Kraushaar’s connection to HomeToGo more visible, while preserving the heritage, local expertise, trusted owner relationships, and established market presence that define both brands. Going forward, Interhome will be presented as Interhome, a HomeToGo Original, and Kraushaar as Kraushaar, a HomeToGo Original. The launch of HomeToGo Originals marks an important step in the continued growth of HomeToGo_PRO, the Group’s B2B segment offering software and service solutions for the entire travel market. Following the acquisition of Interhome in 2025, HomeToGo_PRO now represents around two-thirds (66%) of the HomeToGo Group’s total IFRS Revenues. By bringing Interhome and Kraushaar together under one umbrella brand, HomeToGo Originals further strengthens HomeToGo_PRO with a more unified market presence and reinforces the Group’s position as one of Europe’s leading direct suppliers of vacation rentals, with a strong and expanding portfolio. As HomeToGo continues to grow through its strategic buy-and-build M&A approach, future property management acquisitions will join the HomeToGo Originals brand, further advancing the Group’s directly managed vacation rental offering. Dr. Patrick Andrae, Co-Founder & CEO of HomeToGo: “HomeToGo Originals highlights a strategic advantage that sets our Group apart: combining scalable technology and Marketplace reach with high-quality, on-the-ground vacation rental services. This gives us closer access to supply, deeper owner relationships, and exemplifies the unique edge we gain from working directly with both partners and travelers within the HomeToGo Group. It further reinforces our position as Europe’s leading vacation rental group, backed by one of the largest supplies of directly connected inventory.” Jorg Herrmann, CEO of Interhome: “For more than 60 years, Interhome has stood for trust, local expertise, and exceptional service in holiday homes management. HomeToGo Originals allows us to bring that heritage more visibly into the HomeToGo Group, while preserving our identity. It is a natural next step, combining our strong local presence with HomeToGo’s technology and Marketplace reach to create greater value for owners, guests, and partners across Europe.” Merrit Kraus, Managing Director of Kraushaar: “Kraushaar’s strength has always been our close connection to our owners and the guests who return to us year after year. For us, HomeToGo Originals is about building on what makes Kraushaar trusted: personal service, regional expertise, and hands-on care, now more visibly connected to HomeToGo’s Marketplace reach and innovative technology.” HomeToGo Originals represents a powerful advantage for owners at Interhome and Kraushaar. The new umbrella brand combines professional property management and trusted local service with HomeToGo’s global Marketplace distribution and advanced technology, helping to increase visibility, occupancy, and performance. For travelers, HomeToGo Originals offers a curated selection of carefully managed properties from Interhome and Kraushaar, known for their professional service standards and high-quality support from experienced local teams from search to stay. The new co-branding is now visible across Interhome’s and Kraushaar’s websites, with refreshed logos and brand elements introducing HomeToGo Originals across key customer touchpoints. The rollout will also extend to co-branding the Interhome and Kraushaar local service offices. HomeToGo Originals does not replace Interhome or Kraushaar. It exists alongside the brands to highlight what makes them exceptional: local teams, hands-on service, and a direct human connection with owners and guests, enhanced by HomeToGo’s global Marketplace reach and advanced travel technology. Media Note: HomeToGo Originals images for editorial use can be found here. About the HomeToGo Group HomeToGo was founded in 2014 in Berlin, Germany. Today HomeToGo is Europe’s leading vacation rental group, combining its B2B Software & tech-enabled Service Solutions segment, HomeToGo_PRO, with its AI-powered B2C Marketplace. HomeToGo is the official travel partner and top sponsor of German Bundesliga football club 1. FC Union Berlin. HomeToGo_PRO offers innovative Software & tech-enabled Service Solutions for everyone who wants to be successful with vacation rentals, with a special focus on SaaS for hosts. With millions of vacation rental offers across thousands of trusted partners, HomeToGo’s AI-powered B2C Marketplace seamlessly connects travelers with the world’s largest selection of vacation rentals to find the perfect home for any trip. HomeToGo was born and built in Europe. While HomeToGo SE's registered office is located in Luxembourg, HomeToGo GmbH is headquartered in Berlin, Germany. HomeToGo operates localized apps and websites in more than 30 countries. HomeToGo SE is listed on the Frankfurt Stock Exchange under the stock ticker “HTG” (ISIN LU2290523658). For more information visit: www.hometogo.com/about About Interhome Interhome is a holiday home rental management specialist operating the largest network of local service offices in Europe. The company has a largely exclusive portfolio of over 70,000 holiday properties in more than 20 European countries. Founded in Switzerland in 1965, the company combines intelligent digital solutions with reliable personal support on site, enabling consistently high service quality and seamless processes. Interhome operates more than 120 local service offices and partner locations in Europe, delivering trusted expertise and peace of mind to homeowners. Interhome’s combination of global marketing strength and local, on-the-ground expertise enables property owners to maximize occupancy, protect property value, and generate consistent rental returns. Interhome, a HomeToGo Original, is part of the HomeToGo, Europe’s leading vacation rental group. www.interhome.group About Kraushaar Kraushaar Ferienwohnungen is one of the leading vacation rental providers on the Baltic Sea. With nine locations stretching along the Bay of Lübeck, through Holstein Switzerland, and up to the Kiel Fjord, the company manages around 1,700 holiday homes, taking care of marketing, guest services, and cleaning. For more than 50 years, Kraushaar has combined warm Nordic hospitality with the highest quality standards and personalized service. As a HomeToGo Original and part of HomeToGo, Europe's leading vacation rental group, both guests and property owners also benefit from state-of-the-art technology and international marketing expertise. More at https://www.kraushaar-ferienwohnungen.de/ HomeToGo Investor Relations Contact Carsten Fricke, CFA +49 176 768 62 397 IR@hometogo.com HomeToGo Media Contact: Isabel Nacke isabel.nacke@hometogo.com Interhome Media Contact: Olga Lundquist +41 79 418 90 65 olga.lundquist@interhome.group Kraushaar Media Contact: Jonas Upmann jonas.upmann@hometogo.com View the original release on www.newmediawire.com